<?xml version="1.0" encoding="utf-8"?>
<log>
<entry code="info" level="info">
 <message>[info] Activation of plug-in Xince and Xodel successful, version 1.0. - xodel </message>
 <ref href="xodel"/></entry>
<entry code="info" level="info">
 <message>[info] Xule version: 3.0.30043 - </message>
 <ref href=""/></entry>
<entry code="info" level="info">
 <message>[info] loaded in 2.37 secs at 2025-01-10T13:08:12 - http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml </message>
 <ref href="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml"/></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" concept-data-type="{http://www.xbrl.org/2003/instance}stringItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}AccountingStandardsUpdate201615RetrospectiveMember" concept-data-type="{http://www.xbrl.org/dtr/type/non-numeric}domainItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] AccountingStandardsUpdate201615RetrospectiveMember - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="instant" concept-balance-type="credit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="instant" concept-balance-type="credit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}AccountingStandardsUpdate201616Member" concept-data-type="{http://www.xbrl.org/dtr/type/non-numeric}domainItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] AccountingStandardsUpdate201616Member - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}AccountingStandardsUpdate201604CumulativeEffectPeriodOfAdoptionMember" concept-data-type="{http://www.xbrl.org/dtr/type/non-numeric}domainItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] AccountingStandardsUpdate201604CumulativeEffectPeriodOfAdoptionMember - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}VariableInterestEntitiesByClassificationOfEntityAxis" concept-data-type="{http://www.xbrl.org/2003/instance}stringItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://xbrl.org/2005/xbrldt}dimensionItem" severity="info" cid="2430583881168">[add_back_deprecated_concepts] VariableInterestEntitiesByClassificationOfEntityAxis - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="instant" concept-balance-type="credit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}VariableInterestEntityNonconsolidatedCarryingAmountLiabilities" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="instant" concept-balance-type="credit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] VariableInterestEntityNonconsolidatedCarryingAmountLiabilities - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}AccountingStandardsUpdate201605Member" concept-data-type="{http://www.xbrl.org/dtr/type/non-numeric}domainItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] AccountingStandardsUpdate201605Member - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}AccountingStandardsUpdate201709Member" concept-data-type="{http://www.xbrl.org/dtr/type/non-numeric}domainItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] AccountingStandardsUpdate201709Member - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}CumulativeEffectOnRetainedEarningsNetOfTax1" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="instant" concept-balance-type="credit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] CumulativeEffectOnRetainedEarningsNetOfTax1 - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}ClassificationOfVariableInterestEntityDomain" concept-data-type="{http://www.xbrl.org/dtr/type/non-numeric}domainItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] ClassificationOfVariableInterestEntityDomain - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="duration" concept-balance-type="debit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}VariableInterestEntityNonconsolidatedCarryingAmountAssets" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="instant" concept-balance-type="debit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] VariableInterestEntityNonconsolidatedCarryingAmountAssets - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}AccountingStandardsUpdate201502Member" concept-data-type="{http://www.xbrl.org/dtr/type/non-numeric}domainItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] AccountingStandardsUpdate201502Member - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}VariableInterestEntityNonconsolidatedCarryingAmountAssetsAndLiabilitiesNet" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="instant" concept-balance-type="debit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] VariableInterestEntityNonconsolidatedCarryingAmountAssetsAndLiabilitiesNet - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" concept-data-type="{http://www.xbrl.org/2003/instance}stringItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract - </message></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="956289.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 956,289 - pbsv-20200131.xml 1691</message>
 <ref href="pbsv-20200131.xml#element(/1/312)" sourceLine="1691">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="956,289"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="394278.0" fact-concept="{http://fasb.org/us-gaap/2024}TreasuryStockValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 394,278 - pbsv-20200131.xml 1617</message>
 <ref href="pbsv-20200131.xml#element(/1/238)" sourceLine="1617">
  <property name="label" value="Treasury Stock, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="TreasuryStockValue"/>
  <property name="QName" value="us-gaap:TreasuryStockValue"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="394,278"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2320.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,320 - pbsv-20200131.xml 1692</message>
 <ref href="pbsv-20200131.xml#element(/1/313)" sourceLine="1692">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,320"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1423139.0" fact-concept="{http://fasb.org/us-gaap/2024}AccountsPayableAndAccruedLiabilitiesCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,423,139 - pbsv-20200131.xml 1553</message>
 <ref href="pbsv-20200131.xml#element(/1/174)" sourceLine="1553">
  <property name="label" value="Accounts payable and accrued expenses"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccountsPayableAndAccruedLiabilitiesCurrent"/>
  <property name="QName" value="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,423,139"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21564.0" fact-concept="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,564 - pbsv-20200131.xml 1776</message>
 <ref href="pbsv-20200131.xml#element(/1/397)" sourceLine="1776">
  <property name="label" value="Stock Repurchased During Period, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockRepurchasedDuringPeriodValue"/>
  <property name="QName" value="us-gaap:StockRepurchasedDuringPeriodValue"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,564"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="62390.0" fact-concept="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 62,390 - pbsv-20200131.xml 1845</message>
 <ref href="pbsv-20200131.xml#element(/1/466)" sourceLine="1845">
  <property name="label" value="Repayments of Long-term Capital Lease Obligations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="QName" value="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="62,390"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="--10-31" fact-concept="{http://xbrl.sec.gov/dei/2024}CurrentFiscalYearEndDate" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] --10-31 - pbsv-20200131.xml 1977</message>
 <ref href="pbsv-20200131.xml#element(/1/598)" sourceLine="1977">
  <property name="label" value="Current Fiscal Year End Date"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="CurrentFiscalYearEndDate"/>
  <property name="QName" value="dei:CurrentFiscalYearEndDate"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="--10-31"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20687529.0" fact-concept="{http://fasb.org/us-gaap/2024}RetainedEarningsAccumulatedDeficit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,687,529 - pbsv-20200131.xml 1623</message>
 <ref href="pbsv-20200131.xml#element(/1/244)" sourceLine="1623">
  <property name="label" value="Retained earnings"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="RetainedEarningsAccumulatedDeficit"/>
  <property name="QName" value="us-gaap:RetainedEarningsAccumulatedDeficit"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,687,529"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-57925.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -57,925 - pbsv-20200131.xml 1693</message>
 <ref href="pbsv-20200131.xml#element(/1/314)" sourceLine="1693">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-57,925"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21564.0" fact-concept="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,564 - pbsv-20200131.xml 1779</message>
 <ref href="pbsv-20200131.xml#element(/1/400)" sourceLine="1779">
  <property name="label" value="Stock Repurchased During Period, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockRepurchasedDuringPeriodValue"/>
  <property name="QName" value="us-gaap:StockRepurchasedDuringPeriodValue"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,564"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.122" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.122 - pbsv-20200131.xml 1919</message>
 <ref href="pbsv-20200131.xml#element(/1/540)" sourceLine="1919">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_MajorCustomerDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.122"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21195939.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,195,939 - pbsv-20200131.xml 1619</message>
 <ref href="pbsv-20200131.xml#element(/1/240)" sourceLine="1619">
  <property name="label" value="Stockholders' Equity before Treasury Stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquityBeforeTreasuryStock"/>
  <property name="QName" value="us-gaap:StockholdersEquityBeforeTreasuryStock"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,195,939"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="396032.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 396,032 - pbsv-20200131.xml 1694</message>
 <ref href="pbsv-20200131.xml#element(/1/315)" sourceLine="1694">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="396,032"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1846</message>
 <ref href="pbsv-20200131.xml#element(/1/467)" sourceLine="1846">
  <property name="label" value="Payments for Repurchase of Common Stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsForRepurchaseOfCommonStock"/>
  <property name="QName" value="us-gaap:PaymentsForRepurchaseOfCommonStock"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="65755.0" fact-concept="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 65,755 - pbsv-20200131.xml 1778</message>
 <ref href="pbsv-20200131.xml#element(/1/399)" sourceLine="1778">
  <property name="label" value="Stock Repurchased During Period, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockRepurchasedDuringPeriodValue"/>
  <property name="QName" value="us-gaap:StockRepurchasedDuringPeriodValue"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="65,755"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="87319.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 87,319 - pbsv-20200131.xml 1849</message>
 <ref href="pbsv-20200131.xml#element(/1/470)" sourceLine="1849">
  <property name="label" value="Payments for Repurchase of Common Stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsForRepurchaseOfCommonStock"/>
  <property name="QName" value="us-gaap:PaymentsForRepurchaseOfCommonStock"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="87,319"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="156496.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 156,496 - pbsv-20200131.xml 1555</message>
 <ref href="pbsv-20200131.xml#element(/1/176)" sourceLine="1555">
  <property name="label" value="Current operating lease liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingLeaseLiabilityCurrent"/>
  <property name="QName" value="us-gaap:OperatingLeaseLiabilityCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="156,496"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="81407.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxExpenseBenefit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 81,407 - pbsv-20200131.xml 1695</message>
 <ref href="pbsv-20200131.xml#element(/1/316)" sourceLine="1695">
  <property name="label" value="INCOME TAX EXPENSE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxExpenseBenefit"/>
  <property name="QName" value="us-gaap:IncomeTaxExpenseBenefit"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="81,407"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="10-Q" fact-concept="{http://xbrl.sec.gov/dei/2024}DocumentType" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 10-Q - pbsv-20200131.xml 1974</message>
 <ref href="pbsv-20200131.xml#element(/1/595)" sourceLine="1974">
  <property name="label" value="Document Type"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="DocumentType"/>
  <property name="QName" value="dei:DocumentType"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="10-Q"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.076" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.076 - pbsv-20200131.xml 1920</message>
 <ref href="pbsv-20200131.xml#element(/1/541)" sourceLine="1920">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_MajorCustomerEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.076"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1699.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,699 - pbsv-20200131.xml 1848</message>
 <ref href="pbsv-20200131.xml#element(/1/469)" sourceLine="1848">
  <property name="label" value="Payments for Repurchase of Common Stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsForRepurchaseOfCommonStock"/>
  <property name="QName" value="us-gaap:PaymentsForRepurchaseOfCommonStock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,699"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="65755.0" fact-concept="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 65,755 - pbsv-20200131.xml 1777</message>
 <ref href="pbsv-20200131.xml#element(/1/398)" sourceLine="1777">
  <property name="label" value="Stock Repurchased During Period, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockRepurchasedDuringPeriodValue"/>
  <property name="QName" value="us-gaap:StockRepurchasedDuringPeriodValue"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="65,755"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="392579.0" fact-concept="{http://fasb.org/us-gaap/2024}TreasuryStockValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 392,579 - pbsv-20200131.xml 1618</message>
 <ref href="pbsv-20200131.xml#element(/1/239)" sourceLine="1618">
  <property name="label" value="Treasury Stock, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="TreasuryStockValue"/>
  <property name="QName" value="us-gaap:TreasuryStockValue"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="392,579"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="118213.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxExpenseBenefit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 118,213 - pbsv-20200131.xml 1698</message>
 <ref href="pbsv-20200131.xml#element(/1/319)" sourceLine="1698">
  <property name="label" value="INCOME TAX EXPENSE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxExpenseBenefit"/>
  <property name="QName" value="us-gaap:IncomeTaxExpenseBenefit"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="118,213"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2020-04-30T00:00:00" fact-concept="{http://xbrl.sec.gov/dei/2024}DocumentPeriodEndDate" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2020-04-30 - pbsv-20200131.xml 1975</message>
 <ref href="pbsv-20200131.xml#element(/1/596)" sourceLine="1975">
  <property name="label" value="Document Period End Date"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="DocumentPeriodEndDate"/>
  <property name="QName" value="dei:DocumentPeriodEndDate"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2020-04-30"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.266" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.266 - pbsv-20200131.xml 1921</message>
 <ref href="pbsv-20200131.xml#element(/1/542)" sourceLine="1921">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_MajorCustomerEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.266"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1631</message>
 <ref href="pbsv-20200131.xml#element(/1/252)" sourceLine="1631">
  <property name="label" value="Preferred stock, outstanding"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockSharesOutstanding"/>
  <property name="QName" value="us-gaap:PreferredStockSharesOutstanding"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1590172.0" fact-concept="{http://fasb.org/us-gaap/2024}AccountsPayableAndAccruedLiabilitiesCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,590,172 - pbsv-20200131.xml 1554</message>
 <ref href="pbsv-20200131.xml#element(/1/175)" sourceLine="1554">
  <property name="label" value="Accounts payable and accrued expenses"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccountsPayableAndAccruedLiabilitiesCurrent"/>
  <property name="QName" value="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,590,172"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21564.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,564 - pbsv-20200131.xml 1847</message>
 <ref href="pbsv-20200131.xml#element(/1/468)" sourceLine="1847">
  <property name="label" value="Payments for Repurchase of Common Stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsForRepurchaseOfCommonStock"/>
  <property name="QName" value="us-gaap:PaymentsForRepurchaseOfCommonStock"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,564"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="11331.0" fact-concept="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 11,331 - pbsv-20200131.xml 1559</message>
 <ref href="pbsv-20200131.xml#element(/1/180)" sourceLine="1559">
  <property name="label" value="Current portion-obligations under finance leases"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CapitalLeaseObligationsCurrent"/>
  <property name="QName" value="us-gaap:CapitalLeaseObligationsCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="11,331"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="136702.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxExpenseBenefit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 136,702 - pbsv-20200131.xml 1697</message>
 <ref href="pbsv-20200131.xml#element(/1/318)" sourceLine="1697">
  <property name="label" value="INCOME TAX EXPENSE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxExpenseBenefit"/>
  <property name="QName" value="us-gaap:IncomeTaxExpenseBenefit"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="136,702"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1699.0" fact-concept="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,699 - pbsv-20200131.xml 1780</message>
 <ref href="pbsv-20200131.xml#element(/1/401)" sourceLine="1780">
  <property name="label" value="Stock Repurchased During Period, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockRepurchasedDuringPeriodValue"/>
  <property name="QName" value="us-gaap:StockRepurchasedDuringPeriodValue"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,699"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="102133.0" fact-concept="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeLossNetOfTax" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 102,133 - pbsv-20200131.xml 1621</message>
 <ref href="pbsv-20200131.xml#element(/1/242)" sourceLine="1621">
  <property name="label" value="Accumulated other comprehensive loss"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
  <property name="QName" value="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="102,133"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="327245.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 327,245 - pbsv-20200131.xml 1850</message>
 <ref href="pbsv-20200131.xml#element(/1/471)" sourceLine="1850">
  <property name="label" value="Cash and Cash Equivalents, Period Increase (Decrease)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="327,245"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="False" fact-concept="{http://xbrl.sec.gov/dei/2024}AmendmentFlag" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] False - pbsv-20200131.xml 1976</message>
 <ref href="pbsv-20200131.xml#element(/1/597)" sourceLine="1976">
  <property name="label" value="Amendment Flag"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="AmendmentFlag"/>
  <property name="QName" value="dei:AmendmentFlag"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="false"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.249" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.249 - pbsv-20200131.xml 1922</message>
 <ref href="pbsv-20200131.xml#element(/1/543)" sourceLine="1922">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_GlobalGroupAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.249"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21000085.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,000,085 - pbsv-20200131.xml 1620</message>
 <ref href="pbsv-20200131.xml#element(/1/241)" sourceLine="1620">
  <property name="label" value="Stockholders' Equity before Treasury Stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquityBeforeTreasuryStock"/>
  <property name="QName" value="us-gaap:StockholdersEquityBeforeTreasuryStock"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,000,085"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="643900.0" fact-concept="{http://fasb.org/us-gaap/2024}LoansPayableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 643,900 - pbsv-20200131.xml 1557</message>
 <ref href="pbsv-20200131.xml#element(/1/178)" sourceLine="1557">
  <property name="label" value="Loans short term portion"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LoansPayableCurrent"/>
  <property name="QName" value="us-gaap:LoansPayableCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="643,900"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="75258.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxExpenseBenefit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 75,258 - pbsv-20200131.xml 1696</message>
 <ref href="pbsv-20200131.xml#element(/1/317)" sourceLine="1696">
  <property name="label" value="INCOME TAX EXPENSE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxExpenseBenefit"/>
  <property name="QName" value="us-gaap:IncomeTaxExpenseBenefit"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="75,258"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1699.0" fact-concept="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,699 - pbsv-20200131.xml 1781</message>
 <ref href="pbsv-20200131.xml#element(/1/402)" sourceLine="1781">
  <property name="label" value="Stock Repurchased During Period, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockRepurchasedDuringPeriodValue"/>
  <property name="QName" value="us-gaap:StockRepurchasedDuringPeriodValue"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,699"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-29461.0" fact-concept="{http://fasb.org/us-gaap/2024}EffectOfExchangeRateOnCashAndCashEquivalents" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -29,461 - pbsv-20200131.xml 1854</message>
 <ref href="pbsv-20200131.xml#element(/1/475)" sourceLine="1854">
  <property name="label" value="EFFECT OF EXCHANGE RATE CHANGES ON CASH"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="QName" value="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-29,461"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="687561.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 687,561 - pbsv-20200131.xml 1699</message>
 <ref href="pbsv-20200131.xml#element(/1/320)" sourceLine="1699">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="687,561"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1556</message>
 <ref href="pbsv-20200131.xml#element(/1/177)" sourceLine="1556">
  <property name="label" value="Current operating lease liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingLeaseLiabilityCurrent"/>
  <property name="QName" value="us-gaap:OperatingLeaseLiabilityCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-596809.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -596,809 - pbsv-20200131.xml 1853</message>
 <ref href="pbsv-20200131.xml#element(/1/474)" sourceLine="1853">
  <property name="label" value="Cash and Cash Equivalents, Period Increase (Decrease)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-596,809"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="False" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityEmergingGrowthCompany" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] False - pbsv-20200131.xml 1980</message>
 <ref href="pbsv-20200131.xml#element(/1/601)" sourceLine="1980">
  <property name="label" value="Entity Emerging Growth Company"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityEmergingGrowthCompany"/>
  <property name="QName" value="dei:EntityEmergingGrowthCompany"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="false"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.119" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.119 - pbsv-20200131.xml 1923</message>
 <ref href="pbsv-20200131.xml#element(/1/544)" sourceLine="1923">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_GlobalGroupBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.119"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}StockRepurchaseDuringPeriodShares" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1782</message>
 <ref href="pbsv-20200131.xml#element(/1/403)" sourceLine="1782">
  <property name="label" value="Purchase of treasury stocks"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockRepurchaseDuringPeriodShares"/>
  <property name="QName" value="PBSV:StockRepurchaseDuringPeriodShares"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1178503.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,178,503 - pbsv-20200131.xml 1703</message>
 <ref href="pbsv-20200131.xml#element(/1/324)" sourceLine="1703">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,178,503"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="91823.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 91,823 - pbsv-20200131.xml 1852</message>
 <ref href="pbsv-20200131.xml#element(/1/473)" sourceLine="1852">
  <property name="label" value="Cash and Cash Equivalents, Period Increase (Decrease)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="91,823"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-1556707.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -1,556,707 - pbsv-20200131.xml 1786</message>
 <ref href="pbsv-20200131.xml#element(/1/407)" sourceLine="1786">
  <property name="label" value="Net Cash Provided by (Used in) Operating Activities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInOperatingActivities"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInOperatingActivities"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-1,556,707"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="Yes" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityCurrentReportingStatus" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] Yes - pbsv-20200131.xml 1978</message>
 <ref href="pbsv-20200131.xml#element(/1/599)" sourceLine="1978">
  <property name="label" value="Is Entity's Reporting Status Current?"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityCurrentReportingStatus"/>
  <property name="QName" value="dei:EntityCurrentReportingStatus"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="Yes"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1214461.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,214,461 - pbsv-20200131.xml 1702</message>
 <ref href="pbsv-20200131.xml#element(/1/323)" sourceLine="1702">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,214,461"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2300.0" fact-concept="{http://pharmabioserv.com/20241231}StockRepurchaseDuringPeriodShares" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,300 - pbsv-20200131.xml 1785</message>
 <ref href="pbsv-20200131.xml#element(/1/406)" sourceLine="1785">
  <property name="label" value="Purchase of treasury stocks"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockRepurchaseDuringPeriodShares"/>
  <property name="QName" value="PBSV:StockRepurchaseDuringPeriodShares"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,300"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.146" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.146 - pbsv-20200131.xml 1924</message>
 <ref href="pbsv-20200131.xml#element(/1/545)" sourceLine="1924">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_GlobalGroupCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.146"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="143600.0" fact-concept="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeLossNetOfTax" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 143,600 - pbsv-20200131.xml 1622</message>
 <ref href="pbsv-20200131.xml#element(/1/243)" sourceLine="1622">
  <property name="label" value="Accumulated other comprehensive loss"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
  <property name="QName" value="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="143,600"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-365415.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -365,415 - pbsv-20200131.xml 1851</message>
 <ref href="pbsv-20200131.xml#element(/1/472)" sourceLine="1851">
  <property name="label" value="Cash and Cash Equivalents, Period Increase (Decrease)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-365,415"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}LoansPayableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1558</message>
 <ref href="pbsv-20200131.xml#element(/1/179)" sourceLine="1558">
  <property name="label" value="Loans short term portion"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LoansPayableCurrent"/>
  <property name="QName" value="us-gaap:LoansPayableCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="687561.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 687,561 - pbsv-20200131.xml 1701</message>
 <ref href="pbsv-20200131.xml#element(/1/322)" sourceLine="1701">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="687,561"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="Non-accelerated Filer" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityFilerCategory" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] Non-accelerated Filer - pbsv-20200131.xml 1979</message>
 <ref href="pbsv-20200131.xml#element(/1/600)" sourceLine="1979">
  <property name="label" value="Entity Filer Category"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityFilerCategory"/>
  <property name="QName" value="dei:EntityFilerCategory"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="Non-accelerated Filer"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21357422.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,357,422 - pbsv-20200131.xml 1578</message>
 <ref href="pbsv-20200131.xml#element(/1/199)" sourceLine="1578">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,357,422"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1403936.0" fact-concept="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,403,936 - pbsv-20200131.xml 1625</message>
 <ref href="pbsv-20200131.xml#element(/1/246)" sourceLine="1625">
  <property name="label" value="Additional paid-in capital"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AdditionalPaidInCapitalCommonStock"/>
  <property name="QName" value="us-gaap:AdditionalPaidInCapitalCommonStock"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,403,936"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.118" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.118 - pbsv-20200131.xml 1925</message>
 <ref href="pbsv-20200131.xml#element(/1/546)" sourceLine="1925">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_GlobalGroupDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.118"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="65772.0" fact-concept="{http://pharmabioserv.com/20241231}StockRepurchaseDuringPeriodShares" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 65,772 - pbsv-20200131.xml 1784</message>
 <ref href="pbsv-20200131.xml#element(/1/405)" sourceLine="1784">
  <property name="label" value="Purchase of treasury stocks"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockRepurchaseDuringPeriodShares"/>
  <property name="QName" value="PBSV:StockRepurchaseDuringPeriodShares"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="65,772"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="988.0" fact-concept="{http://fasb.org/us-gaap/2024}InterestPaidNet" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 988 - pbsv-20200131.xml 1858</message>
 <ref href="pbsv-20200131.xml#element(/1/479)" sourceLine="1858">
  <property name="label" value="Cash paid during the period for: Interest"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="InterestPaidNet"/>
  <property name="QName" value="us-gaap:InterestPaidNet"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="988"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="707483.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 707,483 - pbsv-20200131.xml 1700</message>
 <ref href="pbsv-20200131.xml#element(/1/321)" sourceLine="1700">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="707,483"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="True" fact-concept="{http://xbrl.sec.gov/dei/2024}EntitySmallBusiness" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] True - pbsv-20200131.xml 1981</message>
 <ref href="pbsv-20200131.xml#element(/1/602)" sourceLine="1981">
  <property name="label" value="Entity Small Business"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntitySmallBusiness"/>
  <property name="QName" value="dei:EntitySmallBusiness"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="true"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-11140.0" fact-concept="{http://fasb.org/us-gaap/2024}EffectOfExchangeRateOnCashAndCashEquivalents" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -11,140 - pbsv-20200131.xml 1857</message>
 <ref href="pbsv-20200131.xml#element(/1/478)" sourceLine="1857">
  <property name="label" value="EFFECT OF EXCHANGE RATE CHANGES ON CASH"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="QName" value="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-11,140"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="6834262.0" fact-concept="{http://fasb.org/us-gaap/2024}Liabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 6,834,262 - pbsv-20200131.xml 1561</message>
 <ref href="pbsv-20200131.xml#element(/1/182)" sourceLine="1561">
  <property name="label" value="Liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Liabilities"/>
  <property name="QName" value="us-gaap:Liabilities"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="6,834,262"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="19473069.0" fact-concept="{http://fasb.org/us-gaap/2024}RetainedEarningsAccumulatedDeficit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 19,473,069 - pbsv-20200131.xml 1624</message>
 <ref href="pbsv-20200131.xml#element(/1/245)" sourceLine="1624">
  <property name="label" value="Retained earnings"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="RetainedEarningsAccumulatedDeficit"/>
  <property name="QName" value="us-gaap:RetainedEarningsAccumulatedDeficit"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="19,473,069"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="471020.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 471,020 - pbsv-20200131.xml 1704</message>
 <ref href="pbsv-20200131.xml#element(/1/325)" sourceLine="1704">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="471,020"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.076" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.076 - pbsv-20200131.xml 1926</message>
 <ref href="pbsv-20200131.xml#element(/1/547)" sourceLine="1926">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_GlobalGroupEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.076"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="11030.0" fact-concept="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 11,030 - pbsv-20200131.xml 1560</message>
 <ref href="pbsv-20200131.xml#element(/1/181)" sourceLine="1560">
  <property name="label" value="Current portion-obligations under finance leases"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CapitalLeaseObligationsCurrent"/>
  <property name="QName" value="us-gaap:CapitalLeaseObligationsCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="11,030"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20050.0" fact-concept="{http://pharmabioserv.com/20241231}StockRepurchaseDuringPeriodShares" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,050 - pbsv-20200131.xml 1783</message>
 <ref href="pbsv-20200131.xml#element(/1/404)" sourceLine="1783">
  <property name="label" value="Purchase of treasury stocks"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockRepurchaseDuringPeriodShares"/>
  <property name="QName" value="PBSV:StockRepurchaseDuringPeriodShares"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,050"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-38880.0" fact-concept="{http://fasb.org/us-gaap/2024}EffectOfExchangeRateOnCashAndCashEquivalents" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -38,880 - pbsv-20200131.xml 1856</message>
 <ref href="pbsv-20200131.xml#element(/1/477)" sourceLine="1856">
  <property name="label" value="EFFECT OF EXCHANGE RATE CHANGES ON CASH"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="QName" value="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-38,880"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="Yes" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityInteractiveDataCurrent" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] Yes - pbsv-20200131.xml 1985</message>
 <ref href="pbsv-20200131.xml#element(/1/606)" sourceLine="1985">
  <property name="label" value="Entity Interactive Data Current"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityInteractiveDataCurrent"/>
  <property name="QName" value="dei:EntityInteractiveDataCurrent"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="Yes"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="471020.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 471,020 - pbsv-20200131.xml 1705</message>
 <ref href="pbsv-20200131.xml#element(/1/326)" sourceLine="1705">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="471,020"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2341.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,341 - pbsv-20200131.xml 1627</message>
 <ref href="pbsv-20200131.xml#element(/1/248)" sourceLine="1627">
  <property name="label" value="Common Stock, $0.0001 par value; authorized 50,000,000 shares; 23,405,753 and 23,397,707 shares issued, and 23,001,627 and 22,995,881 shares outstanding at April 30, 2020 and October 31, 2019, respectively"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockValue"/>
  <property name="QName" value="us-gaap:CommonStockValue"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,341"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1381076.0" fact-concept="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,381,076 - pbsv-20200131.xml 1626</message>
 <ref href="pbsv-20200131.xml#element(/1/247)" sourceLine="1626">
  <property name="label" value="Additional paid-in capital"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AdditionalPaidInCapitalCommonStock"/>
  <property name="QName" value="us-gaap:AdditionalPaidInCapitalCommonStock"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,381,076"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="707483.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 707,483 - pbsv-20200131.xml 1706</message>
 <ref href="pbsv-20200131.xml#element(/1/327)" sourceLine="1706">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="707,483"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-25218.0" fact-concept="{http://fasb.org/us-gaap/2024}EffectOfExchangeRateOnCashAndCashEquivalents" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -25,218 - pbsv-20200131.xml 1855</message>
 <ref href="pbsv-20200131.xml#element(/1/476)" sourceLine="1855">
  <property name="label" value="EFFECT OF EXCHANGE RATE CHANGES ON CASH"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="QName" value="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-25,218"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.708" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.708 - pbsv-20200131.xml 1927</message>
 <ref href="pbsv-20200131.xml#element(/1/548)" sourceLine="1927">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_GlobalGroupTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.708"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="17950.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherLiabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 17,950 - pbsv-20200131.xml 1563</message>
 <ref href="pbsv-20200131.xml#element(/1/184)" sourceLine="1563">
  <property name="label" value="Other liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherLiabilities"/>
  <property name="QName" value="us-gaap:OtherLiabilities"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="17,950"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="526900.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 526,900 - pbsv-20200131.xml 1707</message>
 <ref href="pbsv-20200131.xml#element(/1/328)" sourceLine="1707">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="526,900"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-1040629.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -1,040,629 - pbsv-20200131.xml 1789</message>
 <ref href="pbsv-20200131.xml#element(/1/410)" sourceLine="1789">
  <property name="label" value="Net Cash Provided by (Used in) Operating Activities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInOperatingActivities"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInOperatingActivities"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-1,040,629"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="211763.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxesPaid" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 211,763 - pbsv-20200131.xml 1862</message>
 <ref href="pbsv-20200131.xml#element(/1/483)" sourceLine="1862">
  <property name="label" value="Cash paid during the period for: Income taxes"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxesPaid"/>
  <property name="QName" value="us-gaap:IncomeTaxesPaid"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="211,763"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="False" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityShellCompany" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] False - pbsv-20200131.xml 1982</message>
 <ref href="pbsv-20200131.xml#element(/1/603)" sourceLine="1982">
  <property name="label" value="Entity Shell Company"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityShellCompany"/>
  <property name="QName" value="dei:EntityShellCompany"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="false"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="526900.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 526,900 - pbsv-20200131.xml 1708</message>
 <ref href="pbsv-20200131.xml#element(/1/329)" sourceLine="1708">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="526,900"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-41688.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -41,688 - pbsv-20200131.xml 1788</message>
 <ref href="pbsv-20200131.xml#element(/1/409)" sourceLine="1788">
  <property name="label" value="Net Cash Provided by (Used in) Operating Activities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInOperatingActivities"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInOperatingActivities"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-41,688"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1904.0" fact-concept="{http://fasb.org/us-gaap/2024}InterestPaidNet" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,904 - pbsv-20200131.xml 1861</message>
 <ref href="pbsv-20200131.xml#element(/1/482)" sourceLine="1861">
  <property name="label" value="Cash paid during the period for: Interest"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="InterestPaidNet"/>
  <property name="QName" value="us-gaap:InterestPaidNet"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,904"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1928</message>
 <ref href="pbsv-20200131.xml#element(/1/549)" sourceLine="1928">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_GlobalGroupAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.00"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1629</message>
 <ref href="pbsv-20200131.xml#element(/1/250)" sourceLine="1629">
  <property name="label" value="Preferred Stock, $0.0001 par value; authorized 10,000,000 shares; none outstanding"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockValue"/>
  <property name="QName" value="us-gaap:PreferredStockValue"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="6025569.0" fact-concept="{http://fasb.org/us-gaap/2024}Liabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 6,025,569 - pbsv-20200131.xml 1562</message>
 <ref href="pbsv-20200131.xml#element(/1/183)" sourceLine="1562">
  <property name="label" value="Liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Liabilities"/>
  <property name="QName" value="us-gaap:Liabilities"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="6,025,569"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.03" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.03 - pbsv-20200131.xml 1709</message>
 <ref href="pbsv-20200131.xml#element(/1/330)" sourceLine="1709">
  <property name="label" value="BASIC AND DILUTED EARNINGS PER COMMON SHARE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.030"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2004.0" fact-concept="{http://fasb.org/us-gaap/2024}InterestPaidNet" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,004 - pbsv-20200131.xml 1860</message>
 <ref href="pbsv-20200131.xml#element(/1/481)" sourceLine="1860">
  <property name="label" value="Cash paid during the period for: Interest"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="InterestPaidNet"/>
  <property name="QName" value="us-gaap:InterestPaidNet"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,004"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="Q2" fact-concept="{http://xbrl.sec.gov/dei/2024}DocumentFiscalPeriodFocus" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] Q2 - pbsv-20200131.xml 1983</message>
 <ref href="pbsv-20200131.xml#element(/1/604)" sourceLine="1983">
  <property name="label" value="Document Fiscal Period Focus"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="DocumentFiscalPeriodFocus"/>
  <property name="QName" value="dei:DocumentFiscalPeriodFocus"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="Q2"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="696916.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityNoncurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 696,916 - pbsv-20200131.xml 1565</message>
 <ref href="pbsv-20200131.xml#element(/1/186)" sourceLine="1565">
  <property name="label" value="Long-term operating lease liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingLeaseLiabilityNoncurrent"/>
  <property name="QName" value="us-gaap:OperatingLeaseLiabilityNoncurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="696,916"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2340.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,340 - pbsv-20200131.xml 1628</message>
 <ref href="pbsv-20200131.xml#element(/1/249)" sourceLine="1628">
  <property name="label" value="Common Stock, $0.0001 par value; authorized 50,000,000 shares; 23,405,753 and 23,397,707 shares issued, and 23,001,627 and 22,995,881 shares outstanding at April 30, 2020 and October 31, 2019, respectively"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockValue"/>
  <property name="QName" value="us-gaap:CommonStockValue"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,340"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-822917.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -822,917 - pbsv-20200131.xml 1787</message>
 <ref href="pbsv-20200131.xml#element(/1/408)" sourceLine="1787">
  <property name="label" value="Net Cash Provided by (Used in) Operating Activities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInOperatingActivities"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInOperatingActivities"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-822,917"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2020" fact-concept="{http://xbrl.sec.gov/dei/2024}DocumentFiscalYearFocus" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2020 - pbsv-20200131.xml 1984</message>
 <ref href="pbsv-20200131.xml#element(/1/605)" sourceLine="1984">
  <property name="label" value="Document Fiscal Year Focus"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="DocumentFiscalYearFocus"/>
  <property name="QName" value="dei:DocumentFiscalYearFocus"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2020"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.142" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.142 - pbsv-20200131.xml 1929</message>
 <ref href="pbsv-20200131.xml#element(/1/550)" sourceLine="1929">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_GlobalGroupBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.142"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23001627.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,001,627 - pbsv-20200131.xml 1713</message>
 <ref href="pbsv-20200131.xml#element(/1/334)" sourceLine="1713">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,001,627"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1425.0" fact-concept="{http://fasb.org/us-gaap/2024}InterestPaidNet" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,425 - pbsv-20200131.xml 1859</message>
 <ref href="pbsv-20200131.xml#element(/1/480)" sourceLine="1859">
  <property name="label" value="Cash paid during the period for: Interest"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="InterestPaidNet"/>
  <property name="QName" value="us-gaap:InterestPaidNet"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,425"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0001304161" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityCentralIndexKey" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0001304161 - pbsv-20200131.xml 1973</message>
 <ref href="pbsv-20200131.xml#element(/1/594)" sourceLine="1973">
  <property name="label" value="Entity Central Index Key"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityCentralIndexKey"/>
  <property name="QName" value="dei:EntityCentralIndexKey"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0001304161"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.051" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.051 - pbsv-20200131.xml 1712</message>
 <ref href="pbsv-20200131.xml#element(/1/333)" sourceLine="1712">
  <property name="label" value="BASIC AND DILUTED EARNINGS PER COMMON SHARE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.051"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-121349.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOperatingLiabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -121,349 - pbsv-20200131.xml 1790</message>
 <ref href="pbsv-20200131.xml#element(/1/411)" sourceLine="1790">
  <property name="label" value="Increase (decrease) in liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOperatingLiabilities"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOperatingLiabilities"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-121,349"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.099" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.099 - pbsv-20200131.xml 1930</message>
 <ref href="pbsv-20200131.xml#element(/1/551)" sourceLine="1930">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_GlobalGroupCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.099"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.053" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.053 - pbsv-20200131.xml 1711</message>
 <ref href="pbsv-20200131.xml#element(/1/332)" sourceLine="1711">
  <property name="label" value="BASIC AND DILUTED EARNINGS PER COMMON SHARE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.053"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-840431.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOperatingLiabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -840,431 - pbsv-20200131.xml 1793</message>
 <ref href="pbsv-20200131.xml#element(/1/414)" sourceLine="1793">
  <property name="label" value="Increase (decrease) in liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOperatingLiabilities"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOperatingLiabilities"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-840,431"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="326898.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxesPaid" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 326,898 - pbsv-20200131.xml 1865</message>
 <ref href="pbsv-20200131.xml#element(/1/486)" sourceLine="1865">
  <property name="label" value="Cash paid during the period for: Income taxes"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxesPaid"/>
  <property name="QName" value="us-gaap:IncomeTaxesPaid"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="326,898"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="17950.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherLiabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 17,950 - pbsv-20200131.xml 1564</message>
 <ref href="pbsv-20200131.xml#element(/1/185)" sourceLine="1564">
  <property name="label" value="Other liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherLiabilities"/>
  <property name="QName" value="us-gaap:OtherLiabilities"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="17,950"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="61337.0" fact-concept="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsNoncurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 61,337 - pbsv-20200131.xml 1567</message>
 <ref href="pbsv-20200131.xml#element(/1/188)" sourceLine="1567">
  <property name="label" value="Obligations under finance lease"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CapitalLeaseObligationsNoncurrent"/>
  <property name="QName" value="us-gaap:CapitalLeaseObligationsNoncurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="61,337"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="211763.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxesPaid" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 211,763 - pbsv-20200131.xml 1864</message>
 <ref href="pbsv-20200131.xml#element(/1/485)" sourceLine="1864">
  <property name="label" value="Cash paid during the period for: Income taxes"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxesPaid"/>
  <property name="QName" value="us-gaap:IncomeTaxesPaid"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="211,763"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The accompanying condensed consolidated finan..." fact-concept="{http://fasb.org/us-gaap/2024}ConsolidationPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The accompanying condensed consolidated financialstatements include the accounts of the Company and all of its wholly owned subsidiaries. All intercompany transactions and balanceshave been eliminated in consolidation.&amp;#160;&lt;/p> - pbsv-20200131.xml 1988</message>
 <ref href="pbsv-20200131.xml#element(/1/609)" sourceLine="1988">
  <property name="label" value="Consolidation"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConsolidationPolicyTextBlock"/>
  <property name="QName" value="us-gaap:ConsolidationPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The accompanying condensed consolidated financialstatements include the accounts of the Company and all of its wholly owned subsidiaries. All intercompany transactions and balanceshave been eliminated in consolidation.&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1630</message>
 <ref href="pbsv-20200131.xml#element(/1/251)" sourceLine="1630">
  <property name="label" value="Preferred Stock, $0.0001 par value; authorized 10,000,000 shares; none outstanding"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockValue"/>
  <property name="QName" value="us-gaap:PreferredStockValue"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.031" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.031 - pbsv-20200131.xml 1710</message>
 <ref href="pbsv-20200131.xml#element(/1/331)" sourceLine="1710">
  <property name="label" value="BASIC AND DILUTED EARNINGS PER COMMON SHARE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.031"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="609610.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOperatingLiabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 609,610 - pbsv-20200131.xml 1792</message>
 <ref href="pbsv-20200131.xml#element(/1/413)" sourceLine="1792">
  <property name="label" value="Increase (decrease) in liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOperatingLiabilities"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOperatingLiabilities"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="609,610"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.122" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.122 - pbsv-20200131.xml 1931</message>
 <ref href="pbsv-20200131.xml#element(/1/552)" sourceLine="1931">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_GlobalGroupDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.122"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23001627.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,001,627 - pbsv-20200131.xml 1635</message>
 <ref href="pbsv-20200131.xml#element(/1/256)" sourceLine="1635">
  <property name="label" value="Common stock, outstanding"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockSharesOutstanding"/>
  <property name="QName" value="us-gaap:CommonStockSharesOutstanding"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,001,627"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityNoncurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1566</message>
 <ref href="pbsv-20200131.xml#element(/1/187)" sourceLine="1566">
  <property name="label" value="Long-term operating lease liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingLeaseLiabilityNoncurrent"/>
  <property name="QName" value="us-gaap:OperatingLeaseLiabilityNoncurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23029203.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,029,203 - pbsv-20200131.xml 1717</message>
 <ref href="pbsv-20200131.xml#element(/1/338)" sourceLine="1717">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,029,203"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="326898.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxesPaid" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 326,898 - pbsv-20200131.xml 1863</message>
 <ref href="pbsv-20200131.xml#element(/1/484)" sourceLine="1863">
  <property name="label" value="Cash paid during the period for: Income taxes"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxesPaid"/>
  <property name="QName" value="us-gaap:IncomeTaxesPaid"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="326,898"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="DE" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityIncorporationStateCountryCode" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] DE - pbsv-20200131.xml 1986</message>
 <ref href="pbsv-20200131.xml#element(/1/607)" sourceLine="1986">
  <property name="label" value="Entity Incorporation State Country Code"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityIncorporationStateCountryCode"/>
  <property name="QName" value="dei:EntityIncorporationStateCountryCode"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="DE"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="24995.0" fact-concept="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentDisposals" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 24,995 - pbsv-20200131.xml 1866</message>
 <ref href="pbsv-20200131.xml#element(/1/487)" sourceLine="1866">
  <property name="label" value="Disposed property and equipment with accumulated depreciation of $17,913 for the three and six months ended April 30, 2020 and $86,773 for the three and six months ended April 30, 2019"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PropertyPlantAndEquipmentDisposals"/>
  <property name="QName" value="us-gaap:PropertyPlantAndEquipmentDisposals"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="24,995"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23405753.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockSharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,405,753 - pbsv-20200131.xml 1633</message>
 <ref href="pbsv-20200131.xml#element(/1/254)" sourceLine="1633">
  <property name="label" value="Common stock, issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockSharesIssued"/>
  <property name="QName" value="us-gaap:CommonStockSharesIssued"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,405,753"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23032107.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,032,107 - pbsv-20200131.xml 1716</message>
 <ref href="pbsv-20200131.xml#element(/1/337)" sourceLine="1716">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,032,107"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-324887.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOperatingLiabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -324,887 - pbsv-20200131.xml 1791</message>
 <ref href="pbsv-20200131.xml#element(/1/412)" sourceLine="1791">
  <property name="label" value="Increase (decrease) in liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOperatingLiabilities"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOperatingLiabilities"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-324,887"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="138419.0" fact-concept="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentDisposals" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 138,419 - pbsv-20200131.xml 1869</message>
 <ref href="pbsv-20200131.xml#element(/1/490)" sourceLine="1869">
  <property name="label" value="Disposed property and equipment with accumulated depreciation of $17,913 for the three and six months ended April 30, 2020 and $86,773 for the three and six months ended April 30, 2019"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PropertyPlantAndEquipmentDisposals"/>
  <property name="QName" value="us-gaap:PropertyPlantAndEquipmentDisposals"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="138,419"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.266" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.266 - pbsv-20200131.xml 1932</message>
 <ref href="pbsv-20200131.xml#element(/1/553)" sourceLine="1932">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_GlobalGroupEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.266"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1632</message>
 <ref href="pbsv-20200131.xml#element(/1/253)" sourceLine="1632">
  <property name="label" value="Preferred stock, outstanding"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockSharesOutstanding"/>
  <property name="QName" value="us-gaap:PreferredStockSharesOutstanding"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="28635923.0" fact-concept="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 28,635,923 - pbsv-20200131.xml 1573</message>
 <ref href="pbsv-20200131.xml#element(/1/194)" sourceLine="1573">
  <property name="label" value="Liabilities and Equity"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LiabilitiesAndStockholdersEquity"/>
  <property name="QName" value="us-gaap:LiabilitiesAndStockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="28,635,923"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23002745.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,002,745 - pbsv-20200131.xml 1715</message>
 <ref href="pbsv-20200131.xml#element(/1/336)" sourceLine="1715">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,002,745"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="24995.0" fact-concept="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentDisposals" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 24,995 - pbsv-20200131.xml 1868</message>
 <ref href="pbsv-20200131.xml#element(/1/489)" sourceLine="1868">
  <property name="label" value="Disposed property and equipment with accumulated depreciation of $17,913 for the three and six months ended April 30, 2020 and $86,773 for the three and six months ended April 30, 2019"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PropertyPlantAndEquipmentDisposals"/>
  <property name="QName" value="us-gaap:PropertyPlantAndEquipmentDisposals"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="24,995"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1287800.0" fact-concept="{http://fasb.org/us-gaap/2024}LoansPayable" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,287,800 - pbsv-20200131.xml 1569</message>
 <ref href="pbsv-20200131.xml#element(/1/190)" sourceLine="1569">
  <property name="label" value="Loans-long term portion"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LoansPayable"/>
  <property name="QName" value="us-gaap:LoansPayable"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,287,800"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-111919.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -111,919 - pbsv-20200131.xml 1794</message>
 <ref href="pbsv-20200131.xml#element(/1/415)" sourceLine="1794">
  <property name="label" value="Increase (Decrease) in Other Operating Assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-111,919"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="000-50956" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityFileNumber" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 000-50956 - pbsv-20200131.xml 1987</message>
 <ref href="pbsv-20200131.xml#element(/1/608)" sourceLine="1987">
  <property name="label" value="Entity File Number"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityFileNumber"/>
  <property name="QName" value="dei:EntityFileNumber"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="000-50956"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.629" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.629 - pbsv-20200131.xml 1933</message>
 <ref href="pbsv-20200131.xml#element(/1/554)" sourceLine="1933">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_GlobalGroupTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.629"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="67079.0" fact-concept="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsNoncurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 67,079 - pbsv-20200131.xml 1568</message>
 <ref href="pbsv-20200131.xml#element(/1/189)" sourceLine="1568">
  <property name="label" value="Obligations under finance lease"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CapitalLeaseObligationsNoncurrent"/>
  <property name="QName" value="us-gaap:CapitalLeaseObligationsNoncurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="67,079"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23002903.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,002,903 - pbsv-20200131.xml 1714</message>
 <ref href="pbsv-20200131.xml#element(/1/335)" sourceLine="1714">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,002,903"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-29733.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributa..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -29,733 - pbsv-20200131.xml 1721</message>
 <ref href="pbsv-20200131.xml#element(/1/342)" sourceLine="1721">
  <property name="label" value="Foreign currency translation loss"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-29,733"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="725524.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 725,524 - pbsv-20200131.xml 1796</message>
 <ref href="pbsv-20200131.xml#element(/1/417)" sourceLine="1796">
  <property name="label" value="Increase (Decrease) in Other Operating Assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="725,524"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="138419.0" fact-concept="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentDisposals" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 138,419 - pbsv-20200131.xml 1867</message>
 <ref href="pbsv-20200131.xml#element(/1/488)" sourceLine="1867">
  <property name="label" value="Disposed property and equipment with accumulated depreciation of $17,913 for the three and six months ended April 30, 2020 and $86,773 for the three and six months ended April 30, 2019"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PropertyPlantAndEquipmentDisposals"/>
  <property name="QName" value="us-gaap:PropertyPlantAndEquipmentDisposals"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="138,419"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.213" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.213 - pbsv-20200131.xml 1934</message>
 <ref href="pbsv-20200131.xml#element(/1/555)" sourceLine="1934">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_MajorCustomerAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.213"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23105166.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,105,166 - pbsv-20200131.xml 1720</message>
 <ref href="pbsv-20200131.xml#element(/1/341)" sourceLine="1720">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,105,166"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1870</message>
 <ref href="pbsv-20200131.xml#element(/1/491)" sourceLine="1870">
  <property name="label" value="Obligations under capital lease incurred for the acquisition of a vehicle"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="QName" value="PBSV:ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Basic earnings per share of common stock isc..." fact-concept="{http://fasb.org/us-gaap/2024}EarningsPerSharePolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Basic earnings per share of common stock iscalculated by dividing net earnings by the weighted average number of shares of common stock outstanding. Diluted earnings pershare includes the dilution of common stock equivalents, which include principally shares that may be issued upon the exerciseof warrants, stock option and restricted stock unit awards.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The diluted weighted average shares of commonstock outstanding were calculated using the treasury stock method for the respective periods.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1999</message>
 <ref href="pbsv-20200131.xml#element(/1/620)" sourceLine="1999">
  <property name="label" value="Earnings Per Share of Common Stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="EarningsPerSharePolicyTextBlock"/>
  <property name="QName" value="us-gaap:EarningsPerSharePolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Basic earnings per share of common stock iscalculated by dividing net earnings by the weighted average number of shares of common stock outstanding. Diluted earnings pershare includes the dilution of common stock equivalents, which include principally shares that may be issued upon the exerciseof warrants, stock option and restricted stock unit awards.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The diluted weighted average shares of commonstock outstanding were calculated using the treasury stock method for the respective periods.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2058512.0" fact-concept="{http://fasb.org/us-gaap/2024}TaxesPayableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,058,512 - pbsv-20200131.xml 1571</message>
 <ref href="pbsv-20200131.xml#element(/1/192)" sourceLine="1571">
  <property name="label" value="US Tax Reform Transition Tax payable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="TaxesPayableCurrent"/>
  <property name="QName" value="us-gaap:TaxesPayableCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,058,512"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23397707.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockSharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,397,707 - pbsv-20200131.xml 1634</message>
 <ref href="pbsv-20200131.xml#element(/1/255)" sourceLine="1634">
  <property name="label" value="Common stock, issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockSharesIssued"/>
  <property name="QName" value="us-gaap:CommonStockSharesIssued"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,397,707"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-23593.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -23,593 - pbsv-20200131.xml 1795</message>
 <ref href="pbsv-20200131.xml#element(/1/416)" sourceLine="1795">
  <property name="label" value="Increase (Decrease) in Other Operating Assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-23,593"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23025958.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,025,958 - pbsv-20200131.xml 1719</message>
 <ref href="pbsv-20200131.xml#element(/1/340)" sourceLine="1719">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,025,958"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>For purposes of the consolidated statementso..." fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>For purposes of the consolidated statementsof cash flows, cash equivalents include investments in a money market obligations trust that is registered under the U.S. InvestmentCompany Act of 1940, as amended, and liquid investments with original maturities of three months or less.&lt;/p> - pbsv-20200131.xml 1993</message>
 <ref href="pbsv-20200131.xml#element(/1/614)" sourceLine="1993">
  <property name="label" value="Cash Equivalents"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsPolicyTextBlock"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>For purposes of the consolidated statementsof cash flows, cash equivalents include investments in a money market obligations trust that is registered under the U.S. InvestmentCompany Act of 1940, as amended, and liquid investments with original maturities of three months or less.&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounting standards have established a fair..." fact-concept="{http://fasb.org/us-gaap/2024}FairValueOfFinancialInstrumentsPolicy" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounting standards have established a fairvalue hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs whenmeasuring fair value. A financial instrument&amp;#8217;s categorization within the fair value hierarchy is based upon the lowest levelof input that is significant to the fair value measurement. Accounting standards have established three levels of inputs that maybe used to measure fair value:&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%&quot;>&lt;tr>    &lt;td style=&quot;vertical-align: top; width: 10%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;1&lt;/i>:&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom; width: 90%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Quoted prices in active markets for identical        assets and liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;vertical-align: top&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;2:&lt;/i>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Observable inputs other than Level 1 prices        such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions        (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally        from or corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: top&quot;>&lt;font style=&quot;font-size: 8pt&quot;>&lt;i>Level&amp;#160;3&lt;/i>:&lt;/font>&lt;/td>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The carrying value of the Company's financialinstruments (excluding obligations under finance leases), cash and cash equivalents, accounts receivable, accounts payable andaccrued liabilities, are considered reasonable estimates of fair value due to their liquidity or short-term nature. Managementbelieves, based on current rates, that the fair value of its obligations under finance leases approximates the carrying amount.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1991</message>
 <ref href="pbsv-20200131.xml#element(/1/612)" sourceLine="1991">
  <property name="label" value="Fair Value of Financial Instruments"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="FairValueOfFinancialInstrumentsPolicy"/>
  <property name="QName" value="us-gaap:FairValueOfFinancialInstrumentsPolicy"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounting standards have established a fairvalue hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs whenmeasuring fair value. A financial instrument&amp;#8217;s categorization within the fair value hierarchy is based upon the lowest levelof input that is significant to the fair value measurement. Accounting standards have established three levels of inputs that maybe used to measure fair value:&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%&quot;>&lt;tr>    &lt;td style=&quot;vertical-align: top; width: 10%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;1&lt;/i>:&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom; width: 90%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Quoted prices in active markets for identical        assets and liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;vertical-align: top&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;2:&lt;/i>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Observable inputs other than Level 1 prices        such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions        (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally        from or corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: top&quot;>&lt;font style=&quot;font-size: 8pt&quot;>&lt;i>Level&amp;#160;3&lt;/i>:&lt;/font>&lt;/td>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The carrying value of the Company's financialinstruments (excluding obligations under finance leases), cash and cash equivalents, accounts receivable, accounts payable andaccrued liabilities, are considered reasonable estimates of fair value due to their liquidity or short-term nature. Managementbelieves, based on current rates, that the fair value of its obligations under finance leases approximates the carrying amount.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.121" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.121 - pbsv-20200131.xml 1935</message>
 <ref href="pbsv-20200131.xml#element(/1/556)" sourceLine="1935">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_MajorCustomerBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.121"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}LoansPayable" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1570</message>
 <ref href="pbsv-20200131.xml#element(/1/191)" sourceLine="1570">
  <property name="label" value="Loans-long term portion"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LoansPayable"/>
  <property name="QName" value="us-gaap:LoansPayable"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="394991.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 394,991 - pbsv-20200131.xml 1643</message>
 <ref href="pbsv-20200131.xml#element(/1/264)" sourceLine="1643">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="394,991"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0001" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockParOrStatedValuePerShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.0001 - pbsv-20200131.xml 1516</message>
 <ref href="pbsv-20200131.xml#element(/1/137)" sourceLine="1516">
  <property name="label" value="Preferred stock, par value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockParOrStatedValuePerShare"/>
  <property name="QName" value="us-gaap:PreferredStockParOrStatedValuePerShare"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.0001"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23068923.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,068,923 - pbsv-20200131.xml 1718</message>
 <ref href="pbsv-20200131.xml#element(/1/339)" sourceLine="1718">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,068,923"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-80329.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -80,329 - pbsv-20200131.xml 1797</message>
 <ref href="pbsv-20200131.xml#element(/1/418)" sourceLine="1797">
  <property name="label" value="Increase (Decrease) in Other Operating Assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-80,329"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>The Com..." fact-concept="{http://fasb.org/us-gaap/2024}SegmentReportingPolicyPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>The Companyoperates in three reportable business segments: (i) Puerto Rico technical compliance consulting, (ii) United States technical complianceconsulting, and (iii) Europe technical compliance consulting. Accordingly, the accompanying condensed consolidated financial statementsare presented to show these three reportable segments.&lt;/font>&lt;/p> - pbsv-20200131.xml 1989</message>
 <ref href="pbsv-20200131.xml#element(/1/610)" sourceLine="1989">
  <property name="label" value="Segments"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SegmentReportingPolicyPolicyTextBlock"/>
  <property name="QName" value="us-gaap:SegmentReportingPolicyPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>The Companyoperates in three reportable business segments: (i) Puerto Rico technical compliance consulting, (ii) United States technical complianceconsulting, and (iii) Europe technical compliance consulting. Accordingly, the accompanying condensed consolidated financial statementsare presented to show these three reportable segments.&lt;/font>&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0001" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockParOrStatedValuePerShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.0001 - pbsv-20200131.xml 1520</message>
 <ref href="pbsv-20200131.xml#element(/1/141)" sourceLine="1520">
  <property name="label" value="Common stock, par value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockParOrStatedValuePerShare"/>
  <property name="QName" value="us-gaap:CommonStockParOrStatedValuePerShare"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.0001"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="368631.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherAssetsNoncurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 368,631 - pbsv-20200131.xml 1527</message>
 <ref href="pbsv-20200131.xml#element(/1/148)" sourceLine="1527">
  <property name="label" value="Other assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherAssetsNoncurrent"/>
  <property name="QName" value="us-gaap:OtherAssetsNoncurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="368,631"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="404126.0" fact-concept="{http://fasb.org/us-gaap/2024}TreasuryStockShares" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 404,126 - pbsv-20200131.xml 1637</message>
 <ref href="pbsv-20200131.xml#element(/1/258)" sourceLine="1637">
  <property name="label" value="Treasury stock, shares"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="TreasuryStockShares"/>
  <property name="QName" value="us-gaap:TreasuryStockShares"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="404,126"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedI..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1725</message>
 <ref href="pbsv-20200131.xml#element(/1/346)" sourceLine="1725">
  <property name="label" value="Available-for-sale securities other-than-temporary impairment included in net income"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="QName" value="us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="10000000.0" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockSharesAuthorized" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 10,000,000 - pbsv-20200131.xml 1518</message>
 <ref href="pbsv-20200131.xml#element(/1/139)" sourceLine="1518">
  <property name="label" value="Preferred stock, authorized"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockSharesAuthorized"/>
  <property name="QName" value="us-gaap:PreferredStockSharesAuthorized"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="10,000,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.146" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.146 - pbsv-20200131.xml 1936</message>
 <ref href="pbsv-20200131.xml#element(/1/557)" sourceLine="1936">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_MajorCustomerCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.146"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="22995881.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 22,995,881 - pbsv-20200131.xml 1636</message>
 <ref href="pbsv-20200131.xml#element(/1/257)" sourceLine="1636">
  <property name="label" value="Common stock, outstanding"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockSharesOutstanding"/>
  <property name="QName" value="us-gaap:CommonStockSharesOutstanding"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="22,995,881"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2262929.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,262,929 - pbsv-20200131.xml 1798</message>
 <ref href="pbsv-20200131.xml#element(/1/419)" sourceLine="1798">
  <property name="label" value="Increase (Decrease) in Accounts Receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInAccountsReceivable"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInAccountsReceivable"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,262,929"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1874</message>
 <ref href="pbsv-20200131.xml#element(/1/495)" sourceLine="1874">
  <property name="label" value="Conversion of cashless exercise of options to common stock"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="QName" value="PBSV:ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-10950.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributa..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -10,950 - pbsv-20200131.xml 1724</message>
 <ref href="pbsv-20200131.xml#element(/1/345)" sourceLine="1724">
  <property name="label" value="Foreign currency translation loss"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-10,950"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The preparation of condensed consolidated fin..." fact-concept="{http://fasb.org/us-gaap/2024}UseOfEstimates" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The preparation of condensed consolidated financialstatements in conformity with accounting principles generally accepted in the United States of America requires management to makeestimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilitiesat the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reportingperiods. Actual results may differ from these estimates.&lt;/p> - pbsv-20200131.xml 1990</message>
 <ref href="pbsv-20200131.xml#element(/1/611)" sourceLine="1990">
  <property name="label" value="Use of Estimates"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="UseOfEstimates"/>
  <property name="QName" value="us-gaap:UseOfEstimates"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The preparation of condensed consolidated financialstatements in conformity with accounting principles generally accepted in the United States of America requires management to makeestimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilitiesat the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reportingperiods. Actual results may differ from these estimates.&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="86000.0" fact-concept="{http://pharmabioserv.com/20241231}ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 86,000 - pbsv-20200131.xml 1873</message>
 <ref href="pbsv-20200131.xml#element(/1/494)" sourceLine="1873">
  <property name="label" value="Obligations under capital lease incurred for the acquisition of a vehicle"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="QName" value="PBSV:ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="86,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0001" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockParOrStatedValuePerShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.0001 - pbsv-20200131.xml 1517</message>
 <ref href="pbsv-20200131.xml#element(/1/138)" sourceLine="1517">
  <property name="label" value="Preferred stock, par value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockParOrStatedValuePerShare"/>
  <property name="QName" value="us-gaap:PreferredStockParOrStatedValuePerShare"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.0001"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2270000.0" fact-concept="{http://fasb.org/us-gaap/2024}TaxesPayableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,270,000 - pbsv-20200131.xml 1572</message>
 <ref href="pbsv-20200131.xml#element(/1/193)" sourceLine="1572">
  <property name="label" value="US Tax Reform Transition Tax payable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="TaxesPayableCurrent"/>
  <property name="QName" value="us-gaap:TaxesPayableCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,270,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-41467.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributa..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -41,467 - pbsv-20200131.xml 1723</message>
 <ref href="pbsv-20200131.xml#element(/1/344)" sourceLine="1723">
  <property name="label" value="Foreign currency translation loss"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-41,467"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1200788.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,200,788 - pbsv-20200131.xml 1800</message>
 <ref href="pbsv-20200131.xml#element(/1/421)" sourceLine="1800">
  <property name="label" value="Increase (Decrease) in Accounts Receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInAccountsReceivable"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInAccountsReceivable"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,200,788"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.106" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.106 - pbsv-20200131.xml 1937</message>
 <ref href="pbsv-20200131.xml#element(/1/558)" sourceLine="1937">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_MajorCustomerDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.106"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1872</message>
 <ref href="pbsv-20200131.xml#element(/1/493)" sourceLine="1872">
  <property name="label" value="Obligations under capital lease incurred for the acquisition of a vehicle"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="QName" value="PBSV:ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="5647767.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 5,647,767 - pbsv-20200131.xml 1639</message>
 <ref href="pbsv-20200131.xml#element(/1/260)" sourceLine="1639">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="5,647,767"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21801661.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,801,661 - pbsv-20200131.xml 1575</message>
 <ref href="pbsv-20200131.xml#element(/1/196)" sourceLine="1575">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,801,661"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-23267.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributa..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -23,267 - pbsv-20200131.xml 1722</message>
 <ref href="pbsv-20200131.xml#element(/1/343)" sourceLine="1722">
  <property name="label" value="Foreign currency translation loss"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-23,267"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1212558.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,212,558 - pbsv-20200131.xml 1799</message>
 <ref href="pbsv-20200131.xml#element(/1/420)" sourceLine="1799">
  <property name="label" value="Increase (Decrease) in Accounts Receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInAccountsReceivable"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInAccountsReceivable"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,212,558"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="86000.0" fact-concept="{http://pharmabioserv.com/20241231}ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 86,000 - pbsv-20200131.xml 1871</message>
 <ref href="pbsv-20200131.xml#element(/1/492)" sourceLine="1871">
  <property name="label" value="Obligations under capital lease incurred for the acquisition of a vehicle"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="QName" value="PBSV:ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="86,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="26633075.0" fact-concept="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 26,633,075 - pbsv-20200131.xml 1574</message>
 <ref href="pbsv-20200131.xml#element(/1/195)" sourceLine="1574">
  <property name="label" value="Liabilities and Equity"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LiabilitiesAndStockholdersEquity"/>
  <property name="QName" value="us-gaap:LiabilitiesAndStockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="26,633,075"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.101" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.101 - pbsv-20200131.xml 1938</message>
 <ref href="pbsv-20200131.xml#element(/1/559)" sourceLine="1938">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_MajorCustomerEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.101"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-29733.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -29,733 - pbsv-20200131.xml 1729</message>
 <ref href="pbsv-20200131.xml#element(/1/350)" sourceLine="1729">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-29,733"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="401826.0" fact-concept="{http://fasb.org/us-gaap/2024}TreasuryStockShares" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 401,826 - pbsv-20200131.xml 1638</message>
 <ref href="pbsv-20200131.xml#element(/1/259)" sourceLine="1638">
  <property name="label" value="Treasury stock, shares"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="TreasuryStockShares"/>
  <property name="QName" value="us-gaap:TreasuryStockShares"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="401,826"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>On December 22, 2017, Public Law 115-97,comm..." fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxDisclosureTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>On December 22, 2017, Public Law 115-97,commonly known as the Tax Cuts and Jobs Act of 2017 (the &amp;#8220;Tax Reform&amp;#8221;), was enacted. The Tax Reform is applicableto the Company commencing with its fiscal year 2018. The Tax Reform imposed a mandatory one-time transition tax (the&amp;#8220;Transition Tax&amp;#8221;) over foreign subsidiaries undistributed earnings and profits (&amp;#8220;E&amp;#38;Ps&amp;#8221;) earnedprior to a date set by the statute. Based on the Company&amp;#8217;s E&amp;#38;Ps, the Transition Tax is estimated to beapproximately $2.7 million. The Company elected to pay the Transition Tax liability over an eight year period starting withthe Company&amp;#8217;s fiscal year 2019. In the past, most of these E&amp;#38;Ps&amp;#8217; were not repatriated and, considered to bereinvested indefinitely in the foreign location. Therefore no US tax liability was incurred with respect to theseE&amp;#38;Ps&amp;#8217;, unless the E&amp;#38;Ps were repatriated as a dividend. After December 31, 2017, the Tax Reform establisheda 100% tax exemption on the foreign-source portion of dividends which are received attributable to E&amp;#38;Ps, with certainlimitations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In June 2011, Pharma-Bio, Pharma-PR and Pharma-Servobtained a Grant of Industrial Tax Exemption pursuant to the terms and conditions set forth in Act No. 73 of May 28, 2008 (&amp;#8220;theGrant&amp;#8221;) issued by the Puerto Rico Industrial Development Company (&amp;#8220;PRIDCO&amp;#8221;). The Grant was effective as of November1, 2009 and covers a fifteen-year period. The Grant provides relief on various Puerto Rico taxes, including income tax, with certainlimitations, for most of the activities carried on within Puerto Rico, including  services to parties locatedoutside of Puerto Rico. Industrial Development Income (&amp;#8220;IDI&amp;#8221;) covered under the Grant are subject to a fixed incometax rate of 4%. In addition, IDI earnings distributions accumulated since November 1, 2009 are totally exempt from Puerto Ricoearnings distribution tax.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Puerto Rico operations not covered in the exemptactivities of the Grant are subject to Puerto Rico income tax at a maximum tax rate of 37.5% as provided by the 1994 Puerto RicoInternal Revenue Code, as amended. The operations carried out in the United States by the Company&amp;#8217;s subsidiaries, is taxedin the United States at a maximum regular federal income tax rate of 21%.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Deferred income tax assets and liabilities arecomputed for differences between the consolidated financial statements and tax bases of assets and liabilities that will resultin taxable or deductible amounts in the future, based on enacted tax laws and rates applicable to the periods in which the differencesare expected to affect taxable income.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Pharma-Spain, Pharma-IR and Pharma-Bio/Pharma-UShave unused operating losses which result in a potential deferred tax asset. However, an allowance has been provided covering thetotal amount of such balance since it is uncertain whether the net operating losses can be used to offset future taxable incomebefore their expiration dates. Realization of future tax benefits related to a deferred tax asset is dependent on many factors,including the company&amp;#8217;s ability to generate taxable income. Accordingly, the income tax benefit will be recognized when realizationis determined to be more probable than not. These net operating losses are available to offset future taxable income through 2034for Pharma-Spain; indefinitely for Pharma-IR; until 2039 for Pharma-Bio/Pharma-US.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company files income tax returns in theUnited States (federal and various states jurisdictions), Puerto Rico, Ireland, Spain and Brazil. The 2015 (2014 for Puerto Rico)through 2018 tax years are open and may be subject to potential examination in one or more jurisdictions. Currently, the Companyhas no federal, state, Puerto Rico or foreign income tax examination.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1889</message>
 <ref href="pbsv-20200131.xml#element(/1/510)" sourceLine="1889">
  <property name="label" value="D. INCOME TAXES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxDisclosureTextBlock"/>
  <property name="QName" value="us-gaap:IncomeTaxDisclosureTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>On December 22, 2017, Public Law 115-97,commonly known as the Tax Cuts and Jobs Act of 2017 (the &amp;#8220;Tax Reform&amp;#8221;), was enacted. The Tax Reform is applicableto the Company commencing with its fiscal year 2018. The Tax Reform imposed a mandatory one-time transition tax (the&amp;#8220;Transition Tax&amp;#8221;) over foreign subsidiaries undistributed earnings and profits (&amp;#8220;E&amp;#38;Ps&amp;#8221;) earnedprior to a date set by the statute. Based on the Company&amp;#8217;s E&amp;#38;Ps, the Transition Tax is estimated to beapproximately $2.7 million. The Company elected to pay the Transition Tax liability over an eight year period starting withthe Company&amp;#8217;s fiscal year 2019. In the past, most of these E&amp;#38;Ps&amp;#8217; were not repatriated and, considered to bereinvested indefinitely in the foreign location. Therefore no US tax liability was incurred with respect to theseE&amp;#38;Ps&amp;#8217;, unless the E&amp;#38;Ps were repatriated as a dividend. After December 31, 2017, the Tax Reform establisheda 100% tax exemption on the foreign-source portion of dividends which are received attributable to E&amp;#38;Ps, with certainlimitations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In June 2011, Pharma-Bio, Pharma-PR and Pharma-Servobtained a Grant of Industrial Tax Exemption pursuant to the terms and conditions set forth in Act No. 73 of May 28, 2008 (&amp;#8220;theGrant&amp;#8221;) issued by the Puerto Rico Industrial Development Company (&amp;#8220;PRIDCO&amp;#8221;). The Grant was effective as of November1, 2009 and covers a fifteen-year period. The Grant provides relief on various Puerto Rico taxes, including income tax, with certainlimitations, for most of the activities carried on within Puerto Rico, including  services to parties locatedoutside of Puerto Rico. Industrial Development Income (&amp;#8220;IDI&amp;#8221;) covered under the Grant are subject to a fixed incometax rate of 4%. In addition, IDI earnings distributions accumulated since November 1, 2009 are totally exempt from Puerto Ricoearnings distribution tax.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Puerto Rico operations not covered in the exemptactivities of the Grant are subject to Puerto Rico income tax at a maximum tax rate of 37.5% as provided by the 1994 Puerto RicoInternal Revenue Code, as amended. The operations carried out in the United States by the Company&amp;#8217;s subsidiaries, is taxedin the United States at a maximum regular federal income tax rate of 21%.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Deferred income tax assets and liabilities arecomputed for differences between the consolidated financial statements and tax bases of assets and liabilities that will resultin taxable or deductible amounts in the future, based on enacted tax laws and rates applicable to the periods in which the differencesare expected to affect taxable income.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Pharma-Spain, Pharma-IR and Pharma-Bio/Pharma-UShave unused operating losses which result in a potential deferred tax asset. However, an allowance has been provided covering thetotal amount of such balance since it is uncertain whether the net operating losses can be used to offset future taxable incomebefore their expiration dates. Realization of future tax benefits related to a deferred tax asset is dependent on many factors,including the company&amp;#8217;s ability to generate taxable income. Accordingly, the income tax benefit will be recognized when realizationis determined to be more probable than not. These net operating losses are available to offset future taxable income through 2034for Pharma-Spain; indefinitely for Pharma-IR; until 2039 for Pharma-Bio/Pharma-US.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company files income tax returns in theUnited States (federal and various states jurisdictions), Puerto Rico, Ireland, Spain and Brazil. The 2015 (2014 for Puerto Rico)through 2018 tax years are open and may be subject to potential examination in one or more jurisdictions. Currently, the Companyhas no federal, state, Puerto Rico or foreign income tax examination.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In May 2014, the Financial Accounting Standar..." fact-concept="{http://fasb.org/us-gaap/2024}RevenueRecognitionPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In May 2014, the Financial Accounting StandardsBoard (FASB) issued a new accounting standard that amends the guidance for the recognition of revenue from contracts with customersto transfer goods and services. The FASB subsequently issued additional, clarifying standards to address issues arising from implementationof the new revenue recognition standard. The new revenue recognition standard and clarifying standards require an entity to recognizerevenue when control of promised goods or services is transferred to the customer at an amount that reflects the considerationto which the entity expects to be entitled in exchange for those goods or services. We adopted this new standard as of November1, 2018, by applying the modified-retrospective method to those contracts that were not completed as of that date. The resultsfor reporting periods beginning after November 1, 2018, are presented in accordance with the new standard, although comparativeinformation has not been restated and continues to be reported under the accounting standards and policies in effect for thoseperiods. The adoption of this new standard had an immaterial impact on our reported total revenues and operating income as comparedto what reported amounts would have been under the prior standard.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Revenue is primarily derived from: (1) timeand materials contracts (representing approximately 99% of total revenues), which is recognized by applying the proportional performancemodel, whereby revenue is recognized as performance occurs, and (2) short-term fixed-fee contracts or &amp;#34;not to exceed&amp;#34; contracts(representing approximately 1% of total revenues), which revenue is recognized similarly, except that certain milestones also haveto be reached before revenue is recognized. If the Company determines that a contract will result in a loss, the Company recognizesthe estimated loss in the period in which such determination is made.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1992</message>
 <ref href="pbsv-20200131.xml#element(/1/613)" sourceLine="1992">
  <property name="label" value="Revenue Recognition"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="RevenueRecognitionPolicyTextBlock"/>
  <property name="QName" value="us-gaap:RevenueRecognitionPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In May 2014, the Financial Accounting StandardsBoard (FASB) issued a new accounting standard that amends the guidance for the recognition of revenue from contracts with customersto transfer goods and services. The FASB subsequently issued additional, clarifying standards to address issues arising from implementationof the new revenue recognition standard. The new revenue recognition standard and clarifying standards require an entity to recognizerevenue when control of promised goods or services is transferred to the customer at an amount that reflects the considerationto which the entity expects to be entitled in exchange for those goods or services. We adopted this new standard as of November1, 2018, by applying the modified-retrospective method to those contracts that were not completed as of that date. The resultsfor reporting periods beginning after November 1, 2018, are presented in accordance with the new standard, although comparativeinformation has not been restated and continues to be reported under the accounting standards and policies in effect for thoseperiods. The adoption of this new standard had an immaterial impact on our reported total revenues and operating income as comparedto what reported amounts would have been under the prior standard.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Revenue is primarily derived from: (1) timeand materials contracts (representing approximately 99% of total revenues), which is recognized by applying the proportional performancemodel, whereby revenue is recognized as performance occurs, and (2) short-term fixed-fee contracts or &amp;#34;not to exceed&amp;#34; contracts(representing approximately 1% of total revenues), which revenue is recognized similarly, except that certain milestones also haveto be reached before revenue is recognized. If the Company determines that a contract will result in a loss, the Company recognizesthe estimated loss in the period in which such determination is made.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="10000000.0" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockSharesAuthorized" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 10,000,000 - pbsv-20200131.xml 1519</message>
 <ref href="pbsv-20200131.xml#element(/1/140)" sourceLine="1519">
  <property name="label" value="Preferred stock, authorized"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockSharesAuthorized"/>
  <property name="QName" value="us-gaap:PreferredStockSharesAuthorized"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="10,000,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-4475.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedI..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -4,475 - pbsv-20200131.xml 1728</message>
 <ref href="pbsv-20200131.xml#element(/1/349)" sourceLine="1728">
  <property name="label" value="Available-for-sale securities other-than-temporary impairment included in net income"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="QName" value="us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-4,475"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1473845.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,473,845 - pbsv-20200131.xml 1801</message>
 <ref href="pbsv-20200131.xml#element(/1/422)" sourceLine="1801">
  <property name="label" value="Increase (Decrease) in Accounts Receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInAccountsReceivable"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInAccountsReceivable"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,473,845"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1802</message>
 <ref href="pbsv-20200131.xml#element(/1/423)" sourceLine="1802">
  <property name="label" value="Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="QName" value="us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1878</message>
 <ref href="pbsv-20200131.xml#element(/1/499)" sourceLine="1878">
  <property name="label" value="Income tax withheld by clients to be used as a credit in the Company's income tax return"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="QName" value="PBSV:IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.687" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.687 - pbsv-20200131.xml 1939</message>
 <ref href="pbsv-20200131.xml#element(/1/560)" sourceLine="1939">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_MajorCustomerTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.687"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20263663.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,263,663 - pbsv-20200131.xml 1577</message>
 <ref href="pbsv-20200131.xml#element(/1/198)" sourceLine="1577">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2018-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,263,663"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="4293041.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 4,293,041 - pbsv-20200131.xml 1642</message>
 <ref href="pbsv-20200131.xml#element(/1/263)" sourceLine="1642">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="4,293,041"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedI..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1727</message>
 <ref href="pbsv-20200131.xml#element(/1/348)" sourceLine="1727">
  <property name="label" value="Available-for-sale securities other-than-temporary impairment included in net income"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="QName" value="us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3.0" fact-concept="{http://pharmabioserv.com/20241231}ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3 - pbsv-20200131.xml 1877</message>
 <ref href="pbsv-20200131.xml#element(/1/498)" sourceLine="1877">
  <property name="label" value="Conversion of cashless exercise of options to common stock"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="QName" value="PBSV:ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21132403.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,132,403 - pbsv-20200131.xml 1616</message>
 <ref href="pbsv-20200131.xml#element(/1/237)" sourceLine="1616">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,132,403"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="50000000.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockSharesAuthorized" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 50,000,000 - pbsv-20200131.xml 1522</message>
 <ref href="pbsv-20200131.xml#element(/1/143)" sourceLine="1522">
  <property name="label" value="Common stock, authorized"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockSharesAuthorized"/>
  <property name="QName" value="us-gaap:CommonStockSharesAuthorized"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="50,000,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="5116682.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 5,116,682 - pbsv-20200131.xml 1641</message>
 <ref href="pbsv-20200131.xml#element(/1/262)" sourceLine="1641">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="5,116,682"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounts receivable are recorded at their est..." fact-concept="{http://fasb.org/us-gaap/2024}ReceivablesPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounts receivable are recorded at their estimatedrealizable value. Accounts are deemed past due when payment has not been received within the stated time period. The Company'spolicy is to review individual past due amounts periodically and write off amounts for which all collection efforts are deemedto have been exhausted. Due to the nature of the Company&amp;#8217;s customers, bad debts are mainly accounted for using the directwrite-off method whereby an expense is recognized only when a specific account is determined to be uncollectible. The effect ofusing this method approximates that of the allowance method.&lt;/p> - pbsv-20200131.xml 1994</message>
 <ref href="pbsv-20200131.xml#element(/1/615)" sourceLine="1994">
  <property name="label" value="Accounts Receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ReceivablesPolicyTextBlock"/>
  <property name="QName" value="us-gaap:ReceivablesPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounts receivable are recorded at their estimatedrealizable value. Accounts are deemed past due when payment has not been received within the stated time period. The Company'spolicy is to review individual past due amounts periodically and write off amounts for which all collection efforts are deemedto have been exhausted. Due to the nature of the Company&amp;#8217;s customers, bad debts are mainly accounted for using the directwrite-off method whereby an expense is recognized only when a specific account is determined to be uncollectible. The effect ofusing this method approximates that of the allowance method.&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20607506.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,607,506 - pbsv-20200131.xml 1576</message>
 <ref href="pbsv-20200131.xml#element(/1/197)" sourceLine="1576">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,607,506"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedI..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1726</message>
 <ref href="pbsv-20200131.xml#element(/1/347)" sourceLine="1726">
  <property name="label" value="Available-for-sale securities other-than-temporary impairment included in net income"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="QName" value="us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="4475.0" fact-concept="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 4,475 - pbsv-20200131.xml 1805</message>
 <ref href="pbsv-20200131.xml#element(/1/426)" sourceLine="1805">
  <property name="label" value="Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="QName" value="us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="4,475"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1.0" fact-concept="{http://pharmabioserv.com/20241231}ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1 - pbsv-20200131.xml 1876</message>
 <ref href="pbsv-20200131.xml#element(/1/497)" sourceLine="1876">
  <property name="label" value="Conversion of cashless exercise of options to common stock"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="QName" value="PBSV:ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1940</message>
 <ref href="pbsv-20200131.xml#element(/1/561)" sourceLine="1940">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_MajorCustomerAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.00"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0001" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockParOrStatedValuePerShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.0001 - pbsv-20200131.xml 1521</message>
 <ref href="pbsv-20200131.xml#element(/1/142)" sourceLine="1521">
  <property name="label" value="Common stock, par value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockParOrStatedValuePerShare"/>
  <property name="QName" value="us-gaap:CommonStockParOrStatedValuePerShare"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.0001"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-15425.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -15,425 - pbsv-20200131.xml 1733</message>
 <ref href="pbsv-20200131.xml#element(/1/354)" sourceLine="1733">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-15,425"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1804</message>
 <ref href="pbsv-20200131.xml#element(/1/425)" sourceLine="1804">
  <property name="label" value="Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="QName" value="us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2.0" fact-concept="{http://pharmabioserv.com/20241231}ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2 - pbsv-20200131.xml 1875</message>
 <ref href="pbsv-20200131.xml#element(/1/496)" sourceLine="1875">
  <property name="label" value="Conversion of cashless exercise of options to common stock"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="QName" value="PBSV:ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2337.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,337 - pbsv-20200131.xml 1579</message>
 <ref href="pbsv-20200131.xml#element(/1/200)" sourceLine="1579">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,337"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="5150344.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 5,150,344 - pbsv-20200131.xml 1640</message>
 <ref href="pbsv-20200131.xml#element(/1/261)" sourceLine="1640">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="5,150,344"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows an asset and liability ap..." fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows an asset and liability approachmethod of accounting for income taxes. This method measures deferred income taxes by applying enacted statutory rates in effectat the balance sheet date to the differences between the tax basis of assets and liabilities and their reported amounts on thefinancial statements. The resulting deferred tax assets or liabilities are adjusted to reflect changes in tax laws as they occur.A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows guidance from the FinancialAccounting Standards Board (&amp;#8220;FASB&amp;#8221;) related to &lt;i>Accounting for Uncertainty in Income Taxes,&lt;/i> which includes atwo-step approach to recognizing, de-recognizing and measuring uncertain tax positions. As of April 30, 2020, the Company had nosignificant uncertain tax positions that would be reduced as a result of a lapse of the applicable statute of limitations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1995</message>
 <ref href="pbsv-20200131.xml#element(/1/616)" sourceLine="1995">
  <property name="label" value="Income Taxes"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxPolicyTextBlock"/>
  <property name="QName" value="us-gaap:IncomeTaxPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows an asset and liability approachmethod of accounting for income taxes. This method measures deferred income taxes by applying enacted statutory rates in effectat the balance sheet date to the differences between the tax basis of assets and liabilities and their reported amounts on thefinancial statements. The resulting deferred tax assets or liabilities are adjusted to reflect changes in tax laws as they occur.A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows guidance from the FinancialAccounting Standards Board (&amp;#8220;FASB&amp;#8221;) related to &lt;i>Accounting for Uncertainty in Income Taxes,&lt;/i> which includes atwo-step approach to recognizing, de-recognizing and measuring uncertain tax positions. As of April 30, 2020, the Company had nosignificant uncertain tax positions that would be reduced as a result of a lapse of the applicable statute of limitations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-41467.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -41,467 - pbsv-20200131.xml 1732</message>
 <ref href="pbsv-20200131.xml#element(/1/353)" sourceLine="1732">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-41,467"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.073" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.073 - pbsv-20200131.xml 1941</message>
 <ref href="pbsv-20200131.xml#element(/1/562)" sourceLine="1941">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_MajorCustomerBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.073"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="661356.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 661,356 - pbsv-20200131.xml 1644</message>
 <ref href="pbsv-20200131.xml#element(/1/265)" sourceLine="1644">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="661,356"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1803</message>
 <ref href="pbsv-20200131.xml#element(/1/424)" sourceLine="1803">
  <property name="label" value="Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="QName" value="us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="17913.0" fact-concept="{http://pharmabioserv.com/20241231}AccumulatedDepreciationOnPropertyAndEquipmentDisposed" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 17,913 - pbsv-20200131.xml 1882</message>
 <ref href="pbsv-20200131.xml#element(/1/503)" sourceLine="1882">
  <property name="label" value="Accumulated depreciation"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="QName" value="PBSV:AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="17,913"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1580</message>
 <ref href="pbsv-20200131.xml#element(/1/201)" sourceLine="1580">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-29733.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -29,733 - pbsv-20200131.xml 1731</message>
 <ref href="pbsv-20200131.xml#element(/1/352)" sourceLine="1731">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-29,733"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23001627.0" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityCommonStockSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-06-13T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,001,627 - pbsv-20200131.xml 1524</message>
 <ref href="pbsv-20200131.xml#element(/1/145)" sourceLine="1524">
  <property name="label" value="Entity Common Stock, Shares Outstanding"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityCommonStockSharesOutstanding"/>
  <property name="QName" value="dei:EntityCommonStockSharesOutstanding"/>
  <property name="contextRef" value="AsOf2020-06-12">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-06-12"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,001,627"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="133762.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 133,762 - pbsv-20200131.xml 1645</message>
 <ref href="pbsv-20200131.xml#element(/1/266)" sourceLine="1645">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="133,762"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="24000.0" fact-concept="{http://pharmabioserv.com/20241231}IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 24,000 - pbsv-20200131.xml 1881</message>
 <ref href="pbsv-20200131.xml#element(/1/502)" sourceLine="1881">
  <property name="label" value="Income tax withheld by clients to be used as a credit in the Company's income tax return"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="QName" value="PBSV:IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="24,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21579.0" fact-concept="{http://fasb.org/us-gaap/2024}DepreciationDepletionAndAmortization" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,579 - pbsv-20200131.xml 1806</message>
 <ref href="pbsv-20200131.xml#element(/1/427)" sourceLine="1806">
  <property name="label" value="Depreciation and amortization"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DepreciationDepletionAndAmortization"/>
  <property name="QName" value="us-gaap:DepreciationDepletionAndAmortization"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,579"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.105" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.105 - pbsv-20200131.xml 1942</message>
 <ref href="pbsv-20200131.xml#element(/1/563)" sourceLine="1942">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_MajorCustomerCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.105"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1346956.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,346,956 - pbsv-20200131.xml 1581</message>
 <ref href="pbsv-20200131.xml#element(/1/202)" sourceLine="1581">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,346,956"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="141500.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 141,500 - pbsv-20200131.xml 1646</message>
 <ref href="pbsv-20200131.xml#element(/1/267)" sourceLine="1646">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="141,500"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-23267.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -23,267 - pbsv-20200131.xml 1730</message>
 <ref href="pbsv-20200131.xml#element(/1/351)" sourceLine="1730">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-23,267"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="48682.0" fact-concept="{http://fasb.org/us-gaap/2024}DepreciationDepletionAndAmortization" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 48,682 - pbsv-20200131.xml 1809</message>
 <ref href="pbsv-20200131.xml#element(/1/430)" sourceLine="1809">
  <property name="label" value="Depreciation and amortization"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DepreciationDepletionAndAmortization"/>
  <property name="QName" value="us-gaap:DepreciationDepletionAndAmortization"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="48,682"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3649.0" fact-concept="{http://pharmabioserv.com/20241231}IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3,649 - pbsv-20200131.xml 1880</message>
 <ref href="pbsv-20200131.xml#element(/1/501)" sourceLine="1880">
  <property name="label" value="Income tax withheld by clients to be used as a credit in the Company's income tax return"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="QName" value="PBSV:IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3,649"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="7842.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 7,842 - pbsv-20200131.xml 1734</message>
 <ref href="pbsv-20200131.xml#element(/1/355)" sourceLine="1734">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="7,842"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Owned property and equipment are stated at co..." fact-concept="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Owned property and equipment are stated at cost.Vehicles under finance leases are stated at the lower of fair market value or net present value of the minimum lease payments atthe inception of the leases.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Depreciation of owned assets are provided for,when placed in service, in amounts sufficient to relate the cost of depreciable assets to operations over their estimated servicelives, using straight-line basis. Assets under finance leases are amortized over the lease term. While expenditures for repairsand maintenance are expensed when incurred. As of April 30, 2020 and October 31, 2019, the accumulated depreciation amounted to$481,325 and $509,275, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1996</message>
 <ref href="pbsv-20200131.xml#element(/1/617)" sourceLine="1996">
  <property name="label" value="Property and Equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PropertyPlantAndEquipmentPolicyTextBlock"/>
  <property name="QName" value="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Owned property and equipment are stated at cost.Vehicles under finance leases are stated at the lower of fair market value or net present value of the minimum lease payments atthe inception of the leases.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Depreciation of owned assets are provided for,when placed in service, in amounts sufficient to relate the cost of depreciable assets to operations over their estimated servicelives, using straight-line basis. Assets under finance leases are amortized over the lease term. While expenditures for repairsand maintenance are expensed when incurred. As of April 30, 2020 and October 31, 2019, the accumulated depreciation amounted to$481,325 and $509,275, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="50000000.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockSharesAuthorized" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 50,000,000 - pbsv-20200131.xml 1523</message>
 <ref href="pbsv-20200131.xml#element(/1/144)" sourceLine="1523">
  <property name="label" value="Common stock, authorized"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockSharesAuthorized"/>
  <property name="QName" value="us-gaap:CommonStockSharesAuthorized"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="50,000,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2332.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,332 - pbsv-20200131.xml 1647</message>
 <ref href="pbsv-20200131.xml#element(/1/268)" sourceLine="1647">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,332"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="17411.0" fact-concept="{http://pharmabioserv.com/20241231}IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 17,411 - pbsv-20200131.xml 1879</message>
 <ref href="pbsv-20200131.xml#element(/1/500)" sourceLine="1879">
  <property name="label" value="Income tax withheld by clients to be used as a credit in the Company's income tax return"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="QName" value="PBSV:IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="17,411"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="7842.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 7,842 - pbsv-20200131.xml 1735</message>
 <ref href="pbsv-20200131.xml#element(/1/356)" sourceLine="1735">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="7,842"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="42611.0" fact-concept="{http://fasb.org/us-gaap/2024}DepreciationDepletionAndAmortization" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 42,611 - pbsv-20200131.xml 1808</message>
 <ref href="pbsv-20200131.xml#element(/1/429)" sourceLine="1808">
  <property name="label" value="Depreciation and amortization"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DepreciationDepletionAndAmortization"/>
  <property name="QName" value="us-gaap:DepreciationDepletionAndAmortization"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="42,611"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="19111111.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 19,111,111 - pbsv-20200131.xml 1582</message>
 <ref href="pbsv-20200131.xml#element(/1/203)" sourceLine="1582">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="19,111,111"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.116" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.116 - pbsv-20200131.xml 1943</message>
 <ref href="pbsv-20200131.xml#element(/1/564)" sourceLine="1943">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_MajorCustomerDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.116"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="54447.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 54,447 - pbsv-20200131.xml 1648</message>
 <ref href="pbsv-20200131.xml#element(/1/269)" sourceLine="1648">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="54,447"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company evaluates for impairment its long..." fact-concept="{http://fasb.org/us-gaap/2024}ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company evaluates for impairment its long-livedassets to be held and used, and long-lived assets to be disposed of, whenever events or changes in circumstances indicate thatthe carrying amount of an asset may not be recoverable. Based on management estimates, no impairment of the long-lived assets waspresent as of April 30, 2020 and October 31, 2019.&lt;/p> - pbsv-20200131.xml 1997</message>
 <ref href="pbsv-20200131.xml#element(/1/618)" sourceLine="1997">
  <property name="label" value="Impairment of Long-Lived Assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
  <property name="QName" value="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company evaluates for impairment its long-livedassets to be held and used, and long-lived assets to be disposed of, whenever events or changes in circumstances indicate thatthe carrying amount of an asset may not be recoverable. Based on management estimates, no impairment of the long-lived assets waspresent as of April 30, 2020 and October 31, 2019.&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-23267.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -23,267 - pbsv-20200131.xml 1736</message>
 <ref href="pbsv-20200131.xml#element(/1/357)" sourceLine="1736">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-23,267"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>ORGANIZATION&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt ..." fact-concept="{http://fasb.org/us-gaap/2024}OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPol..." fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>ORGANIZATION&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>Pharma-BioServ, Inc. (&amp;#8220;Pharma-Bio&amp;#8221;) is a Delaware corporation organized on January 14, 2004. Pharma-Bio is the parent companyof Pharma-Bio Serv PR, Inc. (&amp;#8220;Pharma-PR&amp;#8221;), Pharma Serv, Inc. (&amp;#8220;Pharma-Serv&amp;#8221;), and Scienza Labs, Inc. (&amp;#8220;ScienzaLabs&amp;#8221;), each a&amp;#160;Puerto Rico corporation, Pharma-Bio Serv US, Inc. (&amp;#8220;Pharma-US&amp;#8221;), a Delaware corporation,Pharma-Bio Serv Validation &amp;#38; Compliance Limited (&amp;#8220;Pharma-IR&amp;#8221;), an Irish corporation currently inactive, Pharma-BioServ SL (&amp;#8220;Pharma-Spain&amp;#8221;), a Spanish limited liability company, and Pharma-Bio Serv Brasil Servicos de Consultoria Ltda.(&amp;#8220;Pharma-Brazil&amp;#8221;), a Brazilian limited liability company. Pharma-Bio, Pharma-PR, Pharma-Serv, Scienza Labs, Pharma-US,Pharma-IR, Pharma-Spain and Pharma-Brazil are collectively referred to as the &amp;#8220;Company.&amp;#8221; The Company operates in PuertoRico, the United States, Ireland, Spain and Brazil under the name of Pharma-Bio Serv and is engaged in providing technical complianceconsulting service.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The condensed consolidated balance sheet ofthe Company as of October 31, 2019 is derived from audited consolidated financial statements but does not include all disclosuresrequired by generally accepted accounting principles. The unaudited interim condensed consolidated financial statements, includeall adjustments, consisting of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentationof the financial position and results of operations and cash flows for the interim periods. The results of operations for the sixmonths ended April 30, 2020 are not necessarily indicative of expected results for the full 2020 fiscal year.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The accompanying financial data as of April30, 2020, and for the three-month and six-month periods ended April 30, 2020 and 2019 has been prepared by us, without audit, pursuantto the rules and regulations of the Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221;). Certain information and footnotedisclosures normally contained in financial statements prepared in accordance with generally accepted accounting principles havebeen condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the financial statementsand notes contained in our audited Consolidated Financial Statements and the notes thereto for the fiscal year ended October 31,2019.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Consolidation&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The accompanying condensed consolidated financialstatements include the accounts of the Company and all of its wholly owned subsidiaries. All intercompany transactions and balanceshave been eliminated in consolidation.&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Segments&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>The Companyoperates in three reportable business segments: (i) Puerto Rico technical compliance consulting, (ii) United States technical complianceconsulting, and (iii) Europe technical compliance consulting. Accordingly, the accompanying condensed consolidated financial statementsare presented to show these three reportable segments.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Use of Estimates&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The preparation of condensed consolidated financialstatements in conformity with accounting principles generally accepted in the United States of America requires management to makeestimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilitiesat the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reportingperiods. Actual results may differ from these estimates.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Fair Value of Financial Instruments&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounting standards have established a fairvalue hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs whenmeasuring fair value. A financial instrument&amp;#8217;s categorization within the fair value hierarchy is based upon the lowest levelof input that is significant to the fair value measurement. Accounting standards have established three levels of inputs that maybe used to measure fair value:&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%&quot;>&lt;tr>    &lt;td style=&quot;vertical-align: top; width: 10%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;1&lt;/i>:&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom; width: 90%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Quoted prices in active markets for identical        assets and liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;vertical-align: top&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;2:&lt;/i>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Observable inputs other than Level 1 prices        such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions        (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally        from or corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: top&quot;>&lt;font style=&quot;font-size: 8pt&quot;>&lt;i>Level&amp;#160;3&lt;/i>:&lt;/font>&lt;/td>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The carrying value of the Company's financialinstruments (excluding obligations under finance leases), cash and cash equivalents, accounts receivable, accounts payable andaccrued liabilities, are considered reasonable estimates of fair value due to their liquidity or short-term nature. Managementbelieves, based on current rates, that the fair value of its obligations under finance leases approximates the carrying amount.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Revenue Recognition&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In May 2014, the Financial Accounting StandardsBoard (FASB) issued a new accounting standard that amends the guidance for the recognition of revenue from contracts with customersto transfer goods and services. The FASB subsequently issued additional, clarifying standards to address issues arising from implementationof the new revenue recognition standard. The new revenue recognition standard and clarifying standards require an entity to recognizerevenue when control of promised goods or services is transferred to the customer at an amount that reflects the considerationto which the entity expects to be entitled in exchange for those goods or services. We adopted this new standard as of November1, 2018, by applying the modified-retrospective method to those contracts that were not completed as of that date. The resultsfor reporting periods beginning after November 1, 2018, are presented in accordance with the new standard, although comparativeinformation has not been restated and continues to be reported under the accounting standards and policies in effect for thoseperiods. The adoption of this new standard had an immaterial impact on our reported total revenues and operating income as comparedto what reported amounts would have been under the prior standard.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Revenue is primarily derived from: (1) timeand materials contracts (representing approximately 99% of total revenues), which is recognized by applying the proportional performancemodel, whereby revenue is recognized as performance occurs, and (2) short-term fixed-fee contracts or &amp;#34;not to exceed&amp;#34; contracts(representing approximately 1% of total revenues), which revenue is recognized similarly, except that certain milestones also haveto be reached before revenue is recognized. If the Company determines that a contract will result in a loss, the Company recognizesthe estimated loss in the period in which such determination is made.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Cash Equivalents&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>For purposes of the consolidated statementsof cash flows, cash equivalents include investments in a money market obligations trust that is registered under the U.S. InvestmentCompany Act of 1940, as amended, and liquid investments with original maturities of three months or less.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Accounts Receivable&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounts receivable are recorded at their estimatedrealizable value. Accounts are deemed past due when payment has not been received within the stated time period. The Company'spolicy is to review individual past due amounts periodically and write off amounts for which all collection efforts are deemedto have been exhausted. Due to the nature of the Company&amp;#8217;s customers, bad debts are mainly accounted for using the directwrite-off method whereby an expense is recognized only when a specific account is determined to be uncollectible. The effect ofusing this method approximates that of the allowance method.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Income Taxes&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows an asset and liability approachmethod of accounting for income taxes. This method measures deferred income taxes by applying enacted statutory rates in effectat the balance sheet date to the differences between the tax basis of assets and liabilities and their reported amounts on thefinancial statements. The resulting deferred tax assets or liabilities are adjusted to reflect changes in tax laws as they occur.A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows guidance from the FinancialAccounting Standards Board (&amp;#8220;FASB&amp;#8221;) related to &lt;i>Accounting for Uncertainty in Income Taxes,&lt;/i> which includes atwo-step approach to recognizing, de-recognizing and measuring uncertain tax positions. As of April 30, 2020, the Company had nosignificant uncertain tax positions that would be reduced as a result of a lapse of the applicable statute of limitations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Property and Equipment&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Owned property and equipment are stated at cost.Vehicles under finance leases are stated at the lower of fair market value or net present value of the minimum lease payments atthe inception of the leases.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Depreciation of owned assets are provided for,when placed in service, in amounts sufficient to relate the cost of depreciable assets to operations over their estimated servicelives, using straight-line basis. Assets under finance leases are amortized over the lease term. While expenditures for repairsand maintenance are expensed when incurred. As of April 30, 2020 and October 31, 2019, the accumulated depreciation amounted to$481,325 and $509,275, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Impairment of Long-Lived Assets&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company evaluates for impairment its long-livedassets to be held and used, and long-lived assets to be disposed of, whenever events or changes in circumstances indicate thatthe carrying amount of an asset may not be recoverable. Based on management estimates, no impairment of the long-lived assets waspresent as of April 30, 2020 and October 31, 2019.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Stock-based Compensation&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Stock-based compensation expense is recognizedin the consolidated financial statements based on the fair value of the awards granted. Stock-based compensation cost is measuredat the grant date based on the fair value of the award and is recognized as expense over the requisite service period, which generallyrepresents the vesting period, and includes an estimate of awards that will be forfeited. The Company calculates the fair valueof stock options using the Black-Scholes option-pricing model at the grant date, while for restricted stock units the fair marketvalue of the units is determined by Company&amp;#8217;s share market value at grant date. Excess tax benefits related to stock-basedcompensation are reflected as cash flows from financing activities rather than cash flows from operating activities. The Companyhas not recognized such cash flows from financing activities since there has been no tax benefit related to the stock-based compensation.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Earnings Per Share of Common Stock&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Basic earnings per share of common stock iscalculated by dividing net earnings by the weighted average number of shares of common stock outstanding. Diluted earnings pershare includes the dilution of common stock equivalents, which include principally shares that may be issued upon the exerciseof warrants, stock option and restricted stock unit awards.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The diluted weighted average shares of commonstock outstanding were calculated using the treasury stock method for the respective periods.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Foreign Operations&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The functional currency of the Company&amp;#8217;sforeign subsidiaries is its local currency. The assets and liabilities of the Company&amp;#8217;s foreign subsidiaries are translatedinto U.S. dollars at exchange rates in effect at the balance sheet date. Income and expense items are translated at the averageexchange rates prevailing during the period. The cumulative translation effect for subsidiaries using a functional currency otherthan the U.S. dollar is included as a cumulative translation adjustment in stockholders&amp;#8217; equity and as a component of comprehensiveincome.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s intercompany accounts aretypically denominated in the functional currency of the foreign subsidiary. Gains and losses resulting from the remeasurement ofintercompany receivables that the Company considers to be of a long-term investment nature are recorded as a cumulative translationadjustment in stockholders&amp;#8217; equity and as a component of comprehensive income, while gains and losses resulting from theremeasurement of intercompany receivables from those international subsidiaries for which the Company anticipates settlement inthe foreseeable future are recorded in the consolidated statements of operations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Subsequent Events&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company has evaluated subsequent eventsthrough&amp;#160;the filing date of this report. The Company has determined that there are no events occurring in this period thatrequired disclosure or adjustment.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Reclassifications&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Certain reclassifications have been made tothe April 30, 2019 condensed consolidated financial statements to conform them to the April 30, 2020 condensed consolidated financialstatements presentation. Such reclassifications do not affect net income as previously reported.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Recently Adopted Accounting Pronouncements&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In February 2016, the FASB issued ASU 2016-02,Leases (Topic 842) (&amp;#8220;ASU 2016-02&amp;#8221;). ASU 2016-02 is intended to increase transparency and comparability of accountingfor lease transactions. For all leases with terms greater than twelve months, the new guidance will require lessees to recognizeright-of-use assets and corresponding lease liabilities on the balance sheet and to disclose qualitative and quantitative informationabout lease transactions. The new standard maintains a distinction between finance leases and operating leases. As a result, theeffect of leases in the statement of operations and statement of cash flows is largely unchanged. In July 2018, the FASB issuedASU 2018-11, Leases - Targeted Improvements, to allow a company to elect an optional modified retrospective transition method thatapplies the new lease requirements through a cumulative-effect adjustment in the period of adoption.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Effective November 1, 2019, the Company adoptedthe new lease accounting standard using the modified retrospective transition option of applying the new standard at the adoptiondate. We categorize leases at their inception as either operating or finance leases. The Company leases include an operationallease for office space and a finance lease agreement for a vehicle. The adoption of the new standard resulted in the operatinglease being included in operating lease right-of-use assets, current operating lease liabilities, and long-term operating leaseliabilities in our condensed consolidated balance sheets, but did not have an impact on the Company&amp;#8217;s beginning balance ofretained earnings, consolidated statement of operations or statement of cash flows. Finance leases are included in net propertyand equipment, current installments of long-term debt, and long-term debt in our condensed consolidated balance sheets. The mostsignificant impact was the recognition of right-of-use assets and lease liabilities on account of the Company&amp;#8217;s operatingleases. The Company recognized $941,009 of right-of-use assets and $911,922 in operating lease liabilities at November 1, 2019.As of April 30, 2020, the total right-of-use assets related to the Company&amp;#8217;s operating leases was $874,840 and operatinglease liabilities current and non-current were approximately $156,496 and $696,916, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Recent Accounting Pronouncements&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Recent accounting pronouncements pending adoptionnot discussed above or in the 2019 Form 10-K are either not applicable or will not have or are not expected to have a materialimpact on us.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1886</message>
 <ref href="pbsv-20200131.xml#element(/1/507)" sourceLine="1886">
  <property name="label" value="A. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
  <property name="QName" value="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>ORGANIZATION&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>Pharma-BioServ, Inc. (&amp;#8220;Pharma-Bio&amp;#8221;) is a Delaware corporation organized on January 14, 2004. Pharma-Bio is the parent companyof Pharma-Bio Serv PR, Inc. (&amp;#8220;Pharma-PR&amp;#8221;), Pharma Serv, Inc. (&amp;#8220;Pharma-Serv&amp;#8221;), and Scienza Labs, Inc. (&amp;#8220;ScienzaLabs&amp;#8221;), each a&amp;#160;Puerto Rico corporation, Pharma-Bio Serv US, Inc. (&amp;#8220;Pharma-US&amp;#8221;), a Delaware corporation,Pharma-Bio Serv Validation &amp;#38; Compliance Limited (&amp;#8220;Pharma-IR&amp;#8221;), an Irish corporation currently inactive, Pharma-BioServ SL (&amp;#8220;Pharma-Spain&amp;#8221;), a Spanish limited liability company, and Pharma-Bio Serv Brasil Servicos de Consultoria Ltda.(&amp;#8220;Pharma-Brazil&amp;#8221;), a Brazilian limited liability company. Pharma-Bio, Pharma-PR, Pharma-Serv, Scienza Labs, Pharma-US,Pharma-IR, Pharma-Spain and Pharma-Brazil are collectively referred to as the &amp;#8220;Company.&amp;#8221; The Company operates in PuertoRico, the United States, Ireland, Spain and Brazil under the name of Pharma-Bio Serv and is engaged in providing technical complianceconsulting service.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The condensed consolidated balance sheet ofthe Company as of October 31, 2019 is derived from audited consolidated financial statements but does not include all disclosuresrequired by generally accepted accounting principles. The unaudited interim condensed consolidated financial statements, includeall adjustments, consisting of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentationof the financial position and results of operations and cash flows for the interim periods. The results of operations for the sixmonths ended April 30, 2020 are not necessarily indicative of expected results for the full 2020 fiscal year.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The accompanying financial data as of April30, 2020, and for the three-month and six-month periods ended April 30, 2020 and 2019 has been prepared by us, without audit, pursuantto the rules and regulations of the Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221;). Certain information and footnotedisclosures normally contained in financial statements prepared in accordance with generally accepted accounting principles havebeen condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the financial statementsand notes contained in our audited Consolidated Financial Statements and the notes thereto for the fiscal year ended October 31,2019.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Consolidation&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The accompanying condensed consolidated financialstatements include the accounts of the Company and all of its wholly owned subsidiaries. All intercompany transactions and balanceshave been eliminated in consolidation.&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Segments&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>The Companyoperates in three reportable business segments: (i) Puerto Rico technical compliance consulting, (ii) United States technical complianceconsulting, and (iii) Europe technical compliance consulting. Accordingly, the accompanying condensed consolidated financial statementsare presented to show these three reportable segments.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Use of Estimates&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The preparation of condensed consolidated financialstatements in conformity with accounting principles generally accepted in the United States of America requires management to makeestimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilitiesat the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reportingperiods. Actual results may differ from these estimates.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Fair Value of Financial Instruments&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounting standards have established a fairvalue hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs whenmeasuring fair value. A financial instrument&amp;#8217;s categorization within the fair value hierarchy is based upon the lowest levelof input that is significant to the fair value measurement. Accounting standards have established three levels of inputs that maybe used to measure fair value:&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%&quot;>&lt;tr>    &lt;td style=&quot;vertical-align: top; width: 10%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;1&lt;/i>:&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom; width: 90%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Quoted prices in active markets for identical        assets and liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;vertical-align: top&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;2:&lt;/i>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Observable inputs other than Level 1 prices        such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions        (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally        from or corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: top&quot;>&lt;font style=&quot;font-size: 8pt&quot;>&lt;i>Level&amp;#160;3&lt;/i>:&lt;/font>&lt;/td>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The carrying value of the Company's financialinstruments (excluding obligations under finance leases), cash and cash equivalents, accounts receivable, accounts payable andaccrued liabilities, are considered reasonable estimates of fair value due to their liquidity or short-term nature. Managementbelieves, based on current rates, that the fair value of its obligations under finance leases approximates the carrying amount.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Revenue Recognition&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In May 2014, the Financial Accounting StandardsBoard (FASB) issued a new accounting standard that amends the guidance for the recognition of revenue from contracts with customersto transfer goods and services. The FASB subsequently issued additional, clarifying standards to address issues arising from implementationof the new revenue recognition standard. The new revenue recognition standard and clarifying standards require an entity to recognizerevenue when control of promised goods or services is transferred to the customer at an amount that reflects the considerationto which the entity expects to be entitled in exchange for those goods or services. We adopted this new standard as of November1, 2018, by applying the modified-retrospective method to those contracts that were not completed as of that date. The resultsfor reporting periods beginning after November 1, 2018, are presented in accordance with the new standard, although comparativeinformation has not been restated and continues to be reported under the accounting standards and policies in effect for thoseperiods. The adoption of this new standard had an immaterial impact on our reported total revenues and operating income as comparedto what reported amounts would have been under the prior standard.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Revenue is primarily derived from: (1) timeand materials contracts (representing approximately 99% of total revenues), which is recognized by applying the proportional performancemodel, whereby revenue is recognized as performance occurs, and (2) short-term fixed-fee contracts or &amp;#34;not to exceed&amp;#34; contracts(representing approximately 1% of total revenues), which revenue is recognized similarly, except that certain milestones also haveto be reached before revenue is recognized. If the Company determines that a contract will result in a loss, the Company recognizesthe estimated loss in the period in which such determination is made.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Cash Equivalents&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>For purposes of the consolidated statementsof cash flows, cash equivalents include investments in a money market obligations trust that is registered under the U.S. InvestmentCompany Act of 1940, as amended, and liquid investments with original maturities of three months or less.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Accounts Receivable&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounts receivable are recorded at their estimatedrealizable value. Accounts are deemed past due when payment has not been received within the stated time period. The Company'spolicy is to review individual past due amounts periodically and write off amounts for which all collection efforts are deemedto have been exhausted. Due to the nature of the Company&amp;#8217;s customers, bad debts are mainly accounted for using the directwrite-off method whereby an expense is recognized only when a specific account is determined to be uncollectible. The effect ofusing this method approximates that of the allowance method.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Income Taxes&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows an asset and liability approachmethod of accounting for income taxes. This method measures deferred income taxes by applying enacted statutory rates in effectat the balance sheet date to the differences between the tax basis of assets and liabilities and their reported amounts on thefinancial statements. The resulting deferred tax assets or liabilities are adjusted to reflect changes in tax laws as they occur.A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows guidance from the FinancialAccounting Standards Board (&amp;#8220;FASB&amp;#8221;) related to &lt;i>Accounting for Uncertainty in Income Taxes,&lt;/i> which includes atwo-step approach to recognizing, de-recognizing and measuring uncertain tax positions. As of April 30, 2020, the Company had nosignificant uncertain tax positions that would be reduced as a result of a lapse of the applicable statute of limitations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Property and Equipment&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Owned property and equipment are stated at cost.Vehicles under finance leases are stated at the lower of fair market value or net present value of the minimum lease payments atthe inception of the leases.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Depreciation of owned assets are provided for,when placed in service, in amounts sufficient to relate the cost of depreciable assets to operations over their estimated servicelives, using straight-line basis. Assets under finance leases are amortized over the lease term. While expenditures for repairsand maintenance are expensed when incurred. As of April 30, 2020 and October 31, 2019, the accumulated depreciation amounted to$481,325 and $509,275, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Impairment of Long-Lived Assets&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company evaluates for impairment its long-livedassets to be held and used, and long-lived assets to be disposed of, whenever events or changes in circumstances indicate thatthe carrying amount of an asset may not be recoverable. Based on management estimates, no impairment of the long-lived assets waspresent as of April 30, 2020 and October 31, 2019.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Stock-based Compensation&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Stock-based compensation expense is recognizedin the consolidated financial statements based on the fair value of the awards granted. Stock-based compensation cost is measuredat the grant date based on the fair value of the award and is recognized as expense over the requisite service period, which generallyrepresents the vesting period, and includes an estimate of awards that will be forfeited. The Company calculates the fair valueof stock options using the Black-Scholes option-pricing model at the grant date, while for restricted stock units the fair marketvalue of the units is determined by Company&amp;#8217;s share market value at grant date. Excess tax benefits related to stock-basedcompensation are reflected as cash flows from financing activities rather than cash flows from operating activities. The Companyhas not recognized such cash flows from financing activities since there has been no tax benefit related to the stock-based compensation.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Earnings Per Share of Common Stock&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Basic earnings per share of common stock iscalculated by dividing net earnings by the weighted average number of shares of common stock outstanding. Diluted earnings pershare includes the dilution of common stock equivalents, which include principally shares that may be issued upon the exerciseof warrants, stock option and restricted stock unit awards.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The diluted weighted average shares of commonstock outstanding were calculated using the treasury stock method for the respective periods.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Foreign Operations&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The functional currency of the Company&amp;#8217;sforeign subsidiaries is its local currency. The assets and liabilities of the Company&amp;#8217;s foreign subsidiaries are translatedinto U.S. dollars at exchange rates in effect at the balance sheet date. Income and expense items are translated at the averageexchange rates prevailing during the period. The cumulative translation effect for subsidiaries using a functional currency otherthan the U.S. dollar is included as a cumulative translation adjustment in stockholders&amp;#8217; equity and as a component of comprehensiveincome.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s intercompany accounts aretypically denominated in the functional currency of the foreign subsidiary. Gains and losses resulting from the remeasurement ofintercompany receivables that the Company considers to be of a long-term investment nature are recorded as a cumulative translationadjustment in stockholders&amp;#8217; equity and as a component of comprehensive income, while gains and losses resulting from theremeasurement of intercompany receivables from those international subsidiaries for which the Company anticipates settlement inthe foreseeable future are recorded in the consolidated statements of operations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Subsequent Events&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company has evaluated subsequent eventsthrough&amp;#160;the filing date of this report. The Company has determined that there are no events occurring in this period thatrequired disclosure or adjustment.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Reclassifications&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Certain reclassifications have been made tothe April 30, 2019 condensed consolidated financial statements to conform them to the April 30, 2020 condensed consolidated financialstatements presentation. Such reclassifications do not affect net income as previously reported.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Recently Adopted Accounting Pronouncements&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In February 2016, the FASB issued ASU 2016-02,Leases (Topic 842) (&amp;#8220;ASU 2016-02&amp;#8221;). ASU 2016-02 is intended to increase transparency and comparability of accountingfor lease transactions. For all leases with terms greater than twelve months, the new guidance will require lessees to recognizeright-of-use assets and corresponding lease liabilities on the balance sheet and to disclose qualitative and quantitative informationabout lease transactions. The new standard maintains a distinction between finance leases and operating leases. As a result, theeffect of leases in the statement of operations and statement of cash flows is largely unchanged. In July 2018, the FASB issuedASU 2018-11, Leases - Targeted Improvements, to allow a company to elect an optional modified retrospective transition method thatapplies the new lease requirements through a cumulative-effect adjustment in the period of adoption.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Effective November 1, 2019, the Company adoptedthe new lease accounting standard using the modified retrospective transition option of applying the new standard at the adoptiondate. We categorize leases at their inception as either operating or finance leases. The Company leases include an operationallease for office space and a finance lease agreement for a vehicle. The adoption of the new standard resulted in the operatinglease being included in operating lease right-of-use assets, current operating lease liabilities, and long-term operating leaseliabilities in our condensed consolidated balance sheets, but did not have an impact on the Company&amp;#8217;s beginning balance ofretained earnings, consolidated statement of operations or statement of cash flows. Finance leases are included in net propertyand equipment, current installments of long-term debt, and long-term debt in our condensed consolidated balance sheets. The mostsignificant impact was the recognition of right-of-use assets and lease liabilities on account of the Company&amp;#8217;s operatingleases. The Company recognized $941,009 of right-of-use assets and $911,922 in operating lease liabilities at November 1, 2019.As of April 30, 2020, the total right-of-use assets related to the Company&amp;#8217;s operating leases was $874,840 and operatinglease liabilities current and non-current were approximately $156,496 and $696,916, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Recent Accounting Pronouncements&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Recent accounting pronouncements pending adoptionnot discussed above or in the 2019 Form 10-K are either not applicable or will not have or are not expected to have a materialimpact on us.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="107947.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 107,947 - pbsv-20200131.xml 1583</message>
 <ref href="pbsv-20200131.xml#element(/1/204)" sourceLine="1583">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="107,947"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="10260934.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 10,260,934 - pbsv-20200131.xml 1649</message>
 <ref href="pbsv-20200131.xml#element(/1/270)" sourceLine="1649">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="10,260,934"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company has evaluated subsequent eventst..." fact-concept="{http://fasb.org/us-gaap/2024}SubsequentEventsPolicyPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company has evaluated subsequent eventsthrough&amp;#160;the filing date of this report. The Company has determined that there are no events occurring in this period thatrequired disclosure or adjustment.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 2001</message>
 <ref href="pbsv-20200131.xml#element(/1/622)" sourceLine="2001">
  <property name="label" value="Subsequent Events"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SubsequentEventsPolicyPolicyTextBlock"/>
  <property name="QName" value="us-gaap:SubsequentEventsPolicyPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company has evaluated subsequent eventsthrough&amp;#160;the filing date of this report. The Company has determined that there are no events occurring in this period thatrequired disclosure or adjustment.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="250752.0" fact-concept="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentNet" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 250,752 - pbsv-20200131.xml 1531</message>
 <ref href="pbsv-20200131.xml#element(/1/152)" sourceLine="1531">
  <property name="label" value="Property and equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PropertyPlantAndEquipmentNet"/>
  <property name="QName" value="us-gaap:PropertyPlantAndEquipmentNet"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="250,752"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-11734.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -11,734 - pbsv-20200131.xml 1737</message>
 <ref href="pbsv-20200131.xml#element(/1/358)" sourceLine="1737">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-11,734"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21844.0" fact-concept="{http://fasb.org/us-gaap/2024}DepreciationDepletionAndAmortization" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,844 - pbsv-20200131.xml 1807</message>
 <ref href="pbsv-20200131.xml#element(/1/428)" sourceLine="1807">
  <property name="label" value="Depreciation and amortization"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DepreciationDepletionAndAmortization"/>
  <property name="QName" value="us-gaap:DepreciationDepletionAndAmortization"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,844"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="86773.0" fact-concept="{http://pharmabioserv.com/20241231}AccumulatedDepreciationOnPropertyAndEquipmentDisposed" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 86,773 - pbsv-20200131.xml 1885</message>
 <ref href="pbsv-20200131.xml#element(/1/506)" sourceLine="1885">
  <property name="label" value="Accumulated depreciation"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="QName" value="PBSV:AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="86,773"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.222" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.222 - pbsv-20200131.xml 1944</message>
 <ref href="pbsv-20200131.xml#element(/1/565)" sourceLine="1944">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_MajorCustomerEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.222"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="9716541.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 9,716,541 - pbsv-20200131.xml 1650</message>
 <ref href="pbsv-20200131.xml#element(/1/271)" sourceLine="1650">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="9,716,541"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-304688.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -304,688 - pbsv-20200131.xml 1584</message>
 <ref href="pbsv-20200131.xml#element(/1/205)" sourceLine="1584">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-304,688"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-11734.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -11,734 - pbsv-20200131.xml 1738</message>
 <ref href="pbsv-20200131.xml#element(/1/359)" sourceLine="1738">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-11,734"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="17913.0" fact-concept="{http://pharmabioserv.com/20241231}AccumulatedDepreciationOnPropertyAndEquipmentDisposed" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 17,913 - pbsv-20200131.xml 1884</message>
 <ref href="pbsv-20200131.xml#element(/1/505)" sourceLine="1884">
  <property name="label" value="Accumulated depreciation"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="QName" value="PBSV:AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="17,913"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="9297592.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 9,297,592 - pbsv-20200131.xml 1651</message>
 <ref href="pbsv-20200131.xml#element(/1/272)" sourceLine="1651">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="9,297,592"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Stock-based compensation expense is recognize..." fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensationOptionAndIncentivePlansPolicy" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Stock-based compensation expense is recognizedin the consolidated financial statements based on the fair value of the awards granted. Stock-based compensation cost is measuredat the grant date based on the fair value of the award and is recognized as expense over the requisite service period, which generallyrepresents the vesting period, and includes an estimate of awards that will be forfeited. The Company calculates the fair valueof stock options using the Black-Scholes option-pricing model at the grant date, while for restricted stock units the fair marketvalue of the units is determined by Company&amp;#8217;s share market value at grant date. Excess tax benefits related to stock-basedcompensation are reflected as cash flows from financing activities rather than cash flows from operating activities. The Companyhas not recognized such cash flows from financing activities since there has been no tax benefit related to the stock-based compensation.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1998</message>
 <ref href="pbsv-20200131.xml#element(/1/619)" sourceLine="1998">
  <property name="label" value="Stock-based Compensation"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
  <property name="QName" value="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Stock-based compensation expense is recognizedin the consolidated financial statements based on the fair value of the awards granted. Stock-based compensation cost is measuredat the grant date based on the fair value of the award and is recognized as expense over the requisite service period, which generallyrepresents the vesting period, and includes an estimate of awards that will be forfeited. The Company calculates the fair valueof stock options using the Black-Scholes option-pricing model at the grant date, while for restricted stock units the fair marketvalue of the units is determined by Company&amp;#8217;s share market value at grant date. Excess tax benefits related to stock-basedcompensation are reflected as cash flows from financing activities rather than cash flows from operating activities. The Companyhas not recognized such cash flows from financing activities since there has been no tax benefit related to the stock-based compensation.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="4918.0" fact-concept="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 4,918 - pbsv-20200131.xml 1810</message>
 <ref href="pbsv-20200131.xml#element(/1/431)" sourceLine="1810">
  <property name="label" value="Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GainLossOnDispositionOfAssets"/>
  <property name="QName" value="us-gaap:GainLossOnDispositionOfAssets"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="4,918"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="86773.0" fact-concept="{http://pharmabioserv.com/20241231}AccumulatedDepreciationOnPropertyAndEquipmentDisposed" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 86,773 - pbsv-20200131.xml 1883</message>
 <ref href="pbsv-20200131.xml#element(/1/504)" sourceLine="1883">
  <property name="label" value="Accumulated depreciation"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="QName" value="PBSV:AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="86,773"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="28635923.0" fact-concept="{http://fasb.org/us-gaap/2024}Assets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 28,635,923 - pbsv-20200131.xml 1525</message>
 <ref href="pbsv-20200131.xml#element(/1/146)" sourceLine="1525">
  <property name="label" value="Assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Assets"/>
  <property name="QName" value="us-gaap:Assets"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="28,635,923"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.516" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.516 - pbsv-20200131.xml 1945</message>
 <ref href="pbsv-20200131.xml#element(/1/566)" sourceLine="1945">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_MajorCustomerTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.516"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2340.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,340 - pbsv-20200131.xml 1585</message>
 <ref href="pbsv-20200131.xml#element(/1/206)" sourceLine="1585">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,340"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="784353.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 784,353 - pbsv-20200131.xml 1652</message>
 <ref href="pbsv-20200131.xml#element(/1/273)" sourceLine="1652">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="784,353"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>On Sept..." fact-concept="{http://fasb.org/us-gaap/2024}MarketableSecuritiesTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>On September17, 2018 (the &amp;#8220;Sales Closing Date&amp;#8221;), the Company sold substantially all of its Lab business assets (the &amp;#8220;LaboratoryAssets&amp;#8221;). Upon the completion of the Laboratory Assets sale, the Company received, as partial payment, a $3 million PromissoryNote from the purchaser. The Promissory Note is composed of two tranches; (i) Tranche A for $2 million and secured with lab equipmentand (ii) Tranche B for $1 million which is unsecured. The interest rate accrual is 3% for Tranche A and 5% for Tranche B. As ofApril 30, 2020, pursuant to the terms of the Promissory Note, the Company has collected $1,750,000. The Promissory Note final installmentof $1,250,000 from Tranche A is due September 17, 2020.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1887</message>
 <ref href="pbsv-20200131.xml#element(/1/508)" sourceLine="1887">
  <property name="label" value="B. PROMISSORY NOTE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="MarketableSecuritiesTextBlock"/>
  <property name="QName" value="us-gaap:MarketableSecuritiesTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>On September17, 2018 (the &amp;#8220;Sales Closing Date&amp;#8221;), the Company sold substantially all of its Lab business assets (the &amp;#8220;LaboratoryAssets&amp;#8221;). Upon the completion of the Laboratory Assets sale, the Company received, as partial payment, a $3 million PromissoryNote from the purchaser. The Promissory Note is composed of two tranches; (i) Tranche A for $2 million and secured with lab equipmentand (ii) Tranche B for $1 million which is unsecured. The interest rate accrual is 3% for Tranche A and 5% for Tranche B. As ofApril 30, 2020, pursuant to the terms of the Promissory Note, the Company has collected $1,750,000. The Promissory Note final installmentof $1,250,000 from Tranche A is due September 17, 2020.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="657828.0" fact-concept="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 657,828 - pbsv-20200131.xml 1739</message>
 <ref href="pbsv-20200131.xml#element(/1/360)" sourceLine="1739">
  <property name="label" value="Comprehensive Income (Loss), Net of Tax, Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ComprehensiveIncomeNetOfTax"/>
  <property name="QName" value="us-gaap:ComprehensiveIncomeNetOfTax"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="657,828"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="4918.0" fact-concept="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 4,918 - pbsv-20200131.xml 1812</message>
 <ref href="pbsv-20200131.xml#element(/1/433)" sourceLine="1812">
  <property name="label" value="Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GainLossOnDispositionOfAssets"/>
  <property name="QName" value="us-gaap:GainLossOnDispositionOfAssets"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="4,918"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The functional currency of the Company&amp;#8217;..." fact-concept="{http://fasb.org/us-gaap/2024}ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The functional currency of the Company&amp;#8217;sforeign subsidiaries is its local currency. The assets and liabilities of the Company&amp;#8217;s foreign subsidiaries are translatedinto U.S. dollars at exchange rates in effect at the balance sheet date. Income and expense items are translated at the averageexchange rates prevailing during the period. The cumulative translation effect for subsidiaries using a functional currency otherthan the U.S. dollar is included as a cumulative translation adjustment in stockholders&amp;#8217; equity and as a component of comprehensiveincome.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s intercompany accounts aretypically denominated in the functional currency of the foreign subsidiary. Gains and losses resulting from the remeasurement ofintercompany receivables that the Company considers to be of a long-term investment nature are recorded as a cumulative translationadjustment in stockholders&amp;#8217; equity and as a component of comprehensive income, while gains and losses resulting from theremeasurement of intercompany receivables from those international subsidiaries for which the Company anticipates settlement inthe foreseeable future are recorded in the consolidated statements of operations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 2000</message>
 <ref href="pbsv-20200131.xml#element(/1/621)" sourceLine="2000">
  <property name="label" value="Foreign Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
  <property name="QName" value="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The functional currency of the Company&amp;#8217;sforeign subsidiaries is its local currency. The assets and liabilities of the Company&amp;#8217;s foreign subsidiaries are translatedinto U.S. dollars at exchange rates in effect at the balance sheet date. Income and expense items are translated at the averageexchange rates prevailing during the period. The cumulative translation effect for subsidiaries using a functional currency otherthan the U.S. dollar is included as a cumulative translation adjustment in stockholders&amp;#8217; equity and as a component of comprehensiveincome.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s intercompany accounts aretypically denominated in the functional currency of the foreign subsidiary. Gains and losses resulting from the remeasurement ofintercompany receivables that the Company considers to be of a long-term investment nature are recorded as a cumulative translationadjustment in stockholders&amp;#8217; equity and as a component of comprehensive income, while gains and losses resulting from theremeasurement of intercompany receivables from those international subsidiaries for which the Company anticipates settlement inthe foreseeable future are recorded in the consolidated statements of operations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="155950.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 155,950 - pbsv-20200131.xml 1653</message>
 <ref href="pbsv-20200131.xml#element(/1/274)" sourceLine="1653">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="155,950"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1586</message>
 <ref href="pbsv-20200131.xml#element(/1/207)" sourceLine="1586">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>OnApri..." fact-concept="{http://fasb.org/us-gaap/2024}DebtDisclosureTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>OnApril 23, 2020, Pharma-PR, Pharma-Serv, and Pharma-US (collectively, the &amp;#8220;&lt;/font>Borrowers&lt;font style=&quot;background-color: white&quot;>&amp;#8221;)entered into loan agreements and related promissory notes (the &amp;#8220;&lt;/font>SBA Loan Documents&lt;font style=&quot;background-color: white&quot;>&amp;#8221;)to receive U.S. Small Business Administration Loans (the &amp;#8220;&lt;/font>SBA Loans&lt;font style=&quot;background-color: white&quot;>&amp;#8221;).These loans were originated pursuant to the Paycheck Protection Program (the &amp;#8220;&lt;/font>PPP&lt;font style=&quot;background-color: white&quot;>&amp;#8221;)established under the Coronavirus Aid, Relief, and Economic Security Act (the &amp;#8220;&lt;/font>CARES Act&lt;font style=&quot;background-color: white&quot;>&amp;#8221;),and in the aggregate amount of $1,931,700 (the &amp;#8220;&lt;/font>Loan Proceeds&lt;font style=&quot;background-color: white&quot;>&amp;#8221;). TheBorrowers received the Loan Proceeds on April 23, 2020. In accordance with the SBA Loan Documents, the SBA Loans (i) have afixed interest rate of 1%, (ii) begin repayment six months from the date of disbursement of each SBA Loan, and (iii)   mature two years from the date of first disbursement. These SBA Loans have  no prepayment penalty.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1888</message>
 <ref href="pbsv-20200131.xml#element(/1/509)" sourceLine="1888">
  <property name="label" value="C. LOANS"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DebtDisclosureTextBlock"/>
  <property name="QName" value="us-gaap:DebtDisclosureTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>OnApril 23, 2020, Pharma-PR, Pharma-Serv, and Pharma-US (collectively, the &amp;#8220;&lt;/font>Borrowers&lt;font style=&quot;background-color: white&quot;>&amp;#8221;)entered into loan agreements and related promissory notes (the &amp;#8220;&lt;/font>SBA Loan Documents&lt;font style=&quot;background-color: white&quot;>&amp;#8221;)to receive U.S. Small Business Administration Loans (the &amp;#8220;&lt;/font>SBA Loans&lt;font style=&quot;background-color: white&quot;>&amp;#8221;).These loans were originated pursuant to the Paycheck Protection Program (the &amp;#8220;&lt;/font>PPP&lt;font style=&quot;background-color: white&quot;>&amp;#8221;)established under the Coronavirus Aid, Relief, and Economic Security Act (the &amp;#8220;&lt;/font>CARES Act&lt;font style=&quot;background-color: white&quot;>&amp;#8221;),and in the aggregate amount of $1,931,700 (the &amp;#8220;&lt;/font>Loan Proceeds&lt;font style=&quot;background-color: white&quot;>&amp;#8221;). TheBorrowers received the Loan Proceeds on April 23, 2020. In accordance with the SBA Loan Documents, the SBA Loans (i) have afixed interest rate of 1%, (ii) begin repayment six months from the date of disbursement of each SBA Loan, and (iii)   mature two years from the date of first disbursement. These SBA Loans have  no prepayment penalty.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="26633075.0" fact-concept="{http://fasb.org/us-gaap/2024}Assets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 26,633,075 - pbsv-20200131.xml 1526</message>
 <ref href="pbsv-20200131.xml#element(/1/147)" sourceLine="1526">
  <property name="label" value="Assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Assets"/>
  <property name="QName" value="us-gaap:Assets"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="26,633,075"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.213" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.213 - pbsv-20200131.xml 1946</message>
 <ref href="pbsv-20200131.xml#element(/1/567)" sourceLine="1946">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_GlobalGroupAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.213"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23039.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,039 - pbsv-20200131.xml 1654</message>
 <ref href="pbsv-20200131.xml#element(/1/275)" sourceLine="1654">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,039"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1172994.0" fact-concept="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,172,994 - pbsv-20200131.xml 1741</message>
 <ref href="pbsv-20200131.xml#element(/1/362)" sourceLine="1741">
  <property name="label" value="Comprehensive Income (Loss), Net of Tax, Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ComprehensiveIncomeNetOfTax"/>
  <property name="QName" value="us-gaap:ComprehensiveIncomeNetOfTax"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,172,994"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s segments are based on the..." fact-concept="{http://fasb.org/us-gaap/2024}SegmentReportingDisclosureTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s segments are based on theorganizational structure for which financial results are regularly evaluated by the Company&amp;#8217;s chief operating decision makerto determine resource allocation and assess performance. Each reportable segment is managed by its own management team and reportsto executive management. The Company has three reportable segments: (i) Puerto Rico technical compliance consulting, (ii) UnitedStates technical compliance consulting, and (iii) Europe technical compliance consulting. These reportable segments provide servicesprimarily to the pharmaceutical, chemical, medical device and biotechnology industries in their respective markets.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The following table presents information aboutthe reported revenue from services and earnings from operations of the Company for the three-month and six-month periods endedin April 30, 2020 and 2019. There is no intersegment revenue for the mentioned periods. Corporate expenses that support the operatingunits have been allocated to the segments. Asset information by reportable segment is not presented, since the Company does notproduce such information internally, nor does it use such data to manage its business.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>Six months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>REVENUES:&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;width: 40%; text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>5,116,682&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>4,293,041&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>9,297,592&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>8,181,595&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>394,991&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>661,356&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>784,353&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,188,001&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>133,762&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>141,500&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>155,950&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>233,231&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,332&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>54,447&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>23,039&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>113,714&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>Total consolidated revenues&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,647,767&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,150,344&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>10,260,934&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>9,716,541&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>INCOME (LOSS) BEFORE TAXES:&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>633,633&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>581,019&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,150,772&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>956,289&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(41,887&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>14,230&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;vertical-align: bottom; text-align: right&quot;>(61,930&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,320&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>7,489&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(8,014&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(61,684&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(57,925&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>169,733&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>195,506&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>324,005&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>396,032&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 0.25in&quot;>Total consolidated income before taxes&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>768,968&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>782,741&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,351,163&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,296,716&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 12pt Times New Roman, Times, Serif; width: 100%&quot;>&lt;tr style=&quot;vertical-align: top&quot;>    &lt;td style=&quot;border-top: black 1pt solid; width: 2%; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#185;&lt;/font>&lt;/td>    &lt;td style=&quot;border-top: black 1pt solid; width: 98%; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>Other segments represent activities that fall below the reportable threshold and are carried out in Puerto Rico and Brazil. These activities include a Brazilian compliance consulting division and corporate headquarters, as applicable.&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Long lived assets (property and equipment) asof April 30, 2020 and October 31, 2019, and related depreciation and amortization expense for the three and six months ended April30, 2020 and 2019, were concentrated in the corporate headquarters in Puerto Rico. Accordingly, depreciation expense and acquisitionof property and equipment, as presented in the statements of cash flows are mainly related to the corporate headquarters.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 2005</message>
 <ref href="pbsv-20200131.xml#element(/1/626)" sourceLine="2005">
  <property name="label" value="I. SEGMENT DISCLOSURES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SegmentReportingDisclosureTextBlock"/>
  <property name="QName" value="us-gaap:SegmentReportingDisclosureTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s segments are based on theorganizational structure for which financial results are regularly evaluated by the Company&amp;#8217;s chief operating decision makerto determine resource allocation and assess performance. Each reportable segment is managed by its own management team and reportsto executive management. The Company has three reportable segments: (i) Puerto Rico technical compliance consulting, (ii) UnitedStates technical compliance consulting, and (iii) Europe technical compliance consulting. These reportable segments provide servicesprimarily to the pharmaceutical, chemical, medical device and biotechnology industries in their respective markets.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The following table presents information aboutthe reported revenue from services and earnings from operations of the Company for the three-month and six-month periods endedin April 30, 2020 and 2019. There is no intersegment revenue for the mentioned periods. Corporate expenses that support the operatingunits have been allocated to the segments. Asset information by reportable segment is not presented, since the Company does notproduce such information internally, nor does it use such data to manage its business.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>Six months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>REVENUES:&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;width: 40%; text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>5,116,682&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>4,293,041&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>9,297,592&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>8,181,595&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>394,991&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>661,356&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>784,353&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,188,001&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>133,762&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>141,500&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>155,950&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>233,231&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,332&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>54,447&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>23,039&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>113,714&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>Total consolidated revenues&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,647,767&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,150,344&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>10,260,934&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>9,716,541&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>INCOME (LOSS) BEFORE TAXES:&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>633,633&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>581,019&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,150,772&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>956,289&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(41,887&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>14,230&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;vertical-align: bottom; text-align: right&quot;>(61,930&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,320&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>7,489&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(8,014&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(61,684&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(57,925&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>169,733&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>195,506&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>324,005&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>396,032&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 0.25in&quot;>Total consolidated income before taxes&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>768,968&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>782,741&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,351,163&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,296,716&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 12pt Times New Roman, Times, Serif; width: 100%&quot;>&lt;tr style=&quot;vertical-align: top&quot;>    &lt;td style=&quot;border-top: black 1pt solid; width: 2%; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#185;&lt;/font>&lt;/td>    &lt;td style=&quot;border-top: black 1pt solid; width: 98%; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>Other segments represent activities that fall below the reportable threshold and are carried out in Puerto Rico and Brazil. These activities include a Brazilian compliance consulting division and corporate headquarters, as applicable.&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Long lived assets (property and equipment) asof April 30, 2020 and October 31, 2019, and related depreciation and amortization expense for the three and six months ended April30, 2020 and 2019, were concentrated in the corporate headquarters in Puerto Rico. Accordingly, depreciation expense and acquisitionof property and equipment, as presented in the statements of cash flows are mainly related to the corporate headquarters.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="47392.0" fact-concept="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 47,392 - pbsv-20200131.xml 1811</message>
 <ref href="pbsv-20200131.xml#element(/1/432)" sourceLine="1811">
  <property name="label" value="Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GainLossOnDispositionOfAssets"/>
  <property name="QName" value="us-gaap:GainLossOnDispositionOfAssets"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="47,392"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="874840.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingLeaseRightOfUseAsset" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 874,840 - pbsv-20200131.xml 1529</message>
 <ref href="pbsv-20200131.xml#element(/1/150)" sourceLine="1529">
  <property name="label" value="Operating lease right-of-use"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingLeaseRightOfUseAsset"/>
  <property name="QName" value="us-gaap:OperatingLeaseRightOfUseAsset"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="874,840"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1381076.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,381,076 - pbsv-20200131.xml 1587</message>
 <ref href="pbsv-20200131.xml#element(/1/208)" sourceLine="1587">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,381,076"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="8181595.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 8,181,595 - pbsv-20200131.xml 1655</message>
 <ref href="pbsv-20200131.xml#element(/1/276)" sourceLine="1655">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="8,181,595"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The following data shows the amounts used in..." fact-concept="{http://fasb.org/us-gaap/2024}EarningsPerShareTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The following data shows the amounts used inthe calculations of basic and diluted earnings per share.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 12pt Times New Roman, Times, Serif; width: 100%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Six months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;width: 56%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Net income available to common equity holders - used to compute&amp;#160;basic and diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$687,561&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$707,483&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,214,461&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,178,503&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of common shares - used to compute basic earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,001,627&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,903&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,745&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,032,107&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Effect of options to purchase common stock&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;27,576&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;66,020&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,213&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;73,059&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of shares - used to compute diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,029,203&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,068,923&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,025,958&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,105,166&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>For the three-month and six-month periods endedApril 30, 2020, options for the purchase of shares of 340,000 common stock were not considered in computing diluted earnings pershare because the effect was antidilutive. In addition, warrants and options for the purchase of 1,000,000 and 80,000 shares ofcommon stock, respectively, for the three-month and six-month periods ended April 30, 2019, were not included in computing dilutedearnings per share because their effects were also antidilutive.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1891</message>
 <ref href="pbsv-20200131.xml#element(/1/512)" sourceLine="1891">
  <property name="label" value="F. EARNINGS (LOSSES) PER SHARE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="EarningsPerShareTextBlock"/>
  <property name="QName" value="us-gaap:EarningsPerShareTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The following data shows the amounts used inthe calculations of basic and diluted earnings per share.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 12pt Times New Roman, Times, Serif; width: 100%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Six months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;width: 56%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Net income available to common equity holders - used to compute&amp;#160;basic and diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$687,561&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$707,483&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,214,461&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,178,503&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of common shares - used to compute basic earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,001,627&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,903&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,745&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,032,107&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Effect of options to purchase common stock&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;27,576&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;66,020&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,213&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;73,059&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of shares - used to compute diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,029,203&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,068,923&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,025,958&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,105,166&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>For the three-month and six-month periods endedApril 30, 2020, options for the purchase of shares of 340,000 common stock were not considered in computing diluted earnings pershare because the effect was antidilutive. In addition, warrants and options for the purchase of 1,000,000 and 80,000 shares ofcommon stock, respectively, for the three-month and six-month periods ended April 30, 2019, were not included in computing dilutedearnings per share because their effects were also antidilutive.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Certain reclassifications have been made tot..." fact-concept="{http://fasb.org/us-gaap/2024}PriorPeriodReclassificationAdjustmentDescription" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Certain reclassifications have been made tothe April 30, 2019 condensed consolidated financial statements to conform them to the April 30, 2020 condensed consolidated financialstatements presentation. Such reclassifications do not affect net income as previously reported.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 2002</message>
 <ref href="pbsv-20200131.xml#element(/1/623)" sourceLine="2002">
  <property name="label" value="Reclassifications"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PriorPeriodReclassificationAdjustmentDescription"/>
  <property name="QName" value="us-gaap:PriorPeriodReclassificationAdjustmentDescription"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Certain reclassifications have been made tothe April 30, 2019 condensed consolidated financial statements to conform them to the April 30, 2020 condensed consolidated financialstatements presentation. Such reclassifications do not affect net income as previously reported.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.149" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.149 - pbsv-20200131.xml 1947</message>
 <ref href="pbsv-20200131.xml#element(/1/568)" sourceLine="1947">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_GlobalGroupBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.149"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1188001.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,188,001 - pbsv-20200131.xml 1656</message>
 <ref href="pbsv-20200131.xml#element(/1/277)" sourceLine="1656">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,188,001"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>OnDece..." fact-concept="{http://fasb.org/us-gaap/2024}DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>OnDecember 2014, the Company entered into a stock warrant agreement with a firm in exchange for providing (i) businessdevelopment and (ii) mergers and acquisition services to the Company. The Company warrants for the purchase of 1,000,000common shares issued to this firm expired on December 1, 2019 without being exercised.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1890</message>
 <ref href="pbsv-20200131.xml#element(/1/511)" sourceLine="1890">
  <property name="label" value="E. WARRANTS"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
  <property name="QName" value="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>OnDecember 2014, the Company entered into a stock warrant agreement with a firm in exchange for providing (i) businessdevelopment and (ii) mergers and acquisition services to the Company. The Company warrants for the purchase of 1,000,000common shares issued to this firm expired on December 1, 2019 without being exercised.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="19473069.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 19,473,069 - pbsv-20200131.xml 1588</message>
 <ref href="pbsv-20200131.xml#element(/1/209)" sourceLine="1588">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="19,473,069"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="684216.0" fact-concept="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 684,216 - pbsv-20200131.xml 1740</message>
 <ref href="pbsv-20200131.xml#element(/1/361)" sourceLine="1740">
  <property name="label" value="Comprehensive Income (Loss), Net of Tax, Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ComprehensiveIncomeNetOfTax"/>
  <property name="QName" value="us-gaap:ComprehensiveIncomeNetOfTax"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="684,216"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="233231.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 233,231 - pbsv-20200131.xml 1657</message>
 <ref href="pbsv-20200131.xml#element(/1/278)" sourceLine="1657">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="233,231"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Cash and cash equivalents&lt;/b>&lt;/p>&lt;p styl..." fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskDisclosureTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Cash and cash equivalents&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s domestic cash and cash equivalentsconsist of cash deposits in FDIC insured banks (substantially covered by FDIC insurance by the spread of deposits in multiple FDICinsured banks), a money market obligations trust registered under the US Investment Company Act of 1940, as amended, and U.S. Treasurysecurities with maturities of three months or less. In the foreign markets we serve, we also maintain cash deposits in foreignbanks, which have no specific insurance. No losses have been experienced or are expected on these accounts.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Accounts receivable and revenues&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Management deems all of its accounts receivableto be fully collectible, and, as such, does not maintain any allowances for uncollectible receivables.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company's revenues, and the related receivables,are concentrated in the pharmaceutical industry in Puerto Rico, the United States, Ireland, Spain and Brazil. Although a few customersrepresent a significant source of revenue, the Company&amp;#8217;s functions are not a continuous process, accordingly, the clientbase for which the services are typically rendered, on a project-by-project basis, changes regularly.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company provided a substantial portion ofits services to five customers, which accounted for 10% or more of its revenues in either of the three-month and six-month periodsended April 30, 2020 and 2019. During the three months ended April 30, 2020, revenues from these customers were 24.9%, 9.3%, 14.6%,11.8% and 7.6%, or a total of 68.2%, as compared to the same period last year of 0.0%, 11.1%, 9.9%, 12.2% and 26.6%, or a totalof 59.8%, respectively. During the six months ended April 30, 2020, revenues from these customers were 21.3%, 12.1%, 14.6%, 10.6%and 10.1%, or a total of 68.7%, as compared to the same period last year of 0.0%, 7.3%, 10.5%, 11.6% and 22.2%, or a total of 51.6%,respectively. At April 30, 2020, amounts due from these customers represented 85.2% of the Company&amp;#8217;s total accounts receivablebalance. This customer information is based on revenues earned from said customers at the segment level because in management&amp;#8217;sopinion contracts by segments are totally independent of each other, and therefore such information is more meaningful to the reader.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>At the global level, five global groups of affiliatedcompanies accounted for 10% or more of its revenues in either of the three-month and six-month periods ended April 30, 2020 and2019. During the three months ended April 30, 2020, aggregate revenues from these global groups of affiliated companies were 24.9%,11.9%, 14.6%, 11.8%, and 7.6%, or a total of 70.8%, as compared to the same period last year for 0.0%, 14.2%, 9.9%, 12.2%, and26.6%, or a total of 62.9%, respectively. During the six months ended April 30, 2020, aggregate revenues from these global groupof affiliated companies were 21.3%, 14.9%, 14.6%, 10.6% and 10.1%, or a total of 71.5%, as compared to the same period last yearfor 0.0%, 10.7%, 10.5%, 11.6% and 22.2%, or a total of 55.0%, respectively. At April 30, 2020, amounts due from these global groupsof affiliated companies represented 86.1% of total accounts receivable balance.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>Asof April 30, 2020, one of the Company&amp;#8217;s customers (representing 10.2% of revenues during the six months ended April 30,2020) owes the Company approximately $5.3 million (including $1.25 million from a Promissory Note due September 2020). Thisoutstanding obligation represents approximately 21.6% of the Company&amp;#8217;s total working capital. The Company is providingmultiple services to this customer related to their construction and validation of a manufacturing facility in Puerto Rico. A significant portion of thecustomer&amp;#8217;s funding comes from different financing sources. Management estimates that collectability of the account isreasonably assured, accordingly, no provision for losses, if any, have been recorded in the financial statements.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 2007</message>
 <ref href="pbsv-20200131.xml#element(/1/628)" sourceLine="2007">
  <property name="label" value="H. CONCENTRATIONS OF RISK"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskDisclosureTextBlock"/>
  <property name="QName" value="us-gaap:ConcentrationRiskDisclosureTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Cash and cash equivalents&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s domestic cash and cash equivalentsconsist of cash deposits in FDIC insured banks (substantially covered by FDIC insurance by the spread of deposits in multiple FDICinsured banks), a money market obligations trust registered under the US Investment Company Act of 1940, as amended, and U.S. Treasurysecurities with maturities of three months or less. In the foreign markets we serve, we also maintain cash deposits in foreignbanks, which have no specific insurance. No losses have been experienced or are expected on these accounts.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Accounts receivable and revenues&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Management deems all of its accounts receivableto be fully collectible, and, as such, does not maintain any allowances for uncollectible receivables.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company's revenues, and the related receivables,are concentrated in the pharmaceutical industry in Puerto Rico, the United States, Ireland, Spain and Brazil. Although a few customersrepresent a significant source of revenue, the Company&amp;#8217;s functions are not a continuous process, accordingly, the clientbase for which the services are typically rendered, on a project-by-project basis, changes regularly.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company provided a substantial portion ofits services to five customers, which accounted for 10% or more of its revenues in either of the three-month and six-month periodsended April 30, 2020 and 2019. During the three months ended April 30, 2020, revenues from these customers were 24.9%, 9.3%, 14.6%,11.8% and 7.6%, or a total of 68.2%, as compared to the same period last year of 0.0%, 11.1%, 9.9%, 12.2% and 26.6%, or a totalof 59.8%, respectively. During the six months ended April 30, 2020, revenues from these customers were 21.3%, 12.1%, 14.6%, 10.6%and 10.1%, or a total of 68.7%, as compared to the same period last year of 0.0%, 7.3%, 10.5%, 11.6% and 22.2%, or a total of 51.6%,respectively. At April 30, 2020, amounts due from these customers represented 85.2% of the Company&amp;#8217;s total accounts receivablebalance. This customer information is based on revenues earned from said customers at the segment level because in management&amp;#8217;sopinion contracts by segments are totally independent of each other, and therefore such information is more meaningful to the reader.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>At the global level, five global groups of affiliatedcompanies accounted for 10% or more of its revenues in either of the three-month and six-month periods ended April 30, 2020 and2019. During the three months ended April 30, 2020, aggregate revenues from these global groups of affiliated companies were 24.9%,11.9%, 14.6%, 11.8%, and 7.6%, or a total of 70.8%, as compared to the same period last year for 0.0%, 14.2%, 9.9%, 12.2%, and26.6%, or a total of 62.9%, respectively. During the six months ended April 30, 2020, aggregate revenues from these global groupof affiliated companies were 21.3%, 14.9%, 14.6%, 10.6% and 10.1%, or a total of 71.5%, as compared to the same period last yearfor 0.0%, 10.7%, 10.5%, 11.6% and 22.2%, or a total of 55.0%, respectively. At April 30, 2020, amounts due from these global groupsof affiliated companies represented 86.1% of total accounts receivable balance.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>Asof April 30, 2020, one of the Company&amp;#8217;s customers (representing 10.2% of revenues during the six months ended April 30,2020) owes the Company approximately $5.3 million (including $1.25 million from a Promissory Note due September 2020). Thisoutstanding obligation represents approximately 21.6% of the Company&amp;#8217;s total working capital. The Company is providingmultiple services to this customer related to their construction and validation of a manufacturing facility in Puerto Rico. A significant portion of thecustomer&amp;#8217;s funding comes from different financing sources. Management estimates that collectability of the account isreasonably assured, accordingly, no provision for losses, if any, have been recorded in the financial statements.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="47392.0" fact-concept="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 47,392 - pbsv-20200131.xml 1813</message>
 <ref href="pbsv-20200131.xml#element(/1/434)" sourceLine="1813">
  <property name="label" value="Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GainLossOnDispositionOfAssets"/>
  <property name="QName" value="us-gaap:GainLossOnDispositionOfAssets"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="47,392"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="367437.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherAssetsNoncurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 367,437 - pbsv-20200131.xml 1528</message>
 <ref href="pbsv-20200131.xml#element(/1/149)" sourceLine="1528">
  <property name="label" value="Other assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherAssetsNoncurrent"/>
  <property name="QName" value="us-gaap:OtherAssetsNoncurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="367,437"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.146" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.146 - pbsv-20200131.xml 1948</message>
 <ref href="pbsv-20200131.xml#element(/1/569)" sourceLine="1948">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_GlobalGroupCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.146"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="143600.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 143,600 - pbsv-20200131.xml 1589</message>
 <ref href="pbsv-20200131.xml#element(/1/210)" sourceLine="1589">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="143,600"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="113714.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 113,714 - pbsv-20200131.xml 1658</message>
 <ref href="pbsv-20200131.xml#element(/1/279)" sourceLine="1658">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="113,714"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1163078.0" fact-concept="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,163,078 - pbsv-20200131.xml 1742</message>
 <ref href="pbsv-20200131.xml#element(/1/363)" sourceLine="1742">
  <property name="label" value="Comprehensive Income (Loss), Net of Tax, Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ComprehensiveIncomeNetOfTax"/>
  <property name="QName" value="us-gaap:ComprehensiveIncomeNetOfTax"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,163,078"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-15548.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -15,548 - pbsv-20200131.xml 1814</message>
 <ref href="pbsv-20200131.xml#element(/1/435)" sourceLine="1814">
  <property name="label" value="Net Cash Provided by (Used in) Investing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-15,548"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23373817.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,373,817 - pbsv-20200131.xml 1743</message>
 <ref href="pbsv-20200131.xml#element(/1/364)" sourceLine="1743">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,373,817"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3778867.0" fact-concept="{http://fasb.org/us-gaap/2024}CostOfRevenue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3,778,867 - pbsv-20200131.xml 1659</message>
 <ref href="pbsv-20200131.xml#element(/1/280)" sourceLine="1659">
  <property name="label" value="COST OF SERVICES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CostOfRevenue"/>
  <property name="QName" value="us-gaap:CostOfRevenue"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3,778,867"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In February 2016, the FASB issued ASU 2016-02..." fact-concept="{http://fasb.org/us-gaap/2024}NewAccountingPronouncementsPolicyPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In February 2016, the FASB issued ASU 2016-02,Leases (Topic 842) (&amp;#8220;ASU 2016-02&amp;#8221;). ASU 2016-02 is intended to increase transparency and comparability of accountingfor lease transactions. For all leases with terms greater than twelve months, the new guidance will require lessees to recognizeright-of-use assets and corresponding lease liabilities on the balance sheet and to disclose qualitative and quantitative informationabout lease transactions. The new standard maintains a distinction between finance leases and operating leases. As a result, theeffect of leases in the statement of operations and statement of cash flows is largely unchanged. In July 2018, the FASB issuedASU 2018-11, Leases - Targeted Improvements, to allow a company to elect an optional modified retrospective transition method thatapplies the new lease requirements through a cumulative-effect adjustment in the period of adoption.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Effective November 1, 2019, the Company adoptedthe new lease accounting standard using the modified retrospective transition option of applying the new standard at the adoptiondate. We categorize leases at their inception as either operating or finance leases. The Company leases include an operationallease for office space and a finance lease agreement for a vehicle. The adoption of the new standard resulted in the operatinglease being included in operating lease right-of-use assets, current operating lease liabilities, and long-term operating leaseliabilities in our condensed consolidated balance sheets, but did not have an impact on the Company&amp;#8217;s beginning balance ofretained earnings, consolidated statement of operations or statement of cash flows. Finance leases are included in net propertyand equipment, current installments of long-term debt, and long-term debt in our condensed consolidated balance sheets. The mostsignificant impact was the recognition of right-of-use assets and lease liabilities on account of the Company&amp;#8217;s operatingleases. The Company recognized $941,009 of right-of-use assets and $911,922 in operating lease liabilities at November 1, 2019.As of April 30, 2020, the total right-of-use assets related to the Company&amp;#8217;s operating leases was $874,840 and operatinglease liabilities current and non-current were approximately $156,496 and $696,916, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 2003</message>
 <ref href="pbsv-20200131.xml#element(/1/624)" sourceLine="2003">
  <property name="label" value="Recently Adopted Accounting Pronouncements"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NewAccountingPronouncementsPolicyPolicyTextBlock"/>
  <property name="QName" value="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In February 2016, the FASB issued ASU 2016-02,Leases (Topic 842) (&amp;#8220;ASU 2016-02&amp;#8221;). ASU 2016-02 is intended to increase transparency and comparability of accountingfor lease transactions. For all leases with terms greater than twelve months, the new guidance will require lessees to recognizeright-of-use assets and corresponding lease liabilities on the balance sheet and to disclose qualitative and quantitative informationabout lease transactions. The new standard maintains a distinction between finance leases and operating leases. As a result, theeffect of leases in the statement of operations and statement of cash flows is largely unchanged. In July 2018, the FASB issuedASU 2018-11, Leases - Targeted Improvements, to allow a company to elect an optional modified retrospective transition method thatapplies the new lease requirements through a cumulative-effect adjustment in the period of adoption.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Effective November 1, 2019, the Company adoptedthe new lease accounting standard using the modified retrospective transition option of applying the new standard at the adoptiondate. We categorize leases at their inception as either operating or finance leases. The Company leases include an operationallease for office space and a finance lease agreement for a vehicle. The adoption of the new standard resulted in the operatinglease being included in operating lease right-of-use assets, current operating lease liabilities, and long-term operating leaseliabilities in our condensed consolidated balance sheets, but did not have an impact on the Company&amp;#8217;s beginning balance ofretained earnings, consolidated statement of operations or statement of cash flows. Finance leases are included in net propertyand equipment, current installments of long-term debt, and long-term debt in our condensed consolidated balance sheets. The mostsignificant impact was the recognition of right-of-use assets and lease liabilities on account of the Company&amp;#8217;s operatingleases. The Company recognized $941,009 of right-of-use assets and $911,922 in operating lease liabilities at November 1, 2019.As of April 30, 2020, the total right-of-use assets related to the Company&amp;#8217;s operating leases was $874,840 and operatinglease liabilities current and non-current were approximately $156,496 and $696,916, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-392579.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -392,579 - pbsv-20200131.xml 1590</message>
 <ref href="pbsv-20200131.xml#element(/1/211)" sourceLine="1590">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-392,579"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingLeaseRightOfUseAsset" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1530</message>
 <ref href="pbsv-20200131.xml#element(/1/151)" sourceLine="1530">
  <property name="label" value="Operating lease right-of-use"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingLeaseRightOfUseAsset"/>
  <property name="QName" value="us-gaap:OperatingLeaseRightOfUseAsset"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.106" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.106 - pbsv-20200131.xml 1949</message>
 <ref href="pbsv-20200131.xml#element(/1/570)" sourceLine="1949">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_GlobalGroupDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.106"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="604669.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 604,669 - pbsv-20200131.xml 1817</message>
 <ref href="pbsv-20200131.xml#element(/1/438)" sourceLine="1817">
  <property name="label" value="Net Cash Provided by (Used in) Investing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="604,669"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1868900.0" fact-concept="{http://fasb.org/us-gaap/2024}GrossProfit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,868,900 - pbsv-20200131.xml 1663</message>
 <ref href="pbsv-20200131.xml#element(/1/284)" sourceLine="1663">
  <property name="label" value="Gross Profit"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GrossProfit"/>
  <property name="QName" value="us-gaap:GrossProfit"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,868,900"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1746</message>
 <ref href="pbsv-20200131.xml#element(/1/367)" sourceLine="1746">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="481325.0" fact-concept="{http://fasb.org/us-gaap/2024}AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 481,325 - pbsv-20200131.xml 1892</message>
 <ref href="pbsv-20200131.xml#element(/1/513)" sourceLine="1892">
  <property name="label" value="Accumulated depreciation and amortization"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="481,325"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2340.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,340 - pbsv-20200131.xml 1591</message>
 <ref href="pbsv-20200131.xml#element(/1/212)" sourceLine="1591">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,340"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-26874.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -26,874 - pbsv-20200131.xml 1816</message>
 <ref href="pbsv-20200131.xml#element(/1/437)" sourceLine="1816">
  <property name="label" value="Net Cash Provided by (Used in) Investing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-26,874"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="6644079.0" fact-concept="{http://fasb.org/us-gaap/2024}CostOfRevenue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 6,644,079 - pbsv-20200131.xml 1662</message>
 <ref href="pbsv-20200131.xml#element(/1/283)" sourceLine="1662">
  <property name="label" value="COST OF SERVICES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CostOfRevenue"/>
  <property name="QName" value="us-gaap:CostOfRevenue"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="6,644,079"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23397707.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,397,707 - pbsv-20200131.xml 1745</message>
 <ref href="pbsv-20200131.xml#element(/1/366)" sourceLine="1745">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,397,707"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="27576.0" fact-concept="{http://fasb.org/us-gaap/2024}IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 27,576 - pbsv-20200131.xml 1894</message>
 <ref href="pbsv-20200131.xml#element(/1/515)" sourceLine="1894">
  <property name="label" value="Effect of options to purchase common stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="QName" value="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="27,576"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>On June 13, 2014, the Board of Directors oft..." fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquityNoteDisclosureTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>On June 13, 2014, the Board of Directors ofthe Company authorized the Company to repurchase up to two million shares of its outstanding common stock (the &amp;#8220;RepurchaseProgram&amp;#8221;). The timing, manner, price and amount of any repurchases under the Repurchase Program will be at the discretionof the Company, subject to the requirements of the Securities Exchange Act of 1934, as amended, and related rules. The RepurchaseProgram does not oblige the Company to repurchase any shares and it may be modified, suspended or terminated at any time and forany reason. No shares will be repurchased under the Repurchase Program directly from directors or officers of the Company. As ofApril 30, 2020 and October 31, 2019, a total of 341,154 and 338,854 shares of the Company&amp;#8217;s common stock were purchased underthe Repurchase Program for an aggregate amount of $331,306 and $329,607, respectively. During April 2020, the Company suspended purchases under the Repurchase Program to conserve cash due to the economic uncertaintycaused by the coronavirus pandemic. Also, on November 26, 2018, the Companyrepurchased 62,972 shares of common stock, outside of the Repurchase Program, from the Company&amp;#8217;s Chief Executive Officerat $1.00 per share. These shares were repurchased at a discount to market to provide for an orderly disposition of the shares.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 2004</message>
 <ref href="pbsv-20200131.xml#element(/1/625)" sourceLine="2004">
  <property name="label" value="G. EQUITY TRANSACTIONS"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquityNoteDisclosureTextBlock"/>
  <property name="QName" value="us-gaap:StockholdersEquityNoteDisclosureTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>On June 13, 2014, the Board of Directors ofthe Company authorized the Company to repurchase up to two million shares of its outstanding common stock (the &amp;#8220;RepurchaseProgram&amp;#8221;). The timing, manner, price and amount of any repurchases under the Repurchase Program will be at the discretionof the Company, subject to the requirements of the Securities Exchange Act of 1934, as amended, and related rules. The RepurchaseProgram does not oblige the Company to repurchase any shares and it may be modified, suspended or terminated at any time and forany reason. No shares will be repurchased under the Repurchase Program directly from directors or officers of the Company. As ofApril 30, 2020 and October 31, 2019, a total of 341,154 and 338,854 shares of the Company&amp;#8217;s common stock were purchased underthe Repurchase Program for an aggregate amount of $331,306 and $329,607, respectively. During April 2020, the Company suspended purchases under the Repurchase Program to conserve cash due to the economic uncertaintycaused by the coronavirus pandemic. Also, on November 26, 2018, the Companyrepurchased 62,972 shares of common stock, outside of the Repurchase Program, from the Company&amp;#8217;s Chief Executive Officerat $1.00 per share. These shares were repurchased at a discount to market to provide for an orderly disposition of the shares.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.101" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.101 - pbsv-20200131.xml 1950</message>
 <ref href="pbsv-20200131.xml#element(/1/571)" sourceLine="1950">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_GlobalGroupEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.101"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2341.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,341 - pbsv-20200131.xml 1592</message>
 <ref href="pbsv-20200131.xml#element(/1/213)" sourceLine="1592">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,341"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="6806142.0" fact-concept="{http://fasb.org/us-gaap/2024}CostOfRevenue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 6,806,142 - pbsv-20200131.xml 1661</message>
 <ref href="pbsv-20200131.xml#element(/1/282)" sourceLine="1661">
  <property name="label" value="COST OF SERVICES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CostOfRevenue"/>
  <property name="QName" value="us-gaap:CostOfRevenue"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="6,806,142"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="27141700.0" fact-concept="{http://fasb.org/us-gaap/2024}AssetsCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 27,141,700 - pbsv-20200131.xml 1533</message>
 <ref href="pbsv-20200131.xml#element(/1/154)" sourceLine="1533">
  <property name="label" value="Assets, Current"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AssetsCurrent"/>
  <property name="QName" value="us-gaap:AssetsCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="27,141,700"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="563277.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 563,277 - pbsv-20200131.xml 1815</message>
 <ref href="pbsv-20200131.xml#element(/1/436)" sourceLine="1815">
  <property name="label" value="Net Cash Provided by (Used in) Investing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="563,277"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 12pt Times New Roman, Times, Serif; width: 100%&quot;>&lt;tr style=&quot;vertical-align:..." fact-concept="{http://fasb.org/us-gaap/2024}ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 12pt Times New Roman, Times, Serif; width: 100%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Six months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;width: 56%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Net income available to common equity holders - used to compute&amp;#160;basic and diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$687,561&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$707,483&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,214,461&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,178,503&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of common shares - used to compute basic earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,001,627&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,903&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,745&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,032,107&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Effect of options to purchase common stock&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;27,576&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;66,020&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,213&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;73,059&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of shares - used to compute diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,029,203&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,068,923&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,025,958&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,105,166&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;/table> - pbsv-20200131.xml 2006</message>
 <ref href="pbsv-20200131.xml#element(/1/627)" sourceLine="2006">
  <property name="label" value="Schedule of calculations of basic and diluted earnings (losses) per share"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
  <property name="QName" value="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 12pt Times New Roman, Times, Serif; width: 100%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Six months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;width: 56%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Net income available to common equity holders - used to compute&amp;#160;basic and diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$687,561&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$707,483&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,214,461&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,178,503&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of common shares - used to compute basic earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,001,627&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,903&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,745&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,032,107&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Effect of options to purchase common stock&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;27,576&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;66,020&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,213&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;73,059&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of shares - used to compute diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,029,203&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,068,923&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,025,958&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,105,166&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;/table>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="290658.0" fact-concept="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentNet" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 290,658 - pbsv-20200131.xml 1532</message>
 <ref href="pbsv-20200131.xml#element(/1/153)" sourceLine="1532">
  <property name="label" value="Property and equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PropertyPlantAndEquipmentNet"/>
  <property name="QName" value="us-gaap:PropertyPlantAndEquipmentNet"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="290,658"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1744</message>
 <ref href="pbsv-20200131.xml#element(/1/365)" sourceLine="1744">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="340000.0" fact-concept="{http://fasb.org/us-gaap/2024}AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 340,000 - pbsv-20200131.xml 1898</message>
 <ref href="pbsv-20200131.xml#element(/1/519)" sourceLine="1898">
  <property name="label" value="Antidilutive options excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="QName" value="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="340,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.715" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.715 - pbsv-20200131.xml 1951</message>
 <ref href="pbsv-20200131.xml#element(/1/572)" sourceLine="1951">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_GlobalGroupTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.715"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1593</message>
 <ref href="pbsv-20200131.xml#element(/1/214)" sourceLine="1593">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3556942.0" fact-concept="{http://fasb.org/us-gaap/2024}CostOfRevenue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3,556,942 - pbsv-20200131.xml 1660</message>
 <ref href="pbsv-20200131.xml#element(/1/281)" sourceLine="1660">
  <property name="label" value="COST OF SERVICES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CostOfRevenue"/>
  <property name="QName" value="us-gaap:CostOfRevenue"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3,556,942"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromCollectionOfOtherReceivables" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1818</message>
 <ref href="pbsv-20200131.xml#element(/1/439)" sourceLine="1818">
  <property name="label" value="Collection from promissory note receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromCollectionOfOtherReceivables"/>
  <property name="QName" value="us-gaap:ProceedsFromCollectionOfOtherReceivables"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23397707.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,397,707 - pbsv-20200131.xml 1747</message>
 <ref href="pbsv-20200131.xml#element(/1/368)" sourceLine="1747">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,397,707"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="509275.0" fact-concept="{http://fasb.org/us-gaap/2024}AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 509,275 - pbsv-20200131.xml 1893</message>
 <ref href="pbsv-20200131.xml#element(/1/514)" sourceLine="1893">
  <property name="label" value="Accumulated depreciation and amortization"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="509,275"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1594</message>
 <ref href="pbsv-20200131.xml#element(/1/215)" sourceLine="1594">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23405753.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,405,753 - pbsv-20200131.xml 1748</message>
 <ref href="pbsv-20200131.xml#element(/1/369)" sourceLine="1748">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,405,753"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="12000.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromSaleOfPropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 12,000 - pbsv-20200131.xml 1822</message>
 <ref href="pbsv-20200131.xml#element(/1/443)" sourceLine="1822">
  <property name="label" value="Proceeds from sale of property and equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="12,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Ti..." fact-concept="{http://pharmabioserv.com/20241231}RecentAccountingPronouncementsPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Recent accounting pronouncements pending adoptionnot discussed above or in the 2019 Form 10-K are either not applicable or will not have or are not expected to have a materialimpact on us.&lt;/p> - pbsv-20200131.xml 2008</message>
 <ref href="pbsv-20200131.xml#element(/1/629)" sourceLine="2008">
  <property name="label" value="Recent Accounting Pronouncements"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="RecentAccountingPronouncementsPolicyTextBlock"/>
  <property name="QName" value="PBSV:RecentAccountingPronouncementsPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Recent accounting pronouncements pending adoptionnot discussed above or in the 2019 Form 10-K are either not applicable or will not have or are not expected to have a materialimpact on us.&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="332722.0" fact-concept="{http://fasb.org/us-gaap/2024}PrepaidExpenseAndOtherAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 332,722 - pbsv-20200131.xml 1535</message>
 <ref href="pbsv-20200131.xml#element(/1/156)" sourceLine="1535">
  <property name="label" value="Prepaids and other assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PrepaidExpenseAndOtherAssets"/>
  <property name="QName" value="us-gaap:PrepaidExpenseAndOtherAssets"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="332,722"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3072462.0" fact-concept="{http://fasb.org/us-gaap/2024}GrossProfit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3,072,462 - pbsv-20200131.xml 1666</message>
 <ref href="pbsv-20200131.xml#element(/1/287)" sourceLine="1666">
  <property name="label" value="Gross Profit"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GrossProfit"/>
  <property name="QName" value="us-gaap:GrossProfit"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3,072,462"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="73059.0" fact-concept="{http://fasb.org/us-gaap/2024}IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 73,059 - pbsv-20200131.xml 1897</message>
 <ref href="pbsv-20200131.xml#element(/1/518)" sourceLine="1897">
  <property name="label" value="Effect of options to purchase common stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="QName" value="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="73,059"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1952</message>
 <ref href="pbsv-20200131.xml#element(/1/573)" sourceLine="1952">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_GlobalGroupAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.00"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1749</message>
 <ref href="pbsv-20200131.xml#element(/1/370)" sourceLine="1749">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="500000.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromCollectionOfOtherReceivables" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 500,000 - pbsv-20200131.xml 1821</message>
 <ref href="pbsv-20200131.xml#element(/1/442)" sourceLine="1821">
  <property name="label" value="Collection from promissory note receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromCollectionOfOtherReceivables"/>
  <property name="QName" value="us-gaap:ProceedsFromCollectionOfOtherReceivables"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="500,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1364956.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,364,956 - pbsv-20200131.xml 1595</message>
 <ref href="pbsv-20200131.xml#element(/1/216)" sourceLine="1595">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,364,956"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3454792.0" fact-concept="{http://fasb.org/us-gaap/2024}GrossProfit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3,454,792 - pbsv-20200131.xml 1665</message>
 <ref href="pbsv-20200131.xml#element(/1/286)" sourceLine="1665">
  <property name="label" value="Gross Profit"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GrossProfit"/>
  <property name="QName" value="us-gaap:GrossProfit"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3,454,792"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23213.0" fact-concept="{http://fasb.org/us-gaap/2024}IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,213 - pbsv-20200131.xml 1896</message>
 <ref href="pbsv-20200131.xml#element(/1/517)" sourceLine="1896">
  <property name="label" value="Effect of options to purchase common stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="QName" value="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,213"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1750</message>
 <ref href="pbsv-20200131.xml#element(/1/371)" sourceLine="1750">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromCollectionOfOtherReceivables" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1820</message>
 <ref href="pbsv-20200131.xml#element(/1/441)" sourceLine="1820">
  <property name="label" value="Collection from promissory note receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromCollectionOfOtherReceivables"/>
  <property name="QName" value="us-gaap:ProceedsFromCollectionOfOtherReceivables"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.107" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.107 - pbsv-20200131.xml 1953</message>
 <ref href="pbsv-20200131.xml#element(/1/574)" sourceLine="1953">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_GlobalGroupBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.107"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1403936.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,403,936 - pbsv-20200131.xml 1596</message>
 <ref href="pbsv-20200131.xml#element(/1/217)" sourceLine="1596">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,403,936"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1593402.0" fact-concept="{http://fasb.org/us-gaap/2024}GrossProfit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,593,402 - pbsv-20200131.xml 1664</message>
 <ref href="pbsv-20200131.xml#element(/1/285)" sourceLine="1664">
  <property name="label" value="Gross Profit"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GrossProfit"/>
  <property name="QName" value="us-gaap:GrossProfit"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,593,402"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23377259.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,377,259 - pbsv-20200131.xml 1751</message>
 <ref href="pbsv-20200131.xml#element(/1/372)" sourceLine="1751">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,377,259"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="66020.0" fact-concept="{http://fasb.org/us-gaap/2024}IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 66,020 - pbsv-20200131.xml 1895</message>
 <ref href="pbsv-20200131.xml#element(/1/516)" sourceLine="1895">
  <property name="label" value="Effect of options to purchase common stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="QName" value="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="66,020"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="25974980.0" fact-concept="{http://fasb.org/us-gaap/2024}AssetsCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 25,974,980 - pbsv-20200131.xml 1534</message>
 <ref href="pbsv-20200131.xml#element(/1/155)" sourceLine="1534">
  <property name="label" value="Assets, Current"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AssetsCurrent"/>
  <property name="QName" value="us-gaap:AssetsCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="25,974,980"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1148516.0" fact-concept="{http://fasb.org/us-gaap/2024}SellingGeneralAndAdministrativeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,148,516 - pbsv-20200131.xml 1667</message>
 <ref href="pbsv-20200131.xml#element(/1/288)" sourceLine="1667">
  <property name="label" value="SELLING, GENERAL AND ADMINISTRATIVE EXPENSES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SellingGeneralAndAdministrativeExpense"/>
  <property name="QName" value="us-gaap:SellingGeneralAndAdministrativeExpense"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,148,516"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="500000.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromCollectionOfOtherReceivables" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 500,000 - pbsv-20200131.xml 1819</message>
 <ref href="pbsv-20200131.xml#element(/1/440)" sourceLine="1819">
  <property name="label" value="Collection from promissory note receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromCollectionOfOtherReceivables"/>
  <property name="QName" value="us-gaap:ProceedsFromCollectionOfOtherReceivables"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="500,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2163033.0" fact-concept="{http://fasb.org/us-gaap/2024}SellingGeneralAndAdministrativeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,163,033 - pbsv-20200131.xml 1670</message>
 <ref href="pbsv-20200131.xml#element(/1/291)" sourceLine="1670">
  <property name="label" value="SELLING, GENERAL AND ADMINISTRATIVE EXPENSES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SellingGeneralAndAdministrativeExpense"/>
  <property name="QName" value="us-gaap:SellingGeneralAndAdministrativeExpense"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,163,033"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1752</message>
 <ref href="pbsv-20200131.xml#element(/1/373)" sourceLine="1752">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1902</message>
 <ref href="pbsv-20200131.xml#element(/1/523)" sourceLine="1902">
  <property name="label" value="Antidilutive warrants excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="QName" value="PBSV:AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="8781026.0" fact-concept="{http://fasb.org/us-gaap/2024}AccountsReceivableNetCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 8,781,026 - pbsv-20200131.xml 1540</message>
 <ref href="pbsv-20200131.xml#element(/1/161)" sourceLine="1540">
  <property name="label" value="Accounts receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccountsReceivableNetCurrent"/>
  <property name="QName" value="us-gaap:AccountsReceivableNetCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="8,781,026"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.105" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.105 - pbsv-20200131.xml 1954</message>
 <ref href="pbsv-20200131.xml#element(/1/575)" sourceLine="1954">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_GlobalGroupCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.105"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20289611.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,289,611 - pbsv-20200131.xml 1597</message>
 <ref href="pbsv-20200131.xml#element(/1/218)" sourceLine="1597">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,289,611"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="27548.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 27,548 - pbsv-20200131.xml 1826</message>
 <ref href="pbsv-20200131.xml#element(/1/447)" sourceLine="1826">
  <property name="label" value="Payments to Acquire Property, Plant, and Equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="27,548"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1250000.0" fact-concept="{http://pharmabioserv.com/20241231}PromissoryNoteReceivableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,250,000 - pbsv-20200131.xml 1537</message>
 <ref href="pbsv-20200131.xml#element(/1/158)" sourceLine="1537">
  <property name="label" value="Current portion - promissory note receivable due from sale of assets from discontinued operations"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="PromissoryNoteReceivableCurrent"/>
  <property name="QName" value="PBSV:PromissoryNoteReceivableCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,250,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23405753.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,405,753 - pbsv-20200131.xml 1753</message>
 <ref href="pbsv-20200131.xml#element(/1/374)" sourceLine="1753">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,405,753"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="80000.0" fact-concept="{http://fasb.org/us-gaap/2024}AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 80,000 - pbsv-20200131.xml 1901</message>
 <ref href="pbsv-20200131.xml#element(/1/522)" sourceLine="1901">
  <property name="label" value="Antidilutive options excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="QName" value="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="80,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2197649.0" fact-concept="{http://fasb.org/us-gaap/2024}SellingGeneralAndAdministrativeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,197,649 - pbsv-20200131.xml 1669</message>
 <ref href="pbsv-20200131.xml#element(/1/290)" sourceLine="1669">
  <property name="label" value="SELLING, GENERAL AND ADMINISTRATIVE EXPENSES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SellingGeneralAndAdministrativeExpense"/>
  <property name="QName" value="us-gaap:SellingGeneralAndAdministrativeExpense"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,197,649"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="99038.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromSaleOfPropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 99,038 - pbsv-20200131.xml 1825</message>
 <ref href="pbsv-20200131.xml#element(/1/446)" sourceLine="1825">
  <property name="label" value="Proceeds from sale of property and equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="99,038"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20687529.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,687,529 - pbsv-20200131.xml 1598</message>
 <ref href="pbsv-20200131.xml#element(/1/219)" sourceLine="1598">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,687,529"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1754</message>
 <ref href="pbsv-20200131.xml#element(/1/375)" sourceLine="1754">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="340000.0" fact-concept="{http://fasb.org/us-gaap/2024}AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 340,000 - pbsv-20200131.xml 1900</message>
 <ref href="pbsv-20200131.xml#element(/1/521)" sourceLine="1900">
  <property name="label" value="Antidilutive options excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="QName" value="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="340,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%&quot;>&lt;..." fact-concept="{http://fasb.org/us-gaap/2024}ScheduleOfSegmentReportingInformationBySegmentTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>Six months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>REVENUES:&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;width: 40%; text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>5,116,682&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>4,293,041&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>9,297,592&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>8,181,595&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>394,991&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>661,356&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>784,353&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,188,001&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>133,762&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>141,500&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>155,950&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>233,231&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,332&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>54,447&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>23,039&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>113,714&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>Total consolidated revenues&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,647,767&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,150,344&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>10,260,934&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>9,716,541&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>INCOME (LOSS) BEFORE TAXES:&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>633,633&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>581,019&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,150,772&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>956,289&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(41,887&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>14,230&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;vertical-align: bottom; text-align: right&quot;>(61,930&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,320&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>7,489&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(8,014&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(61,684&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(57,925&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>169,733&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>195,506&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>324,005&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>396,032&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 0.25in&quot;>Total consolidated income before taxes&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>768,968&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>782,741&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,351,163&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,296,716&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;/table> - pbsv-20200131.xml 2009</message>
 <ref href="pbsv-20200131.xml#element(/1/630)" sourceLine="2009">
  <property name="label" value="Schedule of segment reporting information"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
  <property name="QName" value="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>Six months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>REVENUES:&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;width: 40%; text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>5,116,682&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>4,293,041&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>9,297,592&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>8,181,595&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>394,991&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>661,356&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>784,353&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,188,001&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>133,762&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>141,500&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>155,950&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>233,231&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,332&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>54,447&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>23,039&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>113,714&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>Total consolidated revenues&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,647,767&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,150,344&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>10,260,934&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>9,716,541&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>INCOME (LOSS) BEFORE TAXES:&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>633,633&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>581,019&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,150,772&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>956,289&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(41,887&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>14,230&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;vertical-align: bottom; text-align: right&quot;>(61,930&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,320&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>7,489&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(8,014&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(61,684&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(57,925&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>169,733&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>195,506&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>324,005&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>396,032&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 0.25in&quot;>Total consolidated income before taxes&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>768,968&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>782,741&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,351,163&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,296,716&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;/table>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.116" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.116 - pbsv-20200131.xml 1955</message>
 <ref href="pbsv-20200131.xml#element(/1/576)" sourceLine="1955">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_GlobalGroupDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.116"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="12000.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromSaleOfPropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 12,000 - pbsv-20200131.xml 1824</message>
 <ref href="pbsv-20200131.xml#element(/1/445)" sourceLine="1824">
  <property name="label" value="Proceeds from sale of property and equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="12,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="11430.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 11,430 - pbsv-20200131.xml 1755</message>
 <ref href="pbsv-20200131.xml#element(/1/376)" sourceLine="1755">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="11,430"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="453780.0" fact-concept="{http://fasb.org/us-gaap/2024}PrepaidExpenseAndOtherAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 453,780 - pbsv-20200131.xml 1536</message>
 <ref href="pbsv-20200131.xml#element(/1/157)" sourceLine="1536">
  <property name="label" value="Prepaids and other assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PrepaidExpenseAndOtherAssets"/>
  <property name="QName" value="us-gaap:PrepaidExpenseAndOtherAssets"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="453,780"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="92522.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 92,522 - pbsv-20200131.xml 1599</message>
 <ref href="pbsv-20200131.xml#element(/1/220)" sourceLine="1599">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="92,522"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1116474.0" fact-concept="{http://fasb.org/us-gaap/2024}SellingGeneralAndAdministrativeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,116,474 - pbsv-20200131.xml 1668</message>
 <ref href="pbsv-20200131.xml#element(/1/289)" sourceLine="1668">
  <property name="label" value="SELLING, GENERAL AND ADMINISTRATIVE EXPENSES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SellingGeneralAndAdministrativeExpense"/>
  <property name="QName" value="us-gaap:SellingGeneralAndAdministrativeExpense"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,116,474"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="80000.0" fact-concept="{http://fasb.org/us-gaap/2024}AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 80,000 - pbsv-20200131.xml 1899</message>
 <ref href="pbsv-20200131.xml#element(/1/520)" sourceLine="1899">
  <property name="label" value="Antidilutive options excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="QName" value="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="80,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="99038.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromSaleOfPropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 99,038 - pbsv-20200131.xml 1823</message>
 <ref href="pbsv-20200131.xml#element(/1/444)" sourceLine="1823">
  <property name="label" value="Proceeds from sale of property and equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="99,038"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.222" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.222 - pbsv-20200131.xml 1956</message>
 <ref href="pbsv-20200131.xml#element(/1/577)" sourceLine="1956">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_GlobalGroupEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.222"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="102133.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 102,133 - pbsv-20200131.xml 1600</message>
 <ref href="pbsv-20200131.xml#element(/1/221)" sourceLine="1600">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="102,133"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="22860.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 22,860 - pbsv-20200131.xml 1758</message>
 <ref href="pbsv-20200131.xml#element(/1/379)" sourceLine="1758">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="22,860"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="48584.0" fact-concept="{http://fasb.org/us-gaap/2024}NonoperatingIncomeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 48,584 - pbsv-20200131.xml 1671</message>
 <ref href="pbsv-20200131.xml#element(/1/292)" sourceLine="1671">
  <property name="label" value="OTHER INCOME, NET"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NonoperatingIncomeExpense"/>
  <property name="QName" value="us-gaap:NonoperatingIncomeExpense"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="48,584"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="15581997.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 15,581,997 - pbsv-20200131.xml 1541</message>
 <ref href="pbsv-20200131.xml#element(/1/162)" sourceLine="1541">
  <property name="label" value="Cash and cash equivalents"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsAtCarryingValue"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsAtCarryingValue"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="15,581,997"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="38844.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 38,844 - pbsv-20200131.xml 1829</message>
 <ref href="pbsv-20200131.xml#element(/1/450)" sourceLine="1829">
  <property name="label" value="Payments to Acquire Property, Plant, and Equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="38,844"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.249" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.249 - pbsv-20200131.xml 1910</message>
 <ref href="pbsv-20200131.xml#element(/1/531)" sourceLine="1910">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_MajorCustomerAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.249"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="9976981.0" fact-concept="{http://fasb.org/us-gaap/2024}AccountsReceivableNetCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 9,976,981 - pbsv-20200131.xml 1539</message>
 <ref href="pbsv-20200131.xml#element(/1/160)" sourceLine="1539">
  <property name="label" value="Accounts receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccountsReceivableNetCurrent"/>
  <property name="QName" value="us-gaap:AccountsReceivableNetCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="9,976,981"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.55" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.55 - pbsv-20200131.xml 1957</message>
 <ref href="pbsv-20200131.xml#element(/1/578)" sourceLine="1957">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_GlobalGroupTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.55"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-392007.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -392,007 - pbsv-20200131.xml 1601</message>
 <ref href="pbsv-20200131.xml#element(/1/222)" sourceLine="1601">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-392,007"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="94020.0" fact-concept="{http://fasb.org/us-gaap/2024}NonoperatingIncomeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 94,020 - pbsv-20200131.xml 1673</message>
 <ref href="pbsv-20200131.xml#element(/1/294)" sourceLine="1673">
  <property name="label" value="OTHER INCOME, NET"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NonoperatingIncomeExpense"/>
  <property name="QName" value="us-gaap:NonoperatingIncomeExpense"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="94,020"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="11430.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 11,430 - pbsv-20200131.xml 1757</message>
 <ref href="pbsv-20200131.xml#element(/1/378)" sourceLine="1757">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="11,430"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="341154.0" fact-concept="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgram" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 341,154 - pbsv-20200131.xml 1906</message>
 <ref href="pbsv-20200131.xml#element(/1/527)" sourceLine="1906">
  <property name="label" value="Shares purchased under Repurchase Program"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="SharesPurchasedUnderRepurchaseProgram"/>
  <property name="QName" value="PBSV:SharesPurchasedUnderRepurchaseProgram"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="341,154"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.852" fact-concept="{http://pharmabioserv.com/20241231}AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.852 - pbsv-20200131.xml 1958</message>
 <ref href="pbsv-20200131.xml#element(/1/579)" sourceLine="1958">
  <property name="label" value="Amount due from major customers as percentage of accounts receivable"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable"/>
  <property name="QName" value="PBSV:AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_MajorCustomerTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.852"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="38874.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 38,874 - pbsv-20200131.xml 1828</message>
 <ref href="pbsv-20200131.xml#element(/1/449)" sourceLine="1828">
  <property name="label" value="Payments to Acquire Property, Plant, and Equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="38,874"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-394278.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -394,278 - pbsv-20200131.xml 1602</message>
 <ref href="pbsv-20200131.xml#element(/1/223)" sourceLine="1602">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-394,278"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="9000.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 9,000 - pbsv-20200131.xml 1756</message>
 <ref href="pbsv-20200131.xml#element(/1/377)" sourceLine="1756">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="9,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1250000.0" fact-concept="{http://pharmabioserv.com/20241231}PromissoryNoteReceivableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,250,000 - pbsv-20200131.xml 1538</message>
 <ref href="pbsv-20200131.xml#element(/1/159)" sourceLine="1538">
  <property name="label" value="Current portion - promissory note receivable due from sale of assets from discontinued operations"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="PromissoryNoteReceivableCurrent"/>
  <property name="QName" value="PBSV:PromissoryNoteReceivableCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,250,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="305813.0" fact-concept="{http://fasb.org/us-gaap/2024}NonoperatingIncomeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 305,813 - pbsv-20200131.xml 1672</message>
 <ref href="pbsv-20200131.xml#element(/1/293)" sourceLine="1672">
  <property name="label" value="OTHER INCOME, NET"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NonoperatingIncomeExpense"/>
  <property name="QName" value="us-gaap:NonoperatingIncomeExpense"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="305,813"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="18000.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 18,000 - pbsv-20200131.xml 1759</message>
 <ref href="pbsv-20200131.xml#element(/1/380)" sourceLine="1759">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="18,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="35761.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 35,761 - pbsv-20200131.xml 1827</message>
 <ref href="pbsv-20200131.xml#element(/1/448)" sourceLine="1827">
  <property name="label" value="Payments to Acquire Property, Plant, and Equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="35,761"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1000000.0" fact-concept="{http://pharmabioserv.com/20241231}AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,000,000 - pbsv-20200131.xml 1905</message>
 <ref href="pbsv-20200131.xml#element(/1/526)" sourceLine="1905">
  <property name="label" value="Antidilutive warrants excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="QName" value="PBSV:AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,000,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1830</message>
 <ref href="pbsv-20200131.xml#element(/1/451)" sourceLine="1830">
  <property name="label" value="DisposalOfMarketableSecurities"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="DisposalOfMarketableSecurities"/>
  <property name="QName" value="PBSV:DisposalOfMarketableSecurities"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2338.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,338 - pbsv-20200131.xml 1603</message>
 <ref href="pbsv-20200131.xml#element(/1/224)" sourceLine="1603">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,338"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1904</message>
 <ref href="pbsv-20200131.xml#element(/1/525)" sourceLine="1904">
  <property name="label" value="Antidilutive warrants excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="QName" value="PBSV:AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="9000.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 9,000 - pbsv-20200131.xml 1760</message>
 <ref href="pbsv-20200131.xml#element(/1/381)" sourceLine="1760">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="9,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1928961.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,928,961 - pbsv-20200131.xml 1834</message>
 <ref href="pbsv-20200131.xml#element(/1/455)" sourceLine="1834">
  <property name="label" value="Net Cash Provided by (Used in) Financing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,928,961"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1000000.0" fact-concept="{http://pharmabioserv.com/20241231}AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,000,000 - pbsv-20200131.xml 1903</message>
 <ref href="pbsv-20200131.xml#element(/1/524)" sourceLine="1903">
  <property name="label" value="Antidilutive warrants excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="QName" value="PBSV:AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,000,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="909429.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 909,429 - pbsv-20200131.xml 1967</message>
 <ref href="pbsv-20200131.xml#element(/1/588)" sourceLine="1967">
  <property name="label" value="INCOME FROM OPERATIONS"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingIncomeLoss"/>
  <property name="QName" value="us-gaap:OperatingIncomeLoss"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="909,429"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1604</message>
 <ref href="pbsv-20200131.xml#element(/1/225)" sourceLine="1604">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.093" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.093 - pbsv-20200131.xml 1912</message>
 <ref href="pbsv-20200131.xml#element(/1/533)" sourceLine="1912">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_MajorCustomerBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.093"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="387287.0" fact-concept="{http://fasb.org/us-gaap/2024}NonoperatingIncomeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 387,287 - pbsv-20200131.xml 1674</message>
 <ref href="pbsv-20200131.xml#element(/1/295)" sourceLine="1674">
  <property name="label" value="OTHER INCOME, NET"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NonoperatingIncomeExpense"/>
  <property name="QName" value="us-gaap:NonoperatingIncomeExpense"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="387,287"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="9000.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 9,000 - pbsv-20200131.xml 1761</message>
 <ref href="pbsv-20200131.xml#element(/1/382)" sourceLine="1761">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="9,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-44475.0" fact-concept="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -44,475 - pbsv-20200131.xml 1833</message>
 <ref href="pbsv-20200131.xml#element(/1/454)" sourceLine="1833">
  <property name="label" value="DisposalOfMarketableSecurities"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="DisposalOfMarketableSecurities"/>
  <property name="QName" value="PBSV:DisposalOfMarketableSecurities"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-44,475"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="768968.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 768,968 - pbsv-20200131.xml 1675</message>
 <ref href="pbsv-20200131.xml#element(/1/296)" sourceLine="1675">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="768,968"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1355956.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,355,956 - pbsv-20200131.xml 1605</message>
 <ref href="pbsv-20200131.xml#element(/1/226)" sourceLine="1605">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,355,956"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="16029920.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 16,029,920 - pbsv-20200131.xml 1543</message>
 <ref href="pbsv-20200131.xml#element(/1/164)" sourceLine="1543">
  <property name="label" value="Cash and cash equivalents"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsAtCarryingValue"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsAtCarryingValue"/>
  <property name="contextRef" value="AsOf2018-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="16,029,920"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="687561.0" fact-concept="{http://pharmabioserv.com/20241231}NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 687,561 - pbsv-20200131.xml 1960</message>
 <ref href="pbsv-20200131.xml#element(/1/581)" sourceLine="1960">
  <property name="label" value="Net income (loss) available to common equity holders - used to compute basic and diluted earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="QName" value="PBSV:NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="687,561"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="9000.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 9,000 - pbsv-20200131.xml 1762</message>
 <ref href="pbsv-20200131.xml#element(/1/383)" sourceLine="1762">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="9,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1832</message>
 <ref href="pbsv-20200131.xml#element(/1/453)" sourceLine="1832">
  <property name="label" value="DisposalOfMarketableSecurities"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="DisposalOfMarketableSecurities"/>
  <property name="QName" value="PBSV:DisposalOfMarketableSecurities"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="19582131.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 19,582,131 - pbsv-20200131.xml 1606</message>
 <ref href="pbsv-20200131.xml#element(/1/227)" sourceLine="1606">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="19,582,131"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="581019.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 581,019 - pbsv-20200131.xml 1678</message>
 <ref href="pbsv-20200131.xml#element(/1/299)" sourceLine="1678">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="581,019"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="15490174.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 15,490,174 - pbsv-20200131.xml 1542</message>
 <ref href="pbsv-20200131.xml#element(/1/163)" sourceLine="1542">
  <property name="label" value="Cash and cash equivalents"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsAtCarryingValue"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsAtCarryingValue"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="15,490,174"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.861" fact-concept="{http://pharmabioserv.com/20241231}AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.861 - pbsv-20200131.xml 1959</message>
 <ref href="pbsv-20200131.xml#element(/1/580)" sourceLine="1959">
  <property name="label" value="Amount due from major customers as percentage of accounts receivable"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable"/>
  <property name="QName" value="PBSV:AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_GlobalGroupTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.861"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="11430.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 11,430 - pbsv-20200131.xml 1763</message>
 <ref href="pbsv-20200131.xml#element(/1/384)" sourceLine="1763">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="11,430"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="331306.0" fact-concept="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgramValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 331,306 - pbsv-20200131.xml 1908</message>
 <ref href="pbsv-20200131.xml#element(/1/529)" sourceLine="1908">
  <property name="label" value="Shares purchased under Repurchase Program, amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="SharesPurchasedUnderRepurchaseProgramValue"/>
  <property name="QName" value="PBSV:SharesPurchasedUnderRepurchaseProgramValue"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="331,306"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="633633.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 633,633 - pbsv-20200131.xml 1677</message>
 <ref href="pbsv-20200131.xml#element(/1/298)" sourceLine="1677">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="633,633"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="338854.0" fact-concept="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgram" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 338,854 - pbsv-20200131.xml 1907</message>
 <ref href="pbsv-20200131.xml#element(/1/528)" sourceLine="1907">
  <property name="label" value="Shares purchased under Repurchase Program"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="SharesPurchasedUnderRepurchaseProgram"/>
  <property name="QName" value="PBSV:SharesPurchasedUnderRepurchaseProgram"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="338,854"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="720384.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 720,384 - pbsv-20200131.xml 1964</message>
 <ref href="pbsv-20200131.xml#element(/1/585)" sourceLine="1964">
  <property name="label" value="INCOME FROM OPERATIONS"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingIncomeLoss"/>
  <property name="QName" value="us-gaap:OperatingIncomeLoss"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="720,384"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="115789.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 115,789 - pbsv-20200131.xml 1607</message>
 <ref href="pbsv-20200131.xml#element(/1/228)" sourceLine="1607">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="115,789"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1831</message>
 <ref href="pbsv-20200131.xml#element(/1/452)" sourceLine="1831">
  <property name="label" value="DisposalOfMarketableSecurities"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="DisposalOfMarketableSecurities"/>
  <property name="QName" value="PBSV:DisposalOfMarketableSecurities"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="11430.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 11,430 - pbsv-20200131.xml 1764</message>
 <ref href="pbsv-20200131.xml#element(/1/385)" sourceLine="1764">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="11,430"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1178503.0" fact-concept="{http://pharmabioserv.com/20241231}NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,178,503 - pbsv-20200131.xml 1963</message>
 <ref href="pbsv-20200131.xml#element(/1/584)" sourceLine="1963">
  <property name="label" value="Net income (loss) available to common equity holders - used to compute basic and diluted earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="QName" value="PBSV:NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,178,503"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-370443.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -370,443 - pbsv-20200131.xml 1608</message>
 <ref href="pbsv-20200131.xml#element(/1/229)" sourceLine="1608">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-370,443"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="782741.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 782,741 - pbsv-20200131.xml 1676</message>
 <ref href="pbsv-20200131.xml#element(/1/297)" sourceLine="1676">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="782,741"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-149709.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -149,709 - pbsv-20200131.xml 1837</message>
 <ref href="pbsv-20200131.xml#element(/1/458)" sourceLine="1837">
  <property name="label" value="Net Cash Provided by (Used in) Financing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-149,709"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="15433111.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 15,433,111 - pbsv-20200131.xml 1544</message>
 <ref href="pbsv-20200131.xml#element(/1/165)" sourceLine="1544">
  <property name="label" value="Cash and cash equivalents"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsAtCarryingValue"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsAtCarryingValue"/>
  <property name="contextRef" value="AsOf2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="15,433,111"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1214461.0" fact-concept="{http://pharmabioserv.com/20241231}NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,214,461 - pbsv-20200131.xml 1962</message>
 <ref href="pbsv-20200131.xml#element(/1/583)" sourceLine="1962">
  <property name="label" value="Net income (loss) available to common equity holders - used to compute basic and diluted earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="QName" value="PBSV:NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,214,461"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3442.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3,442 - pbsv-20200131.xml 1765</message>
 <ref href="pbsv-20200131.xml#element(/1/386)" sourceLine="1765">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Shares"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodSharesStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodSharesStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3,442"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="329607.0" fact-concept="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgramValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 329,607 - pbsv-20200131.xml 1909</message>
 <ref href="pbsv-20200131.xml#element(/1/530)" sourceLine="1909">
  <property name="label" value="Shares purchased under Repurchase Program, amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="SharesPurchasedUnderRepurchaseProgramValue"/>
  <property name="QName" value="PBSV:SharesPurchasedUnderRepurchaseProgramValue"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="329,607"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-41887.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -41,887 - pbsv-20200131.xml 1679</message>
 <ref href="pbsv-20200131.xml#element(/1/300)" sourceLine="1679">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-41,887"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="199265.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 199,265 - pbsv-20200131.xml 1836</message>
 <ref href="pbsv-20200131.xml#element(/1/457)" sourceLine="1836">
  <property name="label" value="Net Cash Provided by (Used in) Financing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="199,265"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="707483.0" fact-concept="{http://pharmabioserv.com/20241231}NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 707,483 - pbsv-20200131.xml 1961</message>
 <ref href="pbsv-20200131.xml#element(/1/582)" sourceLine="1961">
  <property name="label" value="Net income (loss) available to common equity holders - used to compute basic and diluted earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="QName" value="PBSV:NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="707,483"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="58993.0" fact-concept="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 58,993 - pbsv-20200131.xml 1843</message>
 <ref href="pbsv-20200131.xml#element(/1/464)" sourceLine="1843">
  <property name="label" value="Repayments of Long-term Capital Lease Obligations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="QName" value="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="58,993"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20685771.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,685,771 - pbsv-20200131.xml 1609</message>
 <ref href="pbsv-20200131.xml#element(/1/230)" sourceLine="1609">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,685,771"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1911</message>
 <ref href="pbsv-20200131.xml#element(/1/532)" sourceLine="1911">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_MajorCustomerAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.00"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="15798526.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 15,798,526 - pbsv-20200131.xml 1545</message>
 <ref href="pbsv-20200131.xml#element(/1/166)" sourceLine="1545">
  <property name="label" value="Cash and cash equivalents"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsAtCarryingValue"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsAtCarryingValue"/>
  <property name="contextRef" value="AsOf2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="15,798,526"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1257143.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,257,143 - pbsv-20200131.xml 1966</message>
 <ref href="pbsv-20200131.xml#element(/1/587)" sourceLine="1966">
  <property name="label" value="INCOME FROM OPERATIONS"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingIncomeLoss"/>
  <property name="QName" value="us-gaap:OperatingIncomeLoss"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,257,143"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="14230.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 14,230 - pbsv-20200131.xml 1680</message>
 <ref href="pbsv-20200131.xml#element(/1/301)" sourceLine="1680">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="14,230"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1 - pbsv-20200131.xml 1773</message>
 <ref href="pbsv-20200131.xml#element(/1/394)" sourceLine="1773">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2341.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,341 - pbsv-20200131.xml 1610</message>
 <ref href="pbsv-20200131.xml#element(/1/231)" sourceLine="1610">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,341"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="7489.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 7,489 - pbsv-20200131.xml 1681</message>
 <ref href="pbsv-20200131.xml#element(/1/302)" sourceLine="1681">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="7,489"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-80557.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -80,557 - pbsv-20200131.xml 1835</message>
 <ref href="pbsv-20200131.xml#element(/1/456)" sourceLine="1835">
  <property name="label" value="Net Cash Provided by (Used in) Financing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-80,557"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.111" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.111 - pbsv-20200131.xml 1913</message>
 <ref href="pbsv-20200131.xml#element(/1/534)" sourceLine="1913">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_MajorCustomerBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.111"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="15254752.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 15,254,752 - pbsv-20200131.xml 1546</message>
 <ref href="pbsv-20200131.xml#element(/1/167)" sourceLine="1546">
  <property name="label" value="Cash and cash equivalents"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsAtCarryingValue"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsAtCarryingValue"/>
  <property name="contextRef" value="AsOf2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="15,254,752"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="476928.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 476,928 - pbsv-20200131.xml 1965</message>
 <ref href="pbsv-20200131.xml#element(/1/586)" sourceLine="1965">
  <property name="label" value="INCOME FROM OPERATIONS"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingIncomeLoss"/>
  <property name="QName" value="us-gaap:OperatingIncomeLoss"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="476,928"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2711747.0" fact-concept="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,711,747 - pbsv-20200131.xml 1547</message>
 <ref href="pbsv-20200131.xml#element(/1/168)" sourceLine="1547">
  <property name="label" value="Liabilities, Current"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LiabilitiesCurrent"/>
  <property name="QName" value="us-gaap:LiabilitiesCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,711,747"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1931700.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromLoans" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,931,700 - pbsv-20200131.xml 1968</message>
 <ref href="pbsv-20200131.xml#element(/1/589)" sourceLine="1968">
  <property name="label" value="Proceeds from loans"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromLoans"/>
  <property name="QName" value="us-gaap:ProceedsFromLoans"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,931,700"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-8014.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -8,014 - pbsv-20200131.xml 1682</message>
 <ref href="pbsv-20200131.xml#element(/1/303)" sourceLine="1682">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-8,014"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-1.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -1 - pbsv-20200131.xml 1774</message>
 <ref href="pbsv-20200131.xml#element(/1/395)" sourceLine="1774">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-1"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1838</message>
 <ref href="pbsv-20200131.xml#element(/1/459)" sourceLine="1838">
  <property name="label" value="Payments of Dividends"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsOfDividends"/>
  <property name="QName" value="us-gaap:PaymentsOfDividends"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1611</message>
 <ref href="pbsv-20200131.xml#element(/1/232)" sourceLine="1611">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="169733.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 169,733 - pbsv-20200131.xml 1683</message>
 <ref href="pbsv-20200131.xml#element(/1/304)" sourceLine="1683">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="169,733"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1775</message>
 <ref href="pbsv-20200131.xml#element(/1/396)" sourceLine="1775">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.146" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.146 - pbsv-20200131.xml 1914</message>
 <ref href="pbsv-20200131.xml#element(/1/535)" sourceLine="1914">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_MajorCustomerCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.146"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="476881.0" fact-concept="{http://fasb.org/us-gaap/2024}AccruedIncomeTaxesCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 476,881 - pbsv-20200131.xml 1549</message>
 <ref href="pbsv-20200131.xml#element(/1/170)" sourceLine="1549">
  <property name="label" value="Current portion of US Tax Reform Transition Tax and income taxes payable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccruedIncomeTaxesCurrent"/>
  <property name="QName" value="us-gaap:AccruedIncomeTaxesCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="476,881"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromLoans" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1971</message>
 <ref href="pbsv-20200131.xml#element(/1/592)" sourceLine="1971">
  <property name="label" value="Proceeds from loans"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromLoans"/>
  <property name="QName" value="us-gaap:ProceedsFromLoans"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1392506.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,392,506 - pbsv-20200131.xml 1612</message>
 <ref href="pbsv-20200131.xml#element(/1/233)" sourceLine="1612">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,392,506"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="195506.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 195,506 - pbsv-20200131.xml 1684</message>
 <ref href="pbsv-20200131.xml#element(/1/305)" sourceLine="1684">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="195,506"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-1.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -1 - pbsv-20200131.xml 1768</message>
 <ref href="pbsv-20200131.xml#element(/1/389)" sourceLine="1768">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-1"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1841</message>
 <ref href="pbsv-20200131.xml#element(/1/462)" sourceLine="1841">
  <property name="label" value="Payments of Dividends"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsOfDividends"/>
  <property name="QName" value="us-gaap:PaymentsOfDividends"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1351163.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,351,163 - pbsv-20200131.xml 1685</message>
 <ref href="pbsv-20200131.xml#element(/1/306)" sourceLine="1685">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,351,163"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="8046.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 8,046 - pbsv-20200131.xml 1767</message>
 <ref href="pbsv-20200131.xml#element(/1/388)" sourceLine="1767">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Shares"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodSharesStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodSharesStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="8,046"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.099" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.099 - pbsv-20200131.xml 1915</message>
 <ref href="pbsv-20200131.xml#element(/1/536)" sourceLine="1915">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_MajorCustomerCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.099"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1931700.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromLoans" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,931,700 - pbsv-20200131.xml 1970</message>
 <ref href="pbsv-20200131.xml#element(/1/591)" sourceLine="1970">
  <property name="label" value="Proceeds from loans"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromLoans"/>
  <property name="QName" value="us-gaap:ProceedsFromLoans"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,931,700"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="19999968.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 19,999,968 - pbsv-20200131.xml 1613</message>
 <ref href="pbsv-20200131.xml#element(/1/234)" sourceLine="1613">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="19,999,968"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1725295.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,725,295 - pbsv-20200131.xml 1840</message>
 <ref href="pbsv-20200131.xml#element(/1/461)" sourceLine="1840">
  <property name="label" value="Payments of Dividends"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsOfDividends"/>
  <property name="QName" value="us-gaap:PaymentsOfDividends"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,725,295"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1296716.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,296,716 - pbsv-20200131.xml 1686</message>
 <ref href="pbsv-20200131.xml#element(/1/307)" sourceLine="1686">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,296,716"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3670540.0" fact-concept="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3,670,540 - pbsv-20200131.xml 1548</message>
 <ref href="pbsv-20200131.xml#element(/1/169)" sourceLine="1548">
  <property name="label" value="Liabilities, Current"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LiabilitiesCurrent"/>
  <property name="QName" value="us-gaap:LiabilitiesCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3,670,540"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20448.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,448 - pbsv-20200131.xml 1766</message>
 <ref href="pbsv-20200131.xml#element(/1/387)" sourceLine="1766">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Shares"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodSharesStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodSharesStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,448"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="131866.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 131,866 - pbsv-20200131.xml 1614</message>
 <ref href="pbsv-20200131.xml#element(/1/235)" sourceLine="1614">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="131,866"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1150772.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,150,772 - pbsv-20200131.xml 1687</message>
 <ref href="pbsv-20200131.xml#element(/1/308)" sourceLine="1687">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,150,772"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1839</message>
 <ref href="pbsv-20200131.xml#element(/1/460)" sourceLine="1839">
  <property name="label" value="Payments of Dividends"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsOfDividends"/>
  <property name="QName" value="us-gaap:PaymentsOfDividends"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.682" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.682 - pbsv-20200131.xml 1916</message>
 <ref href="pbsv-20200131.xml#element(/1/537)" sourceLine="1916">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_MajorCustomerTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.682"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1725295.0" fact-concept="{http://fasb.org/us-gaap/2024}DividendsPayableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,725,295 - pbsv-20200131.xml 1552</message>
 <ref href="pbsv-20200131.xml#element(/1/173)" sourceLine="1552">
  <property name="label" value="Dividend payable to stockholders"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DividendsPayableCurrent"/>
  <property name="QName" value="us-gaap:DividendsPayableCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,725,295"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-3.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -3 - pbsv-20200131.xml 1772</message>
 <ref href="pbsv-20200131.xml#element(/1/393)" sourceLine="1772">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-3"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2739.0" fact-concept="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,739 - pbsv-20200131.xml 1842</message>
 <ref href="pbsv-20200131.xml#element(/1/463)" sourceLine="1842">
  <property name="label" value="Repayments of Long-term Capital Lease Obligations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="QName" value="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,739"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromLoans" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1969</message>
 <ref href="pbsv-20200131.xml#element(/1/590)" sourceLine="1969">
  <property name="label" value="Proceeds from loans"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromLoans"/>
  <property name="QName" value="us-gaap:ProceedsFromLoans"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-61930.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -61,930 - pbsv-20200131.xml 1688</message>
 <ref href="pbsv-20200131.xml#element(/1/309)" sourceLine="1688">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-61,930"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="Pharma-Bio Serv, Inc." fact-concept="{http://xbrl.sec.gov/dei/2024}EntityRegistrantName" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] Pharma-Bio Serv, Inc. - pbsv-20200131.xml 1972</message>
 <ref href="pbsv-20200131.xml#element(/1/593)" sourceLine="1972">
  <property name="label" value="Entity Registrant Name"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityRegistrantName"/>
  <property name="QName" value="dei:EntityRegistrantName"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="Pharma-Bio Serv, Inc."/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-394278.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -394,278 - pbsv-20200131.xml 1615</message>
 <ref href="pbsv-20200131.xml#element(/1/236)" sourceLine="1615">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-394,278"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2 - pbsv-20200131.xml 1771</message>
 <ref href="pbsv-20200131.xml#element(/1/392)" sourceLine="1771">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}DividendsPayableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1551</message>
 <ref href="pbsv-20200131.xml#element(/1/172)" sourceLine="1551">
  <property name="label" value="Dividend payable to stockholders"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DividendsPayableCurrent"/>
  <property name="QName" value="us-gaap:DividendsPayableCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-61684.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -61,684 - pbsv-20200131.xml 1689</message>
 <ref href="pbsv-20200131.xml#element(/1/310)" sourceLine="1689">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-61,684"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="5441.0" fact-concept="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 5,441 - pbsv-20200131.xml 1844</message>
 <ref href="pbsv-20200131.xml#element(/1/465)" sourceLine="1844">
  <property name="label" value="Repayments of Long-term Capital Lease Obligations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="QName" value="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="5,441"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.598" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.598 - pbsv-20200131.xml 1917</message>
 <ref href="pbsv-20200131.xml#element(/1/538)" sourceLine="1917">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_MajorCustomerTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.598"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="344043.0" fact-concept="{http://fasb.org/us-gaap/2024}AccruedIncomeTaxesCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 344,043 - pbsv-20200131.xml 1550</message>
 <ref href="pbsv-20200131.xml#element(/1/171)" sourceLine="1550">
  <property name="label" value="Current portion of US Tax Reform Transition Tax and income taxes payable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccruedIncomeTaxesCurrent"/>
  <property name="QName" value="us-gaap:AccruedIncomeTaxesCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="344,043"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1 - pbsv-20200131.xml 1770</message>
 <ref href="pbsv-20200131.xml#element(/1/391)" sourceLine="1770">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.118" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.118 - pbsv-20200131.xml 1918</message>
 <ref href="pbsv-20200131.xml#element(/1/539)" sourceLine="1918">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_MajorCustomerDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.118"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="324005.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 324,005 - pbsv-20200131.xml 1690</message>
 <ref href="pbsv-20200131.xml#element(/1/311)" sourceLine="1690">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="324,005"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1 - pbsv-20200131.xml 1769</message>
 <ref href="pbsv-20200131.xml#element(/1/390)" sourceLine="1769">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1"/>
 </ref></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24743&quot;]" concept-name="{http://pharmabioserv.com/20241231}NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted" severity="info" cid="2430583881168">[concepts] PBSV:NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24769&quot;]" concept-name="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" severity="info" cid="2430583881168">[concepts] PBSV:DocumentAndEntityInformationAbstract - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24744&quot;]" concept-name="{http://pharmabioserv.com/20241231}RecentAccountingPronouncementsPolicyTextBlock" severity="info" cid="2430583881168">[concepts] PBSV:RecentAccountingPronouncementsPolicyTextBlock - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24755&quot;]" concept-name="{http://pharmabioserv.com/20241231}LabMember" severity="info" cid="2430583881168">[concepts] PBSV:LabMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24735&quot;]" concept-name="{http://pharmabioserv.com/20241231}ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle" severity="info" cid="2430583881168">[concepts] PBSV:ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24736&quot;]" concept-name="{http://pharmabioserv.com/20241231}ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock" severity="info" cid="2430583881168">[concepts] PBSV:ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24770&quot;]" concept-name="{http://pharmabioserv.com/20241231}ConsolidatedStatementsOfChangesInStockholdersEquityParentheticalAbstract" severity="info" cid="2430583881168">[concepts] PBSV:ConsolidatedStatementsOfChangesInStockholdersEquityParentheticalAbstract - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24756&quot;]" concept-name="{http://pharmabioserv.com/20241231}OtherSegmentsMember" severity="info" cid="2430583881168">[concepts] PBSV:OtherSegmentsMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24734&quot;]" concept-name="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" severity="info" cid="2430583881168">[concepts] PBSV:DisposalOfMarketableSecurities - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24733&quot;]" concept-name="{http://pharmabioserv.com/20241231}StockRepurchaseDuringPeriodShares" severity="info" cid="2430583881168">[concepts] PBSV:StockRepurchaseDuringPeriodShares - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24757&quot;]" concept-name="{http://pharmabioserv.com/20241231}MajorCustomerDMember" severity="info" cid="2430583881168">[concepts] PBSV:MajorCustomerDMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24758&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalCustomerCMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalCustomerCMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24759&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalCustomerDMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalCustomerDMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24745&quot;]" concept-name="{http://pharmabioserv.com/20241231}MajorCustomerAMember" severity="info" cid="2430583881168">[concepts] PBSV:MajorCustomerAMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24760&quot;]" concept-name="{http://pharmabioserv.com/20241231}MajorCustomerEMember" severity="info" cid="2430583881168">[concepts] PBSV:MajorCustomerEMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24746&quot;]" concept-name="{http://pharmabioserv.com/20241231}MajorCustomerBMember" severity="info" cid="2430583881168">[concepts] PBSV:MajorCustomerBMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24761&quot;]" concept-name="{http://pharmabioserv.com/20241231}MajorCustomerFMember" severity="info" cid="2430583881168">[concepts] PBSV:MajorCustomerFMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24747&quot;]" concept-name="{http://pharmabioserv.com/20241231}MajorCustomerCMember" severity="info" cid="2430583881168">[concepts] PBSV:MajorCustomerCMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24762&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalGroupAMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalGroupAMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24732&quot;]" concept-name="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" severity="info" cid="2430583881168">[concepts] PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24748&quot;]" concept-name="{http://pharmabioserv.com/20241231}MajorCustomerTotalMember" severity="info" cid="2430583881168">[concepts] PBSV:MajorCustomerTotalMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24763&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalGroupBMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalGroupBMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24749&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalCustomerAMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalCustomerAMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24764&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalGroupCMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalGroupCMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24750&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalCustomerBMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalCustomerBMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24765&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalGroupDMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalGroupDMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24737&quot;]" concept-name="{http://pharmabioserv.com/20241231}IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn" severity="info" cid="2430583881168">[concepts] PBSV:IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24751&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalCustomerTotalMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalCustomerTotalMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24766&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalGroupEMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalGroupEMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24731&quot;]" concept-name="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" severity="info" cid="2430583881168">[concepts] PBSV:StockIssuedDuringPeriodSharesStockOptionsExercisedCashless - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24752&quot;]" concept-name="{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember" severity="info" cid="2430583881168">[concepts] PBSV:PuertoRicoConsultingMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24730&quot;]" concept-name="{http://pharmabioserv.com/20241231}PromissoryNoteReceivableCurrent" severity="info" cid="2430583881168">[concepts] PBSV:PromissoryNoteReceivableCurrent - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24767&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalGroupFMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalGroupFMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24738&quot;]" concept-name="{http://pharmabioserv.com/20241231}AccumulatedDepreciationOnPropertyAndEquipmentDisposed" severity="info" cid="2430583881168">[concepts] PBSV:AccumulatedDepreciationOnPropertyAndEquipmentDisposed - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24753&quot;]" concept-name="{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember" severity="info" cid="2430583881168">[concepts] PBSV:UnitedStatesConsultingMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24739&quot;]" concept-name="{http://pharmabioserv.com/20241231}AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare" severity="info" cid="2430583881168">[concepts] PBSV:AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24740&quot;]" concept-name="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgram" severity="info" cid="2430583881168">[concepts] PBSV:SharesPurchasedUnderRepurchaseProgram - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24768&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalGroupTotalMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalGroupTotalMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24741&quot;]" concept-name="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgramValue" severity="info" cid="2430583881168">[concepts] PBSV:SharesPurchasedUnderRepurchaseProgramValue - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24754&quot;]" concept-name="{http://pharmabioserv.com/20241231}EuropeConsultingMember" severity="info" cid="2430583881168">[concepts] PBSV:EuropeConsultingMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24742&quot;]" concept-name="{http://pharmabioserv.com/20241231}AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable" severity="info" cid="2430583881168">[concepts] PBSV:AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable - </message></entry>
<entry code="createInstance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" instance-name="phmb-20200131_htm" instance-taxonomy="[&quot;./phmb-20200430_taxonomy.zip/phmb-20200430_taxonomy/phmb-20200430.xsd&quot;]" severity="info" cid="2430583881168">[createInstance] True - </message></entry>
<entry code="create_package" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" package-url="http://pharmabioserv.com/20241231" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" document-package-entry-point="True" document-package-entry-point-description="Official Statement  Taxonomy " document-package-entry-point-language="en-US" document-package-entry-point-name="phmb 20200430" document-import="[&quot;https://xbrl.sec.gov/dei/2024/dei-2024.xsd&quot;, &quot;https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-all-2024.xsd&quot;]" import2-url="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-all-2024.xsd" severity="info" cid="2430583881168">[create_package] True - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23714&quot;]" severity="info" cid="2430583881168">[create_roles] http://www.xbrl.org/2009/role/negatedTerseLabel - Negated terse label - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__32&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/G.EquityTransactionsDetailsNarrative - 00000025 - Disclosure - G. EQUITY TRANSACTIONS (Details Narrative) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23713&quot;]" severity="info" cid="2430583881168">[create_roles] http://www.xbrl.org/2009/role/negatedNetLabel - Negated net label - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__21&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/E.Warrants - 00000014 - Disclosure - E. WARRANTS - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__19&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/C.Loans - 00000012 - Disclosure - C. LOANS - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__26&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/A.OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies - 00000019 - Disclosure - A. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__14&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/StatementsOfChangesInStockholdersEquityParenthetical - 00000007 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__28&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/I.SegmentDisclosuresTables - 00000021 - Disclosure - I. SEGMENT DISCLOSURES (Tables) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/G.EquityTransactions - 00000016 - Disclosure - G. EQUITY TRANSACTIONS - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__10&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/BalanceSheetsParenthetical - 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__11&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/StatementsOfOperations - 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__33&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/H.ConcentrationOfRisksDetailsNarrative - 00000026 - Disclosure - H. CONCENTRATION OF RISKS (Details Narrative) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23712&quot;]" severity="info" cid="2430583881168">[create_roles] http://www.xbrl.org/2009/role/negatedTotalLabel - Negated total label - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__24&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/H.ConcentrationsOfRisk - 00000017 - Disclosure - H. CONCENTRATIONS OF RISK - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23726&quot;]" severity="info" cid="2430583881168">[create_roles] http://www.xbrl.org/2009/role/netLabel - Net label - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__29&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/A.OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative - 00000022 - Disclosure - A. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__15&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/StatementsOfCashFlows - 00000008 - Statement - Consolidated Statements of Cash Flows (Unaudited) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__12&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/StatementsOfComprehensiveIncomeLoss - 00000005 - Statement - Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__25&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/I.SegmentDisclosures - 00000018 - Disclosure - I. SEGMENT DISCLOSURES - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__31&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/F.EarningsPerShareDetailsNarrative - 00000024 - Disclosure - F. EARNINGS PER SHARE (Details Narrative) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23711&quot;]" severity="info" cid="2430583881168">[create_roles] http://www.xbrl.org/2009/role/negatedPeriodStartLabel - Negated period start label - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__30&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/F.EarningsPerShareDetails - 00000023 - Disclosure - F. EARNINGS PER SHARE (Details) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23710&quot;]" severity="info" cid="2430583881168">[create_roles] http://www.xbrl.org/2009/role/negatedPeriodEndLabel - Negated period end label - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__17&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/A.OrganizationAndSummaryOfSignificantAccountingPolicies - 00000010 - Disclosure - A. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__20&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/D.IncomeTaxes - 00000013 - Disclosure - D. INCOME TAXES - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__8&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/DocumentAndEntityInformation - 00000001 - Document - Document and Entity Information - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23709&quot;]" severity="info" cid="2430583881168">[create_roles] http://www.xbrl.org/2009/role/negatedLabel - Negated standard label - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__34&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/I.SegmentDisclosuresDetails - 00000027 - Disclosure - I. SEGMENT DISCLOSURES (Details) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__18&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/B.PromissoryNotes - 00000011 - Disclosure - B. PROMISSORY NOTES - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__27&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/F.EarningsPerShareTables - 00000020 - Disclosure - F. EARNINGS PER SHARE (Tables) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__22&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/F.EarningsPerShare - 00000015 - Disclosure - F. EARNINGS PER SHARE - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__9&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/BalanceSheets - 00000002 - Statement - Consolidated Balance Sheets (Unaudited) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__13&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/StatementsOfChangesInStockholdersEquity - 00000006 - Statement - Consolidated Statements of Changes in Stockholders' Equity - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__16&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/StatementsOfCashFlowsParenthetical - 00000009 - Statement - Consolidated Statements of Cash Flows (Parenthetical) - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23948&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeLossNetOfTax" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accumulated other comprehensive loss - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24017&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) BASIC AND DILUTED EARNINGS PER COMMON SHARE - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24374&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Payments to Acquire Property, Plant, and Equipment - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24123&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Acquisition of property and equipment - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23774&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Additional Paid-In Capital - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23942&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalCommonStock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Additional paid-in capital - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23987&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Income Statement [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24211&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeTaxDisclosureTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) D. INCOME TAXES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24091&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24249&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}UseOfEstimates" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Use of Estimates - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24011&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeTaxExpenseBenefit" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) INCOME TAX EXPENSE - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24264&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeTaxPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Income Taxes - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24166&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeTaxesPaid" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Cash paid during the period for: Income taxes - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24316&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Antidilutive options excluded from computation of earnings (losses) per share - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24366&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Increase (Decrease) in Accounts Receivable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24105&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Increase in accounts receivable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24196&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}DebtDisclosureAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Debt Disclosure [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24199&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}MarketableSecuritiesTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) B. PROMISSORY NOTE - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23861&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AssetsAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) ASSETS: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24340&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}Assets" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23888&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}Assets" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) Total assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23876&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AssetsCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) Total current assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24338&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AssetsCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Assets, Current - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24205&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}DebtDisclosureTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) C. LOANS - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24181&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Obligations under capital lease incurred for the acquisition of a vehicle - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24178&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Conversion of cashless exercise of options to common stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24120&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Disposal of marketable securities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24372&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) DisposalOfMarketableSecurities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24080&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}StockRepurchaseDuringPeriodShares" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Purchase of treasury stocks - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24020&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24305&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/verboseLabel) (en-US) Weighted average number of common shares - used to compute basic earnings per share - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24336&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/documentation) (en-US) Custom Element. - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24063&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24310&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/verboseLabel) (en-US) Weighted average number of shares - used to compute diluted earnings (losses) per share - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24023&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24175&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Income tax withheld by clients to be used as a credit in the Company's income tax return - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24108&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) (Increase) decrease in other assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24368&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Increase (Decrease) in Other Operating Assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24111&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOperatingLiabilities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Increase (decrease) in liabilities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24060&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Shares - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24334&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/documentation) (en-US) Custom Element. - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23870&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}PromissoryNoteReceivableCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Current portion - promissory note receivable due from sale of assets from discontinued operations - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24187&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}AccumulatedDepreciationOnPropertyAndEquipmentDisposed" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accumulated depreciation - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24313&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Antidilutive warrants excluded from computation of earnings (losses) per share - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24319&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgram" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Shares purchased under Repurchase Program - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24322&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgramValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Shares purchased under Repurchase Program, amount - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24330&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Amount due from major customers as percentage of accounts receivable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24303&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Net income (loss) available to common equity holders - used to compute basic and diluted earnings (losses) per share - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24291&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}RecentAccountingPronouncementsPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Recent Accounting Pronouncements - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23732&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}MajorCustomerAMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Major Customer A - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23735&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}MajorCustomerBMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Major Customer B - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23738&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}MajorCustomerCMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Major Customer C - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23741&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}MajorCustomerTotalMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Major Customer Total - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23747&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Puerto Rico consulting - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23750&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) United States consulting - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23753&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}EuropeConsultingMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Europe consulting - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23756&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}OtherSegmentsMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Other segments - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23759&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}MajorCustomerDMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Major Customer D - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23762&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}MajorCustomerEMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Major Customer E - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23786&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}GlobalGroupAMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Global Group A - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23789&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}GlobalGroupBMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Global Group B - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23792&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}GlobalGroupCMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Global Group C - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23795&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}GlobalGroupDMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Global Group D - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23798&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}GlobalGroupEMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Global Group E - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23801&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}GlobalGroupTotalMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Global Group Total - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23804&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Document And Entity Information - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24077&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}ConsolidatedStatementsOfChangesInStockholdersEquityParentheticalAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Consolidated Statements Of Changes In Stockholders Equity - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24294&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Schedule of calculations of basic and diluted earnings (losses) per share - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24308&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Effect of options to purchase common stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23771&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PreferredStockMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Preferred Stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23936&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PreferredStockValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Preferred Stock, $0.0001 par value; authorized 10,000,000 shares; none outstanding - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23969&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PreferredStockSharesOutstanding" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Preferred stock, outstanding - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23963&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PreferredStockParOrStatedValuePerShare" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Preferred stock, par value - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23966&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PreferredStockSharesAuthorized" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Preferred stock, authorized - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23873&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PrepaidExpenseAndOtherAssets" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Prepaids and other assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23819&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}AmendmentFlag" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Amendment Flag - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23822&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}CurrentFiscalYearEndDate" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Current Fiscal Year End Date - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24285&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PriorPeriodReclassificationAdjustmentDescription" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Reclassifications - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24297&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ScheduleOfSegmentReportingInformationBySegmentTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Schedule of segment reporting information - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24252&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}FairValueOfFinancialInstrumentsPolicy" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Fair Value of Financial Instruments - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24129&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ProceedsFromCollectionOfOtherReceivables" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Collection from promissory note receivable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24169&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}InterestPaidNet" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Cash paid during the period for: Interest - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24132&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24376&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Net Cash Provided by (Used in) Investing Activities, Continuing Operations - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24150&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) NET CASH USED IN FINANCING ACTIVITIES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24384&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Net Cash Provided by (Used in) Financing Activities, Continuing Operations - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24114&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24370&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Net Cash Provided by (Used in) Operating Activities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24068&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/verboseLabel) (en-US) NET INCOME - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24014&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) NET INCOME (LOSS) - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24028&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) NET INCOME (LOSS) - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24088&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/terseLabel) (en-US) Net income - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24086&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivitiesAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) CASH FLOWS FROM OPERATING ACTIVITIES: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24135&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) CASH FLOWS FROM FINANCING ACTIVITIES: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24117&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) CASH FLOWS FROM INVESTING ACTIVITIES: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24288&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NewAccountingPronouncementsPolicyPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Recently Adopted Accounting Pronouncements - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24138&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ProceedsFromLoans" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Proceeds from loans - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24246&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SegmentReportingPolicyPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Segments - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24237&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SegmentReportingAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Segment Reporting [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24240&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SegmentReportingDisclosureTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) I. SEGMENT DISCLOSURES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24005&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NonoperatingIncomeExpense" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) OTHER INCOME, NET - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23816&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}DocumentPeriodEndDate" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Document Period End Date - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23852&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityIncorporationStateCountryCode" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Incorporation State Country Code - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24126&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ProceedsFromSaleOfPropertyPlantAndEquipment" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Proceeds from sale of property and equipment - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23828&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityFilerCategory" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Filer Category - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23825&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityCurrentReportingStatus" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Is Entity's Reporting Status Current? - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23810&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityCentralIndexKey" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Central Index Key - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23807&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityRegistrantName" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Registrant Name - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23840&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityCommonStockSharesOutstanding" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Common Stock, Shares Outstanding - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23843&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}DocumentFiscalPeriodFocus" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Document Fiscal Period Focus - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23846&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}DocumentFiscalYearFocus" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Document Fiscal Year Focus - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23813&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}DocumentType" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Document Type - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23849&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityInteractiveDataCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Interactive Data Current - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23999&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SellingGeneralAndAdministrativeExpense" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) SELLING, GENERAL AND ADMINISTRATIVE EXPENSES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23921&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsNoncurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Obligations under finance lease - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23894&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Current portion-obligations under finance leases - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24184&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentDisposals" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Disposed property and equipment with accumulated depreciation of $17,913 for the three and six months ended April 30, 2020 and $86,773 for the three and six months ended April 30, 2019 - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23831&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityEmergingGrowthCompany" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Emerging Growth Company - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23837&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityShellCompany" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Shell Company - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23855&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityFileNumber" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity File Number - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23834&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntitySmallBusiness" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Small Business - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24057&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) STOCK-BASED COMPENSATION - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24096&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/verboseLabel) (en-US) Stock-based compensation - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24160&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/periodEndLabel) (en-US) CASH AND CASH EQUIVALENTS - END OF PERIOD - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23864&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Cash and cash equivalents - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24158&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/periodStartLabel) (en-US) CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23879&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentNet" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Property and equipment - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24267&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Property and Equipment - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24386&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Cash and Cash Equivalents, Period Increase (Decrease) - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24156&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24258&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Cash Equivalents - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24099&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}DepreciationDepletionAndAmortization" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Depreciation and amortization - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23924&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityNoncurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Long-term operating lease liabilities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24172&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) SUPPLEMENTARY SCHEDULES OF NON-CASH INVESTING AND FINANCING ACTIVITIES: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23900&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Current operating lease liabilities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23882&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OperatingLeaseRightOfUseAsset" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Operating lease right-of-use - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24273&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ShareBasedCompensationOptionAndIncentivePlansPolicy" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Stock-based Compensation - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24324&quot;]" label-concept-name="{http://fasb.org/srt/2024}MajorCustomersAxis" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/verboseLabel) (en-US) Customer [Axis] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23729&quot;]" label-concept-name="{http://fasb.org/srt/2024}MajorCustomersAxis" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Major Customers [Axis] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24358&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SharesIssued" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Shares, Issued - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24072&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SharesIssued" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/periodEndLabel) (en-US) ENDING BALANCE, Shares - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24052&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SharesIssued" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/periodStartLabel) (en-US) BEGINNING BALANCE - Shares - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24002&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OperatingIncomeLoss" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) INCOME FROM OPERATIONS - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24193&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPol..." severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) A. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24279&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Foreign Operations - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23858&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StatementOfFinancialPositionAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Statement of Financial Position [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24026&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StatementOfOtherComprehensiveIncomeAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Statement of Other Comprehensive Income [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24046&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StatementTable" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Statement [Table] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24049&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StatementLineItems" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Statement [Line Items] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23765&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Equity Components [Axis] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24083&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StatementOfCashFlowsAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Statement of Cash Flows [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24261&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ReceivablesPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accounts Receivable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23744&quot;]" label-concept-name="{http://fasb.org/srt/2024}StatementGeographicalAxis" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Geographical [Axis] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24360&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Stock Repurchased During Period, Value - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24066&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) PURCHASE OF TREASURY STOCK - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24228&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquityNoteDisclosureTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) G. EQUITY TRANSACTIONS - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23951&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) Stockholders' equity before treasury stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24346&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Stockholders' Equity before Treasury Stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23957&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) Total stockholders' equity - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24054&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/periodStartLabel) (en-US) BEGINNING BALANCE - Amount - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24074&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/periodEndLabel) (en-US) ENDING BALANCE, Amount - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24350&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Stockholders' Equity Attributable to Parent - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23768&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CommonStockMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Common Stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23933&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Stockholders' equity: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24225&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/verboseLabel) (en-US) Stockholders' Equity Attributable to Parent [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23972&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CommonStockParOrStatedValuePerShare" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Common stock, par value - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23978&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CommonStockSharesIssued" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Common stock, issued - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23975&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CommonStockSharesAuthorized" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Common stock, authorized - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24037&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedI..." severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Available-for-sale securities other-than-temporary impairment included in net income - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23960&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquity" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) Total liabilities and stockholders' equity - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24352&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquity" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Liabilities and Equity - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23891&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) LIABILITIES AND STOCKHOLDERS' EQUITY: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24344&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}Liabilities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Liabilities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23930&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}Liabilities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) Total liabilities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23912&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) Total current liabilities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24342&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Liabilities, Current - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23939&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CommonStockValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Common Stock, $0.0001 par value; authorized 50,000,000 shares; 23,405,753 and 23,397,707 shares issued, and 23,001,627 and 22,995,881 shares outstanding at April 30, 2020 and October 31, 2019, respectively - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23981&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CommonStockSharesOutstanding" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Common stock, outstanding - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24043&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) COMPREHENSIVE INCOME (LOSS) - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24356&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Comprehensive Income (Loss), Net of Tax, Attributable to Parent - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24234&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ConcentrationRiskDisclosureTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) H. CONCENTRATIONS OF RISK - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24327&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Revenue from major customers - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24243&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ConsolidationPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Consolidation - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24282&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SubsequentEventsPolicyPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Subsequent Events - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24094&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Gain on disposition of property and equipment - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24362&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24163&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SupplementalCashFlowInformationAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24214&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Share-based Payment Arrangement [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24217&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) E. WARRANTS - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23885&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OtherAssetsNoncurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Other assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24102&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Other-than-temporary impairment on available-for-sale securities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24364&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23927&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OtherLiabilities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Other liabilities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23915&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}TaxesPayableCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) US Tax Reform Transition Tax payable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24380&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Repayments of Long-term Capital Lease Obligations - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24144&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Payments on obligations under finance leases - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24354&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}GrossProfit" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Gross Profit - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23996&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}GrossProfit" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) GROSS PROFIT - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24190&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accounting Policies [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24034&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributa..." severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Foreign currency translation loss - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24070&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) OTHER COMPREHENSIVE INCOME, NET OF TAX - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24040&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) TOTAL OTHER COMPREHENSIVE LOSS - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23906&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}DividendsPayableCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Dividend payable to stockholders - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24031&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) OTHER COMPREHENSIVE INCOME (LOSS), NET OF RECLASSIFICATION ADJUSTMENTS AND TAXES: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23903&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AccountsPayableAndAccruedLiabilitiesCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accounts payable and accrued expenses - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24223&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}EarningsPerShareTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) F. EARNINGS (LOSSES) PER SHARE - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24276&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}EarningsPerSharePolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Earnings Per Share of Common Stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23867&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AccountsReceivableNetCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accounts receivable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24220&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Earnings Per Share [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24153&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}EffectOfExchangeRateOnCashAndCashEquivalents" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) EFFECT OF EXCHANGE RATE CHANGES ON CASH - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23945&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}RetainedEarningsAccumulatedDeficit" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Retained earnings - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23777&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}RetainedEarningsMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Retained Earnings - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23984&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}TreasuryStockShares" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Treasury stock, shares - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23993&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CostOfRevenue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) COST OF SERVICES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23897&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LoansPayableCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Loans short term portion - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23918&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LoansPayable" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Loans-long term portion - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24348&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}TreasuryStockValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Treasury Stock, Value - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23954&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}TreasuryStockValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Treasury stock, at cost; 404,126 and 401,826 common shares held at April 30, 2020 and October 31, 2019, respectively - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23783&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}TreasuryStockMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Treasury Stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23780&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accumulated Other Comprehensive Income (Loss) - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23909&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AccruedIncomeTaxesCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Current portion of US Tax Reform Transition Tax and income taxes payable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24300&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accumulated depreciation and amortization - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24378&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Payments for Repurchase of Common Stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24141&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Repurchase of common stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24270&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Impairment of Long-Lived Assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24332&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/verboseLabel) (en-US) INCOME (LOSS) BEFORE TAXES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24008&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) INCOME BEFORE INCOME TAX - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24147&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Cash dividends paid to shareholders - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24382&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Payments of Dividends - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24208&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeTaxDisclosureAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Income Tax Disclosure [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24255&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}RevenueRecognitionPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Revenue Recognition - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23990&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}Revenues" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) REVENUES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24231&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}RisksAndUncertaintiesAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Risks and Uncertainties [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24202&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LongTermNotesAndLoansAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Notes and Loans, Noncurrent [Abstract] - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28951&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28941&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CostOfRevenue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:CostOfRevenue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28948&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:NetIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28950&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:WeightedAverageNumberOfSharesOutstandingBasic - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28946&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28944&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OperatingIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:OperatingIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28942&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}GrossProfit" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:GrossProfit - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28940&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}Revenues" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:Revenues - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28949&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28947&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncomeTaxExpenseBenefit" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:IncomeTaxExpenseBenefit - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28945&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NonoperatingIncomeExpense" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:NonoperatingIncomeExpense - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28943&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}SellingGeneralAndAdministrativeExpense" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:SellingGeneralAndAdministrativeExpense - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28933&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}ConsolidatedStatementsOfChangesInStockholdersEquityParentheticalAbstract" relationship-target="{http://pharmabioserv.com/20241231}StockRepurchaseDuringPeriodShares" severity="info" cid="2430583881168">[relationships] relationship from PBSV:ConsolidatedStatementsOfChangesInStockholdersEquityParentheticalAbstract to PBSV:StockRepurchaseDuringPeriodShares - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28874&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}Revenues" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:Revenues - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28868&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/srt/2024}StatementGeographicalAxis" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to srt:StatementGeographicalAxis - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28870&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:PuertoRicoConsultingMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28875&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28871&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:UnitedStatesConsultingMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28872&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}EuropeConsultingMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:EuropeConsultingMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28873&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}OtherSegmentsMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:OtherSegmentsMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28866&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}SegmentReportingAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StatementTable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:SegmentReportingAbstract to us-gaap:StatementTable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28867&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/us-gaap/2024}StatementLineItems" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to us-gaap:StatementLineItems - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28869&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}StatementGeographicalAxis" relationship-target="{http://fasb.org/srt/2024}SegmentGeographicalDomain" severity="info" cid="2430583881168">[relationships] relationship from srt:StatementGeographicalAxis to srt:SegmentGeographicalDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28756&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}UseOfEstimates" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:UseOfEstimates - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28757&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}FairValueOfFinancialInstrumentsPolicy" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:FairValueOfFinancialInstrumentsPolicy - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28754&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ConsolidationPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:ConsolidationPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28758&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}RevenueRecognitionPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:RevenueRecognitionPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28759&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:CashAndCashEquivalentsPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28760&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ReceivablesPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:ReceivablesPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28761&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncomeTaxPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:IncomeTaxPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28762&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:PropertyPlantAndEquipmentPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28763&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28764&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ShareBasedCompensationOptionAndIncentivePlansPolicy" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28765&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}EarningsPerSharePolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:EarningsPerSharePolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28766&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28767&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}SubsequentEventsPolicyPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:SubsequentEventsPolicyPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28768&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PriorPeriodReclassificationAdjustmentDescription" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:PriorPeriodReclassificationAdjustmentDescription - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28769&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NewAccountingPronouncementsPolicyPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28770&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://pharmabioserv.com/20241231}RecentAccountingPronouncementsPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to PBSV:RecentAccountingPronouncementsPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28755&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}SegmentReportingPolicyPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:SegmentReportingPolicyPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28843&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquityNoteDisclosureTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:StockholdersEquityNoteDisclosureTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28240&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StatementTable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StatementTable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28837&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to us-gaap:WeightedAverageNumberOfSharesOutstandingBasic - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28838&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28836&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://pharmabioserv.com/20241231}NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to PBSV:NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28839&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28865&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}SegmentReportingAbstract" relationship-target="{http://fasb.org/us-gaap/2024}SegmentReportingDisclosureTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:SegmentReportingAbstract to us-gaap:SegmentReportingDisclosureTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29003&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" relationship-target="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:ComprehensiveIncomeNetOfTax to us-gaap:NetIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29002&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" relationship-target="{http://fasb.org/us-gaap/2024}OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedI..." severity="info" cid="2430583881168">[relationships] relationship from us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent to us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29001&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" relationship-target="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributa..." severity="info" cid="2430583881168">[relationships] relationship from us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent to us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29004&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" relationship-target="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:ComprehensiveIncomeNetOfTax to us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28840&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://pharmabioserv.com/20241231}AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to PBSV:AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28841&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28816&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeTaxDisclosureAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncomeTaxDisclosureTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeTaxDisclosureAbstract to us-gaap:IncomeTaxDisclosureTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29010&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://xbrl.sec.gov/country/2024}GB" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to country:GB - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29011&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://xbrl.sec.gov/country/2024}US" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to country:US - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29009&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://xbrl.sec.gov/country/2024}CA" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to country:CA - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28815&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LongTermNotesAndLoansAbstract" relationship-target="{http://fasb.org/us-gaap/2024}DebtDisclosureTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LongTermNotesAndLoansAbstract to us-gaap:DebtDisclosureTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28935&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfOtherComprehensiveIncomeAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfOtherComprehensiveIncomeAbstract to us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28936&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributa..." severity="info" cid="2430583881168">[relationships] relationship from us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract to us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28939&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract to us-gaap:ComprehensiveIncomeNetOfTax - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28937&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedI..." severity="info" cid="2430583881168">[relationships] relationship from us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract to us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28938&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract to us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28934&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfOtherComprehensiveIncomeAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfOtherComprehensiveIncomeAbstract to us-gaap:NetIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28864&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}RisksAndUncertaintiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ConcentrationRiskDisclosureTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:RisksAndUncertaintiesAbstract to us-gaap:ConcentrationRiskDisclosureTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28813&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockSharesOutstanding" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:CommonStockSharesOutstanding - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28809&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PreferredStockSharesOutstanding" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:PreferredStockSharesOutstanding - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28810&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockParOrStatedValuePerShare" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:CommonStockParOrStatedValuePerShare - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28811&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockSharesAuthorized" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:CommonStockSharesAuthorized - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28814&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}TreasuryStockShares" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:TreasuryStockShares - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28812&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockSharesIssued" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:CommonStockSharesIssued - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28806&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfFinancialPositionAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfFinancialPositionAbstract to us-gaap:StockholdersEquityAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28808&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PreferredStockSharesAuthorized" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:PreferredStockSharesAuthorized - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28807&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PreferredStockParOrStatedValuePerShare" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:PreferredStockParOrStatedValuePerShare - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28861&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupTotalMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupTotalMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28849&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}MajorCustomersAxis" relationship-target="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" severity="info" cid="2430583881168">[relationships] relationship from srt:MajorCustomersAxis to srt:NameOfMajorCustomerDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28862&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:ConcentrationRiskPercentage1 - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28848&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/srt/2024}MajorCustomersAxis" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to srt:MajorCustomersAxis - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28850&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerAMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerAMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28863&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://pharmabioserv.com/20241231}AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to PBSV:AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28851&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerBMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerBMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28852&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerCMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerCMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28853&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerDMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerDMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28854&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerEMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerEMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28855&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerTotalMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerTotalMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28846&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}RisksAndUncertaintiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StatementTable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:RisksAndUncertaintiesAbstract to us-gaap:StatementTable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28847&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/us-gaap/2024}StatementLineItems" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to us-gaap:StatementLineItems - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28856&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupAMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupAMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28857&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupBMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupBMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28858&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupCMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupCMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28859&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupDMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupDMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28860&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupEMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupEMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28835&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://fasb.org/us-gaap/2024}EarningsPerShareTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to us-gaap:EarningsPerShareTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28834&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28983&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:ShareBasedCompensation - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28991&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" relationship-target="{http://fasb.org/us-gaap/2024}ProceedsFromSaleOfPropertyPlantAndEquipment" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28995&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" relationship-target="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap:PaymentsOfDividends - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28999&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28984&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}DepreciationDepletionAndAmortization" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:DepreciationDepletionAndAmortization - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28992&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" relationship-target="{http://fasb.org/us-gaap/2024}ProceedsFromCollectionOfOtherReceivables" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to us-gaap:ProceedsFromCollectionOfOtherReceivables - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28996&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" relationship-target="{http://fasb.org/us-gaap/2024}ProceedsFromLoans" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap:ProceedsFromLoans - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29000&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28985&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28986&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:IncreaseDecreaseInAccountsReceivable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28987&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:IncreaseDecreaseInOtherOperatingAssets - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28988&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOperatingLiabilities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:IncreaseDecreaseInOperatingLiabilities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28981&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:NetIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28989&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" relationship-target="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to PBSV:DisposalOfMarketableSecurities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28993&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" relationship-target="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap:PaymentsForRepurchaseOfCommonStock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28997&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap:NetCashProvidedByUsedInOperatingActivities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28982&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:GainLossOnDispositionOfAssets - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28990&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" relationship-target="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28994&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" relationship-target="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap:RepaymentsOfLongTermCapitalLeaseObligations - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28998&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" relationship-target="{http://fasb.org/us-gaap/2024}EffectOfExchangeRateOnCashAndCashEquivalents" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28844&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgram" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to PBSV:SharesPurchasedUnderRepurchaseProgram - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28845&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgramValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to PBSV:SharesPurchasedUnderRepurchaseProgramValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28258&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/srt/2024}MajorCustomersAxis" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to srt:MajorCustomersAxis - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28753&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28771&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}DebtDisclosureAbstract" relationship-target="{http://fasb.org/us-gaap/2024}MarketableSecuritiesTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:DebtDisclosureAbstract to us-gaap:MarketableSecuritiesTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28842&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28772&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfFinancialPositionAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AssetsAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfFinancialPositionAbstract to us-gaap:AssetsAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28773&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:CashAndCashEquivalentsAtCarryingValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28774&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AccountsReceivableNetCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:AccountsReceivableNetCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28775&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://pharmabioserv.com/20241231}PromissoryNoteReceivableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to PBSV:PromissoryNoteReceivableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28776&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PrepaidExpenseAndOtherAssets" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:PrepaidExpenseAndOtherAssets - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28777&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AssetsCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:AssetsCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28778&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentNet" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:PropertyPlantAndEquipmentNet - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28779&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OperatingLeaseRightOfUseAsset" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:OperatingLeaseRightOfUseAsset - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28780&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OtherAssetsNoncurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:OtherAssetsNoncurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28781&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}Assets" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:Assets - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28782&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfFinancialPositionAbstract" relationship-target="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfFinancialPositionAbstract to us-gaap:LiabilitiesAndStockholdersEquityAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28783&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:CapitalLeaseObligationsCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28784&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}LoansPayableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:LoansPayableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28785&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:OperatingLeaseLiabilityCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28786&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AccountsPayableAndAccruedLiabilitiesCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28787&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}DividendsPayableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:DividendsPayableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28788&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AccruedIncomeTaxesCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:AccruedIncomeTaxesCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28789&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:LiabilitiesCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28790&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}TaxesPayableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:TaxesPayableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28791&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}LoansPayable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:LoansPayable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28792&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsNoncurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:CapitalLeaseObligationsNoncurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28793&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityNoncurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:OperatingLeaseLiabilityNoncurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28794&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OtherLiabilities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:OtherLiabilities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28795&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}Liabilities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:Liabilities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28796&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:StockholdersEquityAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28797&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PreferredStockValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:PreferredStockValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28798&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:CommonStockValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28799&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalCommonStock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:AdditionalPaidInCapitalCommonStock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28800&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}RetainedEarningsAccumulatedDeficit" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:RetainedEarningsAccumulatedDeficit - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28801&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeLossNetOfTax" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28802&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:StockholdersEquityBeforeTreasuryStock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28803&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}TreasuryStockValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:TreasuryStockValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28804&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:StockholdersEquity - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28805&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquity" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:LiabilitiesAndStockholdersEquity - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28879&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28880&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:GainLossOnDispositionOfAssets - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28881&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:ShareBasedCompensation - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28882&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}DepreciationDepletionAndAmortization" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:DepreciationDepletionAndAmortization - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28883&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28884&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:IncreaseDecreaseInAccountsReceivable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28885&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:IncreaseDecreaseInOtherOperatingAssets - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28886&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOperatingLiabilities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:IncreaseDecreaseInOperatingLiabilities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28887&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:NetCashProvidedByUsedInOperatingActivities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28888&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfCashFlowsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfCashFlowsAbstract to us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28889&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" relationship-target="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to PBSV:DisposalOfMarketableSecurities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28890&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28891&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ProceedsFromSaleOfPropertyPlantAndEquipment" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28892&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ProceedsFromCollectionOfOtherReceivables" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap:ProceedsFromCollectionOfOtherReceivables - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28893&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28894&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfCashFlowsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfCashFlowsAbstract to us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28895&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ProceedsFromLoans" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:ProceedsFromLoans - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28896&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:PaymentsForRepurchaseOfCommonStock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28897&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:RepaymentsOfLongTermCapitalLeaseObligations - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28898&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:PaymentsOfDividends - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28899&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28900&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}EffectOfExchangeRateOnCashAndCashEquivalents" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28901&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28902&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:CashAndCashEquivalentsAtCarryingValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28903&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:CashAndCashEquivalentsAtCarryingValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28904&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfCashFlowsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}SupplementalCashFlowInformationAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfCashFlowsAbstract to us-gaap:SupplementalCashFlowInformationAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28905&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}SupplementalCashFlowInformationAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncomeTaxesPaid" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:SupplementalCashFlowInformationAbstract to us-gaap:IncomeTaxesPaid - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28906&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}SupplementalCashFlowInformationAbstract" relationship-target="{http://fasb.org/us-gaap/2024}InterestPaidNet" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:SupplementalCashFlowInformationAbstract to us-gaap:InterestPaidNet - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28907&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfCashFlowsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfCashFlowsAbstract to us-gaap:CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28908&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" relationship-target="{http://pharmabioserv.com/20241231}IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to PBSV:IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28909&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" relationship-target="{http://pharmabioserv.com/20241231}ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to PBSV:ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28910&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" relationship-target="{http://pharmabioserv.com/20241231}ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to PBSV:ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28911&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentDisposals" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap:PropertyPlantAndEquipmentDisposals - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28877&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfCashFlowsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivitiesAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfCashFlowsAbstract to us-gaap:NetCashProvidedByUsedInOperatingActivitiesAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28878&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:NetIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28241&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}MajorCustomersAxis" relationship-target="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" severity="info" cid="2430583881168">[relationships] relationship from srt:MajorCustomersAxis to srt:NameOfMajorCustomerDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28242&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}StatementGeographicalAxis" relationship-target="{http://fasb.org/srt/2024}SegmentGeographicalDomain" severity="info" cid="2430583881168">[relationships] relationship from srt:StatementGeographicalAxis to srt:SegmentGeographicalDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28243&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}EquityComponentDomain" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:EquityComponentDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28263&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}OtherSegmentsMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:OtherSegmentsMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28260&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:PuertoRicoConsultingMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28265&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28261&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:UnitedStatesConsultingMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28264&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}Revenues" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:Revenues - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28262&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}EuropeConsultingMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:EuropeConsultingMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28912&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfCashFlowsAbstract" relationship-target="{http://pharmabioserv.com/20241231}AccumulatedDepreciationOnPropertyAndEquipmentDisposed" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfCashFlowsAbstract to PBSV:AccumulatedDepreciationOnPropertyAndEquipmentDisposed - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28752&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPol..." severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28239&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StatementTable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StatementTable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29005&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}GrossProfit" relationship-target="{http://fasb.org/us-gaap/2024}Revenues" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:GrossProfit to us-gaap:Revenues - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29007&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetIncomeLoss" relationship-target="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetIncomeLoss to us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29006&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}GrossProfit" relationship-target="{http://fasb.org/us-gaap/2024}CostOfRevenue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:GrossProfit to us-gaap:CostOfRevenue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29008&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetIncomeLoss" relationship-target="{http://fasb.org/us-gaap/2024}IncomeTaxExpenseBenefit" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetIncomeLoss to us-gaap:IncomeTaxExpenseBenefit - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28238&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StatementTable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StatementTable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28267&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}StatementGeographicalAxis" relationship-target="{http://fasb.org/srt/2024}SegmentGeographicalDomain" severity="info" cid="2430583881168">[relationships] relationship from srt:StatementGeographicalAxis to srt:SegmentGeographicalDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28971&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Liabilities" relationship-target="{http://fasb.org/us-gaap/2024}LoansPayable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Liabilities to us-gaap:LoansPayable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28953&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsCurrent" relationship-target="{http://fasb.org/us-gaap/2024}AccountsReceivableNetCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsCurrent to us-gaap:AccountsReceivableNetCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28957&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Assets" relationship-target="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentNet" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Assets to us-gaap:PropertyPlantAndEquipmentNet - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28961&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" relationship-target="{http://fasb.org/us-gaap/2024}AccountsPayableAndAccruedLiabilitiesCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesCurrent to us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28967&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Liabilities" relationship-target="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsNoncurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Liabilities to us-gaap:CapitalLeaseObligationsNoncurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28973&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityBeforeTreasuryStock to us-gaap:CommonStockValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28978&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquity" relationship-target="{http://fasb.org/us-gaap/2024}TreasuryStockValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquity to us-gaap:TreasuryStockValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28980&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquity" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquity to us-gaap:StockholdersEquity - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28954&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsCurrent" relationship-target="{http://fasb.org/us-gaap/2024}PrepaidExpenseAndOtherAssets" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsCurrent to us-gaap:PrepaidExpenseAndOtherAssets - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28958&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Assets" relationship-target="{http://fasb.org/us-gaap/2024}OtherAssetsNoncurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Assets to us-gaap:OtherAssetsNoncurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28962&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" relationship-target="{http://fasb.org/us-gaap/2024}AccruedIncomeTaxesCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesCurrent to us-gaap:AccruedIncomeTaxesCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28968&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Liabilities" relationship-target="{http://fasb.org/us-gaap/2024}TaxesPayableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Liabilities to us-gaap:TaxesPayableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28974&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" relationship-target="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalCommonStock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityBeforeTreasuryStock to us-gaap:AdditionalPaidInCapitalCommonStock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28955&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsCurrent" relationship-target="{http://pharmabioserv.com/20241231}PromissoryNoteReceivableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsCurrent to PBSV:PromissoryNoteReceivableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28959&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Assets" relationship-target="{http://fasb.org/us-gaap/2024}OperatingLeaseRightOfUseAsset" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Assets to us-gaap:OperatingLeaseRightOfUseAsset - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28963&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" relationship-target="{http://fasb.org/us-gaap/2024}DividendsPayableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesCurrent to us-gaap:DividendsPayableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28952&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsCurrent" relationship-target="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsCurrent to us-gaap:CashAndCashEquivalentsAtCarryingValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28969&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Liabilities" relationship-target="{http://fasb.org/us-gaap/2024}OtherLiabilities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Liabilities to us-gaap:OtherLiabilities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28956&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Assets" relationship-target="{http://fasb.org/us-gaap/2024}AssetsCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Assets to us-gaap:AssetsCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28975&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" relationship-target="{http://fasb.org/us-gaap/2024}RetainedEarningsAccumulatedDeficit" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityBeforeTreasuryStock to us-gaap:RetainedEarningsAccumulatedDeficit - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28960&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" relationship-target="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesCurrent to us-gaap:CapitalLeaseObligationsCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28964&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" relationship-target="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesCurrent to us-gaap:OperatingLeaseLiabilityCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28966&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Liabilities" relationship-target="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Liabilities to us-gaap:LiabilitiesCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28970&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Liabilities" relationship-target="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityNoncurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Liabilities to us-gaap:OperatingLeaseLiabilityNoncurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28972&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" relationship-target="{http://fasb.org/us-gaap/2024}PreferredStockValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityBeforeTreasuryStock to us-gaap:PreferredStockValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28976&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" relationship-target="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeLossNetOfTax" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityBeforeTreasuryStock to us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28977&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquity" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquity to us-gaap:StockholdersEquityBeforeTreasuryStock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28965&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" relationship-target="{http://fasb.org/us-gaap/2024}LoansPayableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesCurrent to us-gaap:LoansPayableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28979&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquity" relationship-target="{http://fasb.org/us-gaap/2024}Liabilities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquity to us-gaap:Liabilities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28824&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityFilerCategory" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityFilerCategory - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28825&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityEmergingGrowthCompany" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityEmergingGrowthCompany - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28826&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntitySmallBusiness" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntitySmallBusiness - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28827&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityShellCompany" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityShellCompany - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28828&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityCommonStockSharesOutstanding" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityCommonStockSharesOutstanding - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28829&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}DocumentFiscalPeriodFocus" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:DocumentFiscalPeriodFocus - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28830&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}DocumentFiscalYearFocus" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:DocumentFiscalYearFocus - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28831&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityInteractiveDataCurrent" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityInteractiveDataCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28832&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityIncorporationStateCountryCode" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityIncorporationStateCountryCode - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28833&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityFileNumber" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityFileNumber - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28817&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityRegistrantName" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityRegistrantName - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28818&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityCentralIndexKey" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityCentralIndexKey - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28819&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}DocumentType" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:DocumentType - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28820&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}DocumentPeriodEndDate" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:DocumentPeriodEndDate - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28821&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}AmendmentFlag" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:AmendmentFlag - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28822&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}CurrentFiscalYearEndDate" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:CurrentFiscalYearEndDate - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28823&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityCurrentReportingStatus" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityCurrentReportingStatus - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28259&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}MajorCustomersAxis" relationship-target="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" severity="info" cid="2430583881168">[relationships] relationship from srt:MajorCustomersAxis to srt:NameOfMajorCustomerDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28252&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupCMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupCMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28257&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://pharmabioserv.com/20241231}AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to PBSV:AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28245&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerBMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerBMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28251&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupBMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupBMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28250&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupAMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupAMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28246&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerCMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerCMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28255&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupTotalMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupTotalMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28247&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerDMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerDMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28253&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupDMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupDMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28248&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerEMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerEMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28256&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:ConcentrationRiskPercentage1 - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28254&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupEMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupEMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28244&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerAMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerAMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28249&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerTotalMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerTotalMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28283&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}EquityComponentDomain" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:EquityComponentDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28266&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/srt/2024}StatementGeographicalAxis" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to srt:StatementGeographicalAxis - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28282&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to us-gaap:StatementEquityComponentsAxis - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28280&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:NetIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28269&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EquityComponentDomain" relationship-target="{http://fasb.org/us-gaap/2024}PreferredStockMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EquityComponentDomain to us-gaap:PreferredStockMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28281&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28270&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EquityComponentDomain" relationship-target="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EquityComponentDomain to us-gaap:AdditionalPaidInCapitalMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28268&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EquityComponentDomain" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EquityComponentDomain to us-gaap:CommonStockMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28271&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EquityComponentDomain" relationship-target="{http://fasb.org/us-gaap/2024}RetainedEarningsMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EquityComponentDomain to us-gaap:RetainedEarningsMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28274&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}SharesIssued" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:SharesIssued - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28272&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EquityComponentDomain" relationship-target="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EquityComponentDomain to us-gaap:AccumulatedOtherComprehensiveIncomeMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28275&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StockholdersEquity - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28273&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EquityComponentDomain" relationship-target="{http://fasb.org/us-gaap/2024}TreasuryStockMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EquityComponentDomain to us-gaap:TreasuryStockMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28276&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:ShareBasedCompensation - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28277&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to PBSV:StockIssuedDuringPeriodSharesStockOptionsExercisedCashless - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28278&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28279&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StockRepurchasedDuringPeriodValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28922&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}TreasuryStockMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:TreasuryStockMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28916&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}EquityComponentDomain" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:EquityComponentDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28926&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to PBSV:StockIssuedDuringPeriodSharesStockOptionsExercisedCashless - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28927&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28928&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StockRepurchasedDuringPeriodValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28913&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StatementTable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfStockholdersEquityAbstract to us-gaap:StatementTable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28929&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:NetIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28930&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28931&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}SharesIssued" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:SharesIssued - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28932&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StockholdersEquity - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28914&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/us-gaap/2024}StatementLineItems" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to us-gaap:StatementLineItems - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28915&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to us-gaap:StatementEquityComponentsAxis - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28917&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:CommonStockMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28918&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}PreferredStockMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:PreferredStockMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28923&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}SharesIssued" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:SharesIssued - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28919&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:AdditionalPaidInCapitalMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28924&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StockholdersEquity - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28920&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}RetainedEarningsMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:RetainedEarningsMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28921&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:AccumulatedOtherComprehensiveIncomeMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28925&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:ShareBasedCompensation - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28876&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}SegmentReportingAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ScheduleOfSegmentReportingInformationBySegmentTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:SegmentReportingAbstract to us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock - </message></entry>
<entry code="Serializer" level="info">
 <message>[Serializer] Writing package D:/DJT/Documents/GitHub/davidtauriello/dqc_us_rules/tests/input/roll-forward/output/phmb-20200430_taxonomy.zip - </message>
 <ref href=""/></entry>
<entry code="XinceInfo" level="info">
 <message>[XinceInfo] Start loading taxonomy model for instance phmb-20200131_htm - </message>
 <ref href=""/></entry>
<entry code="XinceInfo" level="info">
 <message>[XinceInfo] Loaded taxonomy model for instance phmb-20200131_htm - </message>
 <ref href=""/></entry>
<entry code="XinceInfo" level="info">
 <message>[XinceInfo] Writing instance file D:/DJT/Documents/GitHub/davidtauriello/dqc_us_rules/tests/input/roll-forward/output/phmb-20200131_htm.xml - </message>
 <ref href=""/></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="instant" concept-balance-type="credit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}AccountingStandardsUpdate201616Member" concept-data-type="{http://www.xbrl.org/dtr/type/non-numeric}domainItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] AccountingStandardsUpdate201616Member - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}VariableInterestEntitiesByClassificationOfEntityAxis" concept-data-type="{http://www.xbrl.org/2003/instance}stringItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://xbrl.org/2005/xbrldt}dimensionItem" severity="info" cid="2430583881168">[add_back_deprecated_concepts] VariableInterestEntitiesByClassificationOfEntityAxis - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}CumulativeEffectOnRetainedEarningsNetOfTax1" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="instant" concept-balance-type="credit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] CumulativeEffectOnRetainedEarningsNetOfTax1 - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" concept-data-type="{http://www.xbrl.org/2003/instance}stringItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}AccountingStandardsUpdate201605Member" concept-data-type="{http://www.xbrl.org/dtr/type/non-numeric}domainItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] AccountingStandardsUpdate201605Member - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}VariableInterestEntityNonconsolidatedCarryingAmountAssets" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="instant" concept-balance-type="debit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] VariableInterestEntityNonconsolidatedCarryingAmountAssets - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}AccountingStandardsUpdate201615RetrospectiveMember" concept-data-type="{http://www.xbrl.org/dtr/type/non-numeric}domainItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] AccountingStandardsUpdate201615RetrospectiveMember - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}VariableInterestEntityNonconsolidatedCarryingAmountLiabilities" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="instant" concept-balance-type="credit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] VariableInterestEntityNonconsolidatedCarryingAmountLiabilities - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}AccountingStandardsUpdate201502Member" concept-data-type="{http://www.xbrl.org/dtr/type/non-numeric}domainItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] AccountingStandardsUpdate201502Member - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}VariableInterestEntityNonconsolidatedCarryingAmountAssetsAndLiabilitiesNet" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="instant" concept-balance-type="debit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] VariableInterestEntityNonconsolidatedCarryingAmountAssetsAndLiabilitiesNet - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}ClassificationOfVariableInterestEntityDomain" concept-data-type="{http://www.xbrl.org/dtr/type/non-numeric}domainItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] ClassificationOfVariableInterestEntityDomain - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="duration" concept-balance-type="debit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="instant" concept-balance-type="credit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}AccountingStandardsUpdate201604CumulativeEffectPeriodOfAdoptionMember" concept-data-type="{http://www.xbrl.org/dtr/type/non-numeric}domainItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] AccountingStandardsUpdate201604CumulativeEffectPeriodOfAdoptionMember - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}AccountingStandardsUpdate201709Member" concept-data-type="{http://www.xbrl.org/dtr/type/non-numeric}domainItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] AccountingStandardsUpdate201709Member - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" concept-data-type="{http://www.xbrl.org/2003/instance}monetaryItemType" concept-abstract="False" concept-nillable="True" concept-period-type="instant" concept-balance-type="credit" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption - </message></entry>
<entry code="add_back_deprecated_concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept-name="{http://pharmabioserv.com/20241231}DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" concept-data-type="{http://www.xbrl.org/2003/instance}stringItemType" concept-abstract="True" concept-nillable="True" concept-period-type="duration" concept-balance-type="None" concept-substitution-group="{http://www.xbrl.org/2003/instance}item" severity="info" cid="2430583881168">[add_back_deprecated_concepts] DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract - </message></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="956289.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 956,289 - pbsv-20200131.xml 1691</message>
 <ref href="pbsv-20200131.xml#element(/1/312)" sourceLine="1691">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="956,289"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="394278.0" fact-concept="{http://fasb.org/us-gaap/2024}TreasuryStockValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 394,278 - pbsv-20200131.xml 1617</message>
 <ref href="pbsv-20200131.xml#element(/1/238)" sourceLine="1617">
  <property name="label" value="Treasury Stock, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="TreasuryStockValue"/>
  <property name="QName" value="us-gaap:TreasuryStockValue"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="394,278"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2320.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,320 - pbsv-20200131.xml 1692</message>
 <ref href="pbsv-20200131.xml#element(/1/313)" sourceLine="1692">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,320"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1423139.0" fact-concept="{http://fasb.org/us-gaap/2024}AccountsPayableAndAccruedLiabilitiesCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,423,139 - pbsv-20200131.xml 1553</message>
 <ref href="pbsv-20200131.xml#element(/1/174)" sourceLine="1553">
  <property name="label" value="Accounts payable and accrued expenses"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccountsPayableAndAccruedLiabilitiesCurrent"/>
  <property name="QName" value="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,423,139"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21564.0" fact-concept="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,564 - pbsv-20200131.xml 1776</message>
 <ref href="pbsv-20200131.xml#element(/1/397)" sourceLine="1776">
  <property name="label" value="Stock Repurchased During Period, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockRepurchasedDuringPeriodValue"/>
  <property name="QName" value="us-gaap:StockRepurchasedDuringPeriodValue"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,564"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="62390.0" fact-concept="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 62,390 - pbsv-20200131.xml 1845</message>
 <ref href="pbsv-20200131.xml#element(/1/466)" sourceLine="1845">
  <property name="label" value="Repayments of Long-term Capital Lease Obligations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="QName" value="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="62,390"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="--10-31" fact-concept="{http://xbrl.sec.gov/dei/2024}CurrentFiscalYearEndDate" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] --10-31 - pbsv-20200131.xml 1977</message>
 <ref href="pbsv-20200131.xml#element(/1/598)" sourceLine="1977">
  <property name="label" value="Current Fiscal Year End Date"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="CurrentFiscalYearEndDate"/>
  <property name="QName" value="dei:CurrentFiscalYearEndDate"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="--10-31"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20687529.0" fact-concept="{http://fasb.org/us-gaap/2024}RetainedEarningsAccumulatedDeficit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,687,529 - pbsv-20200131.xml 1623</message>
 <ref href="pbsv-20200131.xml#element(/1/244)" sourceLine="1623">
  <property name="label" value="Retained earnings"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="RetainedEarningsAccumulatedDeficit"/>
  <property name="QName" value="us-gaap:RetainedEarningsAccumulatedDeficit"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,687,529"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-57925.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -57,925 - pbsv-20200131.xml 1693</message>
 <ref href="pbsv-20200131.xml#element(/1/314)" sourceLine="1693">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-57,925"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21564.0" fact-concept="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,564 - pbsv-20200131.xml 1779</message>
 <ref href="pbsv-20200131.xml#element(/1/400)" sourceLine="1779">
  <property name="label" value="Stock Repurchased During Period, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockRepurchasedDuringPeriodValue"/>
  <property name="QName" value="us-gaap:StockRepurchasedDuringPeriodValue"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,564"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.122" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.122 - pbsv-20200131.xml 1919</message>
 <ref href="pbsv-20200131.xml#element(/1/540)" sourceLine="1919">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_MajorCustomerDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.122"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21195939.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,195,939 - pbsv-20200131.xml 1619</message>
 <ref href="pbsv-20200131.xml#element(/1/240)" sourceLine="1619">
  <property name="label" value="Stockholders' Equity before Treasury Stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquityBeforeTreasuryStock"/>
  <property name="QName" value="us-gaap:StockholdersEquityBeforeTreasuryStock"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,195,939"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="396032.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 396,032 - pbsv-20200131.xml 1694</message>
 <ref href="pbsv-20200131.xml#element(/1/315)" sourceLine="1694">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="396,032"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1846</message>
 <ref href="pbsv-20200131.xml#element(/1/467)" sourceLine="1846">
  <property name="label" value="Payments for Repurchase of Common Stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsForRepurchaseOfCommonStock"/>
  <property name="QName" value="us-gaap:PaymentsForRepurchaseOfCommonStock"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="65755.0" fact-concept="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 65,755 - pbsv-20200131.xml 1778</message>
 <ref href="pbsv-20200131.xml#element(/1/399)" sourceLine="1778">
  <property name="label" value="Stock Repurchased During Period, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockRepurchasedDuringPeriodValue"/>
  <property name="QName" value="us-gaap:StockRepurchasedDuringPeriodValue"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="65,755"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="87319.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 87,319 - pbsv-20200131.xml 1849</message>
 <ref href="pbsv-20200131.xml#element(/1/470)" sourceLine="1849">
  <property name="label" value="Payments for Repurchase of Common Stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsForRepurchaseOfCommonStock"/>
  <property name="QName" value="us-gaap:PaymentsForRepurchaseOfCommonStock"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="87,319"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="156496.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 156,496 - pbsv-20200131.xml 1555</message>
 <ref href="pbsv-20200131.xml#element(/1/176)" sourceLine="1555">
  <property name="label" value="Current operating lease liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingLeaseLiabilityCurrent"/>
  <property name="QName" value="us-gaap:OperatingLeaseLiabilityCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="156,496"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="81407.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxExpenseBenefit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 81,407 - pbsv-20200131.xml 1695</message>
 <ref href="pbsv-20200131.xml#element(/1/316)" sourceLine="1695">
  <property name="label" value="INCOME TAX EXPENSE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxExpenseBenefit"/>
  <property name="QName" value="us-gaap:IncomeTaxExpenseBenefit"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="81,407"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="10-Q" fact-concept="{http://xbrl.sec.gov/dei/2024}DocumentType" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 10-Q - pbsv-20200131.xml 1974</message>
 <ref href="pbsv-20200131.xml#element(/1/595)" sourceLine="1974">
  <property name="label" value="Document Type"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="DocumentType"/>
  <property name="QName" value="dei:DocumentType"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="10-Q"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.076" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.076 - pbsv-20200131.xml 1920</message>
 <ref href="pbsv-20200131.xml#element(/1/541)" sourceLine="1920">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_MajorCustomerEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.076"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1699.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,699 - pbsv-20200131.xml 1848</message>
 <ref href="pbsv-20200131.xml#element(/1/469)" sourceLine="1848">
  <property name="label" value="Payments for Repurchase of Common Stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsForRepurchaseOfCommonStock"/>
  <property name="QName" value="us-gaap:PaymentsForRepurchaseOfCommonStock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,699"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="65755.0" fact-concept="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 65,755 - pbsv-20200131.xml 1777</message>
 <ref href="pbsv-20200131.xml#element(/1/398)" sourceLine="1777">
  <property name="label" value="Stock Repurchased During Period, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockRepurchasedDuringPeriodValue"/>
  <property name="QName" value="us-gaap:StockRepurchasedDuringPeriodValue"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="65,755"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="392579.0" fact-concept="{http://fasb.org/us-gaap/2024}TreasuryStockValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 392,579 - pbsv-20200131.xml 1618</message>
 <ref href="pbsv-20200131.xml#element(/1/239)" sourceLine="1618">
  <property name="label" value="Treasury Stock, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="TreasuryStockValue"/>
  <property name="QName" value="us-gaap:TreasuryStockValue"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="392,579"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="118213.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxExpenseBenefit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 118,213 - pbsv-20200131.xml 1698</message>
 <ref href="pbsv-20200131.xml#element(/1/319)" sourceLine="1698">
  <property name="label" value="INCOME TAX EXPENSE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxExpenseBenefit"/>
  <property name="QName" value="us-gaap:IncomeTaxExpenseBenefit"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="118,213"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2020-04-30T00:00:00" fact-concept="{http://xbrl.sec.gov/dei/2024}DocumentPeriodEndDate" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2020-04-30 - pbsv-20200131.xml 1975</message>
 <ref href="pbsv-20200131.xml#element(/1/596)" sourceLine="1975">
  <property name="label" value="Document Period End Date"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="DocumentPeriodEndDate"/>
  <property name="QName" value="dei:DocumentPeriodEndDate"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2020-04-30"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.266" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.266 - pbsv-20200131.xml 1921</message>
 <ref href="pbsv-20200131.xml#element(/1/542)" sourceLine="1921">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_MajorCustomerEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.266"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1631</message>
 <ref href="pbsv-20200131.xml#element(/1/252)" sourceLine="1631">
  <property name="label" value="Preferred stock, outstanding"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockSharesOutstanding"/>
  <property name="QName" value="us-gaap:PreferredStockSharesOutstanding"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1590172.0" fact-concept="{http://fasb.org/us-gaap/2024}AccountsPayableAndAccruedLiabilitiesCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,590,172 - pbsv-20200131.xml 1554</message>
 <ref href="pbsv-20200131.xml#element(/1/175)" sourceLine="1554">
  <property name="label" value="Accounts payable and accrued expenses"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccountsPayableAndAccruedLiabilitiesCurrent"/>
  <property name="QName" value="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,590,172"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21564.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,564 - pbsv-20200131.xml 1847</message>
 <ref href="pbsv-20200131.xml#element(/1/468)" sourceLine="1847">
  <property name="label" value="Payments for Repurchase of Common Stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsForRepurchaseOfCommonStock"/>
  <property name="QName" value="us-gaap:PaymentsForRepurchaseOfCommonStock"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,564"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="11331.0" fact-concept="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 11,331 - pbsv-20200131.xml 1559</message>
 <ref href="pbsv-20200131.xml#element(/1/180)" sourceLine="1559">
  <property name="label" value="Current portion-obligations under finance leases"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CapitalLeaseObligationsCurrent"/>
  <property name="QName" value="us-gaap:CapitalLeaseObligationsCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="11,331"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="136702.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxExpenseBenefit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 136,702 - pbsv-20200131.xml 1697</message>
 <ref href="pbsv-20200131.xml#element(/1/318)" sourceLine="1697">
  <property name="label" value="INCOME TAX EXPENSE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxExpenseBenefit"/>
  <property name="QName" value="us-gaap:IncomeTaxExpenseBenefit"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="136,702"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1699.0" fact-concept="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,699 - pbsv-20200131.xml 1780</message>
 <ref href="pbsv-20200131.xml#element(/1/401)" sourceLine="1780">
  <property name="label" value="Stock Repurchased During Period, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockRepurchasedDuringPeriodValue"/>
  <property name="QName" value="us-gaap:StockRepurchasedDuringPeriodValue"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,699"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="102133.0" fact-concept="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeLossNetOfTax" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 102,133 - pbsv-20200131.xml 1621</message>
 <ref href="pbsv-20200131.xml#element(/1/242)" sourceLine="1621">
  <property name="label" value="Accumulated other comprehensive loss"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
  <property name="QName" value="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="102,133"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="327245.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 327,245 - pbsv-20200131.xml 1850</message>
 <ref href="pbsv-20200131.xml#element(/1/471)" sourceLine="1850">
  <property name="label" value="Cash and Cash Equivalents, Period Increase (Decrease)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="327,245"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="False" fact-concept="{http://xbrl.sec.gov/dei/2024}AmendmentFlag" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] False - pbsv-20200131.xml 1976</message>
 <ref href="pbsv-20200131.xml#element(/1/597)" sourceLine="1976">
  <property name="label" value="Amendment Flag"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="AmendmentFlag"/>
  <property name="QName" value="dei:AmendmentFlag"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="false"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.249" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.249 - pbsv-20200131.xml 1922</message>
 <ref href="pbsv-20200131.xml#element(/1/543)" sourceLine="1922">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_GlobalGroupAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.249"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21000085.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,000,085 - pbsv-20200131.xml 1620</message>
 <ref href="pbsv-20200131.xml#element(/1/241)" sourceLine="1620">
  <property name="label" value="Stockholders' Equity before Treasury Stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquityBeforeTreasuryStock"/>
  <property name="QName" value="us-gaap:StockholdersEquityBeforeTreasuryStock"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,000,085"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="643900.0" fact-concept="{http://fasb.org/us-gaap/2024}LoansPayableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 643,900 - pbsv-20200131.xml 1557</message>
 <ref href="pbsv-20200131.xml#element(/1/178)" sourceLine="1557">
  <property name="label" value="Loans short term portion"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LoansPayableCurrent"/>
  <property name="QName" value="us-gaap:LoansPayableCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="643,900"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="75258.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxExpenseBenefit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 75,258 - pbsv-20200131.xml 1696</message>
 <ref href="pbsv-20200131.xml#element(/1/317)" sourceLine="1696">
  <property name="label" value="INCOME TAX EXPENSE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxExpenseBenefit"/>
  <property name="QName" value="us-gaap:IncomeTaxExpenseBenefit"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="75,258"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1699.0" fact-concept="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,699 - pbsv-20200131.xml 1781</message>
 <ref href="pbsv-20200131.xml#element(/1/402)" sourceLine="1781">
  <property name="label" value="Stock Repurchased During Period, Value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockRepurchasedDuringPeriodValue"/>
  <property name="QName" value="us-gaap:StockRepurchasedDuringPeriodValue"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,699"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-29461.0" fact-concept="{http://fasb.org/us-gaap/2024}EffectOfExchangeRateOnCashAndCashEquivalents" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -29,461 - pbsv-20200131.xml 1854</message>
 <ref href="pbsv-20200131.xml#element(/1/475)" sourceLine="1854">
  <property name="label" value="EFFECT OF EXCHANGE RATE CHANGES ON CASH"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="QName" value="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-29,461"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="687561.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 687,561 - pbsv-20200131.xml 1699</message>
 <ref href="pbsv-20200131.xml#element(/1/320)" sourceLine="1699">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="687,561"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1556</message>
 <ref href="pbsv-20200131.xml#element(/1/177)" sourceLine="1556">
  <property name="label" value="Current operating lease liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingLeaseLiabilityCurrent"/>
  <property name="QName" value="us-gaap:OperatingLeaseLiabilityCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-596809.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -596,809 - pbsv-20200131.xml 1853</message>
 <ref href="pbsv-20200131.xml#element(/1/474)" sourceLine="1853">
  <property name="label" value="Cash and Cash Equivalents, Period Increase (Decrease)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-596,809"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="False" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityEmergingGrowthCompany" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] False - pbsv-20200131.xml 1980</message>
 <ref href="pbsv-20200131.xml#element(/1/601)" sourceLine="1980">
  <property name="label" value="Entity Emerging Growth Company"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityEmergingGrowthCompany"/>
  <property name="QName" value="dei:EntityEmergingGrowthCompany"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="false"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.119" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.119 - pbsv-20200131.xml 1923</message>
 <ref href="pbsv-20200131.xml#element(/1/544)" sourceLine="1923">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_GlobalGroupBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.119"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}StockRepurchaseDuringPeriodShares" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1782</message>
 <ref href="pbsv-20200131.xml#element(/1/403)" sourceLine="1782">
  <property name="label" value="Purchase of treasury stocks"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockRepurchaseDuringPeriodShares"/>
  <property name="QName" value="PBSV:StockRepurchaseDuringPeriodShares"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1178503.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,178,503 - pbsv-20200131.xml 1703</message>
 <ref href="pbsv-20200131.xml#element(/1/324)" sourceLine="1703">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,178,503"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="91823.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 91,823 - pbsv-20200131.xml 1852</message>
 <ref href="pbsv-20200131.xml#element(/1/473)" sourceLine="1852">
  <property name="label" value="Cash and Cash Equivalents, Period Increase (Decrease)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="91,823"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-1556707.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -1,556,707 - pbsv-20200131.xml 1786</message>
 <ref href="pbsv-20200131.xml#element(/1/407)" sourceLine="1786">
  <property name="label" value="Net Cash Provided by (Used in) Operating Activities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInOperatingActivities"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInOperatingActivities"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-1,556,707"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="Yes" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityCurrentReportingStatus" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] Yes - pbsv-20200131.xml 1978</message>
 <ref href="pbsv-20200131.xml#element(/1/599)" sourceLine="1978">
  <property name="label" value="Is Entity's Reporting Status Current?"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityCurrentReportingStatus"/>
  <property name="QName" value="dei:EntityCurrentReportingStatus"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="Yes"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1214461.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,214,461 - pbsv-20200131.xml 1702</message>
 <ref href="pbsv-20200131.xml#element(/1/323)" sourceLine="1702">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,214,461"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2300.0" fact-concept="{http://pharmabioserv.com/20241231}StockRepurchaseDuringPeriodShares" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,300 - pbsv-20200131.xml 1785</message>
 <ref href="pbsv-20200131.xml#element(/1/406)" sourceLine="1785">
  <property name="label" value="Purchase of treasury stocks"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockRepurchaseDuringPeriodShares"/>
  <property name="QName" value="PBSV:StockRepurchaseDuringPeriodShares"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,300"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.146" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.146 - pbsv-20200131.xml 1924</message>
 <ref href="pbsv-20200131.xml#element(/1/545)" sourceLine="1924">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_GlobalGroupCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.146"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="143600.0" fact-concept="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeLossNetOfTax" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 143,600 - pbsv-20200131.xml 1622</message>
 <ref href="pbsv-20200131.xml#element(/1/243)" sourceLine="1622">
  <property name="label" value="Accumulated other comprehensive loss"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
  <property name="QName" value="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="143,600"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-365415.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -365,415 - pbsv-20200131.xml 1851</message>
 <ref href="pbsv-20200131.xml#element(/1/472)" sourceLine="1851">
  <property name="label" value="Cash and Cash Equivalents, Period Increase (Decrease)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-365,415"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}LoansPayableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1558</message>
 <ref href="pbsv-20200131.xml#element(/1/179)" sourceLine="1558">
  <property name="label" value="Loans short term portion"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LoansPayableCurrent"/>
  <property name="QName" value="us-gaap:LoansPayableCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="687561.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 687,561 - pbsv-20200131.xml 1701</message>
 <ref href="pbsv-20200131.xml#element(/1/322)" sourceLine="1701">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="687,561"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="Non-accelerated Filer" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityFilerCategory" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] Non-accelerated Filer - pbsv-20200131.xml 1979</message>
 <ref href="pbsv-20200131.xml#element(/1/600)" sourceLine="1979">
  <property name="label" value="Entity Filer Category"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityFilerCategory"/>
  <property name="QName" value="dei:EntityFilerCategory"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="Non-accelerated Filer"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21357422.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,357,422 - pbsv-20200131.xml 1578</message>
 <ref href="pbsv-20200131.xml#element(/1/199)" sourceLine="1578">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,357,422"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1403936.0" fact-concept="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,403,936 - pbsv-20200131.xml 1625</message>
 <ref href="pbsv-20200131.xml#element(/1/246)" sourceLine="1625">
  <property name="label" value="Additional paid-in capital"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AdditionalPaidInCapitalCommonStock"/>
  <property name="QName" value="us-gaap:AdditionalPaidInCapitalCommonStock"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,403,936"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.118" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.118 - pbsv-20200131.xml 1925</message>
 <ref href="pbsv-20200131.xml#element(/1/546)" sourceLine="1925">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_GlobalGroupDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.118"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="65772.0" fact-concept="{http://pharmabioserv.com/20241231}StockRepurchaseDuringPeriodShares" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 65,772 - pbsv-20200131.xml 1784</message>
 <ref href="pbsv-20200131.xml#element(/1/405)" sourceLine="1784">
  <property name="label" value="Purchase of treasury stocks"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockRepurchaseDuringPeriodShares"/>
  <property name="QName" value="PBSV:StockRepurchaseDuringPeriodShares"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="65,772"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="988.0" fact-concept="{http://fasb.org/us-gaap/2024}InterestPaidNet" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 988 - pbsv-20200131.xml 1858</message>
 <ref href="pbsv-20200131.xml#element(/1/479)" sourceLine="1858">
  <property name="label" value="Cash paid during the period for: Interest"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="InterestPaidNet"/>
  <property name="QName" value="us-gaap:InterestPaidNet"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="988"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="707483.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 707,483 - pbsv-20200131.xml 1700</message>
 <ref href="pbsv-20200131.xml#element(/1/321)" sourceLine="1700">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="707,483"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="True" fact-concept="{http://xbrl.sec.gov/dei/2024}EntitySmallBusiness" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] True - pbsv-20200131.xml 1981</message>
 <ref href="pbsv-20200131.xml#element(/1/602)" sourceLine="1981">
  <property name="label" value="Entity Small Business"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntitySmallBusiness"/>
  <property name="QName" value="dei:EntitySmallBusiness"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="true"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-11140.0" fact-concept="{http://fasb.org/us-gaap/2024}EffectOfExchangeRateOnCashAndCashEquivalents" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -11,140 - pbsv-20200131.xml 1857</message>
 <ref href="pbsv-20200131.xml#element(/1/478)" sourceLine="1857">
  <property name="label" value="EFFECT OF EXCHANGE RATE CHANGES ON CASH"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="QName" value="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-11,140"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="6834262.0" fact-concept="{http://fasb.org/us-gaap/2024}Liabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 6,834,262 - pbsv-20200131.xml 1561</message>
 <ref href="pbsv-20200131.xml#element(/1/182)" sourceLine="1561">
  <property name="label" value="Liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Liabilities"/>
  <property name="QName" value="us-gaap:Liabilities"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="6,834,262"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="19473069.0" fact-concept="{http://fasb.org/us-gaap/2024}RetainedEarningsAccumulatedDeficit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 19,473,069 - pbsv-20200131.xml 1624</message>
 <ref href="pbsv-20200131.xml#element(/1/245)" sourceLine="1624">
  <property name="label" value="Retained earnings"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="RetainedEarningsAccumulatedDeficit"/>
  <property name="QName" value="us-gaap:RetainedEarningsAccumulatedDeficit"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="19,473,069"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="471020.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 471,020 - pbsv-20200131.xml 1704</message>
 <ref href="pbsv-20200131.xml#element(/1/325)" sourceLine="1704">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="471,020"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.076" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.076 - pbsv-20200131.xml 1926</message>
 <ref href="pbsv-20200131.xml#element(/1/547)" sourceLine="1926">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_GlobalGroupEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.076"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="11030.0" fact-concept="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 11,030 - pbsv-20200131.xml 1560</message>
 <ref href="pbsv-20200131.xml#element(/1/181)" sourceLine="1560">
  <property name="label" value="Current portion-obligations under finance leases"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CapitalLeaseObligationsCurrent"/>
  <property name="QName" value="us-gaap:CapitalLeaseObligationsCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="11,030"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20050.0" fact-concept="{http://pharmabioserv.com/20241231}StockRepurchaseDuringPeriodShares" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,050 - pbsv-20200131.xml 1783</message>
 <ref href="pbsv-20200131.xml#element(/1/404)" sourceLine="1783">
  <property name="label" value="Purchase of treasury stocks"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockRepurchaseDuringPeriodShares"/>
  <property name="QName" value="PBSV:StockRepurchaseDuringPeriodShares"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,050"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-38880.0" fact-concept="{http://fasb.org/us-gaap/2024}EffectOfExchangeRateOnCashAndCashEquivalents" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -38,880 - pbsv-20200131.xml 1856</message>
 <ref href="pbsv-20200131.xml#element(/1/477)" sourceLine="1856">
  <property name="label" value="EFFECT OF EXCHANGE RATE CHANGES ON CASH"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="QName" value="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-38,880"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="Yes" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityInteractiveDataCurrent" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] Yes - pbsv-20200131.xml 1985</message>
 <ref href="pbsv-20200131.xml#element(/1/606)" sourceLine="1985">
  <property name="label" value="Entity Interactive Data Current"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityInteractiveDataCurrent"/>
  <property name="QName" value="dei:EntityInteractiveDataCurrent"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="Yes"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="471020.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 471,020 - pbsv-20200131.xml 1705</message>
 <ref href="pbsv-20200131.xml#element(/1/326)" sourceLine="1705">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="471,020"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2341.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,341 - pbsv-20200131.xml 1627</message>
 <ref href="pbsv-20200131.xml#element(/1/248)" sourceLine="1627">
  <property name="label" value="Common Stock, $0.0001 par value; authorized 50,000,000 shares; 23,405,753 and 23,397,707 shares issued, and 23,001,627 and 22,995,881 shares outstanding at April 30, 2020 and October 31, 2019, respectively"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockValue"/>
  <property name="QName" value="us-gaap:CommonStockValue"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,341"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1381076.0" fact-concept="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,381,076 - pbsv-20200131.xml 1626</message>
 <ref href="pbsv-20200131.xml#element(/1/247)" sourceLine="1626">
  <property name="label" value="Additional paid-in capital"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AdditionalPaidInCapitalCommonStock"/>
  <property name="QName" value="us-gaap:AdditionalPaidInCapitalCommonStock"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,381,076"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="707483.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 707,483 - pbsv-20200131.xml 1706</message>
 <ref href="pbsv-20200131.xml#element(/1/327)" sourceLine="1706">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="707,483"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-25218.0" fact-concept="{http://fasb.org/us-gaap/2024}EffectOfExchangeRateOnCashAndCashEquivalents" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -25,218 - pbsv-20200131.xml 1855</message>
 <ref href="pbsv-20200131.xml#element(/1/476)" sourceLine="1855">
  <property name="label" value="EFFECT OF EXCHANGE RATE CHANGES ON CASH"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="QName" value="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-25,218"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.708" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.708 - pbsv-20200131.xml 1927</message>
 <ref href="pbsv-20200131.xml#element(/1/548)" sourceLine="1927">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_GlobalGroupTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.708"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="17950.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherLiabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 17,950 - pbsv-20200131.xml 1563</message>
 <ref href="pbsv-20200131.xml#element(/1/184)" sourceLine="1563">
  <property name="label" value="Other liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherLiabilities"/>
  <property name="QName" value="us-gaap:OtherLiabilities"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="17,950"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="526900.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 526,900 - pbsv-20200131.xml 1707</message>
 <ref href="pbsv-20200131.xml#element(/1/328)" sourceLine="1707">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="526,900"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-1040629.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -1,040,629 - pbsv-20200131.xml 1789</message>
 <ref href="pbsv-20200131.xml#element(/1/410)" sourceLine="1789">
  <property name="label" value="Net Cash Provided by (Used in) Operating Activities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInOperatingActivities"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInOperatingActivities"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-1,040,629"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="211763.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxesPaid" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 211,763 - pbsv-20200131.xml 1862</message>
 <ref href="pbsv-20200131.xml#element(/1/483)" sourceLine="1862">
  <property name="label" value="Cash paid during the period for: Income taxes"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxesPaid"/>
  <property name="QName" value="us-gaap:IncomeTaxesPaid"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="211,763"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="False" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityShellCompany" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] False - pbsv-20200131.xml 1982</message>
 <ref href="pbsv-20200131.xml#element(/1/603)" sourceLine="1982">
  <property name="label" value="Entity Shell Company"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityShellCompany"/>
  <property name="QName" value="dei:EntityShellCompany"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="false"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="526900.0" fact-concept="{http://fasb.org/us-gaap/2024}NetIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 526,900 - pbsv-20200131.xml 1708</message>
 <ref href="pbsv-20200131.xml#element(/1/329)" sourceLine="1708">
  <property name="label" value="NET INCOME (LOSS)"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetIncomeLoss"/>
  <property name="QName" value="us-gaap:NetIncomeLoss"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="526,900"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-41688.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -41,688 - pbsv-20200131.xml 1788</message>
 <ref href="pbsv-20200131.xml#element(/1/409)" sourceLine="1788">
  <property name="label" value="Net Cash Provided by (Used in) Operating Activities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInOperatingActivities"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInOperatingActivities"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-41,688"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1904.0" fact-concept="{http://fasb.org/us-gaap/2024}InterestPaidNet" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,904 - pbsv-20200131.xml 1861</message>
 <ref href="pbsv-20200131.xml#element(/1/482)" sourceLine="1861">
  <property name="label" value="Cash paid during the period for: Interest"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="InterestPaidNet"/>
  <property name="QName" value="us-gaap:InterestPaidNet"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,904"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1928</message>
 <ref href="pbsv-20200131.xml#element(/1/549)" sourceLine="1928">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_GlobalGroupAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.00"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1629</message>
 <ref href="pbsv-20200131.xml#element(/1/250)" sourceLine="1629">
  <property name="label" value="Preferred Stock, $0.0001 par value; authorized 10,000,000 shares; none outstanding"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockValue"/>
  <property name="QName" value="us-gaap:PreferredStockValue"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="6025569.0" fact-concept="{http://fasb.org/us-gaap/2024}Liabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 6,025,569 - pbsv-20200131.xml 1562</message>
 <ref href="pbsv-20200131.xml#element(/1/183)" sourceLine="1562">
  <property name="label" value="Liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Liabilities"/>
  <property name="QName" value="us-gaap:Liabilities"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="6,025,569"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.03" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.03 - pbsv-20200131.xml 1709</message>
 <ref href="pbsv-20200131.xml#element(/1/330)" sourceLine="1709">
  <property name="label" value="BASIC AND DILUTED EARNINGS PER COMMON SHARE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.030"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2004.0" fact-concept="{http://fasb.org/us-gaap/2024}InterestPaidNet" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,004 - pbsv-20200131.xml 1860</message>
 <ref href="pbsv-20200131.xml#element(/1/481)" sourceLine="1860">
  <property name="label" value="Cash paid during the period for: Interest"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="InterestPaidNet"/>
  <property name="QName" value="us-gaap:InterestPaidNet"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,004"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="Q2" fact-concept="{http://xbrl.sec.gov/dei/2024}DocumentFiscalPeriodFocus" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] Q2 - pbsv-20200131.xml 1983</message>
 <ref href="pbsv-20200131.xml#element(/1/604)" sourceLine="1983">
  <property name="label" value="Document Fiscal Period Focus"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="DocumentFiscalPeriodFocus"/>
  <property name="QName" value="dei:DocumentFiscalPeriodFocus"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="Q2"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="696916.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityNoncurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 696,916 - pbsv-20200131.xml 1565</message>
 <ref href="pbsv-20200131.xml#element(/1/186)" sourceLine="1565">
  <property name="label" value="Long-term operating lease liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingLeaseLiabilityNoncurrent"/>
  <property name="QName" value="us-gaap:OperatingLeaseLiabilityNoncurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="696,916"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2340.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,340 - pbsv-20200131.xml 1628</message>
 <ref href="pbsv-20200131.xml#element(/1/249)" sourceLine="1628">
  <property name="label" value="Common Stock, $0.0001 par value; authorized 50,000,000 shares; 23,405,753 and 23,397,707 shares issued, and 23,001,627 and 22,995,881 shares outstanding at April 30, 2020 and October 31, 2019, respectively"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockValue"/>
  <property name="QName" value="us-gaap:CommonStockValue"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,340"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-822917.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -822,917 - pbsv-20200131.xml 1787</message>
 <ref href="pbsv-20200131.xml#element(/1/408)" sourceLine="1787">
  <property name="label" value="Net Cash Provided by (Used in) Operating Activities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInOperatingActivities"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInOperatingActivities"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-822,917"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2020" fact-concept="{http://xbrl.sec.gov/dei/2024}DocumentFiscalYearFocus" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2020 - pbsv-20200131.xml 1984</message>
 <ref href="pbsv-20200131.xml#element(/1/605)" sourceLine="1984">
  <property name="label" value="Document Fiscal Year Focus"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="DocumentFiscalYearFocus"/>
  <property name="QName" value="dei:DocumentFiscalYearFocus"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2020"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.142" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.142 - pbsv-20200131.xml 1929</message>
 <ref href="pbsv-20200131.xml#element(/1/550)" sourceLine="1929">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_GlobalGroupBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.142"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23001627.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,001,627 - pbsv-20200131.xml 1713</message>
 <ref href="pbsv-20200131.xml#element(/1/334)" sourceLine="1713">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,001,627"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1425.0" fact-concept="{http://fasb.org/us-gaap/2024}InterestPaidNet" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,425 - pbsv-20200131.xml 1859</message>
 <ref href="pbsv-20200131.xml#element(/1/480)" sourceLine="1859">
  <property name="label" value="Cash paid during the period for: Interest"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="InterestPaidNet"/>
  <property name="QName" value="us-gaap:InterestPaidNet"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,425"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0001304161" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityCentralIndexKey" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0001304161 - pbsv-20200131.xml 1973</message>
 <ref href="pbsv-20200131.xml#element(/1/594)" sourceLine="1973">
  <property name="label" value="Entity Central Index Key"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityCentralIndexKey"/>
  <property name="QName" value="dei:EntityCentralIndexKey"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0001304161"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.051" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.051 - pbsv-20200131.xml 1712</message>
 <ref href="pbsv-20200131.xml#element(/1/333)" sourceLine="1712">
  <property name="label" value="BASIC AND DILUTED EARNINGS PER COMMON SHARE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.051"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-121349.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOperatingLiabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -121,349 - pbsv-20200131.xml 1790</message>
 <ref href="pbsv-20200131.xml#element(/1/411)" sourceLine="1790">
  <property name="label" value="Increase (decrease) in liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOperatingLiabilities"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOperatingLiabilities"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-121,349"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.099" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.099 - pbsv-20200131.xml 1930</message>
 <ref href="pbsv-20200131.xml#element(/1/551)" sourceLine="1930">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_GlobalGroupCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.099"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.053" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.053 - pbsv-20200131.xml 1711</message>
 <ref href="pbsv-20200131.xml#element(/1/332)" sourceLine="1711">
  <property name="label" value="BASIC AND DILUTED EARNINGS PER COMMON SHARE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.053"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-840431.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOperatingLiabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -840,431 - pbsv-20200131.xml 1793</message>
 <ref href="pbsv-20200131.xml#element(/1/414)" sourceLine="1793">
  <property name="label" value="Increase (decrease) in liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOperatingLiabilities"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOperatingLiabilities"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-840,431"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="326898.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxesPaid" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 326,898 - pbsv-20200131.xml 1865</message>
 <ref href="pbsv-20200131.xml#element(/1/486)" sourceLine="1865">
  <property name="label" value="Cash paid during the period for: Income taxes"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxesPaid"/>
  <property name="QName" value="us-gaap:IncomeTaxesPaid"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="326,898"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="17950.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherLiabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 17,950 - pbsv-20200131.xml 1564</message>
 <ref href="pbsv-20200131.xml#element(/1/185)" sourceLine="1564">
  <property name="label" value="Other liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherLiabilities"/>
  <property name="QName" value="us-gaap:OtherLiabilities"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="17,950"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="61337.0" fact-concept="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsNoncurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 61,337 - pbsv-20200131.xml 1567</message>
 <ref href="pbsv-20200131.xml#element(/1/188)" sourceLine="1567">
  <property name="label" value="Obligations under finance lease"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CapitalLeaseObligationsNoncurrent"/>
  <property name="QName" value="us-gaap:CapitalLeaseObligationsNoncurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="61,337"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="211763.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxesPaid" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 211,763 - pbsv-20200131.xml 1864</message>
 <ref href="pbsv-20200131.xml#element(/1/485)" sourceLine="1864">
  <property name="label" value="Cash paid during the period for: Income taxes"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxesPaid"/>
  <property name="QName" value="us-gaap:IncomeTaxesPaid"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="211,763"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The accompanying condensed consolidated finan..." fact-concept="{http://fasb.org/us-gaap/2024}ConsolidationPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The accompanying condensed consolidated financialstatements include the accounts of the Company and all of its wholly owned subsidiaries. All intercompany transactions and balanceshave been eliminated in consolidation.&amp;#160;&lt;/p> - pbsv-20200131.xml 1988</message>
 <ref href="pbsv-20200131.xml#element(/1/609)" sourceLine="1988">
  <property name="label" value="Consolidation"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConsolidationPolicyTextBlock"/>
  <property name="QName" value="us-gaap:ConsolidationPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The accompanying condensed consolidated financialstatements include the accounts of the Company and all of its wholly owned subsidiaries. All intercompany transactions and balanceshave been eliminated in consolidation.&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1630</message>
 <ref href="pbsv-20200131.xml#element(/1/251)" sourceLine="1630">
  <property name="label" value="Preferred Stock, $0.0001 par value; authorized 10,000,000 shares; none outstanding"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockValue"/>
  <property name="QName" value="us-gaap:PreferredStockValue"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.031" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.031 - pbsv-20200131.xml 1710</message>
 <ref href="pbsv-20200131.xml#element(/1/331)" sourceLine="1710">
  <property name="label" value="BASIC AND DILUTED EARNINGS PER COMMON SHARE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.031"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="609610.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOperatingLiabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 609,610 - pbsv-20200131.xml 1792</message>
 <ref href="pbsv-20200131.xml#element(/1/413)" sourceLine="1792">
  <property name="label" value="Increase (decrease) in liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOperatingLiabilities"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOperatingLiabilities"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="609,610"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.122" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.122 - pbsv-20200131.xml 1931</message>
 <ref href="pbsv-20200131.xml#element(/1/552)" sourceLine="1931">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_GlobalGroupDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.122"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23001627.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,001,627 - pbsv-20200131.xml 1635</message>
 <ref href="pbsv-20200131.xml#element(/1/256)" sourceLine="1635">
  <property name="label" value="Common stock, outstanding"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockSharesOutstanding"/>
  <property name="QName" value="us-gaap:CommonStockSharesOutstanding"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,001,627"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityNoncurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1566</message>
 <ref href="pbsv-20200131.xml#element(/1/187)" sourceLine="1566">
  <property name="label" value="Long-term operating lease liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingLeaseLiabilityNoncurrent"/>
  <property name="QName" value="us-gaap:OperatingLeaseLiabilityNoncurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23029203.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,029,203 - pbsv-20200131.xml 1717</message>
 <ref href="pbsv-20200131.xml#element(/1/338)" sourceLine="1717">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,029,203"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="326898.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxesPaid" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 326,898 - pbsv-20200131.xml 1863</message>
 <ref href="pbsv-20200131.xml#element(/1/484)" sourceLine="1863">
  <property name="label" value="Cash paid during the period for: Income taxes"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxesPaid"/>
  <property name="QName" value="us-gaap:IncomeTaxesPaid"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="326,898"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="DE" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityIncorporationStateCountryCode" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] DE - pbsv-20200131.xml 1986</message>
 <ref href="pbsv-20200131.xml#element(/1/607)" sourceLine="1986">
  <property name="label" value="Entity Incorporation State Country Code"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityIncorporationStateCountryCode"/>
  <property name="QName" value="dei:EntityIncorporationStateCountryCode"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="DE"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="24995.0" fact-concept="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentDisposals" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 24,995 - pbsv-20200131.xml 1866</message>
 <ref href="pbsv-20200131.xml#element(/1/487)" sourceLine="1866">
  <property name="label" value="Disposed property and equipment with accumulated depreciation of $17,913 for the three and six months ended April 30, 2020 and $86,773 for the three and six months ended April 30, 2019"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PropertyPlantAndEquipmentDisposals"/>
  <property name="QName" value="us-gaap:PropertyPlantAndEquipmentDisposals"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="24,995"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23405753.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockSharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,405,753 - pbsv-20200131.xml 1633</message>
 <ref href="pbsv-20200131.xml#element(/1/254)" sourceLine="1633">
  <property name="label" value="Common stock, issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockSharesIssued"/>
  <property name="QName" value="us-gaap:CommonStockSharesIssued"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,405,753"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23032107.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,032,107 - pbsv-20200131.xml 1716</message>
 <ref href="pbsv-20200131.xml#element(/1/337)" sourceLine="1716">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,032,107"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-324887.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOperatingLiabilities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -324,887 - pbsv-20200131.xml 1791</message>
 <ref href="pbsv-20200131.xml#element(/1/412)" sourceLine="1791">
  <property name="label" value="Increase (decrease) in liabilities"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOperatingLiabilities"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOperatingLiabilities"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-324,887"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="138419.0" fact-concept="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentDisposals" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 138,419 - pbsv-20200131.xml 1869</message>
 <ref href="pbsv-20200131.xml#element(/1/490)" sourceLine="1869">
  <property name="label" value="Disposed property and equipment with accumulated depreciation of $17,913 for the three and six months ended April 30, 2020 and $86,773 for the three and six months ended April 30, 2019"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PropertyPlantAndEquipmentDisposals"/>
  <property name="QName" value="us-gaap:PropertyPlantAndEquipmentDisposals"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="138,419"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.266" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.266 - pbsv-20200131.xml 1932</message>
 <ref href="pbsv-20200131.xml#element(/1/553)" sourceLine="1932">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_GlobalGroupEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.266"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1632</message>
 <ref href="pbsv-20200131.xml#element(/1/253)" sourceLine="1632">
  <property name="label" value="Preferred stock, outstanding"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockSharesOutstanding"/>
  <property name="QName" value="us-gaap:PreferredStockSharesOutstanding"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="28635923.0" fact-concept="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 28,635,923 - pbsv-20200131.xml 1573</message>
 <ref href="pbsv-20200131.xml#element(/1/194)" sourceLine="1573">
  <property name="label" value="Liabilities and Equity"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LiabilitiesAndStockholdersEquity"/>
  <property name="QName" value="us-gaap:LiabilitiesAndStockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="28,635,923"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23002745.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,002,745 - pbsv-20200131.xml 1715</message>
 <ref href="pbsv-20200131.xml#element(/1/336)" sourceLine="1715">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,002,745"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="24995.0" fact-concept="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentDisposals" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 24,995 - pbsv-20200131.xml 1868</message>
 <ref href="pbsv-20200131.xml#element(/1/489)" sourceLine="1868">
  <property name="label" value="Disposed property and equipment with accumulated depreciation of $17,913 for the three and six months ended April 30, 2020 and $86,773 for the three and six months ended April 30, 2019"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PropertyPlantAndEquipmentDisposals"/>
  <property name="QName" value="us-gaap:PropertyPlantAndEquipmentDisposals"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="24,995"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1287800.0" fact-concept="{http://fasb.org/us-gaap/2024}LoansPayable" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,287,800 - pbsv-20200131.xml 1569</message>
 <ref href="pbsv-20200131.xml#element(/1/190)" sourceLine="1569">
  <property name="label" value="Loans-long term portion"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LoansPayable"/>
  <property name="QName" value="us-gaap:LoansPayable"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,287,800"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-111919.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -111,919 - pbsv-20200131.xml 1794</message>
 <ref href="pbsv-20200131.xml#element(/1/415)" sourceLine="1794">
  <property name="label" value="Increase (Decrease) in Other Operating Assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-111,919"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="000-50956" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityFileNumber" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 000-50956 - pbsv-20200131.xml 1987</message>
 <ref href="pbsv-20200131.xml#element(/1/608)" sourceLine="1987">
  <property name="label" value="Entity File Number"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityFileNumber"/>
  <property name="QName" value="dei:EntityFileNumber"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="000-50956"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.629" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.629 - pbsv-20200131.xml 1933</message>
 <ref href="pbsv-20200131.xml#element(/1/554)" sourceLine="1933">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_GlobalGroupTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.629"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="67079.0" fact-concept="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsNoncurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 67,079 - pbsv-20200131.xml 1568</message>
 <ref href="pbsv-20200131.xml#element(/1/189)" sourceLine="1568">
  <property name="label" value="Obligations under finance lease"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CapitalLeaseObligationsNoncurrent"/>
  <property name="QName" value="us-gaap:CapitalLeaseObligationsNoncurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="67,079"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23002903.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,002,903 - pbsv-20200131.xml 1714</message>
 <ref href="pbsv-20200131.xml#element(/1/335)" sourceLine="1714">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,002,903"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-29733.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributa..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -29,733 - pbsv-20200131.xml 1721</message>
 <ref href="pbsv-20200131.xml#element(/1/342)" sourceLine="1721">
  <property name="label" value="Foreign currency translation loss"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-29,733"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="725524.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 725,524 - pbsv-20200131.xml 1796</message>
 <ref href="pbsv-20200131.xml#element(/1/417)" sourceLine="1796">
  <property name="label" value="Increase (Decrease) in Other Operating Assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="725,524"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="138419.0" fact-concept="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentDisposals" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 138,419 - pbsv-20200131.xml 1867</message>
 <ref href="pbsv-20200131.xml#element(/1/488)" sourceLine="1867">
  <property name="label" value="Disposed property and equipment with accumulated depreciation of $17,913 for the three and six months ended April 30, 2020 and $86,773 for the three and six months ended April 30, 2019"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PropertyPlantAndEquipmentDisposals"/>
  <property name="QName" value="us-gaap:PropertyPlantAndEquipmentDisposals"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="138,419"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.213" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.213 - pbsv-20200131.xml 1934</message>
 <ref href="pbsv-20200131.xml#element(/1/555)" sourceLine="1934">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_MajorCustomerAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.213"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23105166.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,105,166 - pbsv-20200131.xml 1720</message>
 <ref href="pbsv-20200131.xml#element(/1/341)" sourceLine="1720">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,105,166"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1870</message>
 <ref href="pbsv-20200131.xml#element(/1/491)" sourceLine="1870">
  <property name="label" value="Obligations under capital lease incurred for the acquisition of a vehicle"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="QName" value="PBSV:ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Basic earnings per share of common stock isc..." fact-concept="{http://fasb.org/us-gaap/2024}EarningsPerSharePolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Basic earnings per share of common stock iscalculated by dividing net earnings by the weighted average number of shares of common stock outstanding. Diluted earnings pershare includes the dilution of common stock equivalents, which include principally shares that may be issued upon the exerciseof warrants, stock option and restricted stock unit awards.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The diluted weighted average shares of commonstock outstanding were calculated using the treasury stock method for the respective periods.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1999</message>
 <ref href="pbsv-20200131.xml#element(/1/620)" sourceLine="1999">
  <property name="label" value="Earnings Per Share of Common Stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="EarningsPerSharePolicyTextBlock"/>
  <property name="QName" value="us-gaap:EarningsPerSharePolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Basic earnings per share of common stock iscalculated by dividing net earnings by the weighted average number of shares of common stock outstanding. Diluted earnings pershare includes the dilution of common stock equivalents, which include principally shares that may be issued upon the exerciseof warrants, stock option and restricted stock unit awards.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The diluted weighted average shares of commonstock outstanding were calculated using the treasury stock method for the respective periods.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2058512.0" fact-concept="{http://fasb.org/us-gaap/2024}TaxesPayableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,058,512 - pbsv-20200131.xml 1571</message>
 <ref href="pbsv-20200131.xml#element(/1/192)" sourceLine="1571">
  <property name="label" value="US Tax Reform Transition Tax payable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="TaxesPayableCurrent"/>
  <property name="QName" value="us-gaap:TaxesPayableCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,058,512"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23397707.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockSharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,397,707 - pbsv-20200131.xml 1634</message>
 <ref href="pbsv-20200131.xml#element(/1/255)" sourceLine="1634">
  <property name="label" value="Common stock, issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockSharesIssued"/>
  <property name="QName" value="us-gaap:CommonStockSharesIssued"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,397,707"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-23593.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -23,593 - pbsv-20200131.xml 1795</message>
 <ref href="pbsv-20200131.xml#element(/1/416)" sourceLine="1795">
  <property name="label" value="Increase (Decrease) in Other Operating Assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-23,593"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23025958.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,025,958 - pbsv-20200131.xml 1719</message>
 <ref href="pbsv-20200131.xml#element(/1/340)" sourceLine="1719">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,025,958"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>For purposes of the consolidated statementso..." fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>For purposes of the consolidated statementsof cash flows, cash equivalents include investments in a money market obligations trust that is registered under the U.S. InvestmentCompany Act of 1940, as amended, and liquid investments with original maturities of three months or less.&lt;/p> - pbsv-20200131.xml 1993</message>
 <ref href="pbsv-20200131.xml#element(/1/614)" sourceLine="1993">
  <property name="label" value="Cash Equivalents"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsPolicyTextBlock"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>For purposes of the consolidated statementsof cash flows, cash equivalents include investments in a money market obligations trust that is registered under the U.S. InvestmentCompany Act of 1940, as amended, and liquid investments with original maturities of three months or less.&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounting standards have established a fair..." fact-concept="{http://fasb.org/us-gaap/2024}FairValueOfFinancialInstrumentsPolicy" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounting standards have established a fairvalue hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs whenmeasuring fair value. A financial instrument&amp;#8217;s categorization within the fair value hierarchy is based upon the lowest levelof input that is significant to the fair value measurement. Accounting standards have established three levels of inputs that maybe used to measure fair value:&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%&quot;>&lt;tr>    &lt;td style=&quot;vertical-align: top; width: 10%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;1&lt;/i>:&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom; width: 90%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Quoted prices in active markets for identical        assets and liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;vertical-align: top&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;2:&lt;/i>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Observable inputs other than Level 1 prices        such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions        (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally        from or corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: top&quot;>&lt;font style=&quot;font-size: 8pt&quot;>&lt;i>Level&amp;#160;3&lt;/i>:&lt;/font>&lt;/td>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The carrying value of the Company's financialinstruments (excluding obligations under finance leases), cash and cash equivalents, accounts receivable, accounts payable andaccrued liabilities, are considered reasonable estimates of fair value due to their liquidity or short-term nature. Managementbelieves, based on current rates, that the fair value of its obligations under finance leases approximates the carrying amount.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1991</message>
 <ref href="pbsv-20200131.xml#element(/1/612)" sourceLine="1991">
  <property name="label" value="Fair Value of Financial Instruments"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="FairValueOfFinancialInstrumentsPolicy"/>
  <property name="QName" value="us-gaap:FairValueOfFinancialInstrumentsPolicy"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounting standards have established a fairvalue hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs whenmeasuring fair value. A financial instrument&amp;#8217;s categorization within the fair value hierarchy is based upon the lowest levelof input that is significant to the fair value measurement. Accounting standards have established three levels of inputs that maybe used to measure fair value:&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%&quot;>&lt;tr>    &lt;td style=&quot;vertical-align: top; width: 10%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;1&lt;/i>:&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom; width: 90%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Quoted prices in active markets for identical        assets and liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;vertical-align: top&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;2:&lt;/i>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Observable inputs other than Level 1 prices        such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions        (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally        from or corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: top&quot;>&lt;font style=&quot;font-size: 8pt&quot;>&lt;i>Level&amp;#160;3&lt;/i>:&lt;/font>&lt;/td>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The carrying value of the Company's financialinstruments (excluding obligations under finance leases), cash and cash equivalents, accounts receivable, accounts payable andaccrued liabilities, are considered reasonable estimates of fair value due to their liquidity or short-term nature. Managementbelieves, based on current rates, that the fair value of its obligations under finance leases approximates the carrying amount.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.121" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.121 - pbsv-20200131.xml 1935</message>
 <ref href="pbsv-20200131.xml#element(/1/556)" sourceLine="1935">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_MajorCustomerBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.121"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}LoansPayable" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1570</message>
 <ref href="pbsv-20200131.xml#element(/1/191)" sourceLine="1570">
  <property name="label" value="Loans-long term portion"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LoansPayable"/>
  <property name="QName" value="us-gaap:LoansPayable"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="394991.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 394,991 - pbsv-20200131.xml 1643</message>
 <ref href="pbsv-20200131.xml#element(/1/264)" sourceLine="1643">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="394,991"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0001" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockParOrStatedValuePerShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.0001 - pbsv-20200131.xml 1516</message>
 <ref href="pbsv-20200131.xml#element(/1/137)" sourceLine="1516">
  <property name="label" value="Preferred stock, par value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockParOrStatedValuePerShare"/>
  <property name="QName" value="us-gaap:PreferredStockParOrStatedValuePerShare"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.0001"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23068923.0" fact-concept="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,068,923 - pbsv-20200131.xml 1718</message>
 <ref href="pbsv-20200131.xml#element(/1/339)" sourceLine="1718">
  <property name="label" value="WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="QName" value="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,068,923"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-80329.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -80,329 - pbsv-20200131.xml 1797</message>
 <ref href="pbsv-20200131.xml#element(/1/418)" sourceLine="1797">
  <property name="label" value="Increase (Decrease) in Other Operating Assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInOtherOperatingAssets"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-80,329"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>The Com..." fact-concept="{http://fasb.org/us-gaap/2024}SegmentReportingPolicyPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>The Companyoperates in three reportable business segments: (i) Puerto Rico technical compliance consulting, (ii) United States technical complianceconsulting, and (iii) Europe technical compliance consulting. Accordingly, the accompanying condensed consolidated financial statementsare presented to show these three reportable segments.&lt;/font>&lt;/p> - pbsv-20200131.xml 1989</message>
 <ref href="pbsv-20200131.xml#element(/1/610)" sourceLine="1989">
  <property name="label" value="Segments"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SegmentReportingPolicyPolicyTextBlock"/>
  <property name="QName" value="us-gaap:SegmentReportingPolicyPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>The Companyoperates in three reportable business segments: (i) Puerto Rico technical compliance consulting, (ii) United States technical complianceconsulting, and (iii) Europe technical compliance consulting. Accordingly, the accompanying condensed consolidated financial statementsare presented to show these three reportable segments.&lt;/font>&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0001" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockParOrStatedValuePerShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.0001 - pbsv-20200131.xml 1520</message>
 <ref href="pbsv-20200131.xml#element(/1/141)" sourceLine="1520">
  <property name="label" value="Common stock, par value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockParOrStatedValuePerShare"/>
  <property name="QName" value="us-gaap:CommonStockParOrStatedValuePerShare"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.0001"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="368631.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherAssetsNoncurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 368,631 - pbsv-20200131.xml 1527</message>
 <ref href="pbsv-20200131.xml#element(/1/148)" sourceLine="1527">
  <property name="label" value="Other assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherAssetsNoncurrent"/>
  <property name="QName" value="us-gaap:OtherAssetsNoncurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="368,631"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="404126.0" fact-concept="{http://fasb.org/us-gaap/2024}TreasuryStockShares" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 404,126 - pbsv-20200131.xml 1637</message>
 <ref href="pbsv-20200131.xml#element(/1/258)" sourceLine="1637">
  <property name="label" value="Treasury stock, shares"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="TreasuryStockShares"/>
  <property name="QName" value="us-gaap:TreasuryStockShares"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="404,126"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedI..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1725</message>
 <ref href="pbsv-20200131.xml#element(/1/346)" sourceLine="1725">
  <property name="label" value="Available-for-sale securities other-than-temporary impairment included in net income"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="QName" value="us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="10000000.0" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockSharesAuthorized" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 10,000,000 - pbsv-20200131.xml 1518</message>
 <ref href="pbsv-20200131.xml#element(/1/139)" sourceLine="1518">
  <property name="label" value="Preferred stock, authorized"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockSharesAuthorized"/>
  <property name="QName" value="us-gaap:PreferredStockSharesAuthorized"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="10,000,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.146" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.146 - pbsv-20200131.xml 1936</message>
 <ref href="pbsv-20200131.xml#element(/1/557)" sourceLine="1936">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_MajorCustomerCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.146"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="22995881.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 22,995,881 - pbsv-20200131.xml 1636</message>
 <ref href="pbsv-20200131.xml#element(/1/257)" sourceLine="1636">
  <property name="label" value="Common stock, outstanding"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockSharesOutstanding"/>
  <property name="QName" value="us-gaap:CommonStockSharesOutstanding"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="22,995,881"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2262929.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,262,929 - pbsv-20200131.xml 1798</message>
 <ref href="pbsv-20200131.xml#element(/1/419)" sourceLine="1798">
  <property name="label" value="Increase (Decrease) in Accounts Receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInAccountsReceivable"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInAccountsReceivable"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,262,929"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1874</message>
 <ref href="pbsv-20200131.xml#element(/1/495)" sourceLine="1874">
  <property name="label" value="Conversion of cashless exercise of options to common stock"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="QName" value="PBSV:ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-10950.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributa..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -10,950 - pbsv-20200131.xml 1724</message>
 <ref href="pbsv-20200131.xml#element(/1/345)" sourceLine="1724">
  <property name="label" value="Foreign currency translation loss"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-10,950"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The preparation of condensed consolidated fin..." fact-concept="{http://fasb.org/us-gaap/2024}UseOfEstimates" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The preparation of condensed consolidated financialstatements in conformity with accounting principles generally accepted in the United States of America requires management to makeestimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilitiesat the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reportingperiods. Actual results may differ from these estimates.&lt;/p> - pbsv-20200131.xml 1990</message>
 <ref href="pbsv-20200131.xml#element(/1/611)" sourceLine="1990">
  <property name="label" value="Use of Estimates"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="UseOfEstimates"/>
  <property name="QName" value="us-gaap:UseOfEstimates"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The preparation of condensed consolidated financialstatements in conformity with accounting principles generally accepted in the United States of America requires management to makeestimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilitiesat the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reportingperiods. Actual results may differ from these estimates.&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="86000.0" fact-concept="{http://pharmabioserv.com/20241231}ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 86,000 - pbsv-20200131.xml 1873</message>
 <ref href="pbsv-20200131.xml#element(/1/494)" sourceLine="1873">
  <property name="label" value="Obligations under capital lease incurred for the acquisition of a vehicle"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="QName" value="PBSV:ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="86,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0001" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockParOrStatedValuePerShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.0001 - pbsv-20200131.xml 1517</message>
 <ref href="pbsv-20200131.xml#element(/1/138)" sourceLine="1517">
  <property name="label" value="Preferred stock, par value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockParOrStatedValuePerShare"/>
  <property name="QName" value="us-gaap:PreferredStockParOrStatedValuePerShare"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.0001"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2270000.0" fact-concept="{http://fasb.org/us-gaap/2024}TaxesPayableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,270,000 - pbsv-20200131.xml 1572</message>
 <ref href="pbsv-20200131.xml#element(/1/193)" sourceLine="1572">
  <property name="label" value="US Tax Reform Transition Tax payable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="TaxesPayableCurrent"/>
  <property name="QName" value="us-gaap:TaxesPayableCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,270,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-41467.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributa..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -41,467 - pbsv-20200131.xml 1723</message>
 <ref href="pbsv-20200131.xml#element(/1/344)" sourceLine="1723">
  <property name="label" value="Foreign currency translation loss"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-41,467"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1200788.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,200,788 - pbsv-20200131.xml 1800</message>
 <ref href="pbsv-20200131.xml#element(/1/421)" sourceLine="1800">
  <property name="label" value="Increase (Decrease) in Accounts Receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInAccountsReceivable"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInAccountsReceivable"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,200,788"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.106" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.106 - pbsv-20200131.xml 1937</message>
 <ref href="pbsv-20200131.xml#element(/1/558)" sourceLine="1937">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_MajorCustomerDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.106"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1872</message>
 <ref href="pbsv-20200131.xml#element(/1/493)" sourceLine="1872">
  <property name="label" value="Obligations under capital lease incurred for the acquisition of a vehicle"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="QName" value="PBSV:ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="5647767.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 5,647,767 - pbsv-20200131.xml 1639</message>
 <ref href="pbsv-20200131.xml#element(/1/260)" sourceLine="1639">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="5,647,767"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21801661.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,801,661 - pbsv-20200131.xml 1575</message>
 <ref href="pbsv-20200131.xml#element(/1/196)" sourceLine="1575">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,801,661"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-23267.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributa..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -23,267 - pbsv-20200131.xml 1722</message>
 <ref href="pbsv-20200131.xml#element(/1/343)" sourceLine="1722">
  <property name="label" value="Foreign currency translation loss"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-23,267"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1212558.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,212,558 - pbsv-20200131.xml 1799</message>
 <ref href="pbsv-20200131.xml#element(/1/420)" sourceLine="1799">
  <property name="label" value="Increase (Decrease) in Accounts Receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInAccountsReceivable"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInAccountsReceivable"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,212,558"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="86000.0" fact-concept="{http://pharmabioserv.com/20241231}ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 86,000 - pbsv-20200131.xml 1871</message>
 <ref href="pbsv-20200131.xml#element(/1/492)" sourceLine="1871">
  <property name="label" value="Obligations under capital lease incurred for the acquisition of a vehicle"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="QName" value="PBSV:ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="86,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="26633075.0" fact-concept="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 26,633,075 - pbsv-20200131.xml 1574</message>
 <ref href="pbsv-20200131.xml#element(/1/195)" sourceLine="1574">
  <property name="label" value="Liabilities and Equity"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LiabilitiesAndStockholdersEquity"/>
  <property name="QName" value="us-gaap:LiabilitiesAndStockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="26,633,075"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.101" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.101 - pbsv-20200131.xml 1938</message>
 <ref href="pbsv-20200131.xml#element(/1/559)" sourceLine="1938">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_MajorCustomerEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.101"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-29733.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -29,733 - pbsv-20200131.xml 1729</message>
 <ref href="pbsv-20200131.xml#element(/1/350)" sourceLine="1729">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-29,733"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="401826.0" fact-concept="{http://fasb.org/us-gaap/2024}TreasuryStockShares" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 401,826 - pbsv-20200131.xml 1638</message>
 <ref href="pbsv-20200131.xml#element(/1/259)" sourceLine="1638">
  <property name="label" value="Treasury stock, shares"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="TreasuryStockShares"/>
  <property name="QName" value="us-gaap:TreasuryStockShares"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="401,826"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>On December 22, 2017, Public Law 115-97,comm..." fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxDisclosureTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>On December 22, 2017, Public Law 115-97,commonly known as the Tax Cuts and Jobs Act of 2017 (the &amp;#8220;Tax Reform&amp;#8221;), was enacted. The Tax Reform is applicableto the Company commencing with its fiscal year 2018. The Tax Reform imposed a mandatory one-time transition tax (the&amp;#8220;Transition Tax&amp;#8221;) over foreign subsidiaries undistributed earnings and profits (&amp;#8220;E&amp;#38;Ps&amp;#8221;) earnedprior to a date set by the statute. Based on the Company&amp;#8217;s E&amp;#38;Ps, the Transition Tax is estimated to beapproximately $2.7 million. The Company elected to pay the Transition Tax liability over an eight year period starting withthe Company&amp;#8217;s fiscal year 2019. In the past, most of these E&amp;#38;Ps&amp;#8217; were not repatriated and, considered to bereinvested indefinitely in the foreign location. Therefore no US tax liability was incurred with respect to theseE&amp;#38;Ps&amp;#8217;, unless the E&amp;#38;Ps were repatriated as a dividend. After December 31, 2017, the Tax Reform establisheda 100% tax exemption on the foreign-source portion of dividends which are received attributable to E&amp;#38;Ps, with certainlimitations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In June 2011, Pharma-Bio, Pharma-PR and Pharma-Servobtained a Grant of Industrial Tax Exemption pursuant to the terms and conditions set forth in Act No. 73 of May 28, 2008 (&amp;#8220;theGrant&amp;#8221;) issued by the Puerto Rico Industrial Development Company (&amp;#8220;PRIDCO&amp;#8221;). The Grant was effective as of November1, 2009 and covers a fifteen-year period. The Grant provides relief on various Puerto Rico taxes, including income tax, with certainlimitations, for most of the activities carried on within Puerto Rico, including  services to parties locatedoutside of Puerto Rico. Industrial Development Income (&amp;#8220;IDI&amp;#8221;) covered under the Grant are subject to a fixed incometax rate of 4%. In addition, IDI earnings distributions accumulated since November 1, 2009 are totally exempt from Puerto Ricoearnings distribution tax.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Puerto Rico operations not covered in the exemptactivities of the Grant are subject to Puerto Rico income tax at a maximum tax rate of 37.5% as provided by the 1994 Puerto RicoInternal Revenue Code, as amended. The operations carried out in the United States by the Company&amp;#8217;s subsidiaries, is taxedin the United States at a maximum regular federal income tax rate of 21%.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Deferred income tax assets and liabilities arecomputed for differences between the consolidated financial statements and tax bases of assets and liabilities that will resultin taxable or deductible amounts in the future, based on enacted tax laws and rates applicable to the periods in which the differencesare expected to affect taxable income.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Pharma-Spain, Pharma-IR and Pharma-Bio/Pharma-UShave unused operating losses which result in a potential deferred tax asset. However, an allowance has been provided covering thetotal amount of such balance since it is uncertain whether the net operating losses can be used to offset future taxable incomebefore their expiration dates. Realization of future tax benefits related to a deferred tax asset is dependent on many factors,including the company&amp;#8217;s ability to generate taxable income. Accordingly, the income tax benefit will be recognized when realizationis determined to be more probable than not. These net operating losses are available to offset future taxable income through 2034for Pharma-Spain; indefinitely for Pharma-IR; until 2039 for Pharma-Bio/Pharma-US.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company files income tax returns in theUnited States (federal and various states jurisdictions), Puerto Rico, Ireland, Spain and Brazil. The 2015 (2014 for Puerto Rico)through 2018 tax years are open and may be subject to potential examination in one or more jurisdictions. Currently, the Companyhas no federal, state, Puerto Rico or foreign income tax examination.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1889</message>
 <ref href="pbsv-20200131.xml#element(/1/510)" sourceLine="1889">
  <property name="label" value="D. INCOME TAXES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxDisclosureTextBlock"/>
  <property name="QName" value="us-gaap:IncomeTaxDisclosureTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>On December 22, 2017, Public Law 115-97,commonly known as the Tax Cuts and Jobs Act of 2017 (the &amp;#8220;Tax Reform&amp;#8221;), was enacted. The Tax Reform is applicableto the Company commencing with its fiscal year 2018. The Tax Reform imposed a mandatory one-time transition tax (the&amp;#8220;Transition Tax&amp;#8221;) over foreign subsidiaries undistributed earnings and profits (&amp;#8220;E&amp;#38;Ps&amp;#8221;) earnedprior to a date set by the statute. Based on the Company&amp;#8217;s E&amp;#38;Ps, the Transition Tax is estimated to beapproximately $2.7 million. The Company elected to pay the Transition Tax liability over an eight year period starting withthe Company&amp;#8217;s fiscal year 2019. In the past, most of these E&amp;#38;Ps&amp;#8217; were not repatriated and, considered to bereinvested indefinitely in the foreign location. Therefore no US tax liability was incurred with respect to theseE&amp;#38;Ps&amp;#8217;, unless the E&amp;#38;Ps were repatriated as a dividend. After December 31, 2017, the Tax Reform establisheda 100% tax exemption on the foreign-source portion of dividends which are received attributable to E&amp;#38;Ps, with certainlimitations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In June 2011, Pharma-Bio, Pharma-PR and Pharma-Servobtained a Grant of Industrial Tax Exemption pursuant to the terms and conditions set forth in Act No. 73 of May 28, 2008 (&amp;#8220;theGrant&amp;#8221;) issued by the Puerto Rico Industrial Development Company (&amp;#8220;PRIDCO&amp;#8221;). The Grant was effective as of November1, 2009 and covers a fifteen-year period. The Grant provides relief on various Puerto Rico taxes, including income tax, with certainlimitations, for most of the activities carried on within Puerto Rico, including  services to parties locatedoutside of Puerto Rico. Industrial Development Income (&amp;#8220;IDI&amp;#8221;) covered under the Grant are subject to a fixed incometax rate of 4%. In addition, IDI earnings distributions accumulated since November 1, 2009 are totally exempt from Puerto Ricoearnings distribution tax.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Puerto Rico operations not covered in the exemptactivities of the Grant are subject to Puerto Rico income tax at a maximum tax rate of 37.5% as provided by the 1994 Puerto RicoInternal Revenue Code, as amended. The operations carried out in the United States by the Company&amp;#8217;s subsidiaries, is taxedin the United States at a maximum regular federal income tax rate of 21%.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Deferred income tax assets and liabilities arecomputed for differences between the consolidated financial statements and tax bases of assets and liabilities that will resultin taxable or deductible amounts in the future, based on enacted tax laws and rates applicable to the periods in which the differencesare expected to affect taxable income.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Pharma-Spain, Pharma-IR and Pharma-Bio/Pharma-UShave unused operating losses which result in a potential deferred tax asset. However, an allowance has been provided covering thetotal amount of such balance since it is uncertain whether the net operating losses can be used to offset future taxable incomebefore their expiration dates. Realization of future tax benefits related to a deferred tax asset is dependent on many factors,including the company&amp;#8217;s ability to generate taxable income. Accordingly, the income tax benefit will be recognized when realizationis determined to be more probable than not. These net operating losses are available to offset future taxable income through 2034for Pharma-Spain; indefinitely for Pharma-IR; until 2039 for Pharma-Bio/Pharma-US.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company files income tax returns in theUnited States (federal and various states jurisdictions), Puerto Rico, Ireland, Spain and Brazil. The 2015 (2014 for Puerto Rico)through 2018 tax years are open and may be subject to potential examination in one or more jurisdictions. Currently, the Companyhas no federal, state, Puerto Rico or foreign income tax examination.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In May 2014, the Financial Accounting Standar..." fact-concept="{http://fasb.org/us-gaap/2024}RevenueRecognitionPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In May 2014, the Financial Accounting StandardsBoard (FASB) issued a new accounting standard that amends the guidance for the recognition of revenue from contracts with customersto transfer goods and services. The FASB subsequently issued additional, clarifying standards to address issues arising from implementationof the new revenue recognition standard. The new revenue recognition standard and clarifying standards require an entity to recognizerevenue when control of promised goods or services is transferred to the customer at an amount that reflects the considerationto which the entity expects to be entitled in exchange for those goods or services. We adopted this new standard as of November1, 2018, by applying the modified-retrospective method to those contracts that were not completed as of that date. The resultsfor reporting periods beginning after November 1, 2018, are presented in accordance with the new standard, although comparativeinformation has not been restated and continues to be reported under the accounting standards and policies in effect for thoseperiods. The adoption of this new standard had an immaterial impact on our reported total revenues and operating income as comparedto what reported amounts would have been under the prior standard.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Revenue is primarily derived from: (1) timeand materials contracts (representing approximately 99% of total revenues), which is recognized by applying the proportional performancemodel, whereby revenue is recognized as performance occurs, and (2) short-term fixed-fee contracts or &amp;#34;not to exceed&amp;#34; contracts(representing approximately 1% of total revenues), which revenue is recognized similarly, except that certain milestones also haveto be reached before revenue is recognized. If the Company determines that a contract will result in a loss, the Company recognizesthe estimated loss in the period in which such determination is made.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1992</message>
 <ref href="pbsv-20200131.xml#element(/1/613)" sourceLine="1992">
  <property name="label" value="Revenue Recognition"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="RevenueRecognitionPolicyTextBlock"/>
  <property name="QName" value="us-gaap:RevenueRecognitionPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In May 2014, the Financial Accounting StandardsBoard (FASB) issued a new accounting standard that amends the guidance for the recognition of revenue from contracts with customersto transfer goods and services. The FASB subsequently issued additional, clarifying standards to address issues arising from implementationof the new revenue recognition standard. The new revenue recognition standard and clarifying standards require an entity to recognizerevenue when control of promised goods or services is transferred to the customer at an amount that reflects the considerationto which the entity expects to be entitled in exchange for those goods or services. We adopted this new standard as of November1, 2018, by applying the modified-retrospective method to those contracts that were not completed as of that date. The resultsfor reporting periods beginning after November 1, 2018, are presented in accordance with the new standard, although comparativeinformation has not been restated and continues to be reported under the accounting standards and policies in effect for thoseperiods. The adoption of this new standard had an immaterial impact on our reported total revenues and operating income as comparedto what reported amounts would have been under the prior standard.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Revenue is primarily derived from: (1) timeand materials contracts (representing approximately 99% of total revenues), which is recognized by applying the proportional performancemodel, whereby revenue is recognized as performance occurs, and (2) short-term fixed-fee contracts or &amp;#34;not to exceed&amp;#34; contracts(representing approximately 1% of total revenues), which revenue is recognized similarly, except that certain milestones also haveto be reached before revenue is recognized. If the Company determines that a contract will result in a loss, the Company recognizesthe estimated loss in the period in which such determination is made.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="10000000.0" fact-concept="{http://fasb.org/us-gaap/2024}PreferredStockSharesAuthorized" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 10,000,000 - pbsv-20200131.xml 1519</message>
 <ref href="pbsv-20200131.xml#element(/1/140)" sourceLine="1519">
  <property name="label" value="Preferred stock, authorized"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PreferredStockSharesAuthorized"/>
  <property name="QName" value="us-gaap:PreferredStockSharesAuthorized"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="10,000,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-4475.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedI..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -4,475 - pbsv-20200131.xml 1728</message>
 <ref href="pbsv-20200131.xml#element(/1/349)" sourceLine="1728">
  <property name="label" value="Available-for-sale securities other-than-temporary impairment included in net income"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="QName" value="us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-4,475"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1473845.0" fact-concept="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,473,845 - pbsv-20200131.xml 1801</message>
 <ref href="pbsv-20200131.xml#element(/1/422)" sourceLine="1801">
  <property name="label" value="Increase (Decrease) in Accounts Receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncreaseDecreaseInAccountsReceivable"/>
  <property name="QName" value="us-gaap:IncreaseDecreaseInAccountsReceivable"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,473,845"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1802</message>
 <ref href="pbsv-20200131.xml#element(/1/423)" sourceLine="1802">
  <property name="label" value="Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="QName" value="us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1878</message>
 <ref href="pbsv-20200131.xml#element(/1/499)" sourceLine="1878">
  <property name="label" value="Income tax withheld by clients to be used as a credit in the Company's income tax return"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="QName" value="PBSV:IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.687" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.687 - pbsv-20200131.xml 1939</message>
 <ref href="pbsv-20200131.xml#element(/1/560)" sourceLine="1939">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_MajorCustomerTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.687"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20263663.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,263,663 - pbsv-20200131.xml 1577</message>
 <ref href="pbsv-20200131.xml#element(/1/198)" sourceLine="1577">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2018-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,263,663"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="4293041.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 4,293,041 - pbsv-20200131.xml 1642</message>
 <ref href="pbsv-20200131.xml#element(/1/263)" sourceLine="1642">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="4,293,041"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedI..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1727</message>
 <ref href="pbsv-20200131.xml#element(/1/348)" sourceLine="1727">
  <property name="label" value="Available-for-sale securities other-than-temporary impairment included in net income"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="QName" value="us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3.0" fact-concept="{http://pharmabioserv.com/20241231}ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3 - pbsv-20200131.xml 1877</message>
 <ref href="pbsv-20200131.xml#element(/1/498)" sourceLine="1877">
  <property name="label" value="Conversion of cashless exercise of options to common stock"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="QName" value="PBSV:ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21132403.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,132,403 - pbsv-20200131.xml 1616</message>
 <ref href="pbsv-20200131.xml#element(/1/237)" sourceLine="1616">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,132,403"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="50000000.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockSharesAuthorized" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 50,000,000 - pbsv-20200131.xml 1522</message>
 <ref href="pbsv-20200131.xml#element(/1/143)" sourceLine="1522">
  <property name="label" value="Common stock, authorized"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockSharesAuthorized"/>
  <property name="QName" value="us-gaap:CommonStockSharesAuthorized"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="50,000,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="5116682.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 5,116,682 - pbsv-20200131.xml 1641</message>
 <ref href="pbsv-20200131.xml#element(/1/262)" sourceLine="1641">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="5,116,682"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounts receivable are recorded at their est..." fact-concept="{http://fasb.org/us-gaap/2024}ReceivablesPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounts receivable are recorded at their estimatedrealizable value. Accounts are deemed past due when payment has not been received within the stated time period. The Company'spolicy is to review individual past due amounts periodically and write off amounts for which all collection efforts are deemedto have been exhausted. Due to the nature of the Company&amp;#8217;s customers, bad debts are mainly accounted for using the directwrite-off method whereby an expense is recognized only when a specific account is determined to be uncollectible. The effect ofusing this method approximates that of the allowance method.&lt;/p> - pbsv-20200131.xml 1994</message>
 <ref href="pbsv-20200131.xml#element(/1/615)" sourceLine="1994">
  <property name="label" value="Accounts Receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ReceivablesPolicyTextBlock"/>
  <property name="QName" value="us-gaap:ReceivablesPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounts receivable are recorded at their estimatedrealizable value. Accounts are deemed past due when payment has not been received within the stated time period. The Company'spolicy is to review individual past due amounts periodically and write off amounts for which all collection efforts are deemedto have been exhausted. Due to the nature of the Company&amp;#8217;s customers, bad debts are mainly accounted for using the directwrite-off method whereby an expense is recognized only when a specific account is determined to be uncollectible. The effect ofusing this method approximates that of the allowance method.&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20607506.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,607,506 - pbsv-20200131.xml 1576</message>
 <ref href="pbsv-20200131.xml#element(/1/197)" sourceLine="1576">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,607,506"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedI..." fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1726</message>
 <ref href="pbsv-20200131.xml#element(/1/347)" sourceLine="1726">
  <property name="label" value="Available-for-sale securities other-than-temporary impairment included in net income"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="QName" value="us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="4475.0" fact-concept="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 4,475 - pbsv-20200131.xml 1805</message>
 <ref href="pbsv-20200131.xml#element(/1/426)" sourceLine="1805">
  <property name="label" value="Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="QName" value="us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="4,475"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1.0" fact-concept="{http://pharmabioserv.com/20241231}ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1 - pbsv-20200131.xml 1876</message>
 <ref href="pbsv-20200131.xml#element(/1/497)" sourceLine="1876">
  <property name="label" value="Conversion of cashless exercise of options to common stock"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="QName" value="PBSV:ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1940</message>
 <ref href="pbsv-20200131.xml#element(/1/561)" sourceLine="1940">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_MajorCustomerAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.00"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0001" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockParOrStatedValuePerShare" fact-unit="{http://www.xbrl.org/2003/iso4217}USD/{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.0001 - pbsv-20200131.xml 1521</message>
 <ref href="pbsv-20200131.xml#element(/1/142)" sourceLine="1521">
  <property name="label" value="Common stock, par value"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockParOrStatedValuePerShare"/>
  <property name="QName" value="us-gaap:CommonStockParOrStatedValuePerShare"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USDPShares ($ / shares)">
   <property name="mul" value="iso4217:USD"/>
   <property name="div" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.0001"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-15425.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -15,425 - pbsv-20200131.xml 1733</message>
 <ref href="pbsv-20200131.xml#element(/1/354)" sourceLine="1733">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-15,425"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1804</message>
 <ref href="pbsv-20200131.xml#element(/1/425)" sourceLine="1804">
  <property name="label" value="Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="QName" value="us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2.0" fact-concept="{http://pharmabioserv.com/20241231}ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2 - pbsv-20200131.xml 1875</message>
 <ref href="pbsv-20200131.xml#element(/1/496)" sourceLine="1875">
  <property name="label" value="Conversion of cashless exercise of options to common stock"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="QName" value="PBSV:ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2337.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,337 - pbsv-20200131.xml 1579</message>
 <ref href="pbsv-20200131.xml#element(/1/200)" sourceLine="1579">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,337"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="5150344.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 5,150,344 - pbsv-20200131.xml 1640</message>
 <ref href="pbsv-20200131.xml#element(/1/261)" sourceLine="1640">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="5,150,344"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows an asset and liability ap..." fact-concept="{http://fasb.org/us-gaap/2024}IncomeTaxPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows an asset and liability approachmethod of accounting for income taxes. This method measures deferred income taxes by applying enacted statutory rates in effectat the balance sheet date to the differences between the tax basis of assets and liabilities and their reported amounts on thefinancial statements. The resulting deferred tax assets or liabilities are adjusted to reflect changes in tax laws as they occur.A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows guidance from the FinancialAccounting Standards Board (&amp;#8220;FASB&amp;#8221;) related to &lt;i>Accounting for Uncertainty in Income Taxes,&lt;/i> which includes atwo-step approach to recognizing, de-recognizing and measuring uncertain tax positions. As of April 30, 2020, the Company had nosignificant uncertain tax positions that would be reduced as a result of a lapse of the applicable statute of limitations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1995</message>
 <ref href="pbsv-20200131.xml#element(/1/616)" sourceLine="1995">
  <property name="label" value="Income Taxes"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeTaxPolicyTextBlock"/>
  <property name="QName" value="us-gaap:IncomeTaxPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows an asset and liability approachmethod of accounting for income taxes. This method measures deferred income taxes by applying enacted statutory rates in effectat the balance sheet date to the differences between the tax basis of assets and liabilities and their reported amounts on thefinancial statements. The resulting deferred tax assets or liabilities are adjusted to reflect changes in tax laws as they occur.A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows guidance from the FinancialAccounting Standards Board (&amp;#8220;FASB&amp;#8221;) related to &lt;i>Accounting for Uncertainty in Income Taxes,&lt;/i> which includes atwo-step approach to recognizing, de-recognizing and measuring uncertain tax positions. As of April 30, 2020, the Company had nosignificant uncertain tax positions that would be reduced as a result of a lapse of the applicable statute of limitations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-41467.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -41,467 - pbsv-20200131.xml 1732</message>
 <ref href="pbsv-20200131.xml#element(/1/353)" sourceLine="1732">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-41,467"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.073" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.073 - pbsv-20200131.xml 1941</message>
 <ref href="pbsv-20200131.xml#element(/1/562)" sourceLine="1941">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_MajorCustomerBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.073"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="661356.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 661,356 - pbsv-20200131.xml 1644</message>
 <ref href="pbsv-20200131.xml#element(/1/265)" sourceLine="1644">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="661,356"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1803</message>
 <ref href="pbsv-20200131.xml#element(/1/424)" sourceLine="1803">
  <property name="label" value="Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="QName" value="us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="17913.0" fact-concept="{http://pharmabioserv.com/20241231}AccumulatedDepreciationOnPropertyAndEquipmentDisposed" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 17,913 - pbsv-20200131.xml 1882</message>
 <ref href="pbsv-20200131.xml#element(/1/503)" sourceLine="1882">
  <property name="label" value="Accumulated depreciation"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="QName" value="PBSV:AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="17,913"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1580</message>
 <ref href="pbsv-20200131.xml#element(/1/201)" sourceLine="1580">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-29733.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -29,733 - pbsv-20200131.xml 1731</message>
 <ref href="pbsv-20200131.xml#element(/1/352)" sourceLine="1731">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-29,733"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23001627.0" fact-concept="{http://xbrl.sec.gov/dei/2024}EntityCommonStockSharesOutstanding" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-06-13T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,001,627 - pbsv-20200131.xml 1524</message>
 <ref href="pbsv-20200131.xml#element(/1/145)" sourceLine="1524">
  <property name="label" value="Entity Common Stock, Shares Outstanding"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityCommonStockSharesOutstanding"/>
  <property name="QName" value="dei:EntityCommonStockSharesOutstanding"/>
  <property name="contextRef" value="AsOf2020-06-12">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-06-12"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,001,627"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="133762.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 133,762 - pbsv-20200131.xml 1645</message>
 <ref href="pbsv-20200131.xml#element(/1/266)" sourceLine="1645">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="133,762"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="24000.0" fact-concept="{http://pharmabioserv.com/20241231}IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 24,000 - pbsv-20200131.xml 1881</message>
 <ref href="pbsv-20200131.xml#element(/1/502)" sourceLine="1881">
  <property name="label" value="Income tax withheld by clients to be used as a credit in the Company's income tax return"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="QName" value="PBSV:IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="24,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21579.0" fact-concept="{http://fasb.org/us-gaap/2024}DepreciationDepletionAndAmortization" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,579 - pbsv-20200131.xml 1806</message>
 <ref href="pbsv-20200131.xml#element(/1/427)" sourceLine="1806">
  <property name="label" value="Depreciation and amortization"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DepreciationDepletionAndAmortization"/>
  <property name="QName" value="us-gaap:DepreciationDepletionAndAmortization"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,579"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.105" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.105 - pbsv-20200131.xml 1942</message>
 <ref href="pbsv-20200131.xml#element(/1/563)" sourceLine="1942">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_MajorCustomerCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.105"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1346956.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,346,956 - pbsv-20200131.xml 1581</message>
 <ref href="pbsv-20200131.xml#element(/1/202)" sourceLine="1581">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,346,956"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="141500.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 141,500 - pbsv-20200131.xml 1646</message>
 <ref href="pbsv-20200131.xml#element(/1/267)" sourceLine="1646">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="141,500"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-23267.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -23,267 - pbsv-20200131.xml 1730</message>
 <ref href="pbsv-20200131.xml#element(/1/351)" sourceLine="1730">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-23,267"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="48682.0" fact-concept="{http://fasb.org/us-gaap/2024}DepreciationDepletionAndAmortization" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 48,682 - pbsv-20200131.xml 1809</message>
 <ref href="pbsv-20200131.xml#element(/1/430)" sourceLine="1809">
  <property name="label" value="Depreciation and amortization"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DepreciationDepletionAndAmortization"/>
  <property name="QName" value="us-gaap:DepreciationDepletionAndAmortization"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="48,682"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3649.0" fact-concept="{http://pharmabioserv.com/20241231}IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3,649 - pbsv-20200131.xml 1880</message>
 <ref href="pbsv-20200131.xml#element(/1/501)" sourceLine="1880">
  <property name="label" value="Income tax withheld by clients to be used as a credit in the Company's income tax return"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="QName" value="PBSV:IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3,649"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="7842.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 7,842 - pbsv-20200131.xml 1734</message>
 <ref href="pbsv-20200131.xml#element(/1/355)" sourceLine="1734">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="7,842"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Owned property and equipment are stated at co..." fact-concept="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Owned property and equipment are stated at cost.Vehicles under finance leases are stated at the lower of fair market value or net present value of the minimum lease payments atthe inception of the leases.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Depreciation of owned assets are provided for,when placed in service, in amounts sufficient to relate the cost of depreciable assets to operations over their estimated servicelives, using straight-line basis. Assets under finance leases are amortized over the lease term. While expenditures for repairsand maintenance are expensed when incurred. As of April 30, 2020 and October 31, 2019, the accumulated depreciation amounted to$481,325 and $509,275, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1996</message>
 <ref href="pbsv-20200131.xml#element(/1/617)" sourceLine="1996">
  <property name="label" value="Property and Equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PropertyPlantAndEquipmentPolicyTextBlock"/>
  <property name="QName" value="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Owned property and equipment are stated at cost.Vehicles under finance leases are stated at the lower of fair market value or net present value of the minimum lease payments atthe inception of the leases.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Depreciation of owned assets are provided for,when placed in service, in amounts sufficient to relate the cost of depreciable assets to operations over their estimated servicelives, using straight-line basis. Assets under finance leases are amortized over the lease term. While expenditures for repairsand maintenance are expensed when incurred. As of April 30, 2020 and October 31, 2019, the accumulated depreciation amounted to$481,325 and $509,275, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="50000000.0" fact-concept="{http://fasb.org/us-gaap/2024}CommonStockSharesAuthorized" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 50,000,000 - pbsv-20200131.xml 1523</message>
 <ref href="pbsv-20200131.xml#element(/1/144)" sourceLine="1523">
  <property name="label" value="Common stock, authorized"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CommonStockSharesAuthorized"/>
  <property name="QName" value="us-gaap:CommonStockSharesAuthorized"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="50,000,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2332.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,332 - pbsv-20200131.xml 1647</message>
 <ref href="pbsv-20200131.xml#element(/1/268)" sourceLine="1647">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,332"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="17411.0" fact-concept="{http://pharmabioserv.com/20241231}IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 17,411 - pbsv-20200131.xml 1879</message>
 <ref href="pbsv-20200131.xml#element(/1/500)" sourceLine="1879">
  <property name="label" value="Income tax withheld by clients to be used as a credit in the Company's income tax return"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="QName" value="PBSV:IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="17,411"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="7842.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 7,842 - pbsv-20200131.xml 1735</message>
 <ref href="pbsv-20200131.xml#element(/1/356)" sourceLine="1735">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="7,842"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="42611.0" fact-concept="{http://fasb.org/us-gaap/2024}DepreciationDepletionAndAmortization" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 42,611 - pbsv-20200131.xml 1808</message>
 <ref href="pbsv-20200131.xml#element(/1/429)" sourceLine="1808">
  <property name="label" value="Depreciation and amortization"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DepreciationDepletionAndAmortization"/>
  <property name="QName" value="us-gaap:DepreciationDepletionAndAmortization"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="42,611"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="19111111.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 19,111,111 - pbsv-20200131.xml 1582</message>
 <ref href="pbsv-20200131.xml#element(/1/203)" sourceLine="1582">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="19,111,111"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.116" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.116 - pbsv-20200131.xml 1943</message>
 <ref href="pbsv-20200131.xml#element(/1/564)" sourceLine="1943">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_MajorCustomerDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.116"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="54447.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 54,447 - pbsv-20200131.xml 1648</message>
 <ref href="pbsv-20200131.xml#element(/1/269)" sourceLine="1648">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="54,447"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company evaluates for impairment its long..." fact-concept="{http://fasb.org/us-gaap/2024}ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company evaluates for impairment its long-livedassets to be held and used, and long-lived assets to be disposed of, whenever events or changes in circumstances indicate thatthe carrying amount of an asset may not be recoverable. Based on management estimates, no impairment of the long-lived assets waspresent as of April 30, 2020 and October 31, 2019.&lt;/p> - pbsv-20200131.xml 1997</message>
 <ref href="pbsv-20200131.xml#element(/1/618)" sourceLine="1997">
  <property name="label" value="Impairment of Long-Lived Assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
  <property name="QName" value="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company evaluates for impairment its long-livedassets to be held and used, and long-lived assets to be disposed of, whenever events or changes in circumstances indicate thatthe carrying amount of an asset may not be recoverable. Based on management estimates, no impairment of the long-lived assets waspresent as of April 30, 2020 and October 31, 2019.&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-23267.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -23,267 - pbsv-20200131.xml 1736</message>
 <ref href="pbsv-20200131.xml#element(/1/357)" sourceLine="1736">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-23,267"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>ORGANIZATION&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt ..." fact-concept="{http://fasb.org/us-gaap/2024}OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPol..." fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>ORGANIZATION&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>Pharma-BioServ, Inc. (&amp;#8220;Pharma-Bio&amp;#8221;) is a Delaware corporation organized on January 14, 2004. Pharma-Bio is the parent companyof Pharma-Bio Serv PR, Inc. (&amp;#8220;Pharma-PR&amp;#8221;), Pharma Serv, Inc. (&amp;#8220;Pharma-Serv&amp;#8221;), and Scienza Labs, Inc. (&amp;#8220;ScienzaLabs&amp;#8221;), each a&amp;#160;Puerto Rico corporation, Pharma-Bio Serv US, Inc. (&amp;#8220;Pharma-US&amp;#8221;), a Delaware corporation,Pharma-Bio Serv Validation &amp;#38; Compliance Limited (&amp;#8220;Pharma-IR&amp;#8221;), an Irish corporation currently inactive, Pharma-BioServ SL (&amp;#8220;Pharma-Spain&amp;#8221;), a Spanish limited liability company, and Pharma-Bio Serv Brasil Servicos de Consultoria Ltda.(&amp;#8220;Pharma-Brazil&amp;#8221;), a Brazilian limited liability company. Pharma-Bio, Pharma-PR, Pharma-Serv, Scienza Labs, Pharma-US,Pharma-IR, Pharma-Spain and Pharma-Brazil are collectively referred to as the &amp;#8220;Company.&amp;#8221; The Company operates in PuertoRico, the United States, Ireland, Spain and Brazil under the name of Pharma-Bio Serv and is engaged in providing technical complianceconsulting service.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The condensed consolidated balance sheet ofthe Company as of October 31, 2019 is derived from audited consolidated financial statements but does not include all disclosuresrequired by generally accepted accounting principles. The unaudited interim condensed consolidated financial statements, includeall adjustments, consisting of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentationof the financial position and results of operations and cash flows for the interim periods. The results of operations for the sixmonths ended April 30, 2020 are not necessarily indicative of expected results for the full 2020 fiscal year.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The accompanying financial data as of April30, 2020, and for the three-month and six-month periods ended April 30, 2020 and 2019 has been prepared by us, without audit, pursuantto the rules and regulations of the Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221;). Certain information and footnotedisclosures normally contained in financial statements prepared in accordance with generally accepted accounting principles havebeen condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the financial statementsand notes contained in our audited Consolidated Financial Statements and the notes thereto for the fiscal year ended October 31,2019.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Consolidation&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The accompanying condensed consolidated financialstatements include the accounts of the Company and all of its wholly owned subsidiaries. All intercompany transactions and balanceshave been eliminated in consolidation.&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Segments&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>The Companyoperates in three reportable business segments: (i) Puerto Rico technical compliance consulting, (ii) United States technical complianceconsulting, and (iii) Europe technical compliance consulting. Accordingly, the accompanying condensed consolidated financial statementsare presented to show these three reportable segments.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Use of Estimates&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The preparation of condensed consolidated financialstatements in conformity with accounting principles generally accepted in the United States of America requires management to makeestimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilitiesat the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reportingperiods. Actual results may differ from these estimates.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Fair Value of Financial Instruments&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounting standards have established a fairvalue hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs whenmeasuring fair value. A financial instrument&amp;#8217;s categorization within the fair value hierarchy is based upon the lowest levelof input that is significant to the fair value measurement. Accounting standards have established three levels of inputs that maybe used to measure fair value:&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%&quot;>&lt;tr>    &lt;td style=&quot;vertical-align: top; width: 10%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;1&lt;/i>:&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom; width: 90%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Quoted prices in active markets for identical        assets and liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;vertical-align: top&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;2:&lt;/i>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Observable inputs other than Level 1 prices        such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions        (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally        from or corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: top&quot;>&lt;font style=&quot;font-size: 8pt&quot;>&lt;i>Level&amp;#160;3&lt;/i>:&lt;/font>&lt;/td>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The carrying value of the Company's financialinstruments (excluding obligations under finance leases), cash and cash equivalents, accounts receivable, accounts payable andaccrued liabilities, are considered reasonable estimates of fair value due to their liquidity or short-term nature. Managementbelieves, based on current rates, that the fair value of its obligations under finance leases approximates the carrying amount.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Revenue Recognition&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In May 2014, the Financial Accounting StandardsBoard (FASB) issued a new accounting standard that amends the guidance for the recognition of revenue from contracts with customersto transfer goods and services. The FASB subsequently issued additional, clarifying standards to address issues arising from implementationof the new revenue recognition standard. The new revenue recognition standard and clarifying standards require an entity to recognizerevenue when control of promised goods or services is transferred to the customer at an amount that reflects the considerationto which the entity expects to be entitled in exchange for those goods or services. We adopted this new standard as of November1, 2018, by applying the modified-retrospective method to those contracts that were not completed as of that date. The resultsfor reporting periods beginning after November 1, 2018, are presented in accordance with the new standard, although comparativeinformation has not been restated and continues to be reported under the accounting standards and policies in effect for thoseperiods. The adoption of this new standard had an immaterial impact on our reported total revenues and operating income as comparedto what reported amounts would have been under the prior standard.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Revenue is primarily derived from: (1) timeand materials contracts (representing approximately 99% of total revenues), which is recognized by applying the proportional performancemodel, whereby revenue is recognized as performance occurs, and (2) short-term fixed-fee contracts or &amp;#34;not to exceed&amp;#34; contracts(representing approximately 1% of total revenues), which revenue is recognized similarly, except that certain milestones also haveto be reached before revenue is recognized. If the Company determines that a contract will result in a loss, the Company recognizesthe estimated loss in the period in which such determination is made.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Cash Equivalents&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>For purposes of the consolidated statementsof cash flows, cash equivalents include investments in a money market obligations trust that is registered under the U.S. InvestmentCompany Act of 1940, as amended, and liquid investments with original maturities of three months or less.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Accounts Receivable&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounts receivable are recorded at their estimatedrealizable value. Accounts are deemed past due when payment has not been received within the stated time period. The Company'spolicy is to review individual past due amounts periodically and write off amounts for which all collection efforts are deemedto have been exhausted. Due to the nature of the Company&amp;#8217;s customers, bad debts are mainly accounted for using the directwrite-off method whereby an expense is recognized only when a specific account is determined to be uncollectible. The effect ofusing this method approximates that of the allowance method.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Income Taxes&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows an asset and liability approachmethod of accounting for income taxes. This method measures deferred income taxes by applying enacted statutory rates in effectat the balance sheet date to the differences between the tax basis of assets and liabilities and their reported amounts on thefinancial statements. The resulting deferred tax assets or liabilities are adjusted to reflect changes in tax laws as they occur.A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows guidance from the FinancialAccounting Standards Board (&amp;#8220;FASB&amp;#8221;) related to &lt;i>Accounting for Uncertainty in Income Taxes,&lt;/i> which includes atwo-step approach to recognizing, de-recognizing and measuring uncertain tax positions. As of April 30, 2020, the Company had nosignificant uncertain tax positions that would be reduced as a result of a lapse of the applicable statute of limitations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Property and Equipment&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Owned property and equipment are stated at cost.Vehicles under finance leases are stated at the lower of fair market value or net present value of the minimum lease payments atthe inception of the leases.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Depreciation of owned assets are provided for,when placed in service, in amounts sufficient to relate the cost of depreciable assets to operations over their estimated servicelives, using straight-line basis. Assets under finance leases are amortized over the lease term. While expenditures for repairsand maintenance are expensed when incurred. As of April 30, 2020 and October 31, 2019, the accumulated depreciation amounted to$481,325 and $509,275, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Impairment of Long-Lived Assets&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company evaluates for impairment its long-livedassets to be held and used, and long-lived assets to be disposed of, whenever events or changes in circumstances indicate thatthe carrying amount of an asset may not be recoverable. Based on management estimates, no impairment of the long-lived assets waspresent as of April 30, 2020 and October 31, 2019.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Stock-based Compensation&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Stock-based compensation expense is recognizedin the consolidated financial statements based on the fair value of the awards granted. Stock-based compensation cost is measuredat the grant date based on the fair value of the award and is recognized as expense over the requisite service period, which generallyrepresents the vesting period, and includes an estimate of awards that will be forfeited. The Company calculates the fair valueof stock options using the Black-Scholes option-pricing model at the grant date, while for restricted stock units the fair marketvalue of the units is determined by Company&amp;#8217;s share market value at grant date. Excess tax benefits related to stock-basedcompensation are reflected as cash flows from financing activities rather than cash flows from operating activities. The Companyhas not recognized such cash flows from financing activities since there has been no tax benefit related to the stock-based compensation.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Earnings Per Share of Common Stock&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Basic earnings per share of common stock iscalculated by dividing net earnings by the weighted average number of shares of common stock outstanding. Diluted earnings pershare includes the dilution of common stock equivalents, which include principally shares that may be issued upon the exerciseof warrants, stock option and restricted stock unit awards.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The diluted weighted average shares of commonstock outstanding were calculated using the treasury stock method for the respective periods.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Foreign Operations&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The functional currency of the Company&amp;#8217;sforeign subsidiaries is its local currency. The assets and liabilities of the Company&amp;#8217;s foreign subsidiaries are translatedinto U.S. dollars at exchange rates in effect at the balance sheet date. Income and expense items are translated at the averageexchange rates prevailing during the period. The cumulative translation effect for subsidiaries using a functional currency otherthan the U.S. dollar is included as a cumulative translation adjustment in stockholders&amp;#8217; equity and as a component of comprehensiveincome.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s intercompany accounts aretypically denominated in the functional currency of the foreign subsidiary. Gains and losses resulting from the remeasurement ofintercompany receivables that the Company considers to be of a long-term investment nature are recorded as a cumulative translationadjustment in stockholders&amp;#8217; equity and as a component of comprehensive income, while gains and losses resulting from theremeasurement of intercompany receivables from those international subsidiaries for which the Company anticipates settlement inthe foreseeable future are recorded in the consolidated statements of operations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Subsequent Events&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company has evaluated subsequent eventsthrough&amp;#160;the filing date of this report. The Company has determined that there are no events occurring in this period thatrequired disclosure or adjustment.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Reclassifications&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Certain reclassifications have been made tothe April 30, 2019 condensed consolidated financial statements to conform them to the April 30, 2020 condensed consolidated financialstatements presentation. Such reclassifications do not affect net income as previously reported.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Recently Adopted Accounting Pronouncements&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In February 2016, the FASB issued ASU 2016-02,Leases (Topic 842) (&amp;#8220;ASU 2016-02&amp;#8221;). ASU 2016-02 is intended to increase transparency and comparability of accountingfor lease transactions. For all leases with terms greater than twelve months, the new guidance will require lessees to recognizeright-of-use assets and corresponding lease liabilities on the balance sheet and to disclose qualitative and quantitative informationabout lease transactions. The new standard maintains a distinction between finance leases and operating leases. As a result, theeffect of leases in the statement of operations and statement of cash flows is largely unchanged. In July 2018, the FASB issuedASU 2018-11, Leases - Targeted Improvements, to allow a company to elect an optional modified retrospective transition method thatapplies the new lease requirements through a cumulative-effect adjustment in the period of adoption.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Effective November 1, 2019, the Company adoptedthe new lease accounting standard using the modified retrospective transition option of applying the new standard at the adoptiondate. We categorize leases at their inception as either operating or finance leases. The Company leases include an operationallease for office space and a finance lease agreement for a vehicle. The adoption of the new standard resulted in the operatinglease being included in operating lease right-of-use assets, current operating lease liabilities, and long-term operating leaseliabilities in our condensed consolidated balance sheets, but did not have an impact on the Company&amp;#8217;s beginning balance ofretained earnings, consolidated statement of operations or statement of cash flows. Finance leases are included in net propertyand equipment, current installments of long-term debt, and long-term debt in our condensed consolidated balance sheets. The mostsignificant impact was the recognition of right-of-use assets and lease liabilities on account of the Company&amp;#8217;s operatingleases. The Company recognized $941,009 of right-of-use assets and $911,922 in operating lease liabilities at November 1, 2019.As of April 30, 2020, the total right-of-use assets related to the Company&amp;#8217;s operating leases was $874,840 and operatinglease liabilities current and non-current were approximately $156,496 and $696,916, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Recent Accounting Pronouncements&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Recent accounting pronouncements pending adoptionnot discussed above or in the 2019 Form 10-K are either not applicable or will not have or are not expected to have a materialimpact on us.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1886</message>
 <ref href="pbsv-20200131.xml#element(/1/507)" sourceLine="1886">
  <property name="label" value="A. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
  <property name="QName" value="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>ORGANIZATION&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>Pharma-BioServ, Inc. (&amp;#8220;Pharma-Bio&amp;#8221;) is a Delaware corporation organized on January 14, 2004. Pharma-Bio is the parent companyof Pharma-Bio Serv PR, Inc. (&amp;#8220;Pharma-PR&amp;#8221;), Pharma Serv, Inc. (&amp;#8220;Pharma-Serv&amp;#8221;), and Scienza Labs, Inc. (&amp;#8220;ScienzaLabs&amp;#8221;), each a&amp;#160;Puerto Rico corporation, Pharma-Bio Serv US, Inc. (&amp;#8220;Pharma-US&amp;#8221;), a Delaware corporation,Pharma-Bio Serv Validation &amp;#38; Compliance Limited (&amp;#8220;Pharma-IR&amp;#8221;), an Irish corporation currently inactive, Pharma-BioServ SL (&amp;#8220;Pharma-Spain&amp;#8221;), a Spanish limited liability company, and Pharma-Bio Serv Brasil Servicos de Consultoria Ltda.(&amp;#8220;Pharma-Brazil&amp;#8221;), a Brazilian limited liability company. Pharma-Bio, Pharma-PR, Pharma-Serv, Scienza Labs, Pharma-US,Pharma-IR, Pharma-Spain and Pharma-Brazil are collectively referred to as the &amp;#8220;Company.&amp;#8221; The Company operates in PuertoRico, the United States, Ireland, Spain and Brazil under the name of Pharma-Bio Serv and is engaged in providing technical complianceconsulting service.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The condensed consolidated balance sheet ofthe Company as of October 31, 2019 is derived from audited consolidated financial statements but does not include all disclosuresrequired by generally accepted accounting principles. The unaudited interim condensed consolidated financial statements, includeall adjustments, consisting of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentationof the financial position and results of operations and cash flows for the interim periods. The results of operations for the sixmonths ended April 30, 2020 are not necessarily indicative of expected results for the full 2020 fiscal year.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The accompanying financial data as of April30, 2020, and for the three-month and six-month periods ended April 30, 2020 and 2019 has been prepared by us, without audit, pursuantto the rules and regulations of the Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221;). Certain information and footnotedisclosures normally contained in financial statements prepared in accordance with generally accepted accounting principles havebeen condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the financial statementsand notes contained in our audited Consolidated Financial Statements and the notes thereto for the fiscal year ended October 31,2019.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Consolidation&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The accompanying condensed consolidated financialstatements include the accounts of the Company and all of its wholly owned subsidiaries. All intercompany transactions and balanceshave been eliminated in consolidation.&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Segments&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>The Companyoperates in three reportable business segments: (i) Puerto Rico technical compliance consulting, (ii) United States technical complianceconsulting, and (iii) Europe technical compliance consulting. Accordingly, the accompanying condensed consolidated financial statementsare presented to show these three reportable segments.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Use of Estimates&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The preparation of condensed consolidated financialstatements in conformity with accounting principles generally accepted in the United States of America requires management to makeestimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilitiesat the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reportingperiods. Actual results may differ from these estimates.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Fair Value of Financial Instruments&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounting standards have established a fairvalue hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs whenmeasuring fair value. A financial instrument&amp;#8217;s categorization within the fair value hierarchy is based upon the lowest levelof input that is significant to the fair value measurement. Accounting standards have established three levels of inputs that maybe used to measure fair value:&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%&quot;>&lt;tr>    &lt;td style=&quot;vertical-align: top; width: 10%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;1&lt;/i>:&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom; width: 90%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Quoted prices in active markets for identical        assets and liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;vertical-align: top&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;i>Level&amp;#160;2:&lt;/i>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;vertical-align: bottom&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Observable inputs other than Level 1 prices        such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions        (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally        from or corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: top&quot;>&lt;font style=&quot;font-size: 8pt&quot;>&lt;i>Level&amp;#160;3&lt;/i>:&lt;/font>&lt;/td>    &lt;td style=&quot;font: 12pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The carrying value of the Company's financialinstruments (excluding obligations under finance leases), cash and cash equivalents, accounts receivable, accounts payable andaccrued liabilities, are considered reasonable estimates of fair value due to their liquidity or short-term nature. Managementbelieves, based on current rates, that the fair value of its obligations under finance leases approximates the carrying amount.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Revenue Recognition&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In May 2014, the Financial Accounting StandardsBoard (FASB) issued a new accounting standard that amends the guidance for the recognition of revenue from contracts with customersto transfer goods and services. The FASB subsequently issued additional, clarifying standards to address issues arising from implementationof the new revenue recognition standard. The new revenue recognition standard and clarifying standards require an entity to recognizerevenue when control of promised goods or services is transferred to the customer at an amount that reflects the considerationto which the entity expects to be entitled in exchange for those goods or services. We adopted this new standard as of November1, 2018, by applying the modified-retrospective method to those contracts that were not completed as of that date. The resultsfor reporting periods beginning after November 1, 2018, are presented in accordance with the new standard, although comparativeinformation has not been restated and continues to be reported under the accounting standards and policies in effect for thoseperiods. The adoption of this new standard had an immaterial impact on our reported total revenues and operating income as comparedto what reported amounts would have been under the prior standard.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Revenue is primarily derived from: (1) timeand materials contracts (representing approximately 99% of total revenues), which is recognized by applying the proportional performancemodel, whereby revenue is recognized as performance occurs, and (2) short-term fixed-fee contracts or &amp;#34;not to exceed&amp;#34; contracts(representing approximately 1% of total revenues), which revenue is recognized similarly, except that certain milestones also haveto be reached before revenue is recognized. If the Company determines that a contract will result in a loss, the Company recognizesthe estimated loss in the period in which such determination is made.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Cash Equivalents&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>For purposes of the consolidated statementsof cash flows, cash equivalents include investments in a money market obligations trust that is registered under the U.S. InvestmentCompany Act of 1940, as amended, and liquid investments with original maturities of three months or less.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Accounts Receivable&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Accounts receivable are recorded at their estimatedrealizable value. Accounts are deemed past due when payment has not been received within the stated time period. The Company'spolicy is to review individual past due amounts periodically and write off amounts for which all collection efforts are deemedto have been exhausted. Due to the nature of the Company&amp;#8217;s customers, bad debts are mainly accounted for using the directwrite-off method whereby an expense is recognized only when a specific account is determined to be uncollectible. The effect ofusing this method approximates that of the allowance method.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Income Taxes&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows an asset and liability approachmethod of accounting for income taxes. This method measures deferred income taxes by applying enacted statutory rates in effectat the balance sheet date to the differences between the tax basis of assets and liabilities and their reported amounts on thefinancial statements. The resulting deferred tax assets or liabilities are adjusted to reflect changes in tax laws as they occur.A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company follows guidance from the FinancialAccounting Standards Board (&amp;#8220;FASB&amp;#8221;) related to &lt;i>Accounting for Uncertainty in Income Taxes,&lt;/i> which includes atwo-step approach to recognizing, de-recognizing and measuring uncertain tax positions. As of April 30, 2020, the Company had nosignificant uncertain tax positions that would be reduced as a result of a lapse of the applicable statute of limitations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Property and Equipment&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Owned property and equipment are stated at cost.Vehicles under finance leases are stated at the lower of fair market value or net present value of the minimum lease payments atthe inception of the leases.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Depreciation of owned assets are provided for,when placed in service, in amounts sufficient to relate the cost of depreciable assets to operations over their estimated servicelives, using straight-line basis. Assets under finance leases are amortized over the lease term. While expenditures for repairsand maintenance are expensed when incurred. As of April 30, 2020 and October 31, 2019, the accumulated depreciation amounted to$481,325 and $509,275, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Impairment of Long-Lived Assets&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company evaluates for impairment its long-livedassets to be held and used, and long-lived assets to be disposed of, whenever events or changes in circumstances indicate thatthe carrying amount of an asset may not be recoverable. Based on management estimates, no impairment of the long-lived assets waspresent as of April 30, 2020 and October 31, 2019.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Stock-based Compensation&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Stock-based compensation expense is recognizedin the consolidated financial statements based on the fair value of the awards granted. Stock-based compensation cost is measuredat the grant date based on the fair value of the award and is recognized as expense over the requisite service period, which generallyrepresents the vesting period, and includes an estimate of awards that will be forfeited. The Company calculates the fair valueof stock options using the Black-Scholes option-pricing model at the grant date, while for restricted stock units the fair marketvalue of the units is determined by Company&amp;#8217;s share market value at grant date. Excess tax benefits related to stock-basedcompensation are reflected as cash flows from financing activities rather than cash flows from operating activities. The Companyhas not recognized such cash flows from financing activities since there has been no tax benefit related to the stock-based compensation.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Earnings Per Share of Common Stock&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Basic earnings per share of common stock iscalculated by dividing net earnings by the weighted average number of shares of common stock outstanding. Diluted earnings pershare includes the dilution of common stock equivalents, which include principally shares that may be issued upon the exerciseof warrants, stock option and restricted stock unit awards.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The diluted weighted average shares of commonstock outstanding were calculated using the treasury stock method for the respective periods.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Foreign Operations&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The functional currency of the Company&amp;#8217;sforeign subsidiaries is its local currency. The assets and liabilities of the Company&amp;#8217;s foreign subsidiaries are translatedinto U.S. dollars at exchange rates in effect at the balance sheet date. Income and expense items are translated at the averageexchange rates prevailing during the period. The cumulative translation effect for subsidiaries using a functional currency otherthan the U.S. dollar is included as a cumulative translation adjustment in stockholders&amp;#8217; equity and as a component of comprehensiveincome.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s intercompany accounts aretypically denominated in the functional currency of the foreign subsidiary. Gains and losses resulting from the remeasurement ofintercompany receivables that the Company considers to be of a long-term investment nature are recorded as a cumulative translationadjustment in stockholders&amp;#8217; equity and as a component of comprehensive income, while gains and losses resulting from theremeasurement of intercompany receivables from those international subsidiaries for which the Company anticipates settlement inthe foreseeable future are recorded in the consolidated statements of operations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Subsequent Events&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company has evaluated subsequent eventsthrough&amp;#160;the filing date of this report. The Company has determined that there are no events occurring in this period thatrequired disclosure or adjustment.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Reclassifications&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Certain reclassifications have been made tothe April 30, 2019 condensed consolidated financial statements to conform them to the April 30, 2020 condensed consolidated financialstatements presentation. Such reclassifications do not affect net income as previously reported.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Recently Adopted Accounting Pronouncements&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In February 2016, the FASB issued ASU 2016-02,Leases (Topic 842) (&amp;#8220;ASU 2016-02&amp;#8221;). ASU 2016-02 is intended to increase transparency and comparability of accountingfor lease transactions. For all leases with terms greater than twelve months, the new guidance will require lessees to recognizeright-of-use assets and corresponding lease liabilities on the balance sheet and to disclose qualitative and quantitative informationabout lease transactions. The new standard maintains a distinction between finance leases and operating leases. As a result, theeffect of leases in the statement of operations and statement of cash flows is largely unchanged. In July 2018, the FASB issuedASU 2018-11, Leases - Targeted Improvements, to allow a company to elect an optional modified retrospective transition method thatapplies the new lease requirements through a cumulative-effect adjustment in the period of adoption.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Effective November 1, 2019, the Company adoptedthe new lease accounting standard using the modified retrospective transition option of applying the new standard at the adoptiondate. We categorize leases at their inception as either operating or finance leases. The Company leases include an operationallease for office space and a finance lease agreement for a vehicle. The adoption of the new standard resulted in the operatinglease being included in operating lease right-of-use assets, current operating lease liabilities, and long-term operating leaseliabilities in our condensed consolidated balance sheets, but did not have an impact on the Company&amp;#8217;s beginning balance ofretained earnings, consolidated statement of operations or statement of cash flows. Finance leases are included in net propertyand equipment, current installments of long-term debt, and long-term debt in our condensed consolidated balance sheets. The mostsignificant impact was the recognition of right-of-use assets and lease liabilities on account of the Company&amp;#8217;s operatingleases. The Company recognized $941,009 of right-of-use assets and $911,922 in operating lease liabilities at November 1, 2019.As of April 30, 2020, the total right-of-use assets related to the Company&amp;#8217;s operating leases was $874,840 and operatinglease liabilities current and non-current were approximately $156,496 and $696,916, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Recent Accounting Pronouncements&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Recent accounting pronouncements pending adoptionnot discussed above or in the 2019 Form 10-K are either not applicable or will not have or are not expected to have a materialimpact on us.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="107947.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 107,947 - pbsv-20200131.xml 1583</message>
 <ref href="pbsv-20200131.xml#element(/1/204)" sourceLine="1583">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="107,947"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="10260934.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 10,260,934 - pbsv-20200131.xml 1649</message>
 <ref href="pbsv-20200131.xml#element(/1/270)" sourceLine="1649">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="10,260,934"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company has evaluated subsequent eventst..." fact-concept="{http://fasb.org/us-gaap/2024}SubsequentEventsPolicyPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company has evaluated subsequent eventsthrough&amp;#160;the filing date of this report. The Company has determined that there are no events occurring in this period thatrequired disclosure or adjustment.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 2001</message>
 <ref href="pbsv-20200131.xml#element(/1/622)" sourceLine="2001">
  <property name="label" value="Subsequent Events"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SubsequentEventsPolicyPolicyTextBlock"/>
  <property name="QName" value="us-gaap:SubsequentEventsPolicyPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company has evaluated subsequent eventsthrough&amp;#160;the filing date of this report. The Company has determined that there are no events occurring in this period thatrequired disclosure or adjustment.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="250752.0" fact-concept="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentNet" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 250,752 - pbsv-20200131.xml 1531</message>
 <ref href="pbsv-20200131.xml#element(/1/152)" sourceLine="1531">
  <property name="label" value="Property and equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PropertyPlantAndEquipmentNet"/>
  <property name="QName" value="us-gaap:PropertyPlantAndEquipmentNet"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="250,752"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-11734.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -11,734 - pbsv-20200131.xml 1737</message>
 <ref href="pbsv-20200131.xml#element(/1/358)" sourceLine="1737">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-11,734"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="21844.0" fact-concept="{http://fasb.org/us-gaap/2024}DepreciationDepletionAndAmortization" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 21,844 - pbsv-20200131.xml 1807</message>
 <ref href="pbsv-20200131.xml#element(/1/428)" sourceLine="1807">
  <property name="label" value="Depreciation and amortization"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DepreciationDepletionAndAmortization"/>
  <property name="QName" value="us-gaap:DepreciationDepletionAndAmortization"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="21,844"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="86773.0" fact-concept="{http://pharmabioserv.com/20241231}AccumulatedDepreciationOnPropertyAndEquipmentDisposed" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 86,773 - pbsv-20200131.xml 1885</message>
 <ref href="pbsv-20200131.xml#element(/1/506)" sourceLine="1885">
  <property name="label" value="Accumulated depreciation"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="QName" value="PBSV:AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="86,773"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.222" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.222 - pbsv-20200131.xml 1944</message>
 <ref href="pbsv-20200131.xml#element(/1/565)" sourceLine="1944">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_MajorCustomerEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.222"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="9716541.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 9,716,541 - pbsv-20200131.xml 1650</message>
 <ref href="pbsv-20200131.xml#element(/1/271)" sourceLine="1650">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="9,716,541"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-304688.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -304,688 - pbsv-20200131.xml 1584</message>
 <ref href="pbsv-20200131.xml#element(/1/205)" sourceLine="1584">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-304,688"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-11734.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -11,734 - pbsv-20200131.xml 1738</message>
 <ref href="pbsv-20200131.xml#element(/1/359)" sourceLine="1738">
  <property name="label" value="OTHER COMPREHENSIVE INCOME, NET OF TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="QName" value="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-11,734"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="17913.0" fact-concept="{http://pharmabioserv.com/20241231}AccumulatedDepreciationOnPropertyAndEquipmentDisposed" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 17,913 - pbsv-20200131.xml 1884</message>
 <ref href="pbsv-20200131.xml#element(/1/505)" sourceLine="1884">
  <property name="label" value="Accumulated depreciation"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="QName" value="PBSV:AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="17,913"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="9297592.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 9,297,592 - pbsv-20200131.xml 1651</message>
 <ref href="pbsv-20200131.xml#element(/1/272)" sourceLine="1651">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="9,297,592"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Stock-based compensation expense is recognize..." fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensationOptionAndIncentivePlansPolicy" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Stock-based compensation expense is recognizedin the consolidated financial statements based on the fair value of the awards granted. Stock-based compensation cost is measuredat the grant date based on the fair value of the award and is recognized as expense over the requisite service period, which generallyrepresents the vesting period, and includes an estimate of awards that will be forfeited. The Company calculates the fair valueof stock options using the Black-Scholes option-pricing model at the grant date, while for restricted stock units the fair marketvalue of the units is determined by Company&amp;#8217;s share market value at grant date. Excess tax benefits related to stock-basedcompensation are reflected as cash flows from financing activities rather than cash flows from operating activities. The Companyhas not recognized such cash flows from financing activities since there has been no tax benefit related to the stock-based compensation.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1998</message>
 <ref href="pbsv-20200131.xml#element(/1/619)" sourceLine="1998">
  <property name="label" value="Stock-based Compensation"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
  <property name="QName" value="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Stock-based compensation expense is recognizedin the consolidated financial statements based on the fair value of the awards granted. Stock-based compensation cost is measuredat the grant date based on the fair value of the award and is recognized as expense over the requisite service period, which generallyrepresents the vesting period, and includes an estimate of awards that will be forfeited. The Company calculates the fair valueof stock options using the Black-Scholes option-pricing model at the grant date, while for restricted stock units the fair marketvalue of the units is determined by Company&amp;#8217;s share market value at grant date. Excess tax benefits related to stock-basedcompensation are reflected as cash flows from financing activities rather than cash flows from operating activities. The Companyhas not recognized such cash flows from financing activities since there has been no tax benefit related to the stock-based compensation.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="4918.0" fact-concept="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 4,918 - pbsv-20200131.xml 1810</message>
 <ref href="pbsv-20200131.xml#element(/1/431)" sourceLine="1810">
  <property name="label" value="Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GainLossOnDispositionOfAssets"/>
  <property name="QName" value="us-gaap:GainLossOnDispositionOfAssets"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="4,918"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="86773.0" fact-concept="{http://pharmabioserv.com/20241231}AccumulatedDepreciationOnPropertyAndEquipmentDisposed" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 86,773 - pbsv-20200131.xml 1883</message>
 <ref href="pbsv-20200131.xml#element(/1/504)" sourceLine="1883">
  <property name="label" value="Accumulated depreciation"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="QName" value="PBSV:AccumulatedDepreciationOnPropertyAndEquipmentDisposed"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="86,773"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="28635923.0" fact-concept="{http://fasb.org/us-gaap/2024}Assets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 28,635,923 - pbsv-20200131.xml 1525</message>
 <ref href="pbsv-20200131.xml#element(/1/146)" sourceLine="1525">
  <property name="label" value="Assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Assets"/>
  <property name="QName" value="us-gaap:Assets"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="28,635,923"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.516" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.516 - pbsv-20200131.xml 1945</message>
 <ref href="pbsv-20200131.xml#element(/1/566)" sourceLine="1945">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_MajorCustomerTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.516"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2340.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,340 - pbsv-20200131.xml 1585</message>
 <ref href="pbsv-20200131.xml#element(/1/206)" sourceLine="1585">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,340"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="784353.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 784,353 - pbsv-20200131.xml 1652</message>
 <ref href="pbsv-20200131.xml#element(/1/273)" sourceLine="1652">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="784,353"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>On Sept..." fact-concept="{http://fasb.org/us-gaap/2024}MarketableSecuritiesTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>On September17, 2018 (the &amp;#8220;Sales Closing Date&amp;#8221;), the Company sold substantially all of its Lab business assets (the &amp;#8220;LaboratoryAssets&amp;#8221;). Upon the completion of the Laboratory Assets sale, the Company received, as partial payment, a $3 million PromissoryNote from the purchaser. The Promissory Note is composed of two tranches; (i) Tranche A for $2 million and secured with lab equipmentand (ii) Tranche B for $1 million which is unsecured. The interest rate accrual is 3% for Tranche A and 5% for Tranche B. As ofApril 30, 2020, pursuant to the terms of the Promissory Note, the Company has collected $1,750,000. The Promissory Note final installmentof $1,250,000 from Tranche A is due September 17, 2020.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1887</message>
 <ref href="pbsv-20200131.xml#element(/1/508)" sourceLine="1887">
  <property name="label" value="B. PROMISSORY NOTE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="MarketableSecuritiesTextBlock"/>
  <property name="QName" value="us-gaap:MarketableSecuritiesTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>On September17, 2018 (the &amp;#8220;Sales Closing Date&amp;#8221;), the Company sold substantially all of its Lab business assets (the &amp;#8220;LaboratoryAssets&amp;#8221;). Upon the completion of the Laboratory Assets sale, the Company received, as partial payment, a $3 million PromissoryNote from the purchaser. The Promissory Note is composed of two tranches; (i) Tranche A for $2 million and secured with lab equipmentand (ii) Tranche B for $1 million which is unsecured. The interest rate accrual is 3% for Tranche A and 5% for Tranche B. As ofApril 30, 2020, pursuant to the terms of the Promissory Note, the Company has collected $1,750,000. The Promissory Note final installmentof $1,250,000 from Tranche A is due September 17, 2020.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="657828.0" fact-concept="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 657,828 - pbsv-20200131.xml 1739</message>
 <ref href="pbsv-20200131.xml#element(/1/360)" sourceLine="1739">
  <property name="label" value="Comprehensive Income (Loss), Net of Tax, Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ComprehensiveIncomeNetOfTax"/>
  <property name="QName" value="us-gaap:ComprehensiveIncomeNetOfTax"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="657,828"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="4918.0" fact-concept="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 4,918 - pbsv-20200131.xml 1812</message>
 <ref href="pbsv-20200131.xml#element(/1/433)" sourceLine="1812">
  <property name="label" value="Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GainLossOnDispositionOfAssets"/>
  <property name="QName" value="us-gaap:GainLossOnDispositionOfAssets"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="4,918"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The functional currency of the Company&amp;#8217;..." fact-concept="{http://fasb.org/us-gaap/2024}ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The functional currency of the Company&amp;#8217;sforeign subsidiaries is its local currency. The assets and liabilities of the Company&amp;#8217;s foreign subsidiaries are translatedinto U.S. dollars at exchange rates in effect at the balance sheet date. Income and expense items are translated at the averageexchange rates prevailing during the period. The cumulative translation effect for subsidiaries using a functional currency otherthan the U.S. dollar is included as a cumulative translation adjustment in stockholders&amp;#8217; equity and as a component of comprehensiveincome.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s intercompany accounts aretypically denominated in the functional currency of the foreign subsidiary. Gains and losses resulting from the remeasurement ofintercompany receivables that the Company considers to be of a long-term investment nature are recorded as a cumulative translationadjustment in stockholders&amp;#8217; equity and as a component of comprehensive income, while gains and losses resulting from theremeasurement of intercompany receivables from those international subsidiaries for which the Company anticipates settlement inthe foreseeable future are recorded in the consolidated statements of operations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 2000</message>
 <ref href="pbsv-20200131.xml#element(/1/621)" sourceLine="2000">
  <property name="label" value="Foreign Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
  <property name="QName" value="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The functional currency of the Company&amp;#8217;sforeign subsidiaries is its local currency. The assets and liabilities of the Company&amp;#8217;s foreign subsidiaries are translatedinto U.S. dollars at exchange rates in effect at the balance sheet date. Income and expense items are translated at the averageexchange rates prevailing during the period. The cumulative translation effect for subsidiaries using a functional currency otherthan the U.S. dollar is included as a cumulative translation adjustment in stockholders&amp;#8217; equity and as a component of comprehensiveincome.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s intercompany accounts aretypically denominated in the functional currency of the foreign subsidiary. Gains and losses resulting from the remeasurement ofintercompany receivables that the Company considers to be of a long-term investment nature are recorded as a cumulative translationadjustment in stockholders&amp;#8217; equity and as a component of comprehensive income, while gains and losses resulting from theremeasurement of intercompany receivables from those international subsidiaries for which the Company anticipates settlement inthe foreseeable future are recorded in the consolidated statements of operations.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="155950.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 155,950 - pbsv-20200131.xml 1653</message>
 <ref href="pbsv-20200131.xml#element(/1/274)" sourceLine="1653">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="155,950"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1586</message>
 <ref href="pbsv-20200131.xml#element(/1/207)" sourceLine="1586">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>OnApri..." fact-concept="{http://fasb.org/us-gaap/2024}DebtDisclosureTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>OnApril 23, 2020, Pharma-PR, Pharma-Serv, and Pharma-US (collectively, the &amp;#8220;&lt;/font>Borrowers&lt;font style=&quot;background-color: white&quot;>&amp;#8221;)entered into loan agreements and related promissory notes (the &amp;#8220;&lt;/font>SBA Loan Documents&lt;font style=&quot;background-color: white&quot;>&amp;#8221;)to receive U.S. Small Business Administration Loans (the &amp;#8220;&lt;/font>SBA Loans&lt;font style=&quot;background-color: white&quot;>&amp;#8221;).These loans were originated pursuant to the Paycheck Protection Program (the &amp;#8220;&lt;/font>PPP&lt;font style=&quot;background-color: white&quot;>&amp;#8221;)established under the Coronavirus Aid, Relief, and Economic Security Act (the &amp;#8220;&lt;/font>CARES Act&lt;font style=&quot;background-color: white&quot;>&amp;#8221;),and in the aggregate amount of $1,931,700 (the &amp;#8220;&lt;/font>Loan Proceeds&lt;font style=&quot;background-color: white&quot;>&amp;#8221;). TheBorrowers received the Loan Proceeds on April 23, 2020. In accordance with the SBA Loan Documents, the SBA Loans (i) have afixed interest rate of 1%, (ii) begin repayment six months from the date of disbursement of each SBA Loan, and (iii)   mature two years from the date of first disbursement. These SBA Loans have  no prepayment penalty.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1888</message>
 <ref href="pbsv-20200131.xml#element(/1/509)" sourceLine="1888">
  <property name="label" value="C. LOANS"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DebtDisclosureTextBlock"/>
  <property name="QName" value="us-gaap:DebtDisclosureTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>OnApril 23, 2020, Pharma-PR, Pharma-Serv, and Pharma-US (collectively, the &amp;#8220;&lt;/font>Borrowers&lt;font style=&quot;background-color: white&quot;>&amp;#8221;)entered into loan agreements and related promissory notes (the &amp;#8220;&lt;/font>SBA Loan Documents&lt;font style=&quot;background-color: white&quot;>&amp;#8221;)to receive U.S. Small Business Administration Loans (the &amp;#8220;&lt;/font>SBA Loans&lt;font style=&quot;background-color: white&quot;>&amp;#8221;).These loans were originated pursuant to the Paycheck Protection Program (the &amp;#8220;&lt;/font>PPP&lt;font style=&quot;background-color: white&quot;>&amp;#8221;)established under the Coronavirus Aid, Relief, and Economic Security Act (the &amp;#8220;&lt;/font>CARES Act&lt;font style=&quot;background-color: white&quot;>&amp;#8221;),and in the aggregate amount of $1,931,700 (the &amp;#8220;&lt;/font>Loan Proceeds&lt;font style=&quot;background-color: white&quot;>&amp;#8221;). TheBorrowers received the Loan Proceeds on April 23, 2020. In accordance with the SBA Loan Documents, the SBA Loans (i) have afixed interest rate of 1%, (ii) begin repayment six months from the date of disbursement of each SBA Loan, and (iii)   mature two years from the date of first disbursement. These SBA Loans have  no prepayment penalty.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="26633075.0" fact-concept="{http://fasb.org/us-gaap/2024}Assets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 26,633,075 - pbsv-20200131.xml 1526</message>
 <ref href="pbsv-20200131.xml#element(/1/147)" sourceLine="1526">
  <property name="label" value="Assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Assets"/>
  <property name="QName" value="us-gaap:Assets"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="26,633,075"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.213" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.213 - pbsv-20200131.xml 1946</message>
 <ref href="pbsv-20200131.xml#element(/1/567)" sourceLine="1946">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_GlobalGroupAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.213"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23039.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,039 - pbsv-20200131.xml 1654</message>
 <ref href="pbsv-20200131.xml#element(/1/275)" sourceLine="1654">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,039"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1172994.0" fact-concept="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,172,994 - pbsv-20200131.xml 1741</message>
 <ref href="pbsv-20200131.xml#element(/1/362)" sourceLine="1741">
  <property name="label" value="Comprehensive Income (Loss), Net of Tax, Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ComprehensiveIncomeNetOfTax"/>
  <property name="QName" value="us-gaap:ComprehensiveIncomeNetOfTax"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,172,994"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s segments are based on the..." fact-concept="{http://fasb.org/us-gaap/2024}SegmentReportingDisclosureTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s segments are based on theorganizational structure for which financial results are regularly evaluated by the Company&amp;#8217;s chief operating decision makerto determine resource allocation and assess performance. Each reportable segment is managed by its own management team and reportsto executive management. The Company has three reportable segments: (i) Puerto Rico technical compliance consulting, (ii) UnitedStates technical compliance consulting, and (iii) Europe technical compliance consulting. These reportable segments provide servicesprimarily to the pharmaceutical, chemical, medical device and biotechnology industries in their respective markets.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The following table presents information aboutthe reported revenue from services and earnings from operations of the Company for the three-month and six-month periods endedin April 30, 2020 and 2019. There is no intersegment revenue for the mentioned periods. Corporate expenses that support the operatingunits have been allocated to the segments. Asset information by reportable segment is not presented, since the Company does notproduce such information internally, nor does it use such data to manage its business.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>Six months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>REVENUES:&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;width: 40%; text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>5,116,682&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>4,293,041&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>9,297,592&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>8,181,595&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>394,991&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>661,356&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>784,353&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,188,001&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>133,762&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>141,500&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>155,950&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>233,231&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,332&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>54,447&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>23,039&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>113,714&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>Total consolidated revenues&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,647,767&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,150,344&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>10,260,934&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>9,716,541&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>INCOME (LOSS) BEFORE TAXES:&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>633,633&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>581,019&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,150,772&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>956,289&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(41,887&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>14,230&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;vertical-align: bottom; text-align: right&quot;>(61,930&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,320&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>7,489&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(8,014&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(61,684&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(57,925&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>169,733&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>195,506&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>324,005&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>396,032&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 0.25in&quot;>Total consolidated income before taxes&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>768,968&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>782,741&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,351,163&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,296,716&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 12pt Times New Roman, Times, Serif; width: 100%&quot;>&lt;tr style=&quot;vertical-align: top&quot;>    &lt;td style=&quot;border-top: black 1pt solid; width: 2%; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#185;&lt;/font>&lt;/td>    &lt;td style=&quot;border-top: black 1pt solid; width: 98%; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>Other segments represent activities that fall below the reportable threshold and are carried out in Puerto Rico and Brazil. These activities include a Brazilian compliance consulting division and corporate headquarters, as applicable.&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Long lived assets (property and equipment) asof April 30, 2020 and October 31, 2019, and related depreciation and amortization expense for the three and six months ended April30, 2020 and 2019, were concentrated in the corporate headquarters in Puerto Rico. Accordingly, depreciation expense and acquisitionof property and equipment, as presented in the statements of cash flows are mainly related to the corporate headquarters.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 2005</message>
 <ref href="pbsv-20200131.xml#element(/1/626)" sourceLine="2005">
  <property name="label" value="I. SEGMENT DISCLOSURES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SegmentReportingDisclosureTextBlock"/>
  <property name="QName" value="us-gaap:SegmentReportingDisclosureTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s segments are based on theorganizational structure for which financial results are regularly evaluated by the Company&amp;#8217;s chief operating decision makerto determine resource allocation and assess performance. Each reportable segment is managed by its own management team and reportsto executive management. The Company has three reportable segments: (i) Puerto Rico technical compliance consulting, (ii) UnitedStates technical compliance consulting, and (iii) Europe technical compliance consulting. These reportable segments provide servicesprimarily to the pharmaceutical, chemical, medical device and biotechnology industries in their respective markets.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The following table presents information aboutthe reported revenue from services and earnings from operations of the Company for the three-month and six-month periods endedin April 30, 2020 and 2019. There is no intersegment revenue for the mentioned periods. Corporate expenses that support the operatingunits have been allocated to the segments. Asset information by reportable segment is not presented, since the Company does notproduce such information internally, nor does it use such data to manage its business.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>Six months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>REVENUES:&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;width: 40%; text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>5,116,682&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>4,293,041&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>9,297,592&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>8,181,595&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>394,991&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>661,356&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>784,353&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,188,001&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>133,762&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>141,500&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>155,950&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>233,231&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,332&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>54,447&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>23,039&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>113,714&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>Total consolidated revenues&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,647,767&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,150,344&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>10,260,934&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>9,716,541&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>INCOME (LOSS) BEFORE TAXES:&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>633,633&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>581,019&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,150,772&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>956,289&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(41,887&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>14,230&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;vertical-align: bottom; text-align: right&quot;>(61,930&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,320&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>7,489&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(8,014&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(61,684&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(57,925&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>169,733&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>195,506&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>324,005&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>396,032&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 0.25in&quot;>Total consolidated income before taxes&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>768,968&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>782,741&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,351,163&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,296,716&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 12pt Times New Roman, Times, Serif; width: 100%&quot;>&lt;tr style=&quot;vertical-align: top&quot;>    &lt;td style=&quot;border-top: black 1pt solid; width: 2%; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#185;&lt;/font>&lt;/td>    &lt;td style=&quot;border-top: black 1pt solid; width: 98%; text-align: justify&quot;>&lt;font style=&quot;font-size: 8pt&quot;>Other segments represent activities that fall below the reportable threshold and are carried out in Puerto Rico and Brazil. These activities include a Brazilian compliance consulting division and corporate headquarters, as applicable.&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Long lived assets (property and equipment) asof April 30, 2020 and October 31, 2019, and related depreciation and amortization expense for the three and six months ended April30, 2020 and 2019, were concentrated in the corporate headquarters in Puerto Rico. Accordingly, depreciation expense and acquisitionof property and equipment, as presented in the statements of cash flows are mainly related to the corporate headquarters.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="47392.0" fact-concept="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 47,392 - pbsv-20200131.xml 1811</message>
 <ref href="pbsv-20200131.xml#element(/1/432)" sourceLine="1811">
  <property name="label" value="Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GainLossOnDispositionOfAssets"/>
  <property name="QName" value="us-gaap:GainLossOnDispositionOfAssets"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="47,392"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="874840.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingLeaseRightOfUseAsset" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 874,840 - pbsv-20200131.xml 1529</message>
 <ref href="pbsv-20200131.xml#element(/1/150)" sourceLine="1529">
  <property name="label" value="Operating lease right-of-use"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingLeaseRightOfUseAsset"/>
  <property name="QName" value="us-gaap:OperatingLeaseRightOfUseAsset"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="874,840"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1381076.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,381,076 - pbsv-20200131.xml 1587</message>
 <ref href="pbsv-20200131.xml#element(/1/208)" sourceLine="1587">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,381,076"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="8181595.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 8,181,595 - pbsv-20200131.xml 1655</message>
 <ref href="pbsv-20200131.xml#element(/1/276)" sourceLine="1655">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="8,181,595"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The following data shows the amounts used in..." fact-concept="{http://fasb.org/us-gaap/2024}EarningsPerShareTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The following data shows the amounts used inthe calculations of basic and diluted earnings per share.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 12pt Times New Roman, Times, Serif; width: 100%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Six months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;width: 56%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Net income available to common equity holders - used to compute&amp;#160;basic and diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$687,561&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$707,483&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,214,461&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,178,503&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of common shares - used to compute basic earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,001,627&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,903&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,745&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,032,107&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Effect of options to purchase common stock&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;27,576&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;66,020&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,213&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;73,059&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of shares - used to compute diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,029,203&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,068,923&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,025,958&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,105,166&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>For the three-month and six-month periods endedApril 30, 2020, options for the purchase of shares of 340,000 common stock were not considered in computing diluted earnings pershare because the effect was antidilutive. In addition, warrants and options for the purchase of 1,000,000 and 80,000 shares ofcommon stock, respectively, for the three-month and six-month periods ended April 30, 2019, were not included in computing dilutedearnings per share because their effects were also antidilutive.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1891</message>
 <ref href="pbsv-20200131.xml#element(/1/512)" sourceLine="1891">
  <property name="label" value="F. EARNINGS (LOSSES) PER SHARE"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="EarningsPerShareTextBlock"/>
  <property name="QName" value="us-gaap:EarningsPerShareTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The following data shows the amounts used inthe calculations of basic and diluted earnings per share.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 12pt Times New Roman, Times, Serif; width: 100%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Six months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;width: 56%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Net income available to common equity holders - used to compute&amp;#160;basic and diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$687,561&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$707,483&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,214,461&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,178,503&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of common shares - used to compute basic earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,001,627&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,903&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,745&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,032,107&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Effect of options to purchase common stock&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;27,576&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;66,020&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,213&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;73,059&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of shares - used to compute diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,029,203&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,068,923&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,025,958&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,105,166&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;/table>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>For the three-month and six-month periods endedApril 30, 2020, options for the purchase of shares of 340,000 common stock were not considered in computing diluted earnings pershare because the effect was antidilutive. In addition, warrants and options for the purchase of 1,000,000 and 80,000 shares ofcommon stock, respectively, for the three-month and six-month periods ended April 30, 2019, were not included in computing dilutedearnings per share because their effects were also antidilutive.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Certain reclassifications have been made tot..." fact-concept="{http://fasb.org/us-gaap/2024}PriorPeriodReclassificationAdjustmentDescription" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Certain reclassifications have been made tothe April 30, 2019 condensed consolidated financial statements to conform them to the April 30, 2020 condensed consolidated financialstatements presentation. Such reclassifications do not affect net income as previously reported.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 2002</message>
 <ref href="pbsv-20200131.xml#element(/1/623)" sourceLine="2002">
  <property name="label" value="Reclassifications"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PriorPeriodReclassificationAdjustmentDescription"/>
  <property name="QName" value="us-gaap:PriorPeriodReclassificationAdjustmentDescription"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Certain reclassifications have been made tothe April 30, 2019 condensed consolidated financial statements to conform them to the April 30, 2020 condensed consolidated financialstatements presentation. Such reclassifications do not affect net income as previously reported.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.149" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.149 - pbsv-20200131.xml 1947</message>
 <ref href="pbsv-20200131.xml#element(/1/568)" sourceLine="1947">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_GlobalGroupBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.149"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1188001.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,188,001 - pbsv-20200131.xml 1656</message>
 <ref href="pbsv-20200131.xml#element(/1/277)" sourceLine="1656">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,188,001"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>OnDece..." fact-concept="{http://fasb.org/us-gaap/2024}DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>OnDecember 2014, the Company entered into a stock warrant agreement with a firm in exchange for providing (i) businessdevelopment and (ii) mergers and acquisition services to the Company. The Company warrants for the purchase of 1,000,000common shares issued to this firm expired on December 1, 2019 without being exercised.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 1890</message>
 <ref href="pbsv-20200131.xml#element(/1/511)" sourceLine="1890">
  <property name="label" value="E. WARRANTS"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
  <property name="QName" value="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>OnDecember 2014, the Company entered into a stock warrant agreement with a firm in exchange for providing (i) businessdevelopment and (ii) mergers and acquisition services to the Company. The Company warrants for the purchase of 1,000,000common shares issued to this firm expired on December 1, 2019 without being exercised.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="19473069.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 19,473,069 - pbsv-20200131.xml 1588</message>
 <ref href="pbsv-20200131.xml#element(/1/209)" sourceLine="1588">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="19,473,069"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="684216.0" fact-concept="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 684,216 - pbsv-20200131.xml 1740</message>
 <ref href="pbsv-20200131.xml#element(/1/361)" sourceLine="1740">
  <property name="label" value="Comprehensive Income (Loss), Net of Tax, Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ComprehensiveIncomeNetOfTax"/>
  <property name="QName" value="us-gaap:ComprehensiveIncomeNetOfTax"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="684,216"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="233231.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 233,231 - pbsv-20200131.xml 1657</message>
 <ref href="pbsv-20200131.xml#element(/1/278)" sourceLine="1657">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="233,231"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Cash and cash equivalents&lt;/b>&lt;/p>&lt;p styl..." fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskDisclosureTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Cash and cash equivalents&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s domestic cash and cash equivalentsconsist of cash deposits in FDIC insured banks (substantially covered by FDIC insurance by the spread of deposits in multiple FDICinsured banks), a money market obligations trust registered under the US Investment Company Act of 1940, as amended, and U.S. Treasurysecurities with maturities of three months or less. In the foreign markets we serve, we also maintain cash deposits in foreignbanks, which have no specific insurance. No losses have been experienced or are expected on these accounts.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Accounts receivable and revenues&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Management deems all of its accounts receivableto be fully collectible, and, as such, does not maintain any allowances for uncollectible receivables.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company's revenues, and the related receivables,are concentrated in the pharmaceutical industry in Puerto Rico, the United States, Ireland, Spain and Brazil. Although a few customersrepresent a significant source of revenue, the Company&amp;#8217;s functions are not a continuous process, accordingly, the clientbase for which the services are typically rendered, on a project-by-project basis, changes regularly.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company provided a substantial portion ofits services to five customers, which accounted for 10% or more of its revenues in either of the three-month and six-month periodsended April 30, 2020 and 2019. During the three months ended April 30, 2020, revenues from these customers were 24.9%, 9.3%, 14.6%,11.8% and 7.6%, or a total of 68.2%, as compared to the same period last year of 0.0%, 11.1%, 9.9%, 12.2% and 26.6%, or a totalof 59.8%, respectively. During the six months ended April 30, 2020, revenues from these customers were 21.3%, 12.1%, 14.6%, 10.6%and 10.1%, or a total of 68.7%, as compared to the same period last year of 0.0%, 7.3%, 10.5%, 11.6% and 22.2%, or a total of 51.6%,respectively. At April 30, 2020, amounts due from these customers represented 85.2% of the Company&amp;#8217;s total accounts receivablebalance. This customer information is based on revenues earned from said customers at the segment level because in management&amp;#8217;sopinion contracts by segments are totally independent of each other, and therefore such information is more meaningful to the reader.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>At the global level, five global groups of affiliatedcompanies accounted for 10% or more of its revenues in either of the three-month and six-month periods ended April 30, 2020 and2019. During the three months ended April 30, 2020, aggregate revenues from these global groups of affiliated companies were 24.9%,11.9%, 14.6%, 11.8%, and 7.6%, or a total of 70.8%, as compared to the same period last year for 0.0%, 14.2%, 9.9%, 12.2%, and26.6%, or a total of 62.9%, respectively. During the six months ended April 30, 2020, aggregate revenues from these global groupof affiliated companies were 21.3%, 14.9%, 14.6%, 10.6% and 10.1%, or a total of 71.5%, as compared to the same period last yearfor 0.0%, 10.7%, 10.5%, 11.6% and 22.2%, or a total of 55.0%, respectively. At April 30, 2020, amounts due from these global groupsof affiliated companies represented 86.1% of total accounts receivable balance.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>Asof April 30, 2020, one of the Company&amp;#8217;s customers (representing 10.2% of revenues during the six months ended April 30,2020) owes the Company approximately $5.3 million (including $1.25 million from a Promissory Note due September 2020). Thisoutstanding obligation represents approximately 21.6% of the Company&amp;#8217;s total working capital. The Company is providingmultiple services to this customer related to their construction and validation of a manufacturing facility in Puerto Rico. A significant portion of thecustomer&amp;#8217;s funding comes from different financing sources. Management estimates that collectability of the account isreasonably assured, accordingly, no provision for losses, if any, have been recorded in the financial statements.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 2007</message>
 <ref href="pbsv-20200131.xml#element(/1/628)" sourceLine="2007">
  <property name="label" value="H. CONCENTRATIONS OF RISK"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskDisclosureTextBlock"/>
  <property name="QName" value="us-gaap:ConcentrationRiskDisclosureTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Cash and cash equivalents&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company&amp;#8217;s domestic cash and cash equivalentsconsist of cash deposits in FDIC insured banks (substantially covered by FDIC insurance by the spread of deposits in multiple FDICinsured banks), a money market obligations trust registered under the US Investment Company Act of 1940, as amended, and U.S. Treasurysecurities with maturities of three months or less. In the foreign markets we serve, we also maintain cash deposits in foreignbanks, which have no specific insurance. No losses have been experienced or are expected on these accounts.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>Accounts receivable and revenues&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Management deems all of its accounts receivableto be fully collectible, and, as such, does not maintain any allowances for uncollectible receivables.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company's revenues, and the related receivables,are concentrated in the pharmaceutical industry in Puerto Rico, the United States, Ireland, Spain and Brazil. Although a few customersrepresent a significant source of revenue, the Company&amp;#8217;s functions are not a continuous process, accordingly, the clientbase for which the services are typically rendered, on a project-by-project basis, changes regularly.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>The Company provided a substantial portion ofits services to five customers, which accounted for 10% or more of its revenues in either of the three-month and six-month periodsended April 30, 2020 and 2019. During the three months ended April 30, 2020, revenues from these customers were 24.9%, 9.3%, 14.6%,11.8% and 7.6%, or a total of 68.2%, as compared to the same period last year of 0.0%, 11.1%, 9.9%, 12.2% and 26.6%, or a totalof 59.8%, respectively. During the six months ended April 30, 2020, revenues from these customers were 21.3%, 12.1%, 14.6%, 10.6%and 10.1%, or a total of 68.7%, as compared to the same period last year of 0.0%, 7.3%, 10.5%, 11.6% and 22.2%, or a total of 51.6%,respectively. At April 30, 2020, amounts due from these customers represented 85.2% of the Company&amp;#8217;s total accounts receivablebalance. This customer information is based on revenues earned from said customers at the segment level because in management&amp;#8217;sopinion contracts by segments are totally independent of each other, and therefore such information is more meaningful to the reader.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>At the global level, five global groups of affiliatedcompanies accounted for 10% or more of its revenues in either of the three-month and six-month periods ended April 30, 2020 and2019. During the three months ended April 30, 2020, aggregate revenues from these global groups of affiliated companies were 24.9%,11.9%, 14.6%, 11.8%, and 7.6%, or a total of 70.8%, as compared to the same period last year for 0.0%, 14.2%, 9.9%, 12.2%, and26.6%, or a total of 62.9%, respectively. During the six months ended April 30, 2020, aggregate revenues from these global groupof affiliated companies were 21.3%, 14.9%, 14.6%, 10.6% and 10.1%, or a total of 71.5%, as compared to the same period last yearfor 0.0%, 10.7%, 10.5%, 11.6% and 22.2%, or a total of 55.0%, respectively. At April 30, 2020, amounts due from these global groupsof affiliated companies represented 86.1% of total accounts receivable balance.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;font style=&quot;background-color: white&quot;>Asof April 30, 2020, one of the Company&amp;#8217;s customers (representing 10.2% of revenues during the six months ended April 30,2020) owes the Company approximately $5.3 million (including $1.25 million from a Promissory Note due September 2020). Thisoutstanding obligation represents approximately 21.6% of the Company&amp;#8217;s total working capital. The Company is providingmultiple services to this customer related to their construction and validation of a manufacturing facility in Puerto Rico. A significant portion of thecustomer&amp;#8217;s funding comes from different financing sources. Management estimates that collectability of the account isreasonably assured, accordingly, no provision for losses, if any, have been recorded in the financial statements.&lt;/font>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="47392.0" fact-concept="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 47,392 - pbsv-20200131.xml 1813</message>
 <ref href="pbsv-20200131.xml#element(/1/434)" sourceLine="1813">
  <property name="label" value="Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GainLossOnDispositionOfAssets"/>
  <property name="QName" value="us-gaap:GainLossOnDispositionOfAssets"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="47,392"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="367437.0" fact-concept="{http://fasb.org/us-gaap/2024}OtherAssetsNoncurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 367,437 - pbsv-20200131.xml 1528</message>
 <ref href="pbsv-20200131.xml#element(/1/149)" sourceLine="1528">
  <property name="label" value="Other assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OtherAssetsNoncurrent"/>
  <property name="QName" value="us-gaap:OtherAssetsNoncurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="367,437"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.146" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.146 - pbsv-20200131.xml 1948</message>
 <ref href="pbsv-20200131.xml#element(/1/569)" sourceLine="1948">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_GlobalGroupCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.146"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="143600.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 143,600 - pbsv-20200131.xml 1589</message>
 <ref href="pbsv-20200131.xml#element(/1/210)" sourceLine="1589">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="143,600"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="113714.0" fact-concept="{http://fasb.org/us-gaap/2024}Revenues" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 113,714 - pbsv-20200131.xml 1658</message>
 <ref href="pbsv-20200131.xml#element(/1/279)" sourceLine="1658">
  <property name="label" value="REVENUES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="Revenues"/>
  <property name="QName" value="us-gaap:Revenues"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="113,714"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1163078.0" fact-concept="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,163,078 - pbsv-20200131.xml 1742</message>
 <ref href="pbsv-20200131.xml#element(/1/363)" sourceLine="1742">
  <property name="label" value="Comprehensive Income (Loss), Net of Tax, Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ComprehensiveIncomeNetOfTax"/>
  <property name="QName" value="us-gaap:ComprehensiveIncomeNetOfTax"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,163,078"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-15548.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -15,548 - pbsv-20200131.xml 1814</message>
 <ref href="pbsv-20200131.xml#element(/1/435)" sourceLine="1814">
  <property name="label" value="Net Cash Provided by (Used in) Investing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-15,548"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23373817.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,373,817 - pbsv-20200131.xml 1743</message>
 <ref href="pbsv-20200131.xml#element(/1/364)" sourceLine="1743">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,373,817"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3778867.0" fact-concept="{http://fasb.org/us-gaap/2024}CostOfRevenue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3,778,867 - pbsv-20200131.xml 1659</message>
 <ref href="pbsv-20200131.xml#element(/1/280)" sourceLine="1659">
  <property name="label" value="COST OF SERVICES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CostOfRevenue"/>
  <property name="QName" value="us-gaap:CostOfRevenue"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3,778,867"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In February 2016, the FASB issued ASU 2016-02..." fact-concept="{http://fasb.org/us-gaap/2024}NewAccountingPronouncementsPolicyPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In February 2016, the FASB issued ASU 2016-02,Leases (Topic 842) (&amp;#8220;ASU 2016-02&amp;#8221;). ASU 2016-02 is intended to increase transparency and comparability of accountingfor lease transactions. For all leases with terms greater than twelve months, the new guidance will require lessees to recognizeright-of-use assets and corresponding lease liabilities on the balance sheet and to disclose qualitative and quantitative informationabout lease transactions. The new standard maintains a distinction between finance leases and operating leases. As a result, theeffect of leases in the statement of operations and statement of cash flows is largely unchanged. In July 2018, the FASB issuedASU 2018-11, Leases - Targeted Improvements, to allow a company to elect an optional modified retrospective transition method thatapplies the new lease requirements through a cumulative-effect adjustment in the period of adoption.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Effective November 1, 2019, the Company adoptedthe new lease accounting standard using the modified retrospective transition option of applying the new standard at the adoptiondate. We categorize leases at their inception as either operating or finance leases. The Company leases include an operationallease for office space and a finance lease agreement for a vehicle. The adoption of the new standard resulted in the operatinglease being included in operating lease right-of-use assets, current operating lease liabilities, and long-term operating leaseliabilities in our condensed consolidated balance sheets, but did not have an impact on the Company&amp;#8217;s beginning balance ofretained earnings, consolidated statement of operations or statement of cash flows. Finance leases are included in net propertyand equipment, current installments of long-term debt, and long-term debt in our condensed consolidated balance sheets. The mostsignificant impact was the recognition of right-of-use assets and lease liabilities on account of the Company&amp;#8217;s operatingleases. The Company recognized $941,009 of right-of-use assets and $911,922 in operating lease liabilities at November 1, 2019.As of April 30, 2020, the total right-of-use assets related to the Company&amp;#8217;s operating leases was $874,840 and operatinglease liabilities current and non-current were approximately $156,496 and $696,916, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 2003</message>
 <ref href="pbsv-20200131.xml#element(/1/624)" sourceLine="2003">
  <property name="label" value="Recently Adopted Accounting Pronouncements"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NewAccountingPronouncementsPolicyPolicyTextBlock"/>
  <property name="QName" value="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>In February 2016, the FASB issued ASU 2016-02,Leases (Topic 842) (&amp;#8220;ASU 2016-02&amp;#8221;). ASU 2016-02 is intended to increase transparency and comparability of accountingfor lease transactions. For all leases with terms greater than twelve months, the new guidance will require lessees to recognizeright-of-use assets and corresponding lease liabilities on the balance sheet and to disclose qualitative and quantitative informationabout lease transactions. The new standard maintains a distinction between finance leases and operating leases. As a result, theeffect of leases in the statement of operations and statement of cash flows is largely unchanged. In July 2018, the FASB issuedASU 2018-11, Leases - Targeted Improvements, to allow a company to elect an optional modified retrospective transition method thatapplies the new lease requirements through a cumulative-effect adjustment in the period of adoption.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Effective November 1, 2019, the Company adoptedthe new lease accounting standard using the modified retrospective transition option of applying the new standard at the adoptiondate. We categorize leases at their inception as either operating or finance leases. The Company leases include an operationallease for office space and a finance lease agreement for a vehicle. The adoption of the new standard resulted in the operatinglease being included in operating lease right-of-use assets, current operating lease liabilities, and long-term operating leaseliabilities in our condensed consolidated balance sheets, but did not have an impact on the Company&amp;#8217;s beginning balance ofretained earnings, consolidated statement of operations or statement of cash flows. Finance leases are included in net propertyand equipment, current installments of long-term debt, and long-term debt in our condensed consolidated balance sheets. The mostsignificant impact was the recognition of right-of-use assets and lease liabilities on account of the Company&amp;#8217;s operatingleases. The Company recognized $941,009 of right-of-use assets and $911,922 in operating lease liabilities at November 1, 2019.As of April 30, 2020, the total right-of-use assets related to the Company&amp;#8217;s operating leases was $874,840 and operatinglease liabilities current and non-current were approximately $156,496 and $696,916, respectively.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-392579.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -392,579 - pbsv-20200131.xml 1590</message>
 <ref href="pbsv-20200131.xml#element(/1/211)" sourceLine="1590">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-392,579"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingLeaseRightOfUseAsset" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1530</message>
 <ref href="pbsv-20200131.xml#element(/1/151)" sourceLine="1530">
  <property name="label" value="Operating lease right-of-use"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingLeaseRightOfUseAsset"/>
  <property name="QName" value="us-gaap:OperatingLeaseRightOfUseAsset"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.106" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.106 - pbsv-20200131.xml 1949</message>
 <ref href="pbsv-20200131.xml#element(/1/570)" sourceLine="1949">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_GlobalGroupDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.106"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="604669.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 604,669 - pbsv-20200131.xml 1817</message>
 <ref href="pbsv-20200131.xml#element(/1/438)" sourceLine="1817">
  <property name="label" value="Net Cash Provided by (Used in) Investing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="604,669"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1868900.0" fact-concept="{http://fasb.org/us-gaap/2024}GrossProfit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,868,900 - pbsv-20200131.xml 1663</message>
 <ref href="pbsv-20200131.xml#element(/1/284)" sourceLine="1663">
  <property name="label" value="Gross Profit"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GrossProfit"/>
  <property name="QName" value="us-gaap:GrossProfit"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,868,900"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1746</message>
 <ref href="pbsv-20200131.xml#element(/1/367)" sourceLine="1746">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="481325.0" fact-concept="{http://fasb.org/us-gaap/2024}AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 481,325 - pbsv-20200131.xml 1892</message>
 <ref href="pbsv-20200131.xml#element(/1/513)" sourceLine="1892">
  <property name="label" value="Accumulated depreciation and amortization"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="481,325"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2340.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,340 - pbsv-20200131.xml 1591</message>
 <ref href="pbsv-20200131.xml#element(/1/212)" sourceLine="1591">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,340"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-26874.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -26,874 - pbsv-20200131.xml 1816</message>
 <ref href="pbsv-20200131.xml#element(/1/437)" sourceLine="1816">
  <property name="label" value="Net Cash Provided by (Used in) Investing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-26,874"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="6644079.0" fact-concept="{http://fasb.org/us-gaap/2024}CostOfRevenue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 6,644,079 - pbsv-20200131.xml 1662</message>
 <ref href="pbsv-20200131.xml#element(/1/283)" sourceLine="1662">
  <property name="label" value="COST OF SERVICES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CostOfRevenue"/>
  <property name="QName" value="us-gaap:CostOfRevenue"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="6,644,079"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23397707.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,397,707 - pbsv-20200131.xml 1745</message>
 <ref href="pbsv-20200131.xml#element(/1/366)" sourceLine="1745">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2019-10-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,397,707"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="27576.0" fact-concept="{http://fasb.org/us-gaap/2024}IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 27,576 - pbsv-20200131.xml 1894</message>
 <ref href="pbsv-20200131.xml#element(/1/515)" sourceLine="1894">
  <property name="label" value="Effect of options to purchase common stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="QName" value="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="27,576"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>On June 13, 2014, the Board of Directors oft..." fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquityNoteDisclosureTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>On June 13, 2014, the Board of Directors ofthe Company authorized the Company to repurchase up to two million shares of its outstanding common stock (the &amp;#8220;RepurchaseProgram&amp;#8221;). The timing, manner, price and amount of any repurchases under the Repurchase Program will be at the discretionof the Company, subject to the requirements of the Securities Exchange Act of 1934, as amended, and related rules. The RepurchaseProgram does not oblige the Company to repurchase any shares and it may be modified, suspended or terminated at any time and forany reason. No shares will be repurchased under the Repurchase Program directly from directors or officers of the Company. As ofApril 30, 2020 and October 31, 2019, a total of 341,154 and 338,854 shares of the Company&amp;#8217;s common stock were purchased underthe Repurchase Program for an aggregate amount of $331,306 and $329,607, respectively. During April 2020, the Company suspended purchases under the Repurchase Program to conserve cash due to the economic uncertaintycaused by the coronavirus pandemic. Also, on November 26, 2018, the Companyrepurchased 62,972 shares of common stock, outside of the Repurchase Program, from the Company&amp;#8217;s Chief Executive Officerat $1.00 per share. These shares were repurchased at a discount to market to provide for an orderly disposition of the shares.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p> - pbsv-20200131.xml 2004</message>
 <ref href="pbsv-20200131.xml#element(/1/625)" sourceLine="2004">
  <property name="label" value="G. EQUITY TRANSACTIONS"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquityNoteDisclosureTextBlock"/>
  <property name="QName" value="us-gaap:StockholdersEquityNoteDisclosureTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>On June 13, 2014, the Board of Directors ofthe Company authorized the Company to repurchase up to two million shares of its outstanding common stock (the &amp;#8220;RepurchaseProgram&amp;#8221;). The timing, manner, price and amount of any repurchases under the Repurchase Program will be at the discretionof the Company, subject to the requirements of the Securities Exchange Act of 1934, as amended, and related rules. The RepurchaseProgram does not oblige the Company to repurchase any shares and it may be modified, suspended or terminated at any time and forany reason. No shares will be repurchased under the Repurchase Program directly from directors or officers of the Company. As ofApril 30, 2020 and October 31, 2019, a total of 341,154 and 338,854 shares of the Company&amp;#8217;s common stock were purchased underthe Repurchase Program for an aggregate amount of $331,306 and $329,607, respectively. During April 2020, the Company suspended purchases under the Repurchase Program to conserve cash due to the economic uncertaintycaused by the coronavirus pandemic. Also, on November 26, 2018, the Companyrepurchased 62,972 shares of common stock, outside of the Repurchase Program, from the Company&amp;#8217;s Chief Executive Officerat $1.00 per share. These shares were repurchased at a discount to market to provide for an orderly disposition of the shares.&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&amp;#160;&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.101" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.101 - pbsv-20200131.xml 1950</message>
 <ref href="pbsv-20200131.xml#element(/1/571)" sourceLine="1950">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_GlobalGroupEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.101"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2341.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,341 - pbsv-20200131.xml 1592</message>
 <ref href="pbsv-20200131.xml#element(/1/213)" sourceLine="1592">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,341"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="6806142.0" fact-concept="{http://fasb.org/us-gaap/2024}CostOfRevenue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 6,806,142 - pbsv-20200131.xml 1661</message>
 <ref href="pbsv-20200131.xml#element(/1/282)" sourceLine="1661">
  <property name="label" value="COST OF SERVICES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CostOfRevenue"/>
  <property name="QName" value="us-gaap:CostOfRevenue"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="6,806,142"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="27141700.0" fact-concept="{http://fasb.org/us-gaap/2024}AssetsCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 27,141,700 - pbsv-20200131.xml 1533</message>
 <ref href="pbsv-20200131.xml#element(/1/154)" sourceLine="1533">
  <property name="label" value="Assets, Current"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AssetsCurrent"/>
  <property name="QName" value="us-gaap:AssetsCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="27,141,700"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="563277.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 563,277 - pbsv-20200131.xml 1815</message>
 <ref href="pbsv-20200131.xml#element(/1/436)" sourceLine="1815">
  <property name="label" value="Net Cash Provided by (Used in) Investing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="563,277"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 12pt Times New Roman, Times, Serif; width: 100%&quot;>&lt;tr style=&quot;vertical-align:..." fact-concept="{http://fasb.org/us-gaap/2024}ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 12pt Times New Roman, Times, Serif; width: 100%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Six months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;width: 56%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Net income available to common equity holders - used to compute&amp;#160;basic and diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$687,561&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$707,483&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,214,461&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,178,503&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of common shares - used to compute basic earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,001,627&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,903&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,745&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,032,107&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Effect of options to purchase common stock&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;27,576&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;66,020&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,213&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;73,059&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of shares - used to compute diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,029,203&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,068,923&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,025,958&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,105,166&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;/table> - pbsv-20200131.xml 2006</message>
 <ref href="pbsv-20200131.xml#element(/1/627)" sourceLine="2006">
  <property name="label" value="Schedule of calculations of basic and diluted earnings (losses) per share"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
  <property name="QName" value="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font: 12pt Times New Roman, Times, Serif; width: 100%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td colspan=&quot;2&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Six months&amp;#160;ended April 30,&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;width: 56%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>    &lt;td style=&quot;width: 11%&quot;>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>        &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Net income available to common equity holders - used to compute&amp;#160;basic and diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$687,561&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$707,483&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,214,461&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;$1,178,503&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>    &lt;td>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of common shares - used to compute basic earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,001,627&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,903&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,002,745&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,032,107&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: white&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Effect of options to purchase common stock&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;27,576&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;66,020&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,213&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;73,059&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: #CCEEFF&quot;>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>Weighted average number of shares - used to compute diluted earnings per share&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,029,203&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,068,923&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,025,958&amp;#160;&lt;/font>&lt;/td>    &lt;td>&lt;font style=&quot;font-size: 8pt&quot;>&amp;#160;&amp;#160;23,105,166&amp;#160;&lt;/font>&lt;/td>&lt;/tr>&lt;/table>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="290658.0" fact-concept="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentNet" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 290,658 - pbsv-20200131.xml 1532</message>
 <ref href="pbsv-20200131.xml#element(/1/153)" sourceLine="1532">
  <property name="label" value="Property and equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PropertyPlantAndEquipmentNet"/>
  <property name="QName" value="us-gaap:PropertyPlantAndEquipmentNet"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="290,658"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1744</message>
 <ref href="pbsv-20200131.xml#element(/1/365)" sourceLine="1744">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2018-10-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="340000.0" fact-concept="{http://fasb.org/us-gaap/2024}AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 340,000 - pbsv-20200131.xml 1898</message>
 <ref href="pbsv-20200131.xml#element(/1/519)" sourceLine="1898">
  <property name="label" value="Antidilutive options excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="QName" value="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="340,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.715" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.715 - pbsv-20200131.xml 1951</message>
 <ref href="pbsv-20200131.xml#element(/1/572)" sourceLine="1951">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_GlobalGroupTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.715"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1593</message>
 <ref href="pbsv-20200131.xml#element(/1/214)" sourceLine="1593">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3556942.0" fact-concept="{http://fasb.org/us-gaap/2024}CostOfRevenue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3,556,942 - pbsv-20200131.xml 1660</message>
 <ref href="pbsv-20200131.xml#element(/1/281)" sourceLine="1660">
  <property name="label" value="COST OF SERVICES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CostOfRevenue"/>
  <property name="QName" value="us-gaap:CostOfRevenue"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3,556,942"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromCollectionOfOtherReceivables" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1818</message>
 <ref href="pbsv-20200131.xml#element(/1/439)" sourceLine="1818">
  <property name="label" value="Collection from promissory note receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromCollectionOfOtherReceivables"/>
  <property name="QName" value="us-gaap:ProceedsFromCollectionOfOtherReceivables"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23397707.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,397,707 - pbsv-20200131.xml 1747</message>
 <ref href="pbsv-20200131.xml#element(/1/368)" sourceLine="1747">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,397,707"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="509275.0" fact-concept="{http://fasb.org/us-gaap/2024}AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 509,275 - pbsv-20200131.xml 1893</message>
 <ref href="pbsv-20200131.xml#element(/1/514)" sourceLine="1893">
  <property name="label" value="Accumulated depreciation and amortization"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="509,275"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1594</message>
 <ref href="pbsv-20200131.xml#element(/1/215)" sourceLine="1594">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23405753.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,405,753 - pbsv-20200131.xml 1748</message>
 <ref href="pbsv-20200131.xml#element(/1/369)" sourceLine="1748">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,405,753"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="12000.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromSaleOfPropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 12,000 - pbsv-20200131.xml 1822</message>
 <ref href="pbsv-20200131.xml#element(/1/443)" sourceLine="1822">
  <property name="label" value="Proceeds from sale of property and equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="12,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Ti..." fact-concept="{http://pharmabioserv.com/20241231}RecentAccountingPronouncementsPolicyTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Recent accounting pronouncements pending adoptionnot discussed above or in the 2019 Form 10-K are either not applicable or will not have or are not expected to have a materialimpact on us.&lt;/p> - pbsv-20200131.xml 2008</message>
 <ref href="pbsv-20200131.xml#element(/1/629)" sourceLine="2008">
  <property name="label" value="Recent Accounting Pronouncements"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="RecentAccountingPronouncementsPolicyTextBlock"/>
  <property name="QName" value="PBSV:RecentAccountingPronouncementsPolicyTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>&lt;b>&lt;/b>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify&quot;>Recent accounting pronouncements pending adoptionnot discussed above or in the 2019 Form 10-K are either not applicable or will not have or are not expected to have a materialimpact on us.&lt;/p>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="332722.0" fact-concept="{http://fasb.org/us-gaap/2024}PrepaidExpenseAndOtherAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 332,722 - pbsv-20200131.xml 1535</message>
 <ref href="pbsv-20200131.xml#element(/1/156)" sourceLine="1535">
  <property name="label" value="Prepaids and other assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PrepaidExpenseAndOtherAssets"/>
  <property name="QName" value="us-gaap:PrepaidExpenseAndOtherAssets"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="332,722"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3072462.0" fact-concept="{http://fasb.org/us-gaap/2024}GrossProfit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3,072,462 - pbsv-20200131.xml 1666</message>
 <ref href="pbsv-20200131.xml#element(/1/287)" sourceLine="1666">
  <property name="label" value="Gross Profit"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GrossProfit"/>
  <property name="QName" value="us-gaap:GrossProfit"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3,072,462"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="73059.0" fact-concept="{http://fasb.org/us-gaap/2024}IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 73,059 - pbsv-20200131.xml 1897</message>
 <ref href="pbsv-20200131.xml#element(/1/518)" sourceLine="1897">
  <property name="label" value="Effect of options to purchase common stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="QName" value="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="73,059"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1952</message>
 <ref href="pbsv-20200131.xml#element(/1/573)" sourceLine="1952">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_GlobalGroupAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.00"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1749</message>
 <ref href="pbsv-20200131.xml#element(/1/370)" sourceLine="1749">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="500000.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromCollectionOfOtherReceivables" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 500,000 - pbsv-20200131.xml 1821</message>
 <ref href="pbsv-20200131.xml#element(/1/442)" sourceLine="1821">
  <property name="label" value="Collection from promissory note receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromCollectionOfOtherReceivables"/>
  <property name="QName" value="us-gaap:ProceedsFromCollectionOfOtherReceivables"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="500,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1364956.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,364,956 - pbsv-20200131.xml 1595</message>
 <ref href="pbsv-20200131.xml#element(/1/216)" sourceLine="1595">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,364,956"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3454792.0" fact-concept="{http://fasb.org/us-gaap/2024}GrossProfit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3,454,792 - pbsv-20200131.xml 1665</message>
 <ref href="pbsv-20200131.xml#element(/1/286)" sourceLine="1665">
  <property name="label" value="Gross Profit"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GrossProfit"/>
  <property name="QName" value="us-gaap:GrossProfit"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3,454,792"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23213.0" fact-concept="{http://fasb.org/us-gaap/2024}IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,213 - pbsv-20200131.xml 1896</message>
 <ref href="pbsv-20200131.xml#element(/1/517)" sourceLine="1896">
  <property name="label" value="Effect of options to purchase common stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="QName" value="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,213"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1750</message>
 <ref href="pbsv-20200131.xml#element(/1/371)" sourceLine="1750">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromCollectionOfOtherReceivables" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1820</message>
 <ref href="pbsv-20200131.xml#element(/1/441)" sourceLine="1820">
  <property name="label" value="Collection from promissory note receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromCollectionOfOtherReceivables"/>
  <property name="QName" value="us-gaap:ProceedsFromCollectionOfOtherReceivables"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.107" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.107 - pbsv-20200131.xml 1953</message>
 <ref href="pbsv-20200131.xml#element(/1/574)" sourceLine="1953">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_GlobalGroupBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.107"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1403936.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,403,936 - pbsv-20200131.xml 1596</message>
 <ref href="pbsv-20200131.xml#element(/1/217)" sourceLine="1596">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,403,936"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1593402.0" fact-concept="{http://fasb.org/us-gaap/2024}GrossProfit" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,593,402 - pbsv-20200131.xml 1664</message>
 <ref href="pbsv-20200131.xml#element(/1/285)" sourceLine="1664">
  <property name="label" value="Gross Profit"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="GrossProfit"/>
  <property name="QName" value="us-gaap:GrossProfit"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,593,402"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23377259.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,377,259 - pbsv-20200131.xml 1751</message>
 <ref href="pbsv-20200131.xml#element(/1/372)" sourceLine="1751">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,377,259"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="66020.0" fact-concept="{http://fasb.org/us-gaap/2024}IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 66,020 - pbsv-20200131.xml 1895</message>
 <ref href="pbsv-20200131.xml#element(/1/516)" sourceLine="1895">
  <property name="label" value="Effect of options to purchase common stock"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="QName" value="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="66,020"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="25974980.0" fact-concept="{http://fasb.org/us-gaap/2024}AssetsCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 25,974,980 - pbsv-20200131.xml 1534</message>
 <ref href="pbsv-20200131.xml#element(/1/155)" sourceLine="1534">
  <property name="label" value="Assets, Current"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AssetsCurrent"/>
  <property name="QName" value="us-gaap:AssetsCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="25,974,980"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1148516.0" fact-concept="{http://fasb.org/us-gaap/2024}SellingGeneralAndAdministrativeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,148,516 - pbsv-20200131.xml 1667</message>
 <ref href="pbsv-20200131.xml#element(/1/288)" sourceLine="1667">
  <property name="label" value="SELLING, GENERAL AND ADMINISTRATIVE EXPENSES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SellingGeneralAndAdministrativeExpense"/>
  <property name="QName" value="us-gaap:SellingGeneralAndAdministrativeExpense"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,148,516"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="500000.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromCollectionOfOtherReceivables" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 500,000 - pbsv-20200131.xml 1819</message>
 <ref href="pbsv-20200131.xml#element(/1/440)" sourceLine="1819">
  <property name="label" value="Collection from promissory note receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromCollectionOfOtherReceivables"/>
  <property name="QName" value="us-gaap:ProceedsFromCollectionOfOtherReceivables"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="500,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2163033.0" fact-concept="{http://fasb.org/us-gaap/2024}SellingGeneralAndAdministrativeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,163,033 - pbsv-20200131.xml 1670</message>
 <ref href="pbsv-20200131.xml#element(/1/291)" sourceLine="1670">
  <property name="label" value="SELLING, GENERAL AND ADMINISTRATIVE EXPENSES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SellingGeneralAndAdministrativeExpense"/>
  <property name="QName" value="us-gaap:SellingGeneralAndAdministrativeExpense"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,163,033"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1752</message>
 <ref href="pbsv-20200131.xml#element(/1/373)" sourceLine="1752">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1902</message>
 <ref href="pbsv-20200131.xml#element(/1/523)" sourceLine="1902">
  <property name="label" value="Antidilutive warrants excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="QName" value="PBSV:AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="8781026.0" fact-concept="{http://fasb.org/us-gaap/2024}AccountsReceivableNetCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 8,781,026 - pbsv-20200131.xml 1540</message>
 <ref href="pbsv-20200131.xml#element(/1/161)" sourceLine="1540">
  <property name="label" value="Accounts receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccountsReceivableNetCurrent"/>
  <property name="QName" value="us-gaap:AccountsReceivableNetCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="8,781,026"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.105" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.105 - pbsv-20200131.xml 1954</message>
 <ref href="pbsv-20200131.xml#element(/1/575)" sourceLine="1954">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_GlobalGroupCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.105"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20289611.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,289,611 - pbsv-20200131.xml 1597</message>
 <ref href="pbsv-20200131.xml#element(/1/218)" sourceLine="1597">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,289,611"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="27548.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 27,548 - pbsv-20200131.xml 1826</message>
 <ref href="pbsv-20200131.xml#element(/1/447)" sourceLine="1826">
  <property name="label" value="Payments to Acquire Property, Plant, and Equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="27,548"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1250000.0" fact-concept="{http://pharmabioserv.com/20241231}PromissoryNoteReceivableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,250,000 - pbsv-20200131.xml 1537</message>
 <ref href="pbsv-20200131.xml#element(/1/158)" sourceLine="1537">
  <property name="label" value="Current portion - promissory note receivable due from sale of assets from discontinued operations"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="PromissoryNoteReceivableCurrent"/>
  <property name="QName" value="PBSV:PromissoryNoteReceivableCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,250,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="23405753.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 23,405,753 - pbsv-20200131.xml 1753</message>
 <ref href="pbsv-20200131.xml#element(/1/374)" sourceLine="1753">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="23,405,753"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="80000.0" fact-concept="{http://fasb.org/us-gaap/2024}AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 80,000 - pbsv-20200131.xml 1901</message>
 <ref href="pbsv-20200131.xml#element(/1/522)" sourceLine="1901">
  <property name="label" value="Antidilutive options excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="QName" value="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="80,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2197649.0" fact-concept="{http://fasb.org/us-gaap/2024}SellingGeneralAndAdministrativeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,197,649 - pbsv-20200131.xml 1669</message>
 <ref href="pbsv-20200131.xml#element(/1/290)" sourceLine="1669">
  <property name="label" value="SELLING, GENERAL AND ADMINISTRATIVE EXPENSES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SellingGeneralAndAdministrativeExpense"/>
  <property name="QName" value="us-gaap:SellingGeneralAndAdministrativeExpense"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,197,649"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="99038.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromSaleOfPropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 99,038 - pbsv-20200131.xml 1825</message>
 <ref href="pbsv-20200131.xml#element(/1/446)" sourceLine="1825">
  <property name="label" value="Proceeds from sale of property and equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="99,038"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20687529.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,687,529 - pbsv-20200131.xml 1598</message>
 <ref href="pbsv-20200131.xml#element(/1/219)" sourceLine="1598">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,687,529"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}SharesIssued" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1754</message>
 <ref href="pbsv-20200131.xml#element(/1/375)" sourceLine="1754">
  <property name="label" value="Shares, Issued"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SharesIssued"/>
  <property name="QName" value="us-gaap:SharesIssued"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="340000.0" fact-concept="{http://fasb.org/us-gaap/2024}AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 340,000 - pbsv-20200131.xml 1900</message>
 <ref href="pbsv-20200131.xml#element(/1/521)" sourceLine="1900">
  <property name="label" value="Antidilutive options excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="QName" value="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="340,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%&quot;>&lt;..." fact-concept="{http://fasb.org/us-gaap/2024}ScheduleOfSegmentReportingInformationBySegmentTextBlock" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] &lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>Six months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>REVENUES:&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;width: 40%; text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>5,116,682&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>4,293,041&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>9,297,592&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>8,181,595&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>394,991&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>661,356&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>784,353&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,188,001&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>133,762&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>141,500&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>155,950&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>233,231&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,332&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>54,447&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>23,039&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>113,714&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>Total consolidated revenues&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,647,767&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,150,344&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>10,260,934&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>9,716,541&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>INCOME (LOSS) BEFORE TAXES:&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>633,633&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>581,019&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,150,772&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>956,289&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(41,887&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>14,230&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;vertical-align: bottom; text-align: right&quot;>(61,930&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,320&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>7,489&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(8,014&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(61,684&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(57,925&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>169,733&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>195,506&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>324,005&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>396,032&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 0.25in&quot;>Total consolidated income before taxes&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>768,968&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>782,741&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,351,163&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,296,716&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;/table> - pbsv-20200131.xml 2009</message>
 <ref href="pbsv-20200131.xml#element(/1/630)" sourceLine="2009">
  <property name="label" value="Schedule of segment reporting information"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
  <property name="QName" value="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%&quot;>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>Three months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;7&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>Six months ended April 30,&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;vertical-align: bottom; text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;b>2020&lt;/b>&lt;/p>&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot; style=&quot;text-align: center&quot;>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&amp;#160;&lt;/p>&lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;b>2019&lt;/b>&lt;/p> &lt;p style=&quot;font: 8pt Times New Roman, Times, Serif; margin: 0&quot;>&lt;/p>&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom&quot;>    &lt;td>REVENUES:&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td colspan=&quot;3&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;width: 40%; text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>5,116,682&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>4,293,041&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>9,297,592&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;width: 3%&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;width: 1%; text-align: left&quot;>$&lt;/td>&lt;td style=&quot;width: 5%; text-align: right&quot;>8,181,595&lt;/td>&lt;td style=&quot;width: 1%; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>394,991&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>661,356&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>784,353&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,188,001&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>133,762&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>141,500&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>155,950&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>233,231&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,332&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>54,447&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>23,039&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>113,714&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>Total consolidated revenues&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,647,767&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>5,150,344&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>10,260,934&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>9,716,541&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left&quot;>INCOME (LOSS) BEFORE TAXES:&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt&quot;>&amp;#160;&lt;/td>    &lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: right&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;font-size: 12pt; text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Puerto Rico consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>633,633&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>581,019&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,150,772&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>956,289&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>United States consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(41,887&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>14,230&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;vertical-align: bottom; text-align: right&quot;>(61,930&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>2,320&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Europe consulting&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>7,489&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(8,014&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(61,684&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>(57,925&lt;/td>&lt;td style=&quot;text-align: left&quot;>)&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;>    &lt;td style=&quot;text-align: left; text-indent: 9pt&quot;>Other segments&amp;#185;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>169,733&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>195,506&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>324,005&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td style=&quot;text-align: right&quot;>396,032&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;>    &lt;td style=&quot;text-align: left; text-indent: 0.25in&quot;>Total consolidated income before taxes&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>768,968&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>782,741&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,351,163&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;td>&amp;#160;&lt;/td>    &lt;td style=&quot;text-align: left&quot;>$&lt;/td>&lt;td style=&quot;text-align: right&quot;>1,296,716&lt;/td>&lt;td style=&quot;text-align: left&quot;>&amp;#160;&lt;/td>&lt;/tr>&lt;/table>"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.116" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.116 - pbsv-20200131.xml 1955</message>
 <ref href="pbsv-20200131.xml#element(/1/576)" sourceLine="1955">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_GlobalGroupDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.116"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="12000.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromSaleOfPropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 12,000 - pbsv-20200131.xml 1824</message>
 <ref href="pbsv-20200131.xml#element(/1/445)" sourceLine="1824">
  <property name="label" value="Proceeds from sale of property and equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="12,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="11430.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 11,430 - pbsv-20200131.xml 1755</message>
 <ref href="pbsv-20200131.xml#element(/1/376)" sourceLine="1755">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="11,430"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="453780.0" fact-concept="{http://fasb.org/us-gaap/2024}PrepaidExpenseAndOtherAssets" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 453,780 - pbsv-20200131.xml 1536</message>
 <ref href="pbsv-20200131.xml#element(/1/157)" sourceLine="1536">
  <property name="label" value="Prepaids and other assets"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PrepaidExpenseAndOtherAssets"/>
  <property name="QName" value="us-gaap:PrepaidExpenseAndOtherAssets"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="453,780"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="92522.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 92,522 - pbsv-20200131.xml 1599</message>
 <ref href="pbsv-20200131.xml#element(/1/220)" sourceLine="1599">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="92,522"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1116474.0" fact-concept="{http://fasb.org/us-gaap/2024}SellingGeneralAndAdministrativeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,116,474 - pbsv-20200131.xml 1668</message>
 <ref href="pbsv-20200131.xml#element(/1/289)" sourceLine="1668">
  <property name="label" value="SELLING, GENERAL AND ADMINISTRATIVE EXPENSES"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="SellingGeneralAndAdministrativeExpense"/>
  <property name="QName" value="us-gaap:SellingGeneralAndAdministrativeExpense"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,116,474"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="80000.0" fact-concept="{http://fasb.org/us-gaap/2024}AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 80,000 - pbsv-20200131.xml 1899</message>
 <ref href="pbsv-20200131.xml#element(/1/520)" sourceLine="1899">
  <property name="label" value="Antidilutive options excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="QName" value="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="80,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="99038.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromSaleOfPropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 99,038 - pbsv-20200131.xml 1823</message>
 <ref href="pbsv-20200131.xml#element(/1/444)" sourceLine="1823">
  <property name="label" value="Proceeds from sale of property and equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="99,038"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.222" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupEMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.222 - pbsv-20200131.xml 1956</message>
 <ref href="pbsv-20200131.xml#element(/1/577)" sourceLine="1956">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_GlobalGroupEMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupEMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.222"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="102133.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 102,133 - pbsv-20200131.xml 1600</message>
 <ref href="pbsv-20200131.xml#element(/1/221)" sourceLine="1600">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="102,133"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="22860.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 22,860 - pbsv-20200131.xml 1758</message>
 <ref href="pbsv-20200131.xml#element(/1/379)" sourceLine="1758">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="22,860"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="48584.0" fact-concept="{http://fasb.org/us-gaap/2024}NonoperatingIncomeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 48,584 - pbsv-20200131.xml 1671</message>
 <ref href="pbsv-20200131.xml#element(/1/292)" sourceLine="1671">
  <property name="label" value="OTHER INCOME, NET"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NonoperatingIncomeExpense"/>
  <property name="QName" value="us-gaap:NonoperatingIncomeExpense"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="48,584"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="15581997.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 15,581,997 - pbsv-20200131.xml 1541</message>
 <ref href="pbsv-20200131.xml#element(/1/162)" sourceLine="1541">
  <property name="label" value="Cash and cash equivalents"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsAtCarryingValue"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsAtCarryingValue"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="15,581,997"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="38844.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 38,844 - pbsv-20200131.xml 1829</message>
 <ref href="pbsv-20200131.xml#element(/1/450)" sourceLine="1829">
  <property name="label" value="Payments to Acquire Property, Plant, and Equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="38,844"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.249" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.249 - pbsv-20200131.xml 1910</message>
 <ref href="pbsv-20200131.xml#element(/1/531)" sourceLine="1910">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_MajorCustomerAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.249"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="9976981.0" fact-concept="{http://fasb.org/us-gaap/2024}AccountsReceivableNetCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 9,976,981 - pbsv-20200131.xml 1539</message>
 <ref href="pbsv-20200131.xml#element(/1/160)" sourceLine="1539">
  <property name="label" value="Accounts receivable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccountsReceivableNetCurrent"/>
  <property name="QName" value="us-gaap:AccountsReceivableNetCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="9,976,981"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.55" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.55 - pbsv-20200131.xml 1957</message>
 <ref href="pbsv-20200131.xml#element(/1/578)" sourceLine="1957">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30_custom_GlobalGroupTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.55"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-392007.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -392,007 - pbsv-20200131.xml 1601</message>
 <ref href="pbsv-20200131.xml#element(/1/222)" sourceLine="1601">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-04-30_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-392,007"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="94020.0" fact-concept="{http://fasb.org/us-gaap/2024}NonoperatingIncomeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 94,020 - pbsv-20200131.xml 1673</message>
 <ref href="pbsv-20200131.xml#element(/1/294)" sourceLine="1673">
  <property name="label" value="OTHER INCOME, NET"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NonoperatingIncomeExpense"/>
  <property name="QName" value="us-gaap:NonoperatingIncomeExpense"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="94,020"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="11430.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 11,430 - pbsv-20200131.xml 1757</message>
 <ref href="pbsv-20200131.xml#element(/1/378)" sourceLine="1757">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="11,430"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="341154.0" fact-concept="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgram" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 341,154 - pbsv-20200131.xml 1906</message>
 <ref href="pbsv-20200131.xml#element(/1/527)" sourceLine="1906">
  <property name="label" value="Shares purchased under Repurchase Program"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="SharesPurchasedUnderRepurchaseProgram"/>
  <property name="QName" value="PBSV:SharesPurchasedUnderRepurchaseProgram"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="341,154"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.852" fact-concept="{http://pharmabioserv.com/20241231}AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.852 - pbsv-20200131.xml 1958</message>
 <ref href="pbsv-20200131.xml#element(/1/579)" sourceLine="1958">
  <property name="label" value="Amount due from major customers as percentage of accounts receivable"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable"/>
  <property name="QName" value="PBSV:AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_MajorCustomerTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.852"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="38874.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 38,874 - pbsv-20200131.xml 1828</message>
 <ref href="pbsv-20200131.xml#element(/1/449)" sourceLine="1828">
  <property name="label" value="Payments to Acquire Property, Plant, and Equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="38,874"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-394278.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -394,278 - pbsv-20200131.xml 1602</message>
 <ref href="pbsv-20200131.xml#element(/1/223)" sourceLine="1602">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-04-30_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-394,278"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="9000.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 9,000 - pbsv-20200131.xml 1756</message>
 <ref href="pbsv-20200131.xml#element(/1/377)" sourceLine="1756">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="9,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1250000.0" fact-concept="{http://pharmabioserv.com/20241231}PromissoryNoteReceivableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,250,000 - pbsv-20200131.xml 1538</message>
 <ref href="pbsv-20200131.xml#element(/1/159)" sourceLine="1538">
  <property name="label" value="Current portion - promissory note receivable due from sale of assets from discontinued operations"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="PromissoryNoteReceivableCurrent"/>
  <property name="QName" value="PBSV:PromissoryNoteReceivableCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,250,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="305813.0" fact-concept="{http://fasb.org/us-gaap/2024}NonoperatingIncomeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 305,813 - pbsv-20200131.xml 1672</message>
 <ref href="pbsv-20200131.xml#element(/1/293)" sourceLine="1672">
  <property name="label" value="OTHER INCOME, NET"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NonoperatingIncomeExpense"/>
  <property name="QName" value="us-gaap:NonoperatingIncomeExpense"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="305,813"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="18000.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 18,000 - pbsv-20200131.xml 1759</message>
 <ref href="pbsv-20200131.xml#element(/1/380)" sourceLine="1759">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="18,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="35761.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 35,761 - pbsv-20200131.xml 1827</message>
 <ref href="pbsv-20200131.xml#element(/1/448)" sourceLine="1827">
  <property name="label" value="Payments to Acquire Property, Plant, and Equipment"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="QName" value="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="35,761"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1000000.0" fact-concept="{http://pharmabioserv.com/20241231}AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,000,000 - pbsv-20200131.xml 1905</message>
 <ref href="pbsv-20200131.xml#element(/1/526)" sourceLine="1905">
  <property name="label" value="Antidilutive warrants excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="QName" value="PBSV:AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,000,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1830</message>
 <ref href="pbsv-20200131.xml#element(/1/451)" sourceLine="1830">
  <property name="label" value="DisposalOfMarketableSecurities"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="DisposalOfMarketableSecurities"/>
  <property name="QName" value="PBSV:DisposalOfMarketableSecurities"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2338.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,338 - pbsv-20200131.xml 1603</message>
 <ref href="pbsv-20200131.xml#element(/1/224)" sourceLine="1603">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,338"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1904</message>
 <ref href="pbsv-20200131.xml#element(/1/525)" sourceLine="1904">
  <property name="label" value="Antidilutive warrants excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="QName" value="PBSV:AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="9000.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 9,000 - pbsv-20200131.xml 1760</message>
 <ref href="pbsv-20200131.xml#element(/1/381)" sourceLine="1760">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="9,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1928961.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,928,961 - pbsv-20200131.xml 1834</message>
 <ref href="pbsv-20200131.xml#element(/1/455)" sourceLine="1834">
  <property name="label" value="Net Cash Provided by (Used in) Financing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,928,961"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1000000.0" fact-concept="{http://pharmabioserv.com/20241231}AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,000,000 - pbsv-20200131.xml 1903</message>
 <ref href="pbsv-20200131.xml#element(/1/524)" sourceLine="1903">
  <property name="label" value="Antidilutive warrants excluded from computation of earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="QName" value="PBSV:AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,000,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="909429.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 909,429 - pbsv-20200131.xml 1967</message>
 <ref href="pbsv-20200131.xml#element(/1/588)" sourceLine="1967">
  <property name="label" value="INCOME FROM OPERATIONS"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingIncomeLoss"/>
  <property name="QName" value="us-gaap:OperatingIncomeLoss"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="909,429"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1604</message>
 <ref href="pbsv-20200131.xml#element(/1/225)" sourceLine="1604">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.093" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.093 - pbsv-20200131.xml 1912</message>
 <ref href="pbsv-20200131.xml#element(/1/533)" sourceLine="1912">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_MajorCustomerBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.093"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="387287.0" fact-concept="{http://fasb.org/us-gaap/2024}NonoperatingIncomeExpense" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 387,287 - pbsv-20200131.xml 1674</message>
 <ref href="pbsv-20200131.xml#element(/1/295)" sourceLine="1674">
  <property name="label" value="OTHER INCOME, NET"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NonoperatingIncomeExpense"/>
  <property name="QName" value="us-gaap:NonoperatingIncomeExpense"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="387,287"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="9000.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 9,000 - pbsv-20200131.xml 1761</message>
 <ref href="pbsv-20200131.xml#element(/1/382)" sourceLine="1761">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="9,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-44475.0" fact-concept="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -44,475 - pbsv-20200131.xml 1833</message>
 <ref href="pbsv-20200131.xml#element(/1/454)" sourceLine="1833">
  <property name="label" value="DisposalOfMarketableSecurities"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="DisposalOfMarketableSecurities"/>
  <property name="QName" value="PBSV:DisposalOfMarketableSecurities"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-44,475"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="768968.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 768,968 - pbsv-20200131.xml 1675</message>
 <ref href="pbsv-20200131.xml#element(/1/296)" sourceLine="1675">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="768,968"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1355956.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,355,956 - pbsv-20200131.xml 1605</message>
 <ref href="pbsv-20200131.xml#element(/1/226)" sourceLine="1605">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,355,956"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="16029920.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 16,029,920 - pbsv-20200131.xml 1543</message>
 <ref href="pbsv-20200131.xml#element(/1/164)" sourceLine="1543">
  <property name="label" value="Cash and cash equivalents"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsAtCarryingValue"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsAtCarryingValue"/>
  <property name="contextRef" value="AsOf2018-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2018-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="16,029,920"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="687561.0" fact-concept="{http://pharmabioserv.com/20241231}NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 687,561 - pbsv-20200131.xml 1960</message>
 <ref href="pbsv-20200131.xml#element(/1/581)" sourceLine="1960">
  <property name="label" value="Net income (loss) available to common equity holders - used to compute basic and diluted earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="QName" value="PBSV:NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="687,561"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="9000.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 9,000 - pbsv-20200131.xml 1762</message>
 <ref href="pbsv-20200131.xml#element(/1/383)" sourceLine="1762">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="9,000"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1832</message>
 <ref href="pbsv-20200131.xml#element(/1/453)" sourceLine="1832">
  <property name="label" value="DisposalOfMarketableSecurities"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="DisposalOfMarketableSecurities"/>
  <property name="QName" value="PBSV:DisposalOfMarketableSecurities"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="19582131.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 19,582,131 - pbsv-20200131.xml 1606</message>
 <ref href="pbsv-20200131.xml#element(/1/227)" sourceLine="1606">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="19,582,131"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="581019.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 581,019 - pbsv-20200131.xml 1678</message>
 <ref href="pbsv-20200131.xml#element(/1/299)" sourceLine="1678">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="581,019"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="15490174.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 15,490,174 - pbsv-20200131.xml 1542</message>
 <ref href="pbsv-20200131.xml#element(/1/163)" sourceLine="1542">
  <property name="label" value="Cash and cash equivalents"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsAtCarryingValue"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsAtCarryingValue"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="15,490,174"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.861" fact-concept="{http://pharmabioserv.com/20241231}AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}GlobalGroupTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.861 - pbsv-20200131.xml 1959</message>
 <ref href="pbsv-20200131.xml#element(/1/580)" sourceLine="1959">
  <property name="label" value="Amount due from major customers as percentage of accounts receivable"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable"/>
  <property name="QName" value="PBSV:AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_GlobalGroupTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:GlobalGroupTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.861"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="11430.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 11,430 - pbsv-20200131.xml 1763</message>
 <ref href="pbsv-20200131.xml#element(/1/384)" sourceLine="1763">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="11,430"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="331306.0" fact-concept="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgramValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 331,306 - pbsv-20200131.xml 1908</message>
 <ref href="pbsv-20200131.xml#element(/1/529)" sourceLine="1908">
  <property name="label" value="Shares purchased under Repurchase Program, amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="SharesPurchasedUnderRepurchaseProgramValue"/>
  <property name="QName" value="PBSV:SharesPurchasedUnderRepurchaseProgramValue"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="331,306"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="633633.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 633,633 - pbsv-20200131.xml 1677</message>
 <ref href="pbsv-20200131.xml#element(/1/298)" sourceLine="1677">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="633,633"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="338854.0" fact-concept="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgram" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="inf" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 338,854 - pbsv-20200131.xml 1907</message>
 <ref href="pbsv-20200131.xml#element(/1/528)" sourceLine="1907">
  <property name="label" value="Shares purchased under Repurchase Program"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="SharesPurchasedUnderRepurchaseProgram"/>
  <property name="QName" value="PBSV:SharesPurchasedUnderRepurchaseProgram"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="338,854"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="720384.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 720,384 - pbsv-20200131.xml 1964</message>
 <ref href="pbsv-20200131.xml#element(/1/585)" sourceLine="1964">
  <property name="label" value="INCOME FROM OPERATIONS"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingIncomeLoss"/>
  <property name="QName" value="us-gaap:OperatingIncomeLoss"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="720,384"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="115789.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 115,789 - pbsv-20200131.xml 1607</message>
 <ref href="pbsv-20200131.xml#element(/1/228)" sourceLine="1607">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="115,789"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1831</message>
 <ref href="pbsv-20200131.xml#element(/1/452)" sourceLine="1831">
  <property name="label" value="DisposalOfMarketableSecurities"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="DisposalOfMarketableSecurities"/>
  <property name="QName" value="PBSV:DisposalOfMarketableSecurities"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="11430.0" fact-concept="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 11,430 - pbsv-20200131.xml 1764</message>
 <ref href="pbsv-20200131.xml#element(/1/385)" sourceLine="1764">
  <property name="label" value="STOCK-BASED COMPENSATION"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ShareBasedCompensation"/>
  <property name="QName" value="us-gaap:ShareBasedCompensation"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="11,430"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1178503.0" fact-concept="{http://pharmabioserv.com/20241231}NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,178,503 - pbsv-20200131.xml 1963</message>
 <ref href="pbsv-20200131.xml#element(/1/584)" sourceLine="1963">
  <property name="label" value="Net income (loss) available to common equity holders - used to compute basic and diluted earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="QName" value="PBSV:NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,178,503"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-370443.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -370,443 - pbsv-20200131.xml 1608</message>
 <ref href="pbsv-20200131.xml#element(/1/229)" sourceLine="1608">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-01-31_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-370,443"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="782741.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 782,741 - pbsv-20200131.xml 1676</message>
 <ref href="pbsv-20200131.xml#element(/1/297)" sourceLine="1676">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="782,741"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-149709.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -149,709 - pbsv-20200131.xml 1837</message>
 <ref href="pbsv-20200131.xml#element(/1/458)" sourceLine="1837">
  <property name="label" value="Net Cash Provided by (Used in) Financing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-149,709"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="15433111.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 15,433,111 - pbsv-20200131.xml 1544</message>
 <ref href="pbsv-20200131.xml#element(/1/165)" sourceLine="1544">
  <property name="label" value="Cash and cash equivalents"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsAtCarryingValue"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsAtCarryingValue"/>
  <property name="contextRef" value="AsOf2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="15,433,111"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1214461.0" fact-concept="{http://pharmabioserv.com/20241231}NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,214,461 - pbsv-20200131.xml 1962</message>
 <ref href="pbsv-20200131.xml#element(/1/583)" sourceLine="1962">
  <property name="label" value="Net income (loss) available to common equity holders - used to compute basic and diluted earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="QName" value="PBSV:NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,214,461"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3442.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3,442 - pbsv-20200131.xml 1765</message>
 <ref href="pbsv-20200131.xml#element(/1/386)" sourceLine="1765">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Shares"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodSharesStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodSharesStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3,442"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="329607.0" fact-concept="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgramValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 329,607 - pbsv-20200131.xml 1909</message>
 <ref href="pbsv-20200131.xml#element(/1/530)" sourceLine="1909">
  <property name="label" value="Shares purchased under Repurchase Program, amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="SharesPurchasedUnderRepurchaseProgramValue"/>
  <property name="QName" value="PBSV:SharesPurchasedUnderRepurchaseProgramValue"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="329,607"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-41887.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -41,887 - pbsv-20200131.xml 1679</message>
 <ref href="pbsv-20200131.xml#element(/1/300)" sourceLine="1679">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-41,887"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="199265.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 199,265 - pbsv-20200131.xml 1836</message>
 <ref href="pbsv-20200131.xml#element(/1/457)" sourceLine="1836">
  <property name="label" value="Net Cash Provided by (Used in) Financing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="199,265"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="707483.0" fact-concept="{http://pharmabioserv.com/20241231}NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 707,483 - pbsv-20200131.xml 1961</message>
 <ref href="pbsv-20200131.xml#element(/1/582)" sourceLine="1961">
  <property name="label" value="Net income (loss) available to common equity holders - used to compute basic and diluted earnings (losses) per share"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="QName" value="PBSV:NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="707,483"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="58993.0" fact-concept="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 58,993 - pbsv-20200131.xml 1843</message>
 <ref href="pbsv-20200131.xml#element(/1/464)" sourceLine="1843">
  <property name="label" value="Repayments of Long-term Capital Lease Obligations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="QName" value="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="58,993"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20685771.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,685,771 - pbsv-20200131.xml 1609</message>
 <ref href="pbsv-20200131.xml#element(/1/230)" sourceLine="1609">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,685,771"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerAMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1911</message>
 <ref href="pbsv-20200131.xml#element(/1/532)" sourceLine="1911">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_MajorCustomerAMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerAMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.00"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="15798526.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 15,798,526 - pbsv-20200131.xml 1545</message>
 <ref href="pbsv-20200131.xml#element(/1/166)" sourceLine="1545">
  <property name="label" value="Cash and cash equivalents"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsAtCarryingValue"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsAtCarryingValue"/>
  <property name="contextRef" value="AsOf2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="15,798,526"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1257143.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,257,143 - pbsv-20200131.xml 1966</message>
 <ref href="pbsv-20200131.xml#element(/1/587)" sourceLine="1966">
  <property name="label" value="INCOME FROM OPERATIONS"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingIncomeLoss"/>
  <property name="QName" value="us-gaap:OperatingIncomeLoss"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,257,143"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="14230.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 14,230 - pbsv-20200131.xml 1680</message>
 <ref href="pbsv-20200131.xml#element(/1/301)" sourceLine="1680">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="14,230"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1 - pbsv-20200131.xml 1773</message>
 <ref href="pbsv-20200131.xml#element(/1/394)" sourceLine="1773">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2341.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,341 - pbsv-20200131.xml 1610</message>
 <ref href="pbsv-20200131.xml#element(/1/231)" sourceLine="1610">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,341"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="7489.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 7,489 - pbsv-20200131.xml 1681</message>
 <ref href="pbsv-20200131.xml#element(/1/302)" sourceLine="1681">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="7,489"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-80557.0" fact-concept="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -80,557 - pbsv-20200131.xml 1835</message>
 <ref href="pbsv-20200131.xml#element(/1/456)" sourceLine="1835">
  <property name="label" value="Net Cash Provided by (Used in) Financing Activities, Continuing Operations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="QName" value="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-80,557"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.111" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerBMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.111 - pbsv-20200131.xml 1913</message>
 <ref href="pbsv-20200131.xml#element(/1/534)" sourceLine="1913">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_MajorCustomerBMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerBMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.111"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="15254752.0" fact-concept="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 15,254,752 - pbsv-20200131.xml 1546</message>
 <ref href="pbsv-20200131.xml#element(/1/167)" sourceLine="1546">
  <property name="label" value="Cash and cash equivalents"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="CashAndCashEquivalentsAtCarryingValue"/>
  <property name="QName" value="us-gaap:CashAndCashEquivalentsAtCarryingValue"/>
  <property name="contextRef" value="AsOf2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="15,254,752"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="476928.0" fact-concept="{http://fasb.org/us-gaap/2024}OperatingIncomeLoss" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 476,928 - pbsv-20200131.xml 1965</message>
 <ref href="pbsv-20200131.xml#element(/1/586)" sourceLine="1965">
  <property name="label" value="INCOME FROM OPERATIONS"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="OperatingIncomeLoss"/>
  <property name="QName" value="us-gaap:OperatingIncomeLoss"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="476,928"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2711747.0" fact-concept="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,711,747 - pbsv-20200131.xml 1547</message>
 <ref href="pbsv-20200131.xml#element(/1/168)" sourceLine="1547">
  <property name="label" value="Liabilities, Current"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LiabilitiesCurrent"/>
  <property name="QName" value="us-gaap:LiabilitiesCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,711,747"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1931700.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromLoans" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,931,700 - pbsv-20200131.xml 1968</message>
 <ref href="pbsv-20200131.xml#element(/1/589)" sourceLine="1968">
  <property name="label" value="Proceeds from loans"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromLoans"/>
  <property name="QName" value="us-gaap:ProceedsFromLoans"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,931,700"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-8014.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -8,014 - pbsv-20200131.xml 1682</message>
 <ref href="pbsv-20200131.xml#element(/1/303)" sourceLine="1682">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-8,014"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-1.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -1 - pbsv-20200131.xml 1774</message>
 <ref href="pbsv-20200131.xml#element(/1/395)" sourceLine="1774">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-1"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1838</message>
 <ref href="pbsv-20200131.xml#element(/1/459)" sourceLine="1838">
  <property name="label" value="Payments of Dividends"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsOfDividends"/>
  <property name="QName" value="us-gaap:PaymentsOfDividends"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}PreferredStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1611</message>
 <ref href="pbsv-20200131.xml#element(/1/232)" sourceLine="1611">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_PreferredStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:PreferredStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="169733.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 169,733 - pbsv-20200131.xml 1683</message>
 <ref href="pbsv-20200131.xml#element(/1/304)" sourceLine="1683">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="169,733"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1775</message>
 <ref href="pbsv-20200131.xml#element(/1/396)" sourceLine="1775">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.146" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.146 - pbsv-20200131.xml 1914</message>
 <ref href="pbsv-20200131.xml#element(/1/535)" sourceLine="1914">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_MajorCustomerCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.146"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="476881.0" fact-concept="{http://fasb.org/us-gaap/2024}AccruedIncomeTaxesCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 476,881 - pbsv-20200131.xml 1549</message>
 <ref href="pbsv-20200131.xml#element(/1/170)" sourceLine="1549">
  <property name="label" value="Current portion of US Tax Reform Transition Tax and income taxes payable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccruedIncomeTaxesCurrent"/>
  <property name="QName" value="us-gaap:AccruedIncomeTaxesCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="476,881"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromLoans" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1971</message>
 <ref href="pbsv-20200131.xml#element(/1/592)" sourceLine="1971">
  <property name="label" value="Proceeds from loans"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromLoans"/>
  <property name="QName" value="us-gaap:ProceedsFromLoans"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1392506.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,392,506 - pbsv-20200131.xml 1612</message>
 <ref href="pbsv-20200131.xml#element(/1/233)" sourceLine="1612">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_AdditionalPaidInCapitalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AdditionalPaidInCapitalMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,392,506"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="195506.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 195,506 - pbsv-20200131.xml 1684</message>
 <ref href="pbsv-20200131.xml#element(/1/305)" sourceLine="1684">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="195,506"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-1.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -1 - pbsv-20200131.xml 1768</message>
 <ref href="pbsv-20200131.xml#element(/1/389)" sourceLine="1768">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-1"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1841</message>
 <ref href="pbsv-20200131.xml#element(/1/462)" sourceLine="1841">
  <property name="label" value="Payments of Dividends"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsOfDividends"/>
  <property name="QName" value="us-gaap:PaymentsOfDividends"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1351163.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,351,163 - pbsv-20200131.xml 1685</message>
 <ref href="pbsv-20200131.xml#element(/1/306)" sourceLine="1685">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,351,163"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="8046.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-02-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 8,046 - pbsv-20200131.xml 1767</message>
 <ref href="pbsv-20200131.xml#element(/1/388)" sourceLine="1767">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Shares"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodSharesStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodSharesStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-11-01to2020-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="8,046"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.099" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerCMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.099 - pbsv-20200131.xml 1915</message>
 <ref href="pbsv-20200131.xml#element(/1/536)" sourceLine="1915">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_MajorCustomerCMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerCMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.099"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1931700.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromLoans" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,931,700 - pbsv-20200131.xml 1970</message>
 <ref href="pbsv-20200131.xml#element(/1/591)" sourceLine="1970">
  <property name="label" value="Proceeds from loans"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromLoans"/>
  <property name="QName" value="us-gaap:ProceedsFromLoans"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,931,700"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="19999968.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 19,999,968 - pbsv-20200131.xml 1613</message>
 <ref href="pbsv-20200131.xml#element(/1/234)" sourceLine="1613">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="19,999,968"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1725295.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,725,295 - pbsv-20200131.xml 1840</message>
 <ref href="pbsv-20200131.xml#element(/1/461)" sourceLine="1840">
  <property name="label" value="Payments of Dividends"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsOfDividends"/>
  <property name="QName" value="us-gaap:PaymentsOfDividends"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,725,295"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1296716.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,296,716 - pbsv-20200131.xml 1686</message>
 <ref href="pbsv-20200131.xml#element(/1/307)" sourceLine="1686">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2018-11-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,296,716"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="3670540.0" fact-concept="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 3,670,540 - pbsv-20200131.xml 1548</message>
 <ref href="pbsv-20200131.xml#element(/1/169)" sourceLine="1548">
  <property name="label" value="Liabilities, Current"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="LiabilitiesCurrent"/>
  <property name="QName" value="us-gaap:LiabilitiesCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="3,670,540"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="20448.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/instance}shares" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 20,448 - pbsv-20200131.xml 1766</message>
 <ref href="pbsv-20200131.xml#element(/1/387)" sourceLine="1766">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Shares"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodSharesStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodSharesStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="Shares (shares)">
   <property name="measure" value="xbrli:shares"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="20,448"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="131866.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveInco..." fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 131,866 - pbsv-20200131.xml 1614</message>
 <ref href="pbsv-20200131.xml#element(/1/235)" sourceLine="1614">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:AccumulatedOtherComprehensiveIncomeMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="131,866"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1150772.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,150,772 - pbsv-20200131.xml 1687</message>
 <ref href="pbsv-20200131.xml#element(/1/308)" sourceLine="1687">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_PuertoRicoConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:PuertoRicoConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,150,772"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1839</message>
 <ref href="pbsv-20200131.xml#element(/1/460)" sourceLine="1839">
  <property name="label" value="Payments of Dividends"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="PaymentsOfDividends"/>
  <property name="QName" value="us-gaap:PaymentsOfDividends"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.682" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.682 - pbsv-20200131.xml 1916</message>
 <ref href="pbsv-20200131.xml#element(/1/537)" sourceLine="1916">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_MajorCustomerTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.682"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1725295.0" fact-concept="{http://fasb.org/us-gaap/2024}DividendsPayableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1,725,295 - pbsv-20200131.xml 1552</message>
 <ref href="pbsv-20200131.xml#element(/1/173)" sourceLine="1552">
  <property name="label" value="Dividend payable to stockholders"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DividendsPayableCurrent"/>
  <property name="QName" value="us-gaap:DividendsPayableCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1,725,295"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-3.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}RetainedEarningsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -3 - pbsv-20200131.xml 1772</message>
 <ref href="pbsv-20200131.xml#element(/1/393)" sourceLine="1772">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_us-gaap_RetainedEarningsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:RetainedEarningsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-3"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2739.0" fact-concept="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2,739 - pbsv-20200131.xml 1842</message>
 <ref href="pbsv-20200131.xml#element(/1/463)" sourceLine="1842">
  <property name="label" value="Repayments of Long-term Capital Lease Obligations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="QName" value="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2,739"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}ProceedsFromLoans" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1969</message>
 <ref href="pbsv-20200131.xml#element(/1/590)" sourceLine="1969">
  <property name="label" value="Proceeds from loans"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ProceedsFromLoans"/>
  <property name="QName" value="us-gaap:ProceedsFromLoans"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-61930.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -61,930 - pbsv-20200131.xml 1688</message>
 <ref href="pbsv-20200131.xml#element(/1/309)" sourceLine="1688">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_UnitedStatesConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:UnitedStatesConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-61,930"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="Pharma-Bio Serv, Inc." fact-concept="{http://xbrl.sec.gov/dei/2024}EntityRegistrantName" fact-unit="None" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="None" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] Pharma-Bio Serv, Inc. - pbsv-20200131.xml 1972</message>
 <ref href="pbsv-20200131.xml#element(/1/593)" sourceLine="1972">
  <property name="label" value="Entity Registrant Name"/>
  <property name="namespace" value="http://xbrl.sec.gov/dei/2019-01-31"/>
  <property name="name" value="EntityRegistrantName"/>
  <property name="QName" value="dei:EntityRegistrantName"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="decimals" value="None"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="Pharma-Bio Serv, Inc."/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-394278.0" fact-concept="{http://fasb.org/us-gaap/2024}StockholdersEquity" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}TreasuryStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -394,278 - pbsv-20200131.xml 1615</message>
 <ref href="pbsv-20200131.xml#element(/1/236)" sourceLine="1615">
  <property name="label" value="Stockholders' Equity Attributable to Parent"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="StockholdersEquity"/>
  <property name="QName" value="us-gaap:StockholdersEquity"/>
  <property name="contextRef" value="AsOf2020-01-31_us-gaap_TreasuryStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:TreasuryStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-394,278"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="2.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 2 - pbsv-20200131.xml 1771</message>
 <ref href="pbsv-20200131.xml#element(/1/392)" sourceLine="1771">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="2"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.0" fact-concept="{http://fasb.org/us-gaap/2024}DividendsPayableCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0 - pbsv-20200131.xml 1551</message>
 <ref href="pbsv-20200131.xml#element(/1/172)" sourceLine="1551">
  <property name="label" value="Dividend payable to stockholders"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="DividendsPayableCurrent"/>
  <property name="QName" value="us-gaap:DividendsPayableCurrent"/>
  <property name="contextRef" value="AsOf2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="-61684.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}EuropeConsultingMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] -61,684 - pbsv-20200131.xml 1689</message>
 <ref href="pbsv-20200131.xml#element(/1/310)" sourceLine="1689">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_EuropeConsultingMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:EuropeConsultingMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="-61,684"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="5441.0" fact-concept="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 5,441 - pbsv-20200131.xml 1844</message>
 <ref href="pbsv-20200131.xml#element(/1/465)" sourceLine="1844">
  <property name="label" value="Repayments of Long-term Capital Lease Obligations"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="QName" value="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="5,441"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.598" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-02-01T00:00:00/2019-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerTotalMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.598 - pbsv-20200131.xml 1917</message>
 <ref href="pbsv-20200131.xml#element(/1/538)" sourceLine="1917">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2019-02-01to2019-04-30_custom_MajorCustomerTotalMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-02-01"/>
   <property name="endDate" value="2019-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerTotalMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.598"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="344043.0" fact-concept="{http://fasb.org/us-gaap/2024}AccruedIncomeTaxesCurrent" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 344,043 - pbsv-20200131.xml 1550</message>
 <ref href="pbsv-20200131.xml#element(/1/171)" sourceLine="1550">
  <property name="label" value="Current portion of US Tax Reform Transition Tax and income taxes payable"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="AccruedIncomeTaxesCurrent"/>
  <property name="QName" value="us-gaap:AccruedIncomeTaxesCurrent"/>
  <property name="contextRef" value="AsOf2019-10-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="instant" value="2019-10-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="344,043"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1 - pbsv-20200131.xml 1770</message>
 <ref href="pbsv-20200131.xml#element(/1/391)" sourceLine="1770">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="0.118" fact-concept="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" fact-unit="{http://www.xbrl.org/2003/instance}pure" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2020-02-01T00:00:00/2020-05-01T00:00:00" fact-decimals="inf" fact-dimensions="{&quot;{http://fasb.org/srt/2024}MajorCustomersAxis&quot;: &quot;{http://pharmabioserv.com/20241231}MajorCustomerDMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 0.118 - pbsv-20200131.xml 1918</message>
 <ref href="pbsv-20200131.xml#element(/1/539)" sourceLine="1918">
  <property name="label" value="Revenue from major customers"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="ConcentrationRiskPercentage1"/>
  <property name="QName" value="us-gaap:ConcentrationRiskPercentage1"/>
  <property name="contextRef" value="From2020-02-01to2020-04-30_custom_MajorCustomerDMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2020-02-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:MajorCustomersAxis" value="PBSV:MajorCustomerDMember"/>
   </property>
  </property>
  <property name="unitRef" value="Percent (pure)">
   <property name="measure" value="xbrli:pure"/>
  </property>
  <property name="decimals" value="INF"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="0.118"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="324005.0" fact-concept="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2019-11-01T00:00:00/2020-05-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/srt/2024}StatementGeographicalAxis&quot;: &quot;{http://pharmabioserv.com/20241231}OtherSegmentsMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 324,005 - pbsv-20200131.xml 1690</message>
 <ref href="pbsv-20200131.xml#element(/1/311)" sourceLine="1690">
  <property name="label" value="INCOME BEFORE INCOME TAX"/>
  <property name="namespace" value="http://fasb.org/us-gaap/2020-01-31"/>
  <property name="name" value="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="QName" value="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
  <property name="contextRef" value="From2019-11-01to2020-04-30_custom_OtherSegmentsMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2019-11-01"/>
   <property name="endDate" value="2020-04-30"/>
   <property name="dimensions" value="(1)">
    <property name="srt:StatementGeographicalAxis" value="PBSV:OtherSegmentsMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="324,005"/>
 </ref></entry>
<entry code="add_facts_to_instance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" fact-instance="phmb-20200131_htm" fact-value="1.0" fact-concept="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" fact-unit="{http://www.xbrl.org/2003/iso4217}USD" fact-entity="[&quot;http://www.sec.gov/CIK&quot;, &quot;0001304161&quot;]" fact-period="2018-11-01T00:00:00/2019-02-01T00:00:00" fact-decimals="0.0" fact-dimensions="{&quot;{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis&quot;: &quot;{http://fasb.org/us-gaap/2024}CommonStockMember&quot;}" fact-is-nil="False" severity="info" cid="2430583881168">[add_facts_to_instance] 1 - pbsv-20200131.xml 1769</message>
 <ref href="pbsv-20200131.xml#element(/1/390)" sourceLine="1769">
  <property name="label" value="ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount"/>
  <property name="namespace" value="http://pharmabioserv.com/20200131"/>
  <property name="name" value="StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="QName" value="PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless"/>
  <property name="contextRef" value="From2018-11-01to2019-01-31_us-gaap_CommonStockMember">
   <property name="entity" value="0001304161">
    <property name="scheme" value="http://www.sec.gov/CIK"/>
   </property>
   <property name="startDate" value="2018-11-01"/>
   <property name="endDate" value="2019-01-31"/>
   <property name="dimensions" value="(1)">
    <property name="us-gaap:StatementEquityComponentsAxis" value="us-gaap:CommonStockMember"/>
   </property>
  </property>
  <property name="unitRef" value="USD ($)">
   <property name="measure" value="iso4217:USD"/>
  </property>
  <property name="decimals" value="0"/>
  <property name="precision" value="None"/>
  <property name="xsi:nil" value="false"/>
  <property name="value" value="1"/>
 </ref></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24745&quot;]" concept-name="{http://pharmabioserv.com/20241231}MajorCustomerAMember" severity="info" cid="2430583881168">[concepts] PBSV:MajorCustomerAMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24746&quot;]" concept-name="{http://pharmabioserv.com/20241231}MajorCustomerBMember" severity="info" cid="2430583881168">[concepts] PBSV:MajorCustomerBMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24747&quot;]" concept-name="{http://pharmabioserv.com/20241231}MajorCustomerCMember" severity="info" cid="2430583881168">[concepts] PBSV:MajorCustomerCMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24748&quot;]" concept-name="{http://pharmabioserv.com/20241231}MajorCustomerTotalMember" severity="info" cid="2430583881168">[concepts] PBSV:MajorCustomerTotalMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24749&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalCustomerAMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalCustomerAMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24750&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalCustomerBMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalCustomerBMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24751&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalCustomerTotalMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalCustomerTotalMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24752&quot;]" concept-name="{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember" severity="info" cid="2430583881168">[concepts] PBSV:PuertoRicoConsultingMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24753&quot;]" concept-name="{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember" severity="info" cid="2430583881168">[concepts] PBSV:UnitedStatesConsultingMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24754&quot;]" concept-name="{http://pharmabioserv.com/20241231}EuropeConsultingMember" severity="info" cid="2430583881168">[concepts] PBSV:EuropeConsultingMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24755&quot;]" concept-name="{http://pharmabioserv.com/20241231}LabMember" severity="info" cid="2430583881168">[concepts] PBSV:LabMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24756&quot;]" concept-name="{http://pharmabioserv.com/20241231}OtherSegmentsMember" severity="info" cid="2430583881168">[concepts] PBSV:OtherSegmentsMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24757&quot;]" concept-name="{http://pharmabioserv.com/20241231}MajorCustomerDMember" severity="info" cid="2430583881168">[concepts] PBSV:MajorCustomerDMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24758&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalCustomerCMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalCustomerCMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24759&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalCustomerDMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalCustomerDMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24760&quot;]" concept-name="{http://pharmabioserv.com/20241231}MajorCustomerEMember" severity="info" cid="2430583881168">[concepts] PBSV:MajorCustomerEMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24761&quot;]" concept-name="{http://pharmabioserv.com/20241231}MajorCustomerFMember" severity="info" cid="2430583881168">[concepts] PBSV:MajorCustomerFMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24762&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalGroupAMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalGroupAMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24763&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalGroupBMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalGroupBMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24764&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalGroupCMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalGroupCMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24765&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalGroupDMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalGroupDMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24766&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalGroupEMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalGroupEMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24767&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalGroupFMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalGroupFMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24768&quot;]" concept-name="{http://pharmabioserv.com/20241231}GlobalGroupTotalMember" severity="info" cid="2430583881168">[concepts] PBSV:GlobalGroupTotalMember - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24769&quot;]" concept-name="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" severity="info" cid="2430583881168">[concepts] PBSV:DocumentAndEntityInformationAbstract - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24770&quot;]" concept-name="{http://pharmabioserv.com/20241231}ConsolidatedStatementsOfChangesInStockholdersEquityParentheticalAbstract" severity="info" cid="2430583881168">[concepts] PBSV:ConsolidatedStatementsOfChangesInStockholdersEquityParentheticalAbstract - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24730&quot;]" concept-name="{http://pharmabioserv.com/20241231}PromissoryNoteReceivableCurrent" severity="info" cid="2430583881168">[concepts] PBSV:PromissoryNoteReceivableCurrent - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24731&quot;]" concept-name="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" severity="info" cid="2430583881168">[concepts] PBSV:StockIssuedDuringPeriodSharesStockOptionsExercisedCashless - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24732&quot;]" concept-name="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" severity="info" cid="2430583881168">[concepts] PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24733&quot;]" concept-name="{http://pharmabioserv.com/20241231}StockRepurchaseDuringPeriodShares" severity="info" cid="2430583881168">[concepts] PBSV:StockRepurchaseDuringPeriodShares - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24734&quot;]" concept-name="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" severity="info" cid="2430583881168">[concepts] PBSV:DisposalOfMarketableSecurities - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24735&quot;]" concept-name="{http://pharmabioserv.com/20241231}ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle" severity="info" cid="2430583881168">[concepts] PBSV:ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24736&quot;]" concept-name="{http://pharmabioserv.com/20241231}ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock" severity="info" cid="2430583881168">[concepts] PBSV:ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24737&quot;]" concept-name="{http://pharmabioserv.com/20241231}IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn" severity="info" cid="2430583881168">[concepts] PBSV:IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24738&quot;]" concept-name="{http://pharmabioserv.com/20241231}AccumulatedDepreciationOnPropertyAndEquipmentDisposed" severity="info" cid="2430583881168">[concepts] PBSV:AccumulatedDepreciationOnPropertyAndEquipmentDisposed - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24739&quot;]" concept-name="{http://pharmabioserv.com/20241231}AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare" severity="info" cid="2430583881168">[concepts] PBSV:AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24740&quot;]" concept-name="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgram" severity="info" cid="2430583881168">[concepts] PBSV:SharesPurchasedUnderRepurchaseProgram - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24741&quot;]" concept-name="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgramValue" severity="info" cid="2430583881168">[concepts] PBSV:SharesPurchasedUnderRepurchaseProgramValue - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24742&quot;]" concept-name="{http://pharmabioserv.com/20241231}AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable" severity="info" cid="2430583881168">[concepts] PBSV:AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24743&quot;]" concept-name="{http://pharmabioserv.com/20241231}NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted" severity="info" cid="2430583881168">[concepts] PBSV:NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted - </message></entry>
<entry code="concepts" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" concept="[2430583880880, &quot;__24744&quot;]" concept-name="{http://pharmabioserv.com/20241231}RecentAccountingPronouncementsPolicyTextBlock" severity="info" cid="2430583881168">[concepts] PBSV:RecentAccountingPronouncementsPolicyTextBlock - </message></entry>
<entry code="createInstance" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" instance-name="phmb-20200131_htm" instance-taxonomy="[&quot;./phmb-20200430_taxonomy.zip/phmb-20200430_taxonomy/phmb-20200430.xsd&quot;]" severity="info" cid="2430583881168">[createInstance] True - </message></entry>
<entry code="create_package" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" package-url="http://pharmabioserv.com/20241231" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" document-package-entry-point="True" document-package-entry-point-description="Official Statement  Taxonomy " document-package-entry-point-language="en-US" document-package-entry-point-name="phmb 20200430" document-import="[&quot;https://xbrl.sec.gov/dei/2024/dei-2024.xsd&quot;, &quot;https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-all-2024.xsd&quot;]" import2-url="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-all-2024.xsd" severity="info" cid="2430583881168">[create_package] True - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__21&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/E.Warrants - 00000014 - Disclosure - E. WARRANTS - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__26&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/A.OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies - 00000019 - Disclosure - A. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__28&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/I.SegmentDisclosuresTables - 00000021 - Disclosure - I. SEGMENT DISCLOSURES (Tables) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/G.EquityTransactions - 00000016 - Disclosure - G. EQUITY TRANSACTIONS - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__17&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/A.OrganizationAndSummaryOfSignificantAccountingPolicies - 00000010 - Disclosure - A. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23712&quot;]" severity="info" cid="2430583881168">[create_roles] http://www.xbrl.org/2009/role/negatedTotalLabel - Negated total label - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__10&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/BalanceSheetsParenthetical - 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__33&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/H.ConcentrationOfRisksDetailsNarrative - 00000026 - Disclosure - H. CONCENTRATION OF RISKS (Details Narrative) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__18&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/B.PromissoryNotes - 00000011 - Disclosure - B. PROMISSORY NOTES - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__24&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/H.ConcentrationsOfRisk - 00000017 - Disclosure - H. CONCENTRATIONS OF RISK - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23709&quot;]" severity="info" cid="2430583881168">[create_roles] http://www.xbrl.org/2009/role/negatedLabel - Negated standard label - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__13&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/StatementsOfChangesInStockholdersEquity - 00000006 - Statement - Consolidated Statements of Changes in Stockholders' Equity - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__16&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/StatementsOfCashFlowsParenthetical - 00000009 - Statement - Consolidated Statements of Cash Flows (Parenthetical) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__29&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/A.OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative - 00000022 - Disclosure - A. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__12&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/StatementsOfComprehensiveIncomeLoss - 00000005 - Statement - Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__25&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/I.SegmentDisclosures - 00000018 - Disclosure - I. SEGMENT DISCLOSURES - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23726&quot;]" severity="info" cid="2430583881168">[create_roles] http://www.xbrl.org/2009/role/netLabel - Net label - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__31&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/F.EarningsPerShareDetailsNarrative - 00000024 - Disclosure - F. EARNINGS PER SHARE (Details Narrative) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23713&quot;]" severity="info" cid="2430583881168">[create_roles] http://www.xbrl.org/2009/role/negatedNetLabel - Negated net label - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__14&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/StatementsOfChangesInStockholdersEquityParenthetical - 00000007 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__11&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/StatementsOfOperations - 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__30&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/F.EarningsPerShareDetails - 00000023 - Disclosure - F. EARNINGS PER SHARE (Details) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__20&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/D.IncomeTaxes - 00000013 - Disclosure - D. INCOME TAXES - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23714&quot;]" severity="info" cid="2430583881168">[create_roles] http://www.xbrl.org/2009/role/negatedTerseLabel - Negated terse label - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__34&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/I.SegmentDisclosuresDetails - 00000027 - Disclosure - I. SEGMENT DISCLOSURES (Details) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__22&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/F.EarningsPerShare - 00000015 - Disclosure - F. EARNINGS PER SHARE - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__19&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/C.Loans - 00000012 - Disclosure - C. LOANS - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__27&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/F.EarningsPerShareTables - 00000020 - Disclosure - F. EARNINGS PER SHARE (Tables) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__9&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/BalanceSheets - 00000002 - Statement - Consolidated Balance Sheets (Unaudited) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23711&quot;]" severity="info" cid="2430583881168">[create_roles] http://www.xbrl.org/2009/role/negatedPeriodStartLabel - Negated period start label - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__15&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/StatementsOfCashFlows - 00000008 - Statement - Consolidated Statements of Cash Flows (Unaudited) - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__8&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/DocumentAndEntityInformation - 00000001 - Document - Document and Entity Information - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__23710&quot;]" severity="info" cid="2430583881168">[create_roles] http://www.xbrl.org/2009/role/negatedPeriodEndLabel - Negated period end label - </message></entry>
<entry code="create_roles" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" role="[2430583880880, &quot;__32&quot;]" severity="info" cid="2430583881168">[create_roles] http://pharmabioserv.com/role/G.EquityTransactionsDetailsNarrative - 00000025 - Disclosure - G. EQUITY TRANSACTIONS (Details Narrative) - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24249&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}UseOfEstimates" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Use of Estimates - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23924&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityNoncurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Long-term operating lease liabilities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23900&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Current operating lease liabilities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23882&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OperatingLeaseRightOfUseAsset" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Operating lease right-of-use - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24002&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OperatingIncomeLoss" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) INCOME FROM OPERATIONS - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24193&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPol..." severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) A. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24037&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedI..." severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Available-for-sale securities other-than-temporary impairment included in net income - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24305&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/verboseLabel) (en-US) Weighted average number of common shares - used to compute basic earnings per share - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24020&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24023&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24310&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/verboseLabel) (en-US) Weighted average number of shares - used to compute diluted earnings (losses) per share - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23870&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}PromissoryNoteReceivableCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Current portion - promissory note receivable due from sale of assets from discontinued operations - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24060&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Shares - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24334&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/documentation) (en-US) Custom Element. - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24063&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) ISSUANCE OF COMMON STOCK PURSUANT TO THE CASHLESS EXERCISE OF STOCK OPTIONS, Amount - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24336&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/documentation) (en-US) Custom Element. - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24080&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}StockRepurchaseDuringPeriodShares" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Purchase of treasury stocks - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24372&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) DisposalOfMarketableSecurities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24120&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Disposal of marketable securities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24181&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Obligations under capital lease incurred for the acquisition of a vehicle - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24178&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Conversion of cashless exercise of options to common stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24175&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Income tax withheld by clients to be used as a credit in the Company's income tax return - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24187&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}AccumulatedDepreciationOnPropertyAndEquipmentDisposed" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accumulated depreciation - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24313&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Antidilutive warrants excluded from computation of earnings (losses) per share - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24319&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgram" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Shares purchased under Repurchase Program - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24322&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgramValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Shares purchased under Repurchase Program, amount - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24330&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Amount due from major customers as percentage of accounts receivable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24303&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Net income (loss) available to common equity holders - used to compute basic and diluted earnings (losses) per share - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24291&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}RecentAccountingPronouncementsPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Recent Accounting Pronouncements - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23732&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}MajorCustomerAMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Major Customer A - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23735&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}MajorCustomerBMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Major Customer B - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23738&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}MajorCustomerCMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Major Customer C - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23741&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}MajorCustomerTotalMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Major Customer Total - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23747&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Puerto Rico consulting - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23750&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) United States consulting - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23753&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}EuropeConsultingMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Europe consulting - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23756&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}OtherSegmentsMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Other segments - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23759&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}MajorCustomerDMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Major Customer D - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23762&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}MajorCustomerEMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Major Customer E - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23786&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}GlobalGroupAMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Global Group A - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23789&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}GlobalGroupBMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Global Group B - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23792&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}GlobalGroupCMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Global Group C - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23795&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}GlobalGroupDMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Global Group D - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23798&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}GlobalGroupEMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Global Group E - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23801&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}GlobalGroupTotalMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Global Group Total - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23804&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Document And Entity Information - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24077&quot;]" label-concept-name="{http://pharmabioserv.com/20241231}ConsolidatedStatementsOfChangesInStockholdersEquityParentheticalAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Consolidated Statements Of Changes In Stockholders Equity - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23744&quot;]" label-concept-name="{http://fasb.org/srt/2024}StatementGeographicalAxis" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Geographical [Axis] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23885&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OtherAssetsNoncurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Other assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23927&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OtherLiabilities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Other liabilities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24252&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}FairValueOfFinancialInstrumentsPolicy" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Fair Value of Financial Instruments - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24102&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Other-than-temporary impairment on available-for-sale securities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24364&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24070&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) OTHER COMPREHENSIVE INCOME, NET OF TAX - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24040&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) TOTAL OTHER COMPREHENSIVE LOSS - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24034&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributa..." severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Foreign currency translation loss - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24031&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) OTHER COMPREHENSIVE INCOME (LOSS), NET OF RECLASSIFICATION ADJUSTMENTS AND TAXES: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24378&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Payments for Repurchase of Common Stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24141&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Repurchase of common stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24190&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accounting Policies [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24382&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Payments of Dividends - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24147&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Cash dividends paid to shareholders - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23903&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AccountsPayableAndAccruedLiabilitiesCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accounts payable and accrued expenses - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23867&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AccountsReceivableNetCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accounts receivable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24123&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Acquisition of property and equipment - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24374&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Payments to Acquire Property, Plant, and Equipment - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23909&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AccruedIncomeTaxesCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Current portion of US Tax Reform Transition Tax and income taxes payable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24300&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accumulated depreciation and amortization - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23780&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accumulated Other Comprehensive Income (Loss) - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23948&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeLossNetOfTax" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accumulated other comprehensive loss - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23774&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Additional Paid-In Capital - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23942&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalCommonStock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Additional paid-in capital - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24279&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Foreign Operations - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24091&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24316&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Antidilutive options excluded from computation of earnings (losses) per share - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23861&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AssetsAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) ASSETS: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23771&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PreferredStockMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Preferred Stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23936&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PreferredStockValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Preferred Stock, $0.0001 par value; authorized 10,000,000 shares; none outstanding - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23969&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PreferredStockSharesOutstanding" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Preferred stock, outstanding - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23963&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PreferredStockParOrStatedValuePerShare" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Preferred stock, par value - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23966&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PreferredStockSharesAuthorized" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Preferred stock, authorized - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23873&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PrepaidExpenseAndOtherAssets" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Prepaids and other assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24094&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Gain on disposition of property and equipment - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24362&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23888&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}Assets" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) Total assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24340&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}Assets" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23876&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AssetsCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) Total current assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24338&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}AssetsCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Assets, Current - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24285&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PriorPeriodReclassificationAdjustmentDescription" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Reclassifications - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24129&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ProceedsFromCollectionOfOtherReceivables" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Collection from promissory note receivable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23819&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}AmendmentFlag" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Amendment Flag - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24138&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ProceedsFromLoans" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Proceeds from loans - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23996&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}GrossProfit" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) GROSS PROFIT - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24354&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}GrossProfit" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Gross Profit - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24126&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ProceedsFromSaleOfPropertyPlantAndEquipment" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Proceeds from sale of property and equipment - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24184&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentDisposals" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Disposed property and equipment with accumulated depreciation of $17,913 for the three and six months ended April 30, 2020 and $86,773 for the three and six months ended April 30, 2019 - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23879&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentNet" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Property and equipment - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24267&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Property and Equipment - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23921&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsNoncurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Obligations under finance lease - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23894&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Current portion-obligations under finance leases - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24270&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Impairment of Long-Lived Assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24332&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/verboseLabel) (en-US) INCOME (LOSS) BEFORE TAXES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24008&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) INCOME BEFORE INCOME TAX - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24208&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeTaxDisclosureAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Income Tax Disclosure [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24017&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) BASIC AND DILUTED EARNINGS PER COMMON SHARE - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23987&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Income Statement [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24211&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeTaxDisclosureTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) D. INCOME TAXES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24011&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeTaxExpenseBenefit" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) INCOME TAX EXPENSE - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24158&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/periodStartLabel) (en-US) CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24160&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/periodEndLabel) (en-US) CASH AND CASH EQUIVALENTS - END OF PERIOD - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23864&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Cash and cash equivalents - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24386&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Cash and Cash Equivalents, Period Increase (Decrease) - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24156&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24258&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Cash Equivalents - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24172&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) SUPPLEMENTARY SCHEDULES OF NON-CASH INVESTING AND FINANCING ACTIVITIES: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24261&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ReceivablesPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Accounts Receivable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24264&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeTaxPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Income Taxes - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24166&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncomeTaxesPaid" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Cash paid during the period for: Income taxes - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24105&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Increase in accounts receivable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24366&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Increase (Decrease) in Accounts Receivable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24368&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Increase (Decrease) in Other Operating Assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24108&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) (Increase) decrease in other assets - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24111&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOperatingLiabilities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Increase (decrease) in liabilities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24308&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Effect of options to purchase common stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23768&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CommonStockMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Common Stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23972&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CommonStockParOrStatedValuePerShare" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Common stock, par value - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23978&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CommonStockSharesIssued" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Common stock, issued - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23975&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CommonStockSharesAuthorized" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Common stock, authorized - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23981&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CommonStockSharesOutstanding" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Common stock, outstanding - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23939&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CommonStockValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Common Stock, $0.0001 par value; authorized 50,000,000 shares; 23,405,753 and 23,397,707 shares issued, and 23,001,627 and 22,995,881 shares outstanding at April 30, 2020 and October 31, 2019, respectively - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24144&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Payments on obligations under finance leases - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24380&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Repayments of Long-term Capital Lease Obligations - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24169&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}InterestPaidNet" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Cash paid during the period for: Interest - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24043&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) COMPREHENSIVE INCOME (LOSS) - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24356&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Comprehensive Income (Loss), Net of Tax, Attributable to Parent - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24234&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ConcentrationRiskDisclosureTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) H. CONCENTRATIONS OF RISK - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24327&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Revenue from major customers - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24243&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ConsolidationPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Consolidation - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23945&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}RetainedEarningsAccumulatedDeficit" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Retained earnings - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23777&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}RetainedEarningsMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Retained Earnings - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23993&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}CostOfRevenue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) COST OF SERVICES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24255&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}RevenueRecognitionPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Revenue Recognition - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23990&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}Revenues" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) REVENUES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24231&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}RisksAndUncertaintiesAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Risks and Uncertainties [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24196&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}DebtDisclosureAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Debt Disclosure [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24294&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Schedule of calculations of basic and diluted earnings (losses) per share - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23960&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquity" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) Total liabilities and stockholders' equity - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24352&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquity" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Liabilities and Equity - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23891&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) LIABILITIES AND STOCKHOLDERS' EQUITY: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23930&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}Liabilities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) Total liabilities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24344&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}Liabilities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Liabilities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24342&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Liabilities, Current - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23912&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) Total current liabilities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24205&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}DebtDisclosureTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) C. LOANS - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24297&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ScheduleOfSegmentReportingInformationBySegmentTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Schedule of segment reporting information - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24246&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SegmentReportingPolicyPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Segments - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24237&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SegmentReportingAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Segment Reporting [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24240&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SegmentReportingDisclosureTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) I. SEGMENT DISCLOSURES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23999&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SellingGeneralAndAdministrativeExpense" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) SELLING, GENERAL AND ADMINISTRATIVE EXPENSES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24057&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) STOCK-BASED COMPENSATION - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24096&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/verboseLabel) (en-US) Stock-based compensation - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24273&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}ShareBasedCompensationOptionAndIncentivePlansPolicy" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Stock-based Compensation - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23918&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LoansPayable" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Loans-long term portion - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23897&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LoansPayableCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Loans short term portion - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24202&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}LongTermNotesAndLoansAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Notes and Loans, Noncurrent [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24099&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}DepreciationDepletionAndAmortization" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Depreciation and amortization - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24358&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SharesIssued" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Shares, Issued - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24052&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SharesIssued" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/periodStartLabel) (en-US) BEGINNING BALANCE - Shares - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24072&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SharesIssued" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/periodEndLabel) (en-US) ENDING BALANCE, Shares - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23858&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StatementOfFinancialPositionAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Statement of Financial Position [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24026&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StatementOfOtherComprehensiveIncomeAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Statement of Other Comprehensive Income [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24046&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StatementTable" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Statement [Table] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24049&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StatementLineItems" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Statement [Line Items] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24083&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StatementOfCashFlowsAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Statement of Cash Flows [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23765&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Equity Components [Axis] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24066&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) PURCHASE OF TREASURY STOCK - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24360&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Stock Repurchased During Period, Value - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24228&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquityNoteDisclosureTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) G. EQUITY TRANSACTIONS - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23951&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) Stockholders' equity before treasury stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24346&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Stockholders' Equity before Treasury Stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24054&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/periodStartLabel) (en-US) BEGINNING BALANCE - Amount - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23957&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) Total stockholders' equity - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24074&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/periodEndLabel) (en-US) ENDING BALANCE, Amount - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24350&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Stockholders' Equity Attributable to Parent - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23933&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Stockholders' equity: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24225&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/verboseLabel) (en-US) Stockholders' Equity Attributable to Parent [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24199&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}MarketableSecuritiesTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) B. PROMISSORY NOTE - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24282&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SubsequentEventsPolicyPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Subsequent Events - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24163&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}SupplementalCashFlowInformationAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23915&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}TaxesPayableCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) US Tax Reform Transition Tax payable - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24214&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Share-based Payment Arrangement [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24217&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) E. WARRANTS - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24376&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Net Cash Provided by (Used in) Investing Activities, Continuing Operations - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24132&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24384&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Net Cash Provided by (Used in) Financing Activities, Continuing Operations - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24150&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) NET CASH USED IN FINANCING ACTIVITIES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24114&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24370&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Net Cash Provided by (Used in) Operating Activities - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24028&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) NET INCOME (LOSS) - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24088&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/terseLabel) (en-US) Net income - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24068&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/verboseLabel) (en-US) NET INCOME - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24014&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/totalLabel) (en-US) NET INCOME (LOSS) - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24086&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivitiesAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) CASH FLOWS FROM OPERATING ACTIVITIES: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24135&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) CASH FLOWS FROM FINANCING ACTIVITIES: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24117&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) CASH FLOWS FROM INVESTING ACTIVITIES: - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24288&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NewAccountingPronouncementsPolicyPolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Recently Adopted Accounting Pronouncements - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23906&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}DividendsPayableCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Dividend payable to stockholders - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23984&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}TreasuryStockShares" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Treasury stock, shares - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24348&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}TreasuryStockValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Treasury Stock, Value - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23954&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}TreasuryStockValue" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2009/role/negatedLabel) (en-US) Treasury stock, at cost; 404,126 and 401,826 common shares held at April 30, 2020 and October 31, 2019, respectively - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23783&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}TreasuryStockMember" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Treasury Stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24005&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}NonoperatingIncomeExpense" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) OTHER INCOME, NET - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23852&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityIncorporationStateCountryCode" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Incorporation State Country Code - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23816&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}DocumentPeriodEndDate" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Document Period End Date - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24223&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}EarningsPerShareTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) F. EARNINGS (LOSSES) PER SHARE - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24276&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}EarningsPerSharePolicyTextBlock" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Earnings Per Share of Common Stock - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23822&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}CurrentFiscalYearEndDate" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Current Fiscal Year End Date - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24220&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Earnings Per Share [Abstract] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24153&quot;]" label-concept-name="{http://fasb.org/us-gaap/2024}EffectOfExchangeRateOnCashAndCashEquivalents" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) EFFECT OF EXCHANGE RATE CHANGES ON CASH - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23825&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityCurrentReportingStatus" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Is Entity's Reporting Status Current? - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23828&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityFilerCategory" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Filer Category - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23807&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityRegistrantName" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Registrant Name - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23810&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityCentralIndexKey" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Central Index Key - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23840&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityCommonStockSharesOutstanding" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Common Stock, Shares Outstanding - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23846&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}DocumentFiscalYearFocus" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Document Fiscal Year Focus - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23843&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}DocumentFiscalPeriodFocus" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Document Fiscal Period Focus - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23813&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}DocumentType" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Document Type - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23849&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityInteractiveDataCurrent" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Interactive Data Current - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23855&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityFileNumber" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity File Number - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23837&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityShellCompany" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Shell Company - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23831&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntityEmergingGrowthCompany" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Emerging Growth Company - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23834&quot;]" label-concept-name="{http://xbrl.sec.gov/dei/2024}EntitySmallBusiness" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Entity Small Business - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__23729&quot;]" label-concept-name="{http://fasb.org/srt/2024}MajorCustomersAxis" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/label) (en-US) Major Customers [Axis] - </message></entry>
<entry code="labels" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" document-uri="phmb-20200430_lab.xml" document-imported-in="phmb-20200430.xsd" label="[2430583880880, &quot;__24324&quot;]" label-concept-name="{http://fasb.org/srt/2024}MajorCustomersAxis" severity="info" cid="2430583881168">[labels] (http://www.xbrl.org/2003/role/verboseLabel) (en-US) Customer [Axis] - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28815&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LongTermNotesAndLoansAbstract" relationship-target="{http://fasb.org/us-gaap/2024}DebtDisclosureTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LongTermNotesAndLoansAbstract to us-gaap:DebtDisclosureTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28238&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StatementTable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StatementTable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28834&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28808&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PreferredStockSharesAuthorized" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:PreferredStockSharesAuthorized - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28809&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PreferredStockSharesOutstanding" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:PreferredStockSharesOutstanding - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28810&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockParOrStatedValuePerShare" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:CommonStockParOrStatedValuePerShare - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28811&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockSharesAuthorized" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:CommonStockSharesAuthorized - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28812&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockSharesIssued" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:CommonStockSharesIssued - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28813&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockSharesOutstanding" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:CommonStockSharesOutstanding - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28814&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}TreasuryStockShares" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:TreasuryStockShares - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28806&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfFinancialPositionAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfFinancialPositionAbstract to us-gaap:StockholdersEquityAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28807&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PreferredStockParOrStatedValuePerShare" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:PreferredStockParOrStatedValuePerShare - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28933&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}ConsolidatedStatementsOfChangesInStockholdersEquityParentheticalAbstract" relationship-target="{http://pharmabioserv.com/20241231}StockRepurchaseDuringPeriodShares" severity="info" cid="2430583881168">[relationships] relationship from PBSV:ConsolidatedStatementsOfChangesInStockholdersEquityParentheticalAbstract to PBSV:StockRepurchaseDuringPeriodShares - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28268&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EquityComponentDomain" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EquityComponentDomain to us-gaap:CommonStockMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28278&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28277&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to PBSV:StockIssuedDuringPeriodSharesStockOptionsExercisedCashless - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28274&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}SharesIssued" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:SharesIssued - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28275&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StockholdersEquity - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28276&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:ShareBasedCompensation - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28269&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EquityComponentDomain" relationship-target="{http://fasb.org/us-gaap/2024}PreferredStockMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EquityComponentDomain to us-gaap:PreferredStockMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28271&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EquityComponentDomain" relationship-target="{http://fasb.org/us-gaap/2024}RetainedEarningsMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EquityComponentDomain to us-gaap:RetainedEarningsMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28270&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EquityComponentDomain" relationship-target="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EquityComponentDomain to us-gaap:AdditionalPaidInCapitalMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28281&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28273&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EquityComponentDomain" relationship-target="{http://fasb.org/us-gaap/2024}TreasuryStockMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EquityComponentDomain to us-gaap:TreasuryStockMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28272&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EquityComponentDomain" relationship-target="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EquityComponentDomain to us-gaap:AccumulatedOtherComprehensiveIncomeMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28280&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:NetIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28279&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StockRepurchasedDuringPeriodValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28944&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OperatingIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:OperatingIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28945&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NonoperatingIncomeExpense" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:NonoperatingIncomeExpense - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28946&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28947&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncomeTaxExpenseBenefit" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:IncomeTaxExpenseBenefit - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28948&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:NetIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28949&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28950&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:WeightedAverageNumberOfSharesOutstandingBasic - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28940&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}Revenues" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:Revenues - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28951&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28941&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CostOfRevenue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:CostOfRevenue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28942&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}GrossProfit" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:GrossProfit - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28943&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeStatementAbstract" relationship-target="{http://fasb.org/us-gaap/2024}SellingGeneralAndAdministrativeExpense" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeStatementAbstract to us-gaap:SellingGeneralAndAdministrativeExpense - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29002&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" relationship-target="{http://fasb.org/us-gaap/2024}OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedI..." severity="info" cid="2430583881168">[relationships] relationship from us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent to us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29001&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" relationship-target="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributa..." severity="info" cid="2430583881168">[relationships] relationship from us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent to us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29004&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" relationship-target="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:ComprehensiveIncomeNetOfTax to us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29003&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" relationship-target="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:ComprehensiveIncomeNetOfTax to us-gaap:NetIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28257&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://pharmabioserv.com/20241231}AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to PBSV:AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28255&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupTotalMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupTotalMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28245&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerBMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerBMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28246&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerCMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerCMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28247&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerDMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerDMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28248&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerEMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerEMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28249&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerTotalMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerTotalMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28250&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupAMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupAMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28251&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupBMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupBMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28252&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupCMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupCMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28256&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:ConcentrationRiskPercentage1 - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28253&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupDMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupDMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28244&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerAMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerAMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28254&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupEMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupEMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28872&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}EuropeConsultingMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:EuropeConsultingMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28873&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}OtherSegmentsMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:OtherSegmentsMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28866&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}SegmentReportingAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StatementTable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:SegmentReportingAbstract to us-gaap:StatementTable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28867&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/us-gaap/2024}StatementLineItems" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to us-gaap:StatementLineItems - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28869&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}StatementGeographicalAxis" relationship-target="{http://fasb.org/srt/2024}SegmentGeographicalDomain" severity="info" cid="2430583881168">[relationships] relationship from srt:StatementGeographicalAxis to srt:SegmentGeographicalDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28874&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}Revenues" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:Revenues - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28868&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/srt/2024}StatementGeographicalAxis" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to srt:StatementGeographicalAxis - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28870&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:PuertoRicoConsultingMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28875&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28871&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:UnitedStatesConsultingMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28258&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/srt/2024}MajorCustomersAxis" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to srt:MajorCustomersAxis - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28267&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}StatementGeographicalAxis" relationship-target="{http://fasb.org/srt/2024}SegmentGeographicalDomain" severity="info" cid="2430583881168">[relationships] relationship from srt:StatementGeographicalAxis to srt:SegmentGeographicalDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28775&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://pharmabioserv.com/20241231}PromissoryNoteReceivableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to PBSV:PromissoryNoteReceivableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28776&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PrepaidExpenseAndOtherAssets" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:PrepaidExpenseAndOtherAssets - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28777&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AssetsCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:AssetsCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28778&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentNet" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:PropertyPlantAndEquipmentNet - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28779&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OperatingLeaseRightOfUseAsset" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:OperatingLeaseRightOfUseAsset - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28780&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OtherAssetsNoncurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:OtherAssetsNoncurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28781&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}Assets" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:Assets - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28782&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfFinancialPositionAbstract" relationship-target="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfFinancialPositionAbstract to us-gaap:LiabilitiesAndStockholdersEquityAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28783&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:CapitalLeaseObligationsCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28784&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}LoansPayableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:LoansPayableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28785&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:OperatingLeaseLiabilityCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28786&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AccountsPayableAndAccruedLiabilitiesCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28787&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}DividendsPayableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:DividendsPayableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28788&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AccruedIncomeTaxesCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:AccruedIncomeTaxesCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28789&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:LiabilitiesCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28790&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}TaxesPayableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:TaxesPayableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28791&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}LoansPayable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:LoansPayable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28792&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsNoncurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:CapitalLeaseObligationsNoncurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28793&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityNoncurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:OperatingLeaseLiabilityNoncurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28794&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OtherLiabilities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:OtherLiabilities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28795&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}Liabilities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:Liabilities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28796&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquityAbstract to us-gaap:StockholdersEquityAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28797&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PreferredStockValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:PreferredStockValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28798&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:CommonStockValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28799&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalCommonStock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:AdditionalPaidInCapitalCommonStock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28800&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}RetainedEarningsAccumulatedDeficit" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:RetainedEarningsAccumulatedDeficit - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28801&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeLossNetOfTax" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28802&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:StockholdersEquityBeforeTreasuryStock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28803&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}TreasuryStockValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:TreasuryStockValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28804&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:StockholdersEquity - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28805&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquity" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:LiabilitiesAndStockholdersEquity - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28772&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfFinancialPositionAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AssetsAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfFinancialPositionAbstract to us-gaap:AssetsAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28773&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:CashAndCashEquivalentsAtCarryingValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28774&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AccountsReceivableNetCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsAbstract to us-gaap:AccountsReceivableNetCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28819&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}DocumentType" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:DocumentType - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28818&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityCentralIndexKey" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityCentralIndexKey - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28817&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityRegistrantName" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityRegistrantName - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28833&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityFileNumber" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityFileNumber - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28832&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityIncorporationStateCountryCode" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityIncorporationStateCountryCode - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28831&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityInteractiveDataCurrent" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityInteractiveDataCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28830&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}DocumentFiscalYearFocus" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:DocumentFiscalYearFocus - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28829&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}DocumentFiscalPeriodFocus" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:DocumentFiscalPeriodFocus - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28828&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityCommonStockSharesOutstanding" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityCommonStockSharesOutstanding - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28827&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityShellCompany" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityShellCompany - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28826&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntitySmallBusiness" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntitySmallBusiness - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28825&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityEmergingGrowthCompany" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityEmergingGrowthCompany - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28824&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityFilerCategory" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityFilerCategory - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28823&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}EntityCurrentReportingStatus" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:EntityCurrentReportingStatus - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28822&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}CurrentFiscalYearEndDate" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:CurrentFiscalYearEndDate - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28821&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}AmendmentFlag" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:AmendmentFlag - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28820&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://pharmabioserv.com/20241231}DocumentAndEntityInformationAbstract" relationship-target="{http://xbrl.sec.gov/dei/2024}DocumentPeriodEndDate" severity="info" cid="2430583881168">[relationships] relationship from PBSV:DocumentAndEntityInformationAbstract to dei:DocumentPeriodEndDate - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28931&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}SharesIssued" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:SharesIssued - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28932&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StockholdersEquity - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28914&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/us-gaap/2024}StatementLineItems" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to us-gaap:StatementLineItems - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28915&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to us-gaap:StatementEquityComponentsAxis - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28917&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:CommonStockMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28918&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}PreferredStockMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:PreferredStockMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28923&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}SharesIssued" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:SharesIssued - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28919&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:AdditionalPaidInCapitalMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28924&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StockholdersEquity - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28920&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}RetainedEarningsMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:RetainedEarningsMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28921&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:AccumulatedOtherComprehensiveIncomeMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28925&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:ShareBasedCompensation - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28922&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}TreasuryStockMember" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:TreasuryStockMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28916&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}EquityComponentDomain" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:EquityComponentDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28926&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodSharesStockOptionsExercisedCashless" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to PBSV:StockIssuedDuringPeriodSharesStockOptionsExercisedCashless - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28927&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://pharmabioserv.com/20241231}StockIssuedDuringPeriodValueStockOptionsExercisedCashless" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to PBSV:StockIssuedDuringPeriodValueStockOptionsExercisedCashless - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28928&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StockRepurchasedDuringPeriodValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StockRepurchasedDuringPeriodValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28913&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfStockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StatementTable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfStockholdersEquityAbstract to us-gaap:StatementTable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28929&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:NetIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28930&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28265&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28261&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}UnitedStatesConsultingMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:UnitedStatesConsultingMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28262&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}EuropeConsultingMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:EuropeConsultingMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28263&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}OtherSegmentsMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:OtherSegmentsMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28264&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}Revenues" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:Revenues - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28260&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://pharmabioserv.com/20241231}PuertoRicoConsultingMember" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to PBSV:PuertoRicoConsultingMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28266&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/srt/2024}StatementGeographicalAxis" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to srt:StatementGeographicalAxis - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28860&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupEMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupEMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28861&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupTotalMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupTotalMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28849&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}MajorCustomersAxis" relationship-target="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" severity="info" cid="2430583881168">[relationships] relationship from srt:MajorCustomersAxis to srt:NameOfMajorCustomerDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28862&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}ConcentrationRiskPercentage1" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:ConcentrationRiskPercentage1 - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28848&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/srt/2024}MajorCustomersAxis" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to srt:MajorCustomersAxis - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28850&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerAMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerAMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28863&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://pharmabioserv.com/20241231}AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to PBSV:AmountDueFromMajorCustomersAsPercentageOfAccountsReceivable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28851&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerBMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerBMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28852&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerCMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerCMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28853&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerDMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerDMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28854&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerEMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerEMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28855&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}MajorCustomerTotalMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:MajorCustomerTotalMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28846&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}RisksAndUncertaintiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StatementTable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:RisksAndUncertaintiesAbstract to us-gaap:StatementTable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28847&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/us-gaap/2024}StatementLineItems" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to us-gaap:StatementLineItems - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28856&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupAMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupAMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28857&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupBMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupBMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28858&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupCMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupCMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28859&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" relationship-target="{http://pharmabioserv.com/20241231}GlobalGroupDMember" severity="info" cid="2430583881168">[relationships] relationship from srt:NameOfMajorCustomerDomain to PBSV:GlobalGroupDMember - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28259&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}MajorCustomersAxis" relationship-target="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" severity="info" cid="2430583881168">[relationships] relationship from srt:MajorCustomersAxis to srt:NameOfMajorCustomerDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28842&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28816&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}IncomeTaxDisclosureAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncomeTaxDisclosureTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:IncomeTaxDisclosureAbstract to us-gaap:IncomeTaxDisclosureTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28752&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPol..." severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28981&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:NetIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28989&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" relationship-target="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to PBSV:DisposalOfMarketableSecurities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28993&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" relationship-target="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap:PaymentsForRepurchaseOfCommonStock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28997&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap:NetCashProvidedByUsedInOperatingActivities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28982&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:GainLossOnDispositionOfAssets - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28990&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" relationship-target="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28994&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" relationship-target="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap:RepaymentsOfLongTermCapitalLeaseObligations - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28998&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" relationship-target="{http://fasb.org/us-gaap/2024}EffectOfExchangeRateOnCashAndCashEquivalents" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28983&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:ShareBasedCompensation - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28991&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" relationship-target="{http://fasb.org/us-gaap/2024}ProceedsFromSaleOfPropertyPlantAndEquipment" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28995&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" relationship-target="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap:PaymentsOfDividends - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28999&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28984&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}DepreciationDepletionAndAmortization" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:DepreciationDepletionAndAmortization - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28992&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" relationship-target="{http://fasb.org/us-gaap/2024}ProceedsFromCollectionOfOtherReceivables" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to us-gaap:ProceedsFromCollectionOfOtherReceivables - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28996&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" relationship-target="{http://fasb.org/us-gaap/2024}ProceedsFromLoans" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap:ProceedsFromLoans - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29000&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28985&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28986&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:IncreaseDecreaseInAccountsReceivable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28987&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:IncreaseDecreaseInOtherOperatingAssets - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28988&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" relationship-target="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOperatingLiabilities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivities to us-gaap:IncreaseDecreaseInOperatingLiabilities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28753&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28840&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://pharmabioserv.com/20241231}AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to PBSV:AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShare - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28841&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28844&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgram" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to PBSV:SharesPurchasedUnderRepurchaseProgram - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28845&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://pharmabioserv.com/20241231}SharesPurchasedUnderRepurchaseProgramValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to PBSV:SharesPurchasedUnderRepurchaseProgramValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28971&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Liabilities" relationship-target="{http://fasb.org/us-gaap/2024}LoansPayable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Liabilities to us-gaap:LoansPayable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28968&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Liabilities" relationship-target="{http://fasb.org/us-gaap/2024}TaxesPayableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Liabilities to us-gaap:TaxesPayableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28977&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquity" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquity to us-gaap:StockholdersEquityBeforeTreasuryStock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28965&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" relationship-target="{http://fasb.org/us-gaap/2024}LoansPayableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesCurrent to us-gaap:LoansPayableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28962&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" relationship-target="{http://fasb.org/us-gaap/2024}AccruedIncomeTaxesCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesCurrent to us-gaap:AccruedIncomeTaxesCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28972&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" relationship-target="{http://fasb.org/us-gaap/2024}PreferredStockValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityBeforeTreasuryStock to us-gaap:PreferredStockValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28976&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" relationship-target="{http://fasb.org/us-gaap/2024}AccumulatedOtherComprehensiveIncomeLossNetOfTax" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityBeforeTreasuryStock to us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28958&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Assets" relationship-target="{http://fasb.org/us-gaap/2024}OtherAssetsNoncurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Assets to us-gaap:OtherAssetsNoncurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28966&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Liabilities" relationship-target="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Liabilities to us-gaap:LiabilitiesCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28970&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Liabilities" relationship-target="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityNoncurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Liabilities to us-gaap:OperatingLeaseLiabilityNoncurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28954&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsCurrent" relationship-target="{http://fasb.org/us-gaap/2024}PrepaidExpenseAndOtherAssets" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsCurrent to us-gaap:PrepaidExpenseAndOtherAssets - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28960&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" relationship-target="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesCurrent to us-gaap:CapitalLeaseObligationsCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28964&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" relationship-target="{http://fasb.org/us-gaap/2024}OperatingLeaseLiabilityCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesCurrent to us-gaap:OperatingLeaseLiabilityCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28980&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquity" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquity" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquity to us-gaap:StockholdersEquity - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28956&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Assets" relationship-target="{http://fasb.org/us-gaap/2024}AssetsCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Assets to us-gaap:AssetsCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28975&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" relationship-target="{http://fasb.org/us-gaap/2024}RetainedEarningsAccumulatedDeficit" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityBeforeTreasuryStock to us-gaap:RetainedEarningsAccumulatedDeficit - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28978&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquity" relationship-target="{http://fasb.org/us-gaap/2024}TreasuryStockValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquity to us-gaap:TreasuryStockValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28952&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsCurrent" relationship-target="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsCurrent to us-gaap:CashAndCashEquivalentsAtCarryingValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28969&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Liabilities" relationship-target="{http://fasb.org/us-gaap/2024}OtherLiabilities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Liabilities to us-gaap:OtherLiabilities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28973&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" relationship-target="{http://fasb.org/us-gaap/2024}CommonStockValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityBeforeTreasuryStock to us-gaap:CommonStockValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28963&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" relationship-target="{http://fasb.org/us-gaap/2024}DividendsPayableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesCurrent to us-gaap:DividendsPayableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28967&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Liabilities" relationship-target="{http://fasb.org/us-gaap/2024}CapitalLeaseObligationsNoncurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Liabilities to us-gaap:CapitalLeaseObligationsNoncurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28959&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Assets" relationship-target="{http://fasb.org/us-gaap/2024}OperatingLeaseRightOfUseAsset" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Assets to us-gaap:OperatingLeaseRightOfUseAsset - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28957&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}Assets" relationship-target="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentNet" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:Assets to us-gaap:PropertyPlantAndEquipmentNet - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28961&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesCurrent" relationship-target="{http://fasb.org/us-gaap/2024}AccountsPayableAndAccruedLiabilitiesCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesCurrent to us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28955&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsCurrent" relationship-target="{http://pharmabioserv.com/20241231}PromissoryNoteReceivableCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsCurrent to PBSV:PromissoryNoteReceivableCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28953&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AssetsCurrent" relationship-target="{http://fasb.org/us-gaap/2024}AccountsReceivableNetCurrent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AssetsCurrent to us-gaap:AccountsReceivableNetCurrent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28974&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityBeforeTreasuryStock" relationship-target="{http://fasb.org/us-gaap/2024}AdditionalPaidInCapitalCommonStock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityBeforeTreasuryStock to us-gaap:AdditionalPaidInCapitalCommonStock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28979&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}LiabilitiesAndStockholdersEquity" relationship-target="{http://fasb.org/us-gaap/2024}Liabilities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:LiabilitiesAndStockholdersEquity to us-gaap:Liabilities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28876&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}SegmentReportingAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ScheduleOfSegmentReportingInformationBySegmentTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:SegmentReportingAbstract to us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28239&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StatementTable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StatementTable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28242&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}StatementGeographicalAxis" relationship-target="{http://fasb.org/srt/2024}SegmentGeographicalDomain" severity="info" cid="2430583881168">[relationships] relationship from srt:StatementGeographicalAxis to srt:SegmentGeographicalDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28241&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}MajorCustomersAxis" relationship-target="{http://fasb.org/srt/2024}NameOfMajorCustomerDomain" severity="info" cid="2430583881168">[relationships] relationship from srt:MajorCustomersAxis to srt:NameOfMajorCustomerDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28837&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfSharesOutstandingBasic" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to us-gaap:WeightedAverageNumberOfSharesOutstandingBasic - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28838&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28839&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://fasb.org/us-gaap/2024}WeightedAverageNumberOfDilutedSharesOutstanding" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28836&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://pharmabioserv.com/20241231}NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to PBSV:NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28912&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfCashFlowsAbstract" relationship-target="{http://pharmabioserv.com/20241231}AccumulatedDepreciationOnPropertyAndEquipmentDisposed" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfCashFlowsAbstract to PBSV:AccumulatedDepreciationOnPropertyAndEquipmentDisposed - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28897&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}RepaymentsOfLongTermCapitalLeaseObligations" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:RepaymentsOfLongTermCapitalLeaseObligations - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28896&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PaymentsForRepurchaseOfCommonStock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:PaymentsForRepurchaseOfCommonStock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28895&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ProceedsFromLoans" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:ProceedsFromLoans - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28894&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfCashFlowsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfCashFlowsAbstract to us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28893&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28892&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ProceedsFromCollectionOfOtherReceivables" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap:ProceedsFromCollectionOfOtherReceivables - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28891&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ProceedsFromSaleOfPropertyPlantAndEquipment" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28890&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PaymentsToAcquirePropertyPlantAndEquipment" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28911&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentDisposals" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap:PropertyPlantAndEquipmentDisposals - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28889&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" relationship-target="{http://pharmabioserv.com/20241231}DisposalOfMarketableSecurities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to PBSV:DisposalOfMarketableSecurities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28910&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" relationship-target="{http://pharmabioserv.com/20241231}ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to PBSV:ObligationsUnderCapitalLeaseIncurredForAcquisitionOfVehicle - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28888&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfCashFlowsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfCashFlowsAbstract to us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28909&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" relationship-target="{http://pharmabioserv.com/20241231}ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to PBSV:ConversionOfCashlessExerciseOfOptionsToSharesOfCommonStock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28887&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:NetCashProvidedByUsedInOperatingActivities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28908&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" relationship-target="{http://pharmabioserv.com/20241231}IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to PBSV:IncomeTaxWithheldByClientsToBeUsedAsCreditInCompanysIncomeTaxReturn - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28886&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOperatingLiabilities" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:IncreaseDecreaseInOperatingLiabilities - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28907&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfCashFlowsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfCashFlowsAbstract to us-gaap:CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28885&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInOtherOperatingAssets" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:IncreaseDecreaseInOtherOperatingAssets - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28906&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}SupplementalCashFlowInformationAbstract" relationship-target="{http://fasb.org/us-gaap/2024}InterestPaidNet" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:SupplementalCashFlowInformationAbstract to us-gaap:InterestPaidNet - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28884&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncreaseDecreaseInAccountsReceivable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:IncreaseDecreaseInAccountsReceivable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28905&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}SupplementalCashFlowInformationAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncomeTaxesPaid" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:SupplementalCashFlowInformationAbstract to us-gaap:IncomeTaxesPaid - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28883&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28904&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfCashFlowsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}SupplementalCashFlowInformationAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfCashFlowsAbstract to us-gaap:SupplementalCashFlowInformationAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28882&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}DepreciationDepletionAndAmortization" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:DepreciationDepletionAndAmortization - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28903&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:CashAndCashEquivalentsAtCarryingValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28881&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ShareBasedCompensation" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:ShareBasedCompensation - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28902&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsAtCarryingValue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:CashAndCashEquivalentsAtCarryingValue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28880&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}GainLossOnDispositionOfAssets" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:GainLossOnDispositionOfAssets - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28901&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPeriodIncreaseDecrease" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28879&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28900&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}EffectOfExchangeRateOnCashAndCashEquivalents" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28878&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivitiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap:NetIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28899&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28877&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfCashFlowsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInOperatingActivitiesAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfCashFlowsAbstract to us-gaap:NetCashProvidedByUsedInOperatingActivitiesAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28898&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PaymentsOfDividends" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap:PaymentsOfDividends - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28757&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}FairValueOfFinancialInstrumentsPolicy" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:FairValueOfFinancialInstrumentsPolicy - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28758&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}RevenueRecognitionPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:RevenueRecognitionPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28759&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}CashAndCashEquivalentsPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:CashAndCashEquivalentsPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28760&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ReceivablesPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:ReceivablesPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28761&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}IncomeTaxPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:IncomeTaxPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28762&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PropertyPlantAndEquipmentPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:PropertyPlantAndEquipmentPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28763&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28764&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ShareBasedCompensationOptionAndIncentivePlansPolicy" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28765&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}EarningsPerSharePolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:EarningsPerSharePolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28766&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28767&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}SubsequentEventsPolicyPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:SubsequentEventsPolicyPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28768&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}PriorPeriodReclassificationAdjustmentDescription" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:PriorPeriodReclassificationAdjustmentDescription - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28769&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NewAccountingPronouncementsPolicyPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28770&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://pharmabioserv.com/20241231}RecentAccountingPronouncementsPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to PBSV:RecentAccountingPronouncementsPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28754&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ConsolidationPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:ConsolidationPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28755&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}SegmentReportingPolicyPolicyTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:SegmentReportingPolicyPolicyTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28756&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}AccountingPoliciesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}UseOfEstimates" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:AccountingPoliciesAbstract to us-gaap:UseOfEstimates - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28240&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementLineItems" relationship-target="{http://fasb.org/us-gaap/2024}StatementTable" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementLineItems to us-gaap:StatementTable - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29006&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}GrossProfit" relationship-target="{http://fasb.org/us-gaap/2024}CostOfRevenue" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:GrossProfit to us-gaap:CostOfRevenue - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29005&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}GrossProfit" relationship-target="{http://fasb.org/us-gaap/2024}Revenues" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:GrossProfit to us-gaap:Revenues - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29008&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetIncomeLoss" relationship-target="{http://fasb.org/us-gaap/2024}IncomeTaxExpenseBenefit" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetIncomeLoss to us-gaap:IncomeTaxExpenseBenefit - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29007&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}NetIncomeLoss" relationship-target="{http://fasb.org/us-gaap/2024}IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:NetIncomeLoss to us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28864&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}RisksAndUncertaintiesAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ConcentrationRiskDisclosureTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:RisksAndUncertaintiesAbstract to us-gaap:ConcentrationRiskDisclosureTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29010&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://xbrl.sec.gov/country/2024}GB" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to country:GB - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29011&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://xbrl.sec.gov/country/2024}US" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to country:US - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__29009&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/srt/2024}SegmentGeographicalDomain" relationship-target="{http://xbrl.sec.gov/country/2024}CA" severity="info" cid="2430583881168">[relationships] relationship from srt:SegmentGeographicalDomain to country:CA - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28865&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}SegmentReportingAbstract" relationship-target="{http://fasb.org/us-gaap/2024}SegmentReportingDisclosureTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:SegmentReportingAbstract to us-gaap:SegmentReportingDisclosureTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28243&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}EquityComponentDomain" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:EquityComponentDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28283&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" relationship-target="{http://fasb.org/us-gaap/2024}EquityComponentDomain" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementEquityComponentsAxis to us-gaap:EquityComponentDomain - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28282&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementTable" relationship-target="{http://fasb.org/us-gaap/2024}StatementEquityComponentsAxis" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementTable to us-gaap:StatementEquityComponentsAxis - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28934&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfOtherComprehensiveIncomeAbstract" relationship-target="{http://fasb.org/us-gaap/2024}NetIncomeLoss" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfOtherComprehensiveIncomeAbstract to us-gaap:NetIncomeLoss - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28939&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" relationship-target="{http://fasb.org/us-gaap/2024}ComprehensiveIncomeNetOfTax" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract to us-gaap:ComprehensiveIncomeNetOfTax - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28936&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributa..." severity="info" cid="2430583881168">[relationships] relationship from us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract to us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28937&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedI..." severity="info" cid="2430583881168">[relationships] relationship from us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract to us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28938&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract to us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28935&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StatementOfOtherComprehensiveIncomeAbstract" relationship-target="{http://fasb.org/us-gaap/2024}OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StatementOfOtherComprehensiveIncomeAbstract to us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28835&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}EarningsPerShareAbstract" relationship-target="{http://fasb.org/us-gaap/2024}EarningsPerShareTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:EarningsPerShareAbstract to us-gaap:EarningsPerShareTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28843&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}StockholdersEquityAbstract" relationship-target="{http://fasb.org/us-gaap/2024}StockholdersEquityNoteDisclosureTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:StockholdersEquityAbstract to us-gaap:StockholdersEquityNoteDisclosureTextBlock - </message></entry>
<entry code="relationships" level="info">
 <message filing_url="http://www.sec.gov/Archives/edgar/data/1304161/000165495420006640/pbsv-20200131.xml" package-name="phmb-20200430_taxonomy" relationship="[2430583880880, &quot;__28771&quot;]" document-uri="phmb-20200430.xsd" document-namespace="http://pharmabioserv.com/20241231" relationship-source="{http://fasb.org/us-gaap/2024}DebtDisclosureAbstract" relationship-target="{http://fasb.org/us-gaap/2024}MarketableSecuritiesTextBlock" severity="info" cid="2430583881168">[relationships] relationship from us-gaap:DebtDisclosureAbstract to us-gaap:MarketableSecuritiesTextBlock - </message></entry>
</log>
